data_2kha_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kha _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.955 0.407 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 94' ' ' GLN . 7.1 p -68.05 138.51 92.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD2' HG13 ' A' ' 85' ' ' VAL . 36.0 Cg_endo -67.41 -172.57 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.421 2.081 . . . . 0.0 112.665 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -111.41 124.4 52.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.408 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -84.44 106.82 16.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 13.3 mttp -93.32 112.65 24.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.359 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 2.0 mp -101.16 164.96 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 112.055 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.6 pt-20 -155.68 143.39 19.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.15 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.458 ' HB2' ' CG ' ' A' ' 104' ' ' PHE . . . -86.91 110.49 20.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 111.322 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 15.8 mm -81.5 145.25 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.321 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t80 -106.33 141.76 23.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.7 Cg_endo -93.14 -0.14 53.49 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.085 -1.214 . . . . 0.0 112.445 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -161.66 94.56 0.96 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -176.04 169.19 41.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.668 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.46 121.73 7.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -115.09 132.89 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 38.3 t -124.42 158.96 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.83 144.89 25.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.86 128.33 12.15 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.497 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 17.0 Cg_endo -58.01 95.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.513 2.142 . . . . 0.0 111.7 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.1 t0 -60.29 160.6 8.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -147.36 46.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.922 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.14 89.0 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.686 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 10.3 m-85 -84.15 -171.21 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.261 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -132.02 -28.33 1.76 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.66 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.4 tp -140.34 132.37 27.86 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.246 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 44.1 t80 -124.59 92.85 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 84' ' ' TYR . . . -86.83 132.08 33.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 52' ' ' TRP . 40.8 t80 -121.52 123.27 41.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.39 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.531 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.06 118.84 27.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -150.91 133.04 4.11 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.253 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -105.92 148.92 27.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.338 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.57 122.18 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.0 t-20 59.34 58.91 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.1 tt0 175.47 109.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 41.8 mt-10 . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.36 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.53 -25.21 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.633 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.29 -110.43 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.426 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -142.49 -80.09 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.735 0.303 . . . . 0.0 110.584 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 17.3 m-90 -61.05 94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.43 83.0 1.94 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.318 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -133.77 133.67 41.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.56 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.43 111.65 24.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG22 ' CZ3' ' A' ' 64' ' ' TRP . 9.7 mt -93.06 152.09 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -119.91 -23.59 6.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.71 121.0 27.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.59 0.233 . . . . 0.0 111.23 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 31.7 Cg_exo -58.66 -164.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.409 2.072 . . . . 0.0 112.086 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -45.65 2.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 179.18 80.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.499 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.88 0.59 34.68 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 8.0 mtm180 -156.99 131.23 8.47 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.389 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.474 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 15.0 m95 -77.09 155.62 32.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.92 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -134.72 118.95 17.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.394 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 49.6 t80 -110.62 89.45 3.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.079 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.93 137.45 32.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.274 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -138.11 100.91 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.591 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 22.44 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.597 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.65 26.79 5.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.315 . . . . 0.0 111.037 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.92 100.1 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -73.78 75.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -86.31 163.47 17.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.791 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -141.65 148.2 38.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.035 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -55.62 142.22 34.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.259 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.5 -32.43 6.26 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.83 151.19 26.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.912 0.387 . . . . 0.0 111.149 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -114.7 154.3 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.517 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.3 mp -109.25 146.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.061 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 97.6 m-85 -144.17 122.34 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.4 p90 -157.8 -174.9 5.08 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -154.77 131.6 10.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.816 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 76.5 p -110.35 151.87 26.91 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.434 ' CE2' HD13 ' A' ' 86' ' ' ILE . 19.9 t80 -135.76 129.43 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.105 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -113.73 164.08 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.375 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.661 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 24.4 mm -137.52 107.28 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.883 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -99.94 57.12 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.5 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 t0 68.95 69.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.771 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.75 25.29 75.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.31 73.72 1.39 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.201 0.524 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.25 161.08 29.92 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.552 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -152.13 146.56 25.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -124.37 150.55 45.41 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.451 ' N ' HG23 ' A' ' 9' ' ' VAL . 10.3 tt0 -106.6 72.27 0.9 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.665 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.3 p-10 -78.47 176.03 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.47 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 61.05 18.23 8.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.62 162.44 54.31 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.87 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 2.8 tt0 -154.39 155.28 34.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.895 0.379 . . . . 0.0 111.111 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.445 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 51.7 t90 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.423 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.4 t -108.52 159.75 16.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 t -121.42 -1.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.795 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.405 ' CG2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -66.82 -9.92 42.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.813 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.45 150.61 52.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CG ' ' HB2' ' A' ' 16' ' ' ALA . 8.9 m-85 -129.45 143.44 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.012 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 0.0 111.094 -179.709 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.97 0.415 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' CG2' ' HD2' ' A' ' 10' ' ' PRO . 7.3 p -72.96 138.77 79.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CG2' ' A' ' 9' ' ' VAL . 41.1 Cg_endo -67.06 -167.89 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.601 2.2 . . . . 0.0 112.455 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -109.47 114.98 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.12 104.87 13.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.8 159.22 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.751 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HB2' ' CD2' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -150.37 150.9 32.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.193 0.521 . . . . 0.0 111.888 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.71 142.78 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.941 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 104' ' ' PHE . . . -86.83 115.73 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.495 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 17.0 mm -88.25 129.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.244 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.493 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 25.2 t80 -93.77 141.5 23.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -94.17 4.52 53.74 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.332 -1.112 . . . . 0.0 112.477 0.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.97 97.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.025 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.495 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.25 176.95 47.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.326 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tp -150.73 138.87 20.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 110.998 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 110.74 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 25' ' ' SER . 24.0 t -119.82 146.58 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.82 151.63 36.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -139.95 130.12 13.97 Favored Pre-proline 0 N--CA 1.467 0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.008 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.98 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.243 1.962 . . . . 0.0 111.567 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 22.5 t0 -61.98 160.7 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.691 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 30.0 t70 -150.46 45.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.757 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.48 92.34 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.336 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CD1' HG21 ' A' ' 85' ' ' VAL . 21.3 m-85 -76.81 -124.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.348 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -179.58 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.69 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.4 tp -140.8 131.21 25.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.703 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 24.1 t80 -120.01 108.34 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.142 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' TYR . . . -111.05 120.59 42.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 18.4 t80 -110.04 128.81 55.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -124.74 124.75 42.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.9 140.03 7.12 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.143 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -112.21 149.18 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 110.468 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 tp -98.09 119.46 36.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.078 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.5 t-20 62.53 57.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.06 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 52.7 tt0 177.24 109.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.35 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 32.3 mt-10 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.634 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.917 0.389 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -60.88 -17.12 48.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 40.74 -131.56 3.06 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -129.8 -68.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 0.0 110.574 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.9 m-90 -77.13 90.87 3.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.992 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.07 88.54 2.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.931 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.2 tpm_? -133.81 127.63 33.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.93 118.86 32.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.04 146.76 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 p -132.77 36.21 3.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 91.4 1.72 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 43.2 Cg_exo -56.91 171.93 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.592 2.195 . . . . 0.0 112.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -109.15 32.84 4.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.792 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 79.46 89.5 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.04 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 73.16 -3.51 29.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.957 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 60' ' ' LYS . 9.1 ttt180 -157.67 127.26 6.0 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.796 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.46 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 13.2 m95 -79.85 157.58 26.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -134.33 118.71 17.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 11.6 t80 -116.57 84.97 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -94.66 146.41 24.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.142 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD1' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -138.0 109.78 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 22.24 2.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -144.03 36.55 1.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.08 126.71 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -79.46 75.86 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.735 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.7 mt -101.23 130.73 47.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.784 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -121.03 153.89 36.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.961 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.459 HD21 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.75 132.01 51.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.283 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -26.55 16.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.504 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -55.43 154.46 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 151.01 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.448 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.2 mp -110.42 147.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 112.162 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 37.6 m-85 -144.31 125.31 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.598 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.1 p90 -160.64 -174.27 4.37 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.495 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.9 p-90 -151.99 134.32 15.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.288 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -99.65 161.28 13.71 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.013 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 10.5 t80 -141.4 138.19 32.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.703 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.24 161.86 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.69 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 33.7 mm -136.79 111.19 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.722 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -105.7 67.93 0.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.26 55.86 2.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.82 28.17 43.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.7 mt -143.84 75.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.215 0.531 . . . . 0.0 110.212 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.08 160.56 40.71 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.376 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 29.3 m-85 -152.26 153.04 32.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -135.74 146.59 47.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.424 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.0 tt0 -104.68 75.42 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.461 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.9 p30 -78.2 175.22 10.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.565 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 60.47 18.54 8.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.61 161.6 52.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.005 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -154.46 145.49 22.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' A' ' 14' ' ' LEU . 42.0 t90 -141.12 165.95 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.079 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.8 t -111.15 162.02 15.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 101' ' ' VAL . 2.8 t -124.37 11.53 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -10.2 59.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.921 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.98 140.99 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.703 0.287 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' A' ' 75' ' ' LEU . 9.8 m-85 -122.15 129.42 52.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.206 0.527 . . . . 0.0 111.239 -179.747 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 CA--C 1.526 0.054 0 CA-C-O 120.813 0.34 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.74 130.4 94.02 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.267 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 24.2 Cg_exo -63.14 -170.25 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.72 2.28 . . . . 0.0 112.587 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -110.87 124.97 53.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.47 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -77.64 104.49 8.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.24 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.54 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.252 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.454 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 5.2 mp -106.18 162.44 13.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.93 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 24.9 mm-40 -152.96 145.3 24.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.945 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB2' ' CD1' ' A' ' 104' ' ' PHE . . . -87.07 120.85 28.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 111.567 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.6 mm -98.19 114.25 35.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.176 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 54.5 t80 -79.21 142.03 58.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 98.9 Cg_endo -96.73 4.99 40.44 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.603 0.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.76 95.63 0.9 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . 169.23 167.19 29.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.555 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -158.27 121.8 3.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.745 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -97.07 134.91 39.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.009 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.01 152.95 30.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.496 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pt -147.37 122.03 5.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.48 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 9.4 Cg_endo -55.24 99.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.105 1.87 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 20.1 t0 -62.68 161.48 12.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.597 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.439 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -145.39 44.69 1.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.671 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.58 42.69 62.7 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.736 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.2 m-85 -88.08 -171.19 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.401 0.62 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' ILE . 37.8 t -132.04 -27.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.697 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 8.0 tp -138.3 134.99 35.0 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.254 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.496 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 18.6 t80 -126.31 90.65 3.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.89 124.65 31.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.659 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 52' ' ' TRP . 78.8 t80 -114.59 117.59 31.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.4 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -122.57 125.46 45.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.65 141.88 8.14 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.927 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.0 148.54 40.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 110.447 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 126.16 45.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.09 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.7 t-20 58.1 53.49 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.1 tt0 176.69 109.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.167 0.508 . . . . 0.0 110.382 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 29.2 mt-10 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.442 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.88 0.371 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -56.33 -20.31 18.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.599 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.52 -130.47 4.93 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.923 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -129.3 -70.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.8 m-90 -72.77 94.06 1.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -118.09 91.98 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.1 tpt85 -139.51 125.58 19.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -86.4 130.35 34.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.36 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.9 mt -110.42 152.97 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.344 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.9 p -144.48 27.78 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.05 87.38 4.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 21.6 Cg_exo -66.02 -170.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.816 2.344 . . . . 0.0 112.445 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -121.95 24.14 9.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.588 178.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 82.49 90.96 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.352 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 76.0 0.76 65.94 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.759 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.83 121.3 4.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.529 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 19.2 m95 -82.95 157.57 22.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 119.7 18.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.57 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 31.9 t80 -122.64 93.76 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 mmm-85 -95.49 143.35 26.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.345 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.13 94.25 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -89.27 22.6 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.597 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -126.67 28.66 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.71 110.79 20.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.01 76.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 mt -86.79 153.28 21.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.9 142.92 47.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.14 132.0 42.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.297 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.98 -28.37 12.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.84 161.77 12.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -121.07 158.4 27.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.465 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 1.3 mp -116.73 145.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.112 0.482 . . . . 0.0 112.176 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 31.1 m-85 -144.3 126.33 15.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.46 -174.18 4.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.416 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 31.9 p-90 -156.7 128.27 7.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.449 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 6.5 p -106.9 152.63 23.66 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.43 ' CZ ' HD12 ' A' ' 86' ' ' ILE . 17.2 t80 -135.9 117.36 14.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -103.99 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.266 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.641 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.3 mm -137.16 109.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.845 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.89 68.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.875 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 63.31 65.53 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.0 27.01 73.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.399 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 mt -144.52 74.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.179 0.514 . . . . 0.0 110.097 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -89.54 162.11 30.28 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.375 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.05 147.71 26.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -126.06 141.23 52.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.26 76.44 2.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.237 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.5 p30 -83.43 179.69 7.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.232 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.0 t30 59.05 18.38 6.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.57 163.24 44.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.078 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.39 158.38 39.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.1 0.476 . . . . 0.0 111.476 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.429 ' CG ' ' N ' ' A' ' 100' ' ' THR . 49.7 t90 -147.66 165.69 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.8 t -107.75 157.44 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -119.69 -4.19 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.638 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.3 m -62.1 -15.97 49.05 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.607 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.93 159.19 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 21.0 m-85 -138.09 129.87 28.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 121.29 0.567 . . . . 0.0 111.956 -179.067 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG2' ' HD2' ' A' ' 10' ' ' PRO . 7.1 p -66.56 138.28 95.53 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD2' HG13 ' A' ' 85' ' ' VAL . 36.6 Cg_endo -66.01 -168.09 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.493 2.129 . . . . 0.0 112.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -109.55 116.99 32.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -80.45 107.9 13.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.401 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -81.86 156.81 24.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.74 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 99' ' ' TRP . 5.1 mp -146.69 149.9 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.45 . . . . 0.0 111.879 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -148.66 142.37 25.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.95 114.51 23.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.123 0.487 . . . . 0.0 111.465 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 24.3 mm -89.68 130.39 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.238 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.1 t80 -92.93 142.27 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 94.6 Cg_endo -92.49 -2.69 50.5 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.484 0.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -163.27 95.52 0.85 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.9 171.16 43.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.282 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.47 132.02 17.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.0 111.25 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.6 ttt180 -117.97 125.8 51.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.391 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t -126.85 152.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.45 145.1 24.23 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.985 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.487 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pp -143.98 117.06 5.77 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.304 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HA ' ' CD ' ' A' ' 63' ' ' ARG . 84.1 Cg_exo -45.11 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.419 2.079 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 43.0 t0 -80.14 143.52 33.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 111.361 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.96 48.88 2.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.608 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.91 38.49 96.11 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.889 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CD1' HG22 ' A' ' 85' ' ' VAL . 22.1 m-85 -68.65 -123.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.282 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 177.32 -35.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.736 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.5 tp -141.12 126.3 18.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.088 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 11.8 t80 -118.67 95.02 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.61 120.14 33.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.0 t80 -105.83 126.91 52.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.266 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.485 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.47 122.29 33.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -159.37 139.38 6.16 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.806 -1.664 . . . . 0.0 114.211 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 146.97 42.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.503 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.0 tp -89.3 133.09 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 44.76 63.08 1.82 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 177.49 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.38 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 50.9 mt-10 . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.383 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.56 -45.25 56.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.51 -122.44 28.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.17 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -137.96 -72.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.904 0.383 . . . . 0.0 110.451 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.444 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 9.1 m-90 -60.76 88.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.946 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.79 94.3 4.4 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.001 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 3.9 tpt85 -146.94 127.83 14.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.971 0.415 . . . . 0.0 112.117 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.22 123.93 35.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.386 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.15 151.47 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.363 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.5 p -141.11 30.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -153.15 92.16 3.3 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.2 Cg_exo -58.25 169.03 3.19 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.562 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.93 33.93 3.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.828 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 81.12 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.161 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.64 -2.74 21.46 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.846 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.409 ' CD ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 tpp180 -157.61 124.2 4.93 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.619 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 12.1 m95 -76.62 154.94 33.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -134.67 120.52 19.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 32.7 t80 -121.41 106.08 11.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -110.17 141.4 43.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -138.09 111.17 7.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -89.37 22.34 2.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.347 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -125.52 36.8 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.82 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 81.23 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' HB3' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -78.97 169.9 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.599 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 145.22 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.411 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -55.22 136.86 48.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.18 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.31 -29.84 9.58 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.275 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.33 152.92 20.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 0.0 111.194 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -115.25 148.89 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.438 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.429 HD11 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -105.31 150.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.056 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.404 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 75.1 m-85 -144.07 128.04 17.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.161 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.9 p90 -161.07 -174.4 4.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.085 0.945 . . . . 0.0 113.361 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.485 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 52.4 p-90 -158.67 135.79 9.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.13 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 32.5 p -99.36 163.03 12.7 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.27 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.432 ' CE1' HD12 ' A' ' 86' ' ' ILE . 14.8 t80 -144.93 105.5 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.8 164.38 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 34.3 mm -141.03 109.65 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.598 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 67.4 0.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.31 65.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 28.53 71.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.43 73.27 1.39 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -83.18 160.64 38.64 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.501 -0.772 . . . . 0.0 114.233 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.24 147.85 26.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 83' ' ' THR . 12.4 ptt-85 -126.28 147.65 49.66 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.529 0.681 . . . . 0.0 112.701 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -106.01 74.07 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.439 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.0 p30 -82.27 176.21 9.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.703 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 60.05 19.76 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.625 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.86 162.15 42.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -154.34 162.7 41.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.963 0.411 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 14' ' ' LEU . 46.9 t90 -155.08 165.82 35.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.166 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.438 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.2 t -105.65 160.88 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 73' ' ' LEU . 21.4 t -121.89 -0.3 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.746 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.411 ' HA ' ' CD2' ' A' ' 75' ' ' LEU . 25.3 p -63.44 -14.06 46.66 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.17 154.55 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.704 0.288 . . . . 0.0 110.879 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 10.1 m-85 -135.54 144.63 46.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 0.0 110.83 179.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.763 0.316 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 92' ' ' TYR . 8.7 p -66.59 131.03 94.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 20.8 Cg_exo -65.47 -177.53 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.356 2.038 . . . . 0.0 111.988 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -107.79 129.73 55.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 111.674 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.45 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -81.0 101.17 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.224 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -83.26 100.63 10.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 3.7 mp -92.96 157.52 16.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.8 mm-40 -148.92 142.23 25.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.227 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.86 110.54 20.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.141 0.496 . . . . 0.0 111.29 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 19.0 mm -83.35 150.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.252 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -114.0 143.83 30.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.737 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 9.9 Cg_endo -89.55 3.5 69.26 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.285 0.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -170.18 98.39 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.501 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -172.42 -176.45 41.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.426 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.07 134.87 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -126.25 119.79 28.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.11 147.75 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.282 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.52 148.82 34.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.477 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -146.61 126.32 6.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.68 116.35 2.31 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.259 1.973 . . . . 0.0 111.681 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -83.06 112.11 19.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 0.0 111.335 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -101.43 43.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.813 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.03 31.84 80.1 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.882 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.444 ' CD2' HG12 ' A' ' 85' ' ' VAL . 95.5 m-85 -61.2 -113.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.799 0.299 . . . . 0.0 110.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . 6.7 t 176.87 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.718 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.4 132.02 28.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.793 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.477 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.0 t80 -122.32 98.0 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.732 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.3 119.03 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' ' CD2' ' A' ' 81' ' ' PHE . 40.1 t80 -106.01 128.36 53.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.589 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.64 122.11 35.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.582 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.98 145.95 12.0 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.863 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 161.6 21.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.456 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.51 118.19 32.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 52.7 t30 57.66 70.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 73.9 tt0 171.33 110.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.375 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 51.4 mt-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.793 0.33 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.589 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.54 -30.91 44.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.642 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.46 -137.44 15.67 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.584 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.1 -74.78 0.6 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.5 m-90 -60.43 90.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.069 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -117.96 85.22 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.868 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -130.63 127.63 39.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.735 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -94.43 110.89 22.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.517 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' ILE . 10.7 mm -92.1 133.75 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.298 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 t -129.79 36.65 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.05 90.35 1.23 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.9 Cg_exo -53.6 170.26 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.74 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 1.2 tmtm? -112.93 42.13 1.94 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.461 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 1.3 mp0 72.77 88.62 0.1 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.489 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.23 -3.47 22.73 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.052 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 7.1 ttt180 -157.84 125.52 5.25 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.847 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 11.9 m95 -76.3 154.7 34.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 m -134.63 120.64 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.505 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 14.7 t80 -120.5 115.7 23.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -111.14 145.1 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.243 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.08 104.34 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 22.49 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.64 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.03 40.72 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.349 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.53 93.11 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -73.95 75.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.691 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mt -97.69 168.01 10.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -142.02 143.82 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 133.2 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.352 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.96 -28.89 11.68 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.216 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.39 162.62 14.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.851 0.358 . . . . 0.0 111.244 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -121.47 158.42 28.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.207 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.3 mp -113.89 149.91 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.173 0.511 . . . . 0.0 112.17 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 m-85 -143.84 125.18 14.68 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -159.5 -175.3 5.11 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.275 1.035 . . . . 0.0 113.721 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.435 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 38.7 p-90 -153.46 133.95 13.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.483 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.94 155.48 17.66 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.163 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 14.1 t80 -135.6 109.66 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 0.0 111.168 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.81 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -102.91 168.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.393 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.718 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 45.7 mm -145.5 104.44 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 O-C-N 123.292 0.37 . . . . 0.0 111.03 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 75.85 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.328 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.25 57.88 1.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.355 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.76 77.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.277 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -143.97 69.58 1.28 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.423 0.63 . . . . 0.0 110.013 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.81 ' HA3' ' O ' ' A' ' 85' ' ' VAL . . . -83.58 -170.42 46.36 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.432 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 91' ' ' GLY . 21.2 m-85 -151.97 171.04 18.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.775 -0.712 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -144.18 143.7 31.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.404 ' HB2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.13 74.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.519 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -77.9 174.21 11.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.37 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 59.56 19.42 7.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.35 162.79 53.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.198 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -154.4 147.46 24.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.432 ' CE2' ' O ' ' A' ' 100' ' ' THR . 54.2 t90 -141.49 165.23 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.366 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.5 t -106.06 156.7 18.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.86 -3.59 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.936 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 m -62.06 -16.1 49.57 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.935 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -125.09 150.75 46.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 7.7 m-85 -132.63 145.54 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 0.0 110.834 179.742 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.817 0.341 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 94' ' ' GLN . 7.3 p -66.65 137.69 95.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.407 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . 43.5 Cg_endo -70.54 -171.01 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.51 2.14 . . . . 0.0 112.89 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -108.27 127.36 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.71 106.88 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.605 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 108.45 21.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 99' ' ' TRP . 3.8 mp -102.7 156.03 17.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 112.154 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.418 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -137.19 140.62 41.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.014 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . . . -86.49 100.87 12.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.176 0.512 . . . . 0.0 111.361 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 12.5 mm -74.73 141.95 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.309 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 26.2 t80 -104.16 141.05 21.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.57 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 77.3 Cg_endo -94.41 2.8 51.43 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.306 -1.122 . . . . 0.0 112.369 0.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.67 96.46 0.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.582 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -177.52 165.87 35.91 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 67' ' ' ARG . 4.8 tp -138.95 143.64 38.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -135.19 101.91 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -100.32 158.53 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -152.68 145.0 23.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.469 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -144.75 126.67 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.788 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 13.2 Cg_endo -56.67 95.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.454 2.103 . . . . 0.0 111.709 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.71 159.69 8.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.1 t0 -146.85 44.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.585 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.61 40.77 85.75 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.529 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 85' ' ' VAL . 9.7 m-85 -82.96 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.374 0.607 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -131.72 -27.53 1.9 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.515 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.69 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 6.7 tp -140.01 132.28 28.24 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.876 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 31.2 t80 -123.68 98.36 5.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.313 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 84' ' ' TYR . . . -91.88 124.85 36.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.7 t80 -116.95 122.69 45.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.352 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.585 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 51' ' ' HIS . . . -160.85 147.36 14.0 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 118.918 -1.611 . . . . 0.0 114.073 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 132.08 53.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.58 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.0 tp -79.82 105.69 11.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.557 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.1 t-20 76.59 65.39 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.6 tt0 171.98 109.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 32.4 mt-10 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.672 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.14 -24.38 10.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.672 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.43 -139.57 1.7 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.636 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 12.6 m170 -122.43 -74.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.163 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.7 m-90 -67.98 88.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.98 86.37 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 ttm180 -135.02 143.85 46.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.982 0.42 . . . . 0.0 111.707 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.76 118.62 37.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.627 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.1 151.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -140.24 42.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.133 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 98.19 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 58.8 Cg_exo -52.08 -176.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.506 2.138 . . . . 0.0 112.228 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -48.51 3.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.157 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.8 80.76 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.537 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . 70.81 2.05 42.86 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.7 mtt180 -156.79 133.43 10.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.711 -0.244 . . . . 0.0 110.597 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.456 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 10.4 m95 -79.77 153.97 28.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.3 m -135.2 120.26 18.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 44.0 t80 -110.55 82.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.521 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -92.3 126.94 37.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.291 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -138.04 111.44 8.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 22.29 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.345 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.59 31.24 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -108.48 127.0 53.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -87.24 75.86 9.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.0 mt -82.5 154.54 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -130.93 144.51 51.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.409 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 0.4 OUTLIER -67.35 131.46 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.386 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -24.69 25.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.622 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.36 159.97 7.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -108.36 164.83 11.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.634 HG13 ' CE3' ' A' ' 99' ' ' TRP . 5.1 mm -125.99 146.17 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 75.4 m-85 -144.44 130.92 19.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.413 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.467 ' CD1' HG22 ' A' ' 79' ' ' ILE . 4.0 p90 -161.57 -176.4 5.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 122.156 0.979 . . . . 0.0 113.607 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.557 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.5 p-90 -153.37 133.28 13.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.477 -1.692 . . . . 0.0 108.293 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 1.8 p -111.95 153.27 27.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.098 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 35' ' ' ALA . 17.5 t80 -136.39 141.02 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.277 0.361 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -128.85 163.25 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.69 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 25.6 mm -137.52 107.23 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.904 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.22 68.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t0 63.62 65.77 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 29.0 71.62 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.533 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.2 75.2 1.45 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.132 0.491 . . . . 0.0 110.146 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.23 159.08 27.21 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.505 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -152.43 150.47 29.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 83' ' ' THR . 18.1 ptt-85 -129.09 149.99 50.67 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.573 0.702 . . . . 0.0 112.87 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.404 ' N ' HG23 ' A' ' 9' ' ' VAL . 5.4 tt0 -105.58 75.22 1.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.768 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -74.92 172.44 12.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.396 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.1 t30 61.57 18.39 9.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.9 165.41 29.84 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.823 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -154.23 149.23 26.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.074 0.464 . . . . 0.0 111.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.634 ' CE3' HG13 ' A' ' 79' ' ' ILE . 28.6 t90 -151.99 164.57 36.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.984 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -114.21 163.05 15.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 1.7 t -129.67 15.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.715 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.6 p -56.29 -24.51 43.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.524 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -142.68 172.78 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CE1' HD21 ' A' ' 75' ' ' LEU . 13.8 m-85 -133.06 150.04 52.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.121 0.486 . . . . 0.0 110.928 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 85' ' ' VAL . 7.6 p -78.78 141.36 59.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' A' ' 27' ' ' PRO . 82.8 Cg_exo -51.66 -169.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.7 2.267 . . . . 0.0 112.291 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 t -107.29 139.73 41.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.236 0.541 . . . . 0.0 112.274 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 25' ' ' SER . . . -84.2 115.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.222 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.72 106.51 13.72 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 4.1 mp -97.98 152.03 19.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.244 0.545 . . . . 0.0 111.994 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -141.9 136.73 30.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.685 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.39 98.88 11.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.152 0.501 . . . . 0.0 111.188 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 27.1 mm -74.52 147.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.455 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -106.48 146.81 33.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.545 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 12.1 Cg_endo -90.59 3.6 67.81 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.159 -1.184 . . . . 0.0 112.353 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.86 79.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 68' ' ' ASP . . . -146.58 -172.12 16.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -154.69 142.62 20.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.12 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.7 99.31 4.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.42 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 18.4 t -116.95 142.2 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -146.15 141.75 27.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.464 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.533 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pp -135.9 120.15 12.97 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.762 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 10' ' ' PRO . 86.2 Cg_exo -46.27 123.09 6.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.115 1.877 . . . . 0.0 112.172 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.2 t0 -79.02 158.88 27.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.191 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -145.37 46.44 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.867 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.41 37.58 86.01 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.478 ' CD1' HG23 ' A' ' 85' ' ' VAL . 14.4 m-85 -82.94 -172.16 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.266 0.555 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ILE . 48.4 t -131.59 -26.47 2.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.799 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.728 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 12.2 tp -146.45 132.95 19.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.334 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.1 t80 -117.99 106.19 12.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 84' ' ' TYR . . . -103.79 118.4 36.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 52' ' ' TRP . 24.2 t80 -106.23 125.84 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -124.95 122.72 38.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.81 137.83 5.84 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 118.853 -1.642 . . . . 0.0 114.252 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -111.53 142.46 43.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.28 125.69 42.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.987 0.422 . . . . 0.0 111.192 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 63.78 50.94 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.9 tt0 176.42 109.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.578 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 44.8 mt-10 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.373 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 1.4 mt-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.475 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -53.35 -26.04 17.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.813 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.32 -117.03 3.45 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.379 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 m80 -140.41 -73.4 0.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.437 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.7 m-90 -60.39 90.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.05 87.29 2.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CB ' ' CE1' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -131.77 118.08 19.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.007 0.432 . . . . 0.0 111.617 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -92.99 106.45 18.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.9 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.42 148.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.614 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 t -140.1 39.34 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.421 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.41 99.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.468 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.1 Cg_exo -51.73 -175.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.438 2.092 . . . . 0.0 112.362 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -116.82 -67.12 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.069 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.47 84.35 1.37 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.747 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.82 -0.73 34.98 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -157.81 160.38 37.71 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.69 0.281 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.468 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 5.7 m95 -94.92 156.2 16.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.855 0.359 . . . . 0.0 110.225 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -134.69 116.24 14.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 54' ' ' ARG . 11.1 t80 -110.94 112.7 24.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.393 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 2.4 t0 -138.06 107.88 6.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -89.21 22.59 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.53 33.09 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.12 105.27 16.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -73.82 75.89 1.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.6 mt -87.25 156.83 19.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.46 134.92 34.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 131.65 49.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.264 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.01 -29.92 9.22 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.05 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.517 ' HB3' HG23 ' A' ' 101' ' ' VAL . 7.3 t70 -69.22 162.45 27.08 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.08 172.5 6.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.988 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.537 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.7 mp -127.85 142.44 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.785 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 47.2 m-85 -144.31 128.18 17.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 3.7 p90 -161.13 -177.56 6.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.474 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 55.8 p-90 -149.12 131.19 15.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.151 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -100.48 155.47 17.82 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.823 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.439 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 8.2 t80 -134.87 148.15 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.763 0.316 . . . . 0.0 111.057 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -137.91 165.31 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.957 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.664 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 16.8 mm -141.4 107.7 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 O-C-N 123.069 0.231 . . . . 0.0 111.025 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.68 62.58 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.446 0.466 . . . . 0.0 110.56 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 t70 69.28 65.72 0.27 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.32 28.21 71.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.83 74.22 1.42 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.01 161.67 45.79 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.403 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -152.18 148.99 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -134.17 143.11 47.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.4 tt0 -102.54 76.52 1.54 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 5.0 p-10 -77.2 -179.06 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.27 16.23 8.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.657 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.41 162.49 49.79 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.004 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -154.42 152.59 30.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 0.0 111.251 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.537 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 26.7 t90 -155.07 164.94 38.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.061 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -108.48 158.57 17.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 77' ' ' ASP . 2.6 t -119.85 -7.11 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.98 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 t -66.04 -8.42 23.12 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -134.34 137.2 43.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.053 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 4.4 m-85 -122.08 154.99 36.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.112 0.482 . . . . 0.0 110.942 179.642 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.46 0.065 0 CA-C-O 120.974 0.416 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.416 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.7 p -68.66 138.41 90.86 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.473 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.0 -178.46 2.45 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.61 2.206 . . . . 0.0 111.893 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -103.71 120.9 41.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.471 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.424 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.0 109.23 16.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -90.05 130.18 36.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.365 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.422 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mp -121.98 154.79 36.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.145 0.498 . . . . 0.0 111.741 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 3.2 mp0 -147.54 144.62 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.111 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB2' ' CG ' ' A' ' 104' ' ' PHE . . . -86.98 130.61 34.39 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.006 0.432 . . . . 0.0 111.4 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.7 mm -109.55 134.55 51.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.306 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -98.26 144.1 27.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.452 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.459 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.4 Cg_endo -90.35 -7.18 45.47 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.423 0.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -159.11 93.08 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.07 165.33 38.66 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.632 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.84 137.03 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.87 121.89 39.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -121.28 151.86 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -155.03 144.88 21.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.497 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.5 127.64 12.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 52.8 Cg_exo -53.96 106.71 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.238 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 36.4 t0 -76.07 144.84 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.002 0.43 . . . . 0.0 111.296 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 1.8 m-20 -132.59 44.95 2.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.954 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.99 53.64 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 12.7 m-85 -82.04 -170.88 3.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.341 0.591 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 1.1 t -130.92 -29.32 1.89 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.449 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.6 tp -140.47 136.01 32.55 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.811 -0.755 . . . . 0.0 112.396 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.497 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 14.3 t80 -123.74 104.16 8.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.371 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.35 126.67 45.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.811 0.339 . . . . 0.0 110.746 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.3 t80 -113.51 124.07 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.433 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.582 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -126.97 115.48 19.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.24 139.09 6.95 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 118.572 -1.775 . . . . 0.0 114.571 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -122.18 126.86 49.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.7 141.32 28.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.71 40.62 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -176.9 109.55 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.4 mt-10 . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.992 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -55.84 -22.91 27.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.9 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.58 -108.98 0.69 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.042 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t-80 -133.9 -73.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.947 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.46 ' O ' ' O ' ' A' ' 36' ' ' PHE . 27.9 m-90 -72.04 92.74 1.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.55 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.189 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.447 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 21.5 tpt180 -149.18 133.23 17.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.884 0.373 . . . . 0.0 111.947 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.75 143.35 26.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.713 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.87 142.82 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.158 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -134.22 30.68 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.77 89.38 4.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 57.2 Cg_exo -51.89 171.85 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.578 2.186 . . . . 0.0 112.576 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.36 34.96 3.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.96 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.95 87.85 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.226 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.1 -5.82 12.47 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.818 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 9.4 mtt-85 -157.48 130.67 7.73 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.299 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.464 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 12.5 m95 -78.13 154.8 30.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.963 0.411 . . . . 0.0 110.02 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 97.1 m -134.76 118.54 17.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.217 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 82.5 t80 -120.81 91.8 3.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 146.19 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -138.04 106.89 5.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.25 22.35 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.651 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -134.65 43.45 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.09 123.24 42.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -73.94 76.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 142.42 30.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 158.78 38.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -68.87 133.37 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.93 -27.99 15.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.46 164.48 3.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.089 0.471 . . . . 0.0 111.084 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.1 153.58 42.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.419 ' CG2' ' CE1' ' A' ' 81' ' ' PHE . 1.4 mp -113.42 143.1 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.987 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.6 m-85 -144.18 125.71 14.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 5.0 p90 -161.09 -174.5 4.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 122.439 1.114 . . . . 0.0 113.939 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.464 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 16.4 p-90 -151.59 129.85 12.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.034 -1.894 . . . . 0.0 108.148 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.86 161.0 13.88 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.783 -178.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CZ ' HD13 ' A' ' 86' ' ' ILE . 18.3 t80 -141.59 137.87 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.622 0.248 . . . . 0.0 110.566 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -130.94 162.42 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.5 mm -135.16 105.79 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.855 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 66.81 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.529 0.518 . . . . 0.0 110.546 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.17 61.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.93 29.01 63.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 mt -143.82 74.16 1.42 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.134 0.492 . . . . 0.0 110.208 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.83 159.68 42.24 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.542 -0.753 . . . . 0.0 114.595 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -152.44 144.14 23.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.613 -0.793 . . . . 0.0 108.985 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -128.5 140.11 51.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.416 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.92 77.49 2.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.556 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 8.9 p-10 -80.8 176.28 9.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.417 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 60.57 18.31 8.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.36 162.02 50.77 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.131 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.42 158.72 40.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CE2' ' O ' ' A' ' 100' ' ' THR . 58.8 t90 -155.1 166.6 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.255 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 4.7 t -109.83 160.09 16.65 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.68 2.12 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -63.77 -13.44 43.95 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -131.33 150.87 51.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.034 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' A' ' 16' ' ' ALA . 9.3 m-85 -131.73 145.21 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.165 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.733 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 9' ' ' VAL . 3.3 p . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 121.379 0.609 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' H ' ' CG2' ' A' ' 8' ' ' VAL . 7.3 p -81.36 137.75 48.57 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.237 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.35 -174.49 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.586 2.191 . . . . 0.0 112.145 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.71 118.63 37.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.378 . . . . 0.0 111.888 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 26' ' ' ILE . . . -76.8 105.68 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.431 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.95 107.23 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.048 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD21 ' CE2' ' A' ' 36' ' ' PHE . 4.9 mp -96.45 159.22 15.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.232 0.539 . . . . 0.0 111.773 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.12 137.24 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.47 102.63 14.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.207 0.527 . . . . 0.0 111.058 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.472 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 25.2 mm -73.1 135.51 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.409 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 57.9 t80 -94.89 141.28 23.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.695 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.3 Cg_endo -92.31 -3.29 49.77 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.432 0.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.84 94.95 0.87 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -168.96 -171.08 34.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.387 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' ' CD1' ' A' ' 52' ' ' TRP . 13.3 tp -156.93 147.7 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.71 106.65 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.0 157.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -155.03 146.72 23.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 111.589 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.549 HG12 ' CE2' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -141.83 130.52 12.12 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.57 101.54 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.184 1.923 . . . . 0.0 111.052 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 22.8 t70 -69.14 149.8 48.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.298 0.57 . . . . 0.0 111.899 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 9.1 t70 -131.35 42.78 3.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.492 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.02 45.82 30.81 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.702 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 12.5 m-85 -87.5 -171.49 3.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.329 0.585 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ILE . 88.6 p -128.64 -29.18 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.498 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 9.0 tp -142.63 140.53 31.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.593 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 26' ' ' ILE . 46.1 t80 -133.23 99.75 4.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.61 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 54' ' ' ARG . . . -98.2 117.82 33.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.547 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.452 ' CE2' HD21 ' A' ' 14' ' ' LEU . 28.0 t80 -104.94 120.16 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.029 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.491 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -116.82 128.77 55.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.414 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -156.19 132.37 3.31 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.05 -1.548 . . . . 0.0 114.161 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -106.65 144.69 32.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.5 tp -98.97 124.79 44.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.016 0.436 . . . . 0.0 111.547 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 t-20 65.11 49.36 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 60.7 tt0 175.81 109.82 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 110.613 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.7 mt-10 . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.766 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 4.7 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -49.16 -36.03 18.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.869 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.76 -112.33 3.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.026 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 66.0 t60 -145.19 -74.2 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.686 0.279 . . . . 0.0 110.919 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.49 ' CD1' ' CD2' ' A' ' 22' ' ' LEU . 7.7 m-90 -63.79 101.07 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.29 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.93 76.63 1.03 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -96.41 114.3 25.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.502 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.43 95.54 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.161 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -104.03 152.89 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.269 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -121.26 -8.53 9.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -135.38 120.09 13.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.484 0.183 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.466 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.6 Cg_exo -58.13 -165.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.456 2.104 . . . . 0.0 112.33 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -119.49 -44.9 2.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.223 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ARG . 1.5 tp10 -178.59 82.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.711 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 -7.18 19.79 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -157.38 149.75 22.84 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.504 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.47 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.8 m95 -88.21 150.83 23.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.89 0.376 . . . . 0.0 110.163 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -135.52 122.06 20.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.547 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 37.4 t80 -109.22 154.02 22.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 118.78 10.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 0.0 111.229 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.444 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.3 t70 -121.34 98.37 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 22.59 2.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.553 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.33 27.99 4.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.42 100.99 10.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -73.79 75.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.041 0.448 . . . . 0.0 110.67 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.401 ' HB3' ' CG1' ' A' ' 101' ' ' VAL . 57.3 mt -91.57 142.15 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -125.55 146.44 49.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.19 144.92 14.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.08 -35.05 4.44 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.244 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.53 ' HB3' HG22 ' A' ' 101' ' ' VAL . 11.1 t0 -62.15 149.54 41.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -108.31 168.28 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 3.0 mp -124.92 145.8 31.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.196 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.8 m-85 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -159.9 -177.53 6.4 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.488 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 57.4 p-90 -153.54 135.05 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.894 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 72.1 p -99.55 166.69 11.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.071 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 15.9 t80 -150.01 108.69 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.667 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.4 m -102.8 169.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.66 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.661 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 28.3 mm -144.53 101.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.537 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -96.16 62.26 2.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 t0 64.35 62.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.84 60.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mt -143.29 71.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.21 0.528 . . . . 0.0 110.157 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -75.84 160.53 51.71 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.333 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -152.19 140.79 20.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' THR . 8.0 ptt180 -121.84 144.59 48.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.443 ' CA ' HG12 ' A' ' 9' ' ' VAL . 12.4 tt0 -105.4 69.62 0.85 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.689 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.2 p30 -78.24 176.14 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.516 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.8 t30 61.42 17.57 8.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.38 164.75 53.59 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.12 152.03 29.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 26.8 t90 -148.63 164.06 35.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.976 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -107.26 159.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 77' ' ' ASP . 13.8 t -118.7 -5.22 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.814 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.4 p -69.12 -5.23 20.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.09 149.1 48.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.451 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 5.7 m-85 -133.83 148.47 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.038 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.262 0.553 . . . . 0.0 110.92 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.9 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.979 0.419 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 94' ' ' GLN . 8.2 p -70.37 138.05 86.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 9' ' ' VAL . 37.9 Cg_endo -67.18 -168.36 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.486 2.124 . . . . 0.0 112.662 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -105.22 117.66 34.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.451 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.92 99.42 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.616 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -82.16 152.26 26.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.586 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 mp -145.24 157.79 43.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.581 . . . . 0.0 112.07 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 8.8 mt-10 -150.03 142.92 24.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.977 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' CG ' ' A' ' 104' ' ' PHE . . . -86.26 101.68 13.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 111.547 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 26.7 mm -71.82 122.94 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.199 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.488 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 34.0 t80 -87.45 141.83 32.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 90.3 Cg_endo -96.27 5.15 42.91 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.512 0.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -164.65 96.69 0.75 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.765 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . 177.07 166.16 33.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.507 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.47 120.76 7.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.715 0.293 . . . . 0.0 110.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -109.88 133.1 53.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.985 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 22.1 t -121.74 155.06 26.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.339 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.408 ' N ' HG11 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.63 147.07 29.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.788 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.485 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pt -146.11 127.49 7.47 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.451 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 22.8 Cg_endo -60.72 96.94 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.456 2.104 . . . . 0.0 111.463 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 24.1 t0 -59.97 154.94 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.632 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.428 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t70 -139.37 43.6 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.571 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.28 41.51 52.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.709 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.5 m-85 -85.24 -170.83 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.375 0.607 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -131.83 -28.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.544 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.675 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 10.1 tp -139.68 135.67 33.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.378 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 29.9 t80 -126.95 103.3 7.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.387 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.36 118.2 36.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.643 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.4 t80 -105.91 128.47 53.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.505 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -119.28 129.37 54.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -147.07 142.37 10.24 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 118.765 -1.683 . . . . 0.0 114.615 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -119.64 124.55 46.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.347 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 tp -81.7 112.99 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.824 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.5 t-20 58.89 65.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.9 tt0 174.28 110.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 38.1 mt-10 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.422 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.25 -25.87 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.796 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.22 -107.9 0.31 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.47 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.2 t60 -138.38 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 15.8 m-90 -65.56 87.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.58 86.36 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -133.41 126.65 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.001 0.429 . . . . 0.0 111.964 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.6 109.55 21.45 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.363 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 56' ' ' ILE . 18.3 mt -93.3 141.01 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -129.58 23.79 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.91 87.61 7.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 53.6 Cg_exo -52.72 171.46 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.613 2.209 . . . . 0.0 112.538 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 63' ' ' ARG . 4.5 tptm -109.97 36.46 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.678 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 4.5 mt-10 76.64 88.99 0.08 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.22 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.6 -3.68 24.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.2 mtp180 -157.29 129.04 7.03 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.444 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 7.9 m95 -81.53 150.28 28.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -135.07 121.92 21.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.442 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 18.0 t80 -110.44 143.89 40.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.427 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -141.76 118.1 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.197 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 16.1 t70 -126.87 101.56 6.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.636 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.21 22.42 2.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.72 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -123.09 28.77 7.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.29 106.9 15.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -73.93 76.94 1.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.806 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -78.89 166.31 22.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.676 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.81 149.16 46.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD23 ' CE1' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -67.66 131.3 45.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.257 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.51 -26.23 16.89 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -58.26 158.73 6.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.229 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.96 14.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.592 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -122.66 150.95 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.296 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 78.1 m-85 -144.4 130.37 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -161.23 -178.45 6.72 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.15 0.976 . . . . 0.0 113.48 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.5 p-90 -155.03 132.35 11.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.91 163.01 12.63 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.417 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 40.9 t80 -144.26 122.39 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.772 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -117.75 163.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.675 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 32.9 mm -136.39 109.27 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.582 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -103.77 74.4 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.034 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 t0 58.05 48.21 13.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.27 30.18 20.3 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.332 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mt -143.94 75.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.157 0.503 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.34 158.95 44.35 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.429 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -152.35 150.1 29.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.63 -0.785 . . . . 0.0 108.932 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.54 147.47 52.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.447 ' N ' HG22 ' A' ' 9' ' ' VAL . 4.1 tt0 -107.37 73.51 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.8 p30 -85.75 -179.88 6.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.523 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 t30 61.07 18.21 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.518 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.18 163.14 42.95 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.27 128.82 9.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 100' ' ' THR . 47.5 t90 -120.1 170.18 9.53 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 3.7 t -110.62 160.95 16.21 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.71 15.17 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.667 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.443 ' HA ' HD13 ' A' ' 75' ' ' LEU . 26.8 p -58.79 -24.55 61.99 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.892 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -137.31 161.33 36.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.856 0.36 . . . . 0.0 111.177 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.444 ' CE1' HD23 ' A' ' 75' ' ' LEU . 9.5 m-85 -130.18 145.86 51.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.796 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.093 0.473 . . . . 0.0 110.502 179.438 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.421 HG12 ' CA ' ' A' ' 94' ' ' GLN . 7.6 p -68.63 135.32 90.41 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.499 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 16.5 Cg_exo -66.68 -173.6 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.618 2.212 . . . . 0.0 112.236 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.26 125.24 51.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -85.37 106.23 16.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.958 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 ttmt -92.32 119.84 32.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.621 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 5.1 mp -108.14 158.72 17.18 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.521 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -146.12 140.63 26.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.116 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CH2' ' A' ' 99' ' ' TRP . . . -86.34 120.27 27.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.305 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 19.8 mm -92.62 130.72 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.342 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -92.14 142.49 26.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.614 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.2 Cg_endo -93.23 -0.96 51.59 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.386 0.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.59 94.93 0.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.473 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.86 173.11 46.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.476 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.29 130.01 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 111.07 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.26 115.5 23.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.719 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 5.3 t -110.86 161.5 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -152.68 143.58 22.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.046 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.59 124.06 10.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.479 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 10.8 Cg_endo -56.61 99.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.058 1.838 . . . . 0.0 111.359 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.1 t0 -65.51 160.07 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.809 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 4.1 t0 -143.23 43.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.96 42.68 68.19 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.808 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CD1' HG22 ' A' ' 85' ' ' VAL . 12.2 m-85 -84.2 -170.53 3.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.282 0.563 . . . . 0.0 111.114 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -131.97 -28.01 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.645 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 9.6 tp -140.27 134.91 31.7 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.189 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 47.8 t80 -127.4 90.3 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.67 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.1 125.4 32.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 14.2 t80 -115.04 124.02 50.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.345 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.544 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.08 122.31 36.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.06 147.01 15.07 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.972 -1.585 . . . . 0.0 114.112 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.79 155.36 39.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.444 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -92.72 115.23 27.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER 59.88 71.9 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 74.2 tt0 174.31 110.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 31.4 mt-10 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.135 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.81 -26.37 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.664 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.79 -160.2 0.12 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.635 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -100.6 -74.22 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 110.696 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 14.7 m-90 -63.49 91.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -118.15 91.28 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.255 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.468 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.8 tmm_? -145.85 125.34 13.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.679 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.72 128.25 35.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.853 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.99 159.51 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.842 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t -148.39 39.98 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 111.23 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -175.77 96.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 74.4 Cg_exo -49.75 179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.403 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -106.55 -58.43 1.93 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.194 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 82.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.382 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . 74.09 -2.42 43.49 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 33.6 mtt85 -156.66 147.25 21.59 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.354 0.261 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.45 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 9.9 m95 -83.91 159.11 21.37 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.64 118.02 16.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.409 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 36' ' ' PHE . 8.3 t80 -99.8 94.59 6.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.313 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -93.34 124.93 37.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.378 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.6 t70 -138.12 97.57 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.25 22.36 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -133.87 44.15 2.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.74 115.64 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.068 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.96 76.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mt -82.81 164.98 20.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -141.68 150.53 42.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.979 0.419 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.58 132.89 46.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.304 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.61 -26.4 16.24 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.5 165.95 3.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.66 163.32 16.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.383 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -117.6 148.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 3.9 m-85 -144.33 129.71 18.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.0 p90 -161.1 -175.51 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 122.0 0.905 . . . . 0.0 113.2 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.472 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 32.2 p-90 -157.03 124.65 5.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.859 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.6 p -107.2 151.26 25.66 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.981 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 86' ' ' ILE . 24.4 t80 -133.81 124.58 26.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.229 0.331 . . . . 0.0 111.043 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -108.28 163.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.65 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 22.4 mm -136.91 114.31 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.911 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 70.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.4 t0 66.45 62.38 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.2 28.64 72.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.637 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mt -145.06 77.91 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.171 0.51 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -93.17 161.87 25.67 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.627 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -152.13 147.51 26.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -122.97 151.62 41.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' CA ' HG12 ' A' ' 9' ' ' VAL . 4.2 tt0 -106.49 73.98 0.99 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.504 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.472 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.6 p30 -84.96 179.59 7.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.442 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 58.55 19.53 6.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.916 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.85 163.46 33.47 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.279 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.27 161.58 41.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.521 ' CZ2' ' HA ' ' A' ' 15' ' ' GLU . 54.8 t90 -146.43 169.06 19.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.526 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' CZ3' ' A' ' 99' ' ' TRP . 5.1 t -105.22 154.81 19.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.25 17.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.295 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -70.49 -10.71 59.89 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -127.29 162.73 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 75' ' ' LEU . 6.3 m-85 -135.29 123.53 23.08 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 110.852 -179.457 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.46 0.044 0 CA-C-O 120.932 0.396 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 94' ' ' GLN . 12.5 p -66.39 132.15 94.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.492 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.492 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.6 Cg_exo -64.19 -177.13 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.549 2.166 . . . . 0.0 111.933 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.6 122.69 47.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -81.14 109.79 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -95.3 102.35 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.162 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 2.1 mp -90.29 162.65 15.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.102 0.477 . . . . 0.0 111.935 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HB3' HG13 ' A' ' 105' ' ' VAL . 37.9 mt-10 -146.58 140.28 25.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.09 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . . . -86.73 110.62 20.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.995 0.426 . . . . 0.0 111.448 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.519 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 16.9 mm -83.41 159.73 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.486 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 8.8 t80 -122.57 140.82 33.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.597 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 8.8 Cg_endo -88.96 1.78 68.97 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.4 -1.083 . . . . 0.0 112.419 0.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.8 98.21 0.3 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.929 0.395 . . . . 0.0 111.008 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -166.59 -173.13 34.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.437 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 52' ' ' TRP . 6.7 tp -155.81 137.61 14.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.63 106.72 7.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.37 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -114.26 155.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.416 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.86 145.01 25.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.643 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -138.21 127.02 14.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.6 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.4 Cg_endo -58.4 93.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.344 2.029 . . . . 0.0 111.706 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.442 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.6 t0 -58.6 160.82 5.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.628 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 6.0 t0 -145.62 44.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.39 44.06 60.13 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.961 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.2 m-85 -88.28 -170.88 3.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.465 0.65 . . . . 0.0 111.22 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -131.69 -28.94 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.476 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 8.7 tp -138.38 135.3 35.19 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.163 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 37.1 t80 -125.44 98.58 5.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.028 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.88 126.22 37.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 111.062 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 52' ' ' TRP . 25.3 t80 -115.86 123.05 47.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -127.07 120.64 29.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.83 135.23 4.93 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 118.587 -1.768 . . . . 0.0 114.792 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -105.89 147.75 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.126 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.1 tp -97.19 125.26 41.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.279 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 56.8 57.72 4.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 76.5 tt0 174.64 109.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.14 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 60.7 mt-10 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 0.0 111.783 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.4 -25.65 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.9 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.71 -117.71 3.14 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.454 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' GLY . 1.1 t60 -137.48 -73.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.768 0.318 . . . . 0.0 110.555 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.8 m-90 -69.98 90.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.32 90.16 3.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.135 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.19 130.17 18.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 112.035 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.26 123.6 34.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.554 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -102.46 143.32 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.234 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -134.31 34.57 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.27 91.87 1.69 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 48.4 Cg_exo -55.88 170.03 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.57 2.18 . . . . 0.0 112.451 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.73 34.49 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.929 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 80.81 87.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.38 -1.75 25.37 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.735 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HG2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -157.14 125.3 5.55 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.393 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.46 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 18.4 m95 -77.48 156.6 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.2 m -134.59 118.93 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.41 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 54.0 t80 -111.24 93.13 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.6 139.7 30.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.1 t70 -138.02 106.12 5.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.23 22.43 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.667 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -135.31 31.78 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.99 108.71 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.01 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -73.71 83.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.5 mt -86.08 115.48 23.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.016 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.87 131.43 52.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.02 133.57 32.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.432 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.94 -29.71 11.61 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 101' ' ' VAL . 30.9 t0 -65.85 160.9 22.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -119.37 160.23 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.2 mp -114.75 146.79 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.786 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 33.7 m-85 -144.23 125.05 14.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.598 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.8 p90 -161.08 -174.29 4.29 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.208 1.004 . . . . 0.0 113.404 -178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -151.01 127.43 10.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.378 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 24.4 p -107.07 149.7 27.32 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.461 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.429 ' CE2' HD13 ' A' ' 86' ' ' ILE . 17.4 t80 -131.51 146.4 52.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.306 0.379 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.55 162.52 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.103 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.634 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 31.1 mm -134.52 117.13 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.813 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -114.6 65.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t0 66.87 64.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.39 71.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.407 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.1 mt -144.96 77.9 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.233 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.81 161.25 28.11 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.47 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -152.18 139.7 19.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -123.3 145.07 49.0 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.434 ' N ' HG22 ' A' ' 9' ' ' VAL . 28.1 tt0 -100.35 75.74 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.923 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.8 p-10 -79.97 176.5 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.06 19.65 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.809 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.07 165.81 52.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.264 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.15 161.09 42.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.962 0.411 . . . . 0.0 111.225 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.447 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 55.7 t90 -155.21 166.25 34.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 5.6 t -107.03 158.01 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 77' ' ' ASP . 3.8 t -122.33 -3.26 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.099 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -62.02 -16.08 49.07 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.28 161.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.628 0.251 . . . . 0.0 110.574 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 16' ' ' ALA . 45.5 m-85 -137.99 138.01 38.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 15' ' ' GLU . 3.2 m . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.298 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.943 0.402 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 94' ' ' GLN . 7.5 p -70.36 137.93 86.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD2' HG12 ' A' ' 85' ' ' VAL . 26.0 Cg_endo -63.64 -174.71 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.428 2.085 . . . . 0.0 112.554 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -110.1 116.48 31.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.546 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -73.38 99.58 2.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -87.45 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.991 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 4.0 mp -105.7 163.84 12.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.268 0.556 . . . . 0.0 112.16 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -151.06 140.27 21.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.893 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 104' ' ' PHE . . . -86.64 119.14 26.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.374 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.511 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.5 mm -93.42 152.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -116.44 149.18 43.26 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 3.2 Cg_exo -81.06 -6.99 44.27 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.221 0.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -168.36 93.46 0.35 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 111.0 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.511 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -158.47 -167.92 19.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.366 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 tp -158.19 148.3 20.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.082 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.19 104.79 4.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.647 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 17.2 t -113.28 159.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 111.476 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.08 145.01 21.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -142.35 115.9 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.953 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 85.0 Cg_exo -47.13 105.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.166 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 32.4 t0 -71.51 148.9 46.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.205 0.526 . . . . 0.0 111.21 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.2 t0 -134.72 45.34 2.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.488 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.67 36.98 76.55 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.282 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.5 m-85 -78.14 -172.19 2.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 86' ' ' ILE . 95.7 p -133.08 -26.91 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.771 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.8 tp -140.57 128.12 21.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.386 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 13.6 t80 -120.6 93.78 4.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.936 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.82 120.35 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.975 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 52' ' ' TRP . 37.9 t80 -106.18 130.36 54.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.465 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.98 116.41 20.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -155.61 139.79 6.87 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.551 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' A' ' 51' ' ' HIS . 9.6 tptp -117.04 145.56 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.6 tp -93.43 122.6 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 111.146 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.8 t-20 57.25 66.46 1.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 42.8 tt0 170.27 111.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.435 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 19.1 mm-40 . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.735 0.303 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -44.85 -40.18 5.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.6 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.32 176.23 0.07 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 53' ' ' ALA . 6.3 m-70 -79.84 -78.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.534 0.207 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.2 m-90 -57.21 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.49 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 51' ' ' HIS . . . -118.5 90.09 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.252 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 4.4 ttp180 -149.12 133.21 17.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 111.955 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -91.04 136.56 32.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.8 148.62 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 111.193 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.1 p -137.84 22.55 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -146.79 88.49 5.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 56.0 Cg_exo -52.17 171.44 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.587 2.191 . . . . 0.0 112.641 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.72 39.8 1.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.657 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 74.01 89.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.432 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.71 -5.26 17.77 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.5 mtp180 -157.56 132.69 8.83 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.621 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.472 ' CZ2' ' HG3' ' A' ' 59' ' ' PRO . 12.3 m95 -81.81 156.45 24.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -134.62 119.38 18.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.393 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 3.1 t80 -112.86 89.62 3.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.508 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.25 148.99 25.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -138.1 115.56 11.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.771 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.1 22.01 2.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -145.32 27.02 1.28 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.31 30.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.1 76.03 10.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mt -103.31 132.3 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.567 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -122.76 152.68 40.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -54.16 131.82 41.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.297 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 75' ' ' LEU . . . 93.72 -27.0 13.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 9.9 t70 -57.8 149.79 21.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.981 0.419 . . . . 0.0 111.097 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 149.8 32.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.488 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.494 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.1 mp -109.22 148.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.207 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.408 ' N ' HG22 ' A' ' 79' ' ' ILE . 83.6 m-85 -144.45 125.39 14.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.494 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 2.7 p90 -161.2 -174.35 4.29 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 51.2 p-90 -157.97 134.33 9.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.153 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 24.6 p -99.74 161.99 13.27 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.118 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 86' ' ' ILE . 23.8 t80 -144.18 106.05 4.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.645 0.259 . . . . 0.0 110.871 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.739 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.54 164.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.372 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.638 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 23.9 mm -140.58 106.62 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.875 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.5 74.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.661 0.601 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 57.61 62.28 2.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.74 31.37 62.61 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.217 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 mt -142.59 70.36 1.32 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.21 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -77.68 157.84 46.18 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 114.361 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.42 143.86 23.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -126.51 146.29 50.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 3.0 tt0 -105.38 73.82 1.05 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.232 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 19.0 p-10 -85.14 176.78 8.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.72 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 60.05 19.97 9.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.455 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.95 162.87 41.23 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.077 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -154.29 138.97 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.947 0.404 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 31.6 t90 -129.67 166.17 20.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.048 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.9 t -111.58 162.69 14.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 79' ' ' ILE . 11.7 t -123.83 5.4 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.401 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -62.01 -16.97 55.57 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.349 -0.387 . . . . 0.0 112.008 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -136.7 157.31 47.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.342 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 16.3 m-85 -135.83 145.57 46.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.037 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 179.764 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.228 -0.075 0 CA-C-O 121.093 0.473 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 94' ' ' GLN . 2.7 p -66.95 145.82 98.98 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.072 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.2 Cg_exo -65.22 -166.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.605 2.203 . . . . 0.0 111.995 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.53 123.65 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -88.0 111.67 21.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.717 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 tptt -81.99 156.88 24.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.686 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 81' ' ' PHE . 4.9 mp -147.4 143.9 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.981 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -142.1 144.7 33.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.959 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 104' ' ' PHE . . . -87.13 110.03 19.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 28.7 mm -80.6 127.61 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.333 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -89.73 143.01 29.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 60.7 Cg_endo -93.28 2.68 57.12 Favored 'Cis proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.444 0.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -167.55 96.64 0.47 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.469 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.54 -178.2 45.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.433 HD21 ' CD1' ' A' ' 52' ' ' TRP . 5.4 tp -156.09 138.41 14.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 110.972 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 120.59 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.477 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 42.8 t -123.59 150.44 27.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.553 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -153.16 144.49 23.19 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.474 ' CD1' ' CD1' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -137.54 125.84 14.49 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.542 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.2 Cg_endo -64.49 89.55 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.012 1.808 . . . . 0.0 111.414 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 16.5 t0 -50.87 160.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.332 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 36.0 t0 -140.05 41.5 1.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.46 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.96 49.5 7.6 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.088 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CD1' HG23 ' A' ' 85' ' ' VAL . 7.7 m-85 -94.41 -173.58 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.473 0.654 . . . . 0.0 111.169 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 86' ' ' ILE . 12.6 m -127.66 -29.98 2.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.105 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.1 tp -141.36 141.74 33.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.728 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 83' ' ' THR . 51.6 t80 -128.13 103.32 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.299 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.87 121.6 38.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 52' ' ' TRP . 18.8 t80 -112.17 123.04 49.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.524 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.59 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -123.71 122.67 38.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -152.24 136.51 5.46 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 118.836 -1.649 . . . . 0.0 114.463 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 127.12 46.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.42 HD21 ' CH2' ' A' ' 52' ' ' TRP . 0.8 OUTLIER -89.98 140.75 29.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.873 0.368 . . . . 0.0 110.937 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.56 6.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.786 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -179.9 109.05 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.193 0.521 . . . . 0.0 110.445 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.3 mt-10 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.596 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.748 0.309 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -52.84 -24.89 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.67 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.56 -130.83 11.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.541 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -127.95 -77.4 0.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.81 0.338 . . . . 0.0 110.531 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.433 ' CD1' HD21 ' A' ' 22' ' ' LEU . 28.9 m-90 -62.85 94.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.206 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.5 87.88 2.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.9 tpm_? -136.81 127.68 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.953 0.406 . . . . 0.0 112.029 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.87 107.01 18.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.458 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mp -89.04 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.444 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 t -129.58 28.23 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.28 88.07 4.8 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 51.4 Cg_exo -54.99 170.46 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.3 tpmp? -108.41 31.34 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.698 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 81.42 93.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.678 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.31 -6.8 7.04 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 60' ' ' LYS . 11.6 ptt180 -157.53 134.95 10.44 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.893 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.495 ' CD1' ' HB2' ' A' ' 28' ' ' ASP . 6.1 m95 -85.23 154.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -134.6 100.06 4.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.557 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 39.9 t80 -95.88 143.13 27.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.919 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -144.87 145.03 31.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.406 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 47.5 t0 -138.03 100.19 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.476 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -89.17 22.44 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.683 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -138.67 32.52 2.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 0.0 110.811 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.425 ' HB1' ' CZ2' ' A' ' 52' ' ' TRP . . . -104.43 129.56 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.21 83.25 6.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.73 121.33 42.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.68 145.93 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 133.4 56.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.968 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.72 -28.85 14.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.045 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.77 163.25 7.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -122.49 156.75 33.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.493 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 1.2 mp -113.05 145.83 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.207 0.527 . . . . 0.0 112.125 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 15.9 m-85 -144.32 120.35 10.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -152.51 -176.27 5.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.203 1.001 . . . . 0.0 113.674 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 60.1 p-90 -152.38 125.29 8.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.318 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 45.1 p -100.0 149.0 23.9 Favored 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.793 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HD13 ' A' ' 86' ' ' ILE . 9.0 t80 -127.26 157.13 40.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 123.334 0.396 . . . . 0.0 110.849 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.628 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 20.8 mm -138.53 106.29 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.808 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -104.01 62.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.544 0.527 . . . . 0.0 110.72 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 t0 71.71 65.4 0.15 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.78 71.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.579 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mt -144.35 77.71 1.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.267 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -84.35 158.63 34.47 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.562 -0.745 . . . . 0.0 114.568 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -152.54 148.79 27.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.169 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.98 152.4 51.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.512 ' N ' HG13 ' A' ' 9' ' ' VAL . 3.2 tt0 -107.6 76.3 1.06 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.449 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.3 p30 -77.96 178.29 7.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.334 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 63.18 15.04 8.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.2 162.39 54.66 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.978 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.4 157.63 38.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.641 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.432 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 40.3 t90 -155.17 164.41 38.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.061 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.7 t -105.57 158.91 16.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 79' ' ' ILE . 10.3 t -120.33 -4.35 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.047 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.6 t -66.49 -8.59 27.36 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.24 139.37 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.426 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 82.9 m-85 -130.42 131.62 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 0.0 110.835 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.99 0.424 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.81 127.36 93.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.29 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.41 -178.64 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.477 2.118 . . . . 0.0 112.212 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.3 135.19 47.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.267 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.406 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -88.63 111.05 21.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.842 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -92.18 94.14 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 99' ' ' TRP . 1.8 mp -83.83 163.2 20.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 0.0 112.315 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -150.71 138.86 20.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.526 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.39 114.89 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.242 0.544 . . . . 0.0 111.683 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 20.1 mm -96.45 108.65 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -78.92 150.78 75.65 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.01 2.58 69.66 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.962 -1.266 . . . . 0.0 112.282 0.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.59 93.18 0.26 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -171.07 175.25 44.78 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.447 HD21 ' CD1' ' A' ' 52' ' ' TRP . 7.7 tp -150.14 138.87 20.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 110.828 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 -137.11 107.31 6.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.724 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 21.1 t -116.95 155.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.409 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -143.12 144.01 32.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.679 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -136.74 128.07 16.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.394 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.92 102.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.346 2.031 . . . . 0.0 111.785 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.76 151.44 47.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.403 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -139.91 45.95 1.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.717 179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.31 92.58 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 29' ' ' ASP . 14.1 m-85 -78.48 -171.52 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.368 0.604 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 86' ' ' ILE . 40.4 m -131.8 -27.16 1.91 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.3 tp -143.36 132.19 22.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.627 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.47 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 39.0 t80 -122.32 101.64 7.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.906 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.44 126.73 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 10.6 t80 -112.72 130.49 56.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.1 119.13 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.75 139.32 6.64 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 118.586 -1.768 . . . . 0.0 114.676 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.25 142.93 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.233 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.4 tp -96.01 143.04 27.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 p30 44.36 48.98 8.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.363 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 179.44 109.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 110.398 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.49 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 56.0 mt-10 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.639 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.825 0.345 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.533 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -54.48 -24.34 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.745 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.53 -115.58 1.93 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.544 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' GLY . 6.3 t-160 -137.61 -72.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 9.6 m-90 -68.38 88.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.34 88.99 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.486 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 39.7 ttt-85 -146.94 130.37 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.632 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.11 136.49 34.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mt -111.81 157.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.2 t -144.54 41.96 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.41 102.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.1 Cg_exo -54.27 -169.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.427 2.085 . . . . 0.0 112.366 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -119.03 -53.55 2.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.1 83.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.563 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.79 -2.17 34.3 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -156.92 145.64 19.91 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.769 -0.215 . . . . 0.0 110.473 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.457 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 10.7 m95 -81.97 161.94 22.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -134.11 116.95 16.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.48 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 24.2 t80 -99.94 84.12 2.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.353 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.96 124.92 36.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.46 110.13 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.755 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 22.15 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.439 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -135.18 40.22 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.89 111.57 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.207 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -73.96 75.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.92 134.03 39.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.22 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.04 141.45 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 132.22 34.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.68 -27.77 18.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.38 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -62.18 151.24 36.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.815 0.341 . . . . 0.0 111.104 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -110.93 152.95 26.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.84 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.552 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -112.21 145.34 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.561 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.49 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.5 m-85 -144.59 124.92 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.5 p90 -161.22 -173.83 4.04 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.49 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 63.5 p-90 -153.44 128.24 9.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.662 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 23.0 p -106.82 148.96 27.89 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.754 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 93' ' ' ARG . 5.1 t80 -129.61 145.0 51.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.365 0.415 . . . . 0.0 111.063 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -131.18 160.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.373 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.672 ' O ' ' N ' ' A' ' 32' ' ' SER . 37.8 mm -129.63 117.58 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.594 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 55.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 t0 71.87 67.19 0.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.34 23.37 77.47 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.371 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 mt -145.89 79.15 1.55 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -97.61 165.93 22.58 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.48 -0.782 . . . . 0.0 114.399 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -152.05 150.87 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 83' ' ' THR . 13.2 ptt-85 -128.88 145.37 51.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -99.5 77.63 2.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.808 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.49 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.1 p30 -81.77 178.74 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 59.54 19.1 7.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.63 166.4 53.27 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.102 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.11 156.59 37.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.552 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 29.6 t90 -154.67 165.45 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -110.82 161.97 15.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 79' ' ' ILE . 21.3 t -120.44 -3.13 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.805 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.0 m -62.26 -14.34 37.6 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.885 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -131.49 148.54 52.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 4.8 m-85 -130.41 161.42 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 111.051 179.541 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 ' N ' ' A' ' 93' ' ' ARG . 13.2 t -66.08 129.78 94.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.993 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD2' HG11 ' A' ' 9' ' ' VAL . 27.6 Cg_endo -63.32 -171.13 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.354 2.036 . . . . 0.0 111.974 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -114.61 113.57 24.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -88.17 106.39 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.526 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -90.77 163.7 14.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.124 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.406 HD13 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -147.91 159.76 43.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.976 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -148.92 141.43 24.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.095 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . . . -87.07 104.44 16.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.968 0.413 . . . . 0.0 111.512 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.497 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 42.8 mm -72.19 146.36 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.439 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -105.08 142.22 24.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.739 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 97.7 Cg_endo -89.47 -7.79 46.05 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.848 -1.314 . . . . 0.0 112.222 -0.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 94.13 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.497 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -160.72 -165.85 18.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.492 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 tp -155.54 145.73 21.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.33 96.34 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.84 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 45.8 t -107.38 151.45 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -153.58 144.32 22.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.926 0.393 . . . . 0.0 111.612 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' CG2' ' HA ' ' A' ' 12' ' ' ALA . 1.5 pp -137.25 131.75 17.72 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.597 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 104.75 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.148 1.899 . . . . 0.0 111.477 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.3 t0 -70.53 157.99 36.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.367 0.603 . . . . 0.0 111.737 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 2.8 m-20 -146.97 42.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.329 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 45.43 9.49 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.744 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 5.9 m-85 -86.05 -173.29 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.447 0.641 . . . . 0.0 111.102 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -133.59 -26.54 1.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.684 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.753 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.4 tp -142.05 129.49 21.28 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.234 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.461 ' HB3' ' CE3' ' A' ' 64' ' ' TRP . 6.0 t80 -120.58 91.34 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.173 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.63 132.82 35.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TRP . 38.8 t80 -116.94 126.5 53.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.982 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.584 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -128.24 117.91 22.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.26 138.4 6.55 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.737 -1.697 . . . . 0.0 114.631 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.4 OUTLIER -109.78 147.17 33.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.202 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -99.46 127.52 45.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 t30 57.45 54.81 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 175.55 109.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.244 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 35.3 mt-10 . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.365 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 5.7 mm-40 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.9 0.381 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -55.37 -22.05 17.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.085 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.51 4.39 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.245 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -131.64 -79.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.661 0.267 . . . . 0.0 110.347 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 36' ' ' PHE . 13.2 m-90 -61.53 91.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.64 88.65 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.168 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -143.57 124.07 13.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.025 0.44 . . . . 0.0 111.861 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.8 128.67 35.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.663 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 34' ' ' PHE . 11.2 mt -103.65 154.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 45.06 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.009 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.5 93.18 0.25 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.5 Cg_exo -52.06 -176.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.462 2.108 . . . . 0.0 112.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -113.95 -44.86 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.233 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.02 84.37 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.651 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.97 -2.8 32.17 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.424 -0.894 . . . . 0.0 110.923 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -157.11 148.51 22.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.461 ' CE3' ' HB3' ' A' ' 34' ' ' PHE . 5.1 m95 -90.12 157.28 17.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -134.64 114.73 13.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 32.6 t80 -107.41 89.37 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -94.69 144.87 25.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.099 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -138.0 108.44 6.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.582 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.18 22.39 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.522 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -141.26 28.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 115.66 27.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -73.91 75.97 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.629 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.75 142.12 29.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 142.27 49.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.782 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 1.4 tt -56.85 130.2 44.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.01 -28.39 14.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.133 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' HB3' HG23 ' A' ' 101' ' ' VAL . 8.9 t70 -66.56 153.09 43.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.95 0.405 . . . . 0.0 110.877 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.68 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.1 mp -114.83 144.58 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.861 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.0 m-85 -144.53 121.28 11.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.3 p90 -158.5 -172.37 3.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.13 0.967 . . . . 0.0 113.572 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.6 p-90 -155.54 134.25 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.979 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 17.8 p -99.92 165.45 11.55 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.721 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 86' ' ' ILE . 14.2 t80 -147.08 108.13 4.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.66 164.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 32' ' ' SER . 12.1 mm -145.23 106.84 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' CG ' ' HB2' ' A' ' 90' ' ' LEU . 11.9 ptmt -99.63 46.43 0.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 13.7 t0 81.1 77.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.474 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 21.51 75.48 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.265 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.421 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . 6.3 mt -145.64 79.37 1.57 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.332 0.586 . . . . 0.0 110.274 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.04 161.71 41.92 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.325 -0.852 . . . . 0.0 114.44 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.48 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 49.3 m-85 -144.8 134.38 23.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.569 ' N ' HG21 ' A' ' 9' ' ' VAL . 5.7 ptt180 -123.81 140.17 53.25 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.4 OUTLIER -100.8 73.15 1.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.83 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.6 p-10 -81.48 173.33 12.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.689 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 59.65 20.34 8.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.4 162.7 44.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.059 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -154.46 145.95 23.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.263 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.412 ' CG ' ' N ' ' A' ' 100' ' ' THR . 38.7 t90 -140.2 164.29 30.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.5 t -105.01 158.11 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 101' ' ' VAL . 4.0 t -121.12 -3.97 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.768 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -62.63 -14.33 41.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -125.3 149.16 48.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -134.32 146.4 49.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.261 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.718 179.431 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 120.958 0.409 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG11 ' CA ' ' A' ' 94' ' ' GLN . 4.5 p -66.9 132.86 93.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.085 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.5 Cg_exo -64.41 -168.48 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.645 2.23 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.46 124.73 50.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.75 104.52 13.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.488 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -93.16 103.9 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.379 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 81' ' ' PHE . 5.5 mp -97.07 161.53 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 31.3 mt-10 -147.04 136.59 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.893 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . . . -86.55 102.6 14.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 28.1 mm -74.82 156.81 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.541 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -119.0 145.54 38.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.534 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -84.18 -2.66 56.92 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.302 0.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.12 98.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -163.35 -171.31 29.43 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.374 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.82 139.13 18.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.05 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 101.52 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.638 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.36 156.47 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.98 146.27 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.666 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -143.95 122.04 6.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.497 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 13.1 Cg_endo -57.72 101.18 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.092 1.861 . . . . 0.0 111.436 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.3 t0 -63.06 159.53 17.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -140.71 43.48 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.568 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.94 46.04 47.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.59 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 10.5 m-85 -90.4 -171.51 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.409 0.623 . . . . 0.0 111.419 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 86' ' ' ILE . 27.7 t -130.8 -28.26 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.552 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.68 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.1 tp -139.43 135.45 33.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.205 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 26.2 t80 -124.72 106.51 10.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.878 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.15 117.51 34.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 111.017 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' TRP . 56.2 t80 -106.55 124.57 49.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -125.59 129.35 49.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -159.52 139.99 6.54 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 114.438 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.7 tmtp? -116.78 135.79 53.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.214 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 tp -91.05 125.83 35.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 16.6 t-20 65.46 50.06 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.528 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.8 tt0 170.27 110.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.021 0.439 . . . . 0.0 110.337 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.3 mt-10 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.508 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.83 0.347 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -51.92 -25.72 8.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 42.64 -124.96 4.18 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.088 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -137.36 -73.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.302 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.598 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 5.6 m-90 -63.61 82.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.717 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.26 93.04 3.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.212 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 4.3 tpm_? -141.46 125.77 17.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.945 0.402 . . . . 0.0 111.874 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.46 131.96 35.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.826 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.44 143.86 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.983 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.42 26.6 4.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -153.42 92.52 3.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 52.7 Cg_exo -52.72 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.252 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.8 -49.67 2.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.826 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -179.99 82.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.303 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.11 2.72 49.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -157.61 140.49 15.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.523 0.201 . . . . 0.0 111.001 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.457 ' CZ2' ' HG3' ' A' ' 59' ' ' PRO . 7.6 m95 -89.18 154.48 20.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.98 0.419 . . . . 0.0 110.311 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -134.73 119.89 18.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 17.0 t80 -113.65 106.8 14.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.614 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 139.39 38.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -137.37 105.37 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.729 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.29 22.77 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.632 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -134.06 29.87 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.51 99.16 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.073 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -74.09 75.93 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.764 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.65 146.43 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.935 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -130.92 139.82 50.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -52.69 132.55 36.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.2 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.92 -29.17 12.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.067 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 101' ' ' VAL . 7.8 t0 -66.35 153.87 41.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.019 0.438 . . . . 0.0 111.158 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 160.35 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.543 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -118.88 147.11 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.066 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 42.2 m-85 -144.55 129.43 18.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.468 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -161.11 -177.87 6.37 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.557 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.8 p-90 -151.02 133.06 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.481 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.7 OUTLIER -99.98 156.98 16.86 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -178.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 12.0 t80 -139.24 138.8 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.62 0.247 . . . . 0.0 110.838 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -134.25 161.08 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.0 mm -135.85 107.19 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.968 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -100.35 57.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.538 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 68.55 68.7 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.741 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.97 25.47 75.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.392 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.94 73.02 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 110.33 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -87.63 160.96 31.9 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.289 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -152.22 153.1 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -132.84 147.84 52.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.425 ' CA ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -104.05 76.75 1.37 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.399 177.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.458 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.19 177.27 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 61.78 17.28 8.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.801 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.18 163.91 54.9 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.951 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.47 153.84 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.459 . . . . 0.0 111.166 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.543 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 26.6 t90 -153.1 166.75 31.5 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -112.12 162.75 15.08 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 79' ' ' ILE . 20.3 t -121.9 -9.26 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.668 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.426 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 25.6 p -60.36 -14.35 18.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.718 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.45 162.36 22.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 16' ' ' ALA . 89.9 m-85 -140.88 148.07 39.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 15' ' ' GLU . 4.7 m . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.81 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.924 0.392 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 92' ' ' TYR . 11.0 t -66.29 127.26 93.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.77 -177.12 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.467 2.112 . . . . 0.0 112.331 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 t -110.93 111.43 22.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.506 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -82.82 109.61 17.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.521 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -84.23 164.45 19.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.187 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mp -154.12 138.62 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.074 0.464 . . . . 0.0 112.094 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -135.2 136.7 41.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.496 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' CB ' ' CD2' ' A' ' 104' ' ' PHE . . . -86.75 114.52 23.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.7 mm -91.67 111.61 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -83.07 147.01 52.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.438 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 91.2 Cg_endo -92.23 -3.69 49.06 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.897 -1.293 . . . . 0.0 112.606 0.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 91.68 1.18 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.66 173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.574 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.44 144.51 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -133.72 109.88 9.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.86 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 30.0 t -122.76 142.88 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.357 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -143.52 146.94 33.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.473 ' CD1' ' CD1' ' A' ' 64' ' ' TRP . 1.2 pp -136.41 122.92 13.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.303 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 72.1 Cg_exo -47.61 108.68 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.494 2.129 . . . . 0.0 112.026 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 27.5 t0 -76.64 151.03 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 0.0 111.399 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t0 -140.89 46.09 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.752 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.98 69.85 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.404 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 10.1 m-85 -73.64 -170.97 0.94 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.637 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -132.94 -27.76 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 5.8 tp -139.87 127.25 21.39 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.251 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.471 ' CE1' HG12 ' A' ' 26' ' ' ILE . 2.4 t80 -118.49 94.36 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.78 29.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' TRP . 32.5 t80 -105.91 126.36 52.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.473 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.44 132.47 3.52 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.152 -1.499 . . . . 0.0 114.04 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.62 141.63 40.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.4 tp -92.24 117.16 29.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 57.8 t-20 63.92 65.17 0.72 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 36.1 tt0 172.86 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.163 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 78.1 mt-10 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.436 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.455 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -57.44 -32.14 66.6 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.713 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.16 -103.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.279 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -148.59 -78.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 110.546 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 36' ' ' PHE . 10.6 m-90 -59.25 89.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.4 88.86 3.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.223 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -132.45 125.71 31.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.042 0.449 . . . . 0.0 111.776 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -105.74 94.31 5.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.45 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mt -81.49 146.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.142 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.17 22.71 6.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -154.89 100.54 2.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.1 Cg_exo -52.1 171.56 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.426 2.084 . . . . 0.0 112.542 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -114.66 40.9 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 63' ' ' ARG . 6.4 tt0 84.0 86.65 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.845 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.96 -5.72 6.0 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.954 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 1.1 mtt180 -157.25 137.52 12.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.582 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.473 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 12.4 m95 -83.36 154.28 24.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.406 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 4.9 m -134.71 119.48 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.397 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 11.4 t80 -108.28 87.54 2.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.242 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 132.85 36.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.184 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -138.1 103.12 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -89.18 22.41 2.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.698 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -133.1 42.07 3.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.5 100.76 7.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.93 99.82 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -122.01 164.19 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -138.52 144.38 39.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.553 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -62.64 126.75 28.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.572 . . . . 0.0 110.724 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.37 -31.09 4.32 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.354 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.91 149.62 43.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 111.008 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 164.23 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.483 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.8 mp -118.87 147.81 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.13 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 63.5 m-85 -144.46 125.77 14.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -157.5 -178.62 7.47 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.0 p-90 -155.7 134.6 12.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.671 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -99.81 160.97 13.9 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.941 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.435 ' CE1' HD12 ' A' ' 86' ' ' ILE . 16.3 t80 -145.33 105.46 4.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 111.06 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.61 165.17 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.659 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 19.7 mm -142.51 105.99 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.877 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.7 ttpt -96.05 70.01 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.427 0.454 . . . . 0.0 111.104 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 56.72 46.02 20.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.263 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.68 7.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.729 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 7.4 mt -142.9 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -64.85 155.98 47.61 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.191 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.498 ' HB3' HG21 ' A' ' 9' ' ' VAL . 69.9 m-85 -152.52 134.24 14.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.34 -0.93 . . . . 0.0 108.677 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.9 140.7 49.15 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.562 0.696 . . . . 0.0 112.687 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 2.5 tt0 -104.33 73.8 1.14 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.452 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.5 p30 -81.32 174.33 11.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.564 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.18 18.82 9.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.07 163.29 52.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.911 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -152.55 150.67 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 27.8 t90 -149.18 164.45 34.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -106.4 158.56 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 21.5 t -119.86 -10.6 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.178 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.532 ' HA ' HD13 ' A' ' 75' ' ' LEU . 20.9 p -60.24 -11.51 6.53 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.47 148.12 52.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.456 ' CD2' ' CB ' ' A' ' 16' ' ' ALA . 40.9 m-85 -135.32 149.95 49.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.362 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.083 0.468 . . . . 0.0 110.491 179.362 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.856 0.36 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 7.2 p -66.89 130.38 93.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.206 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 38.8 Cg_exo -60.35 -175.26 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.688 2.259 . . . . 0.0 112.383 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.83 125.81 52.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -82.58 105.7 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.726 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -95.87 109.78 22.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.009 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 4.3 mp -105.76 157.01 17.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.265 0.555 . . . . 0.0 112.266 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 38.4 mt-10 -140.69 141.44 34.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.512 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.468 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . . . -86.13 122.78 30.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.157 0.503 . . . . 0.0 111.367 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.495 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.8 mm -104.69 109.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -79.0 150.55 75.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.883 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.59 -1.62 61.82 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.188 0.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.75 98.12 0.31 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.4 164.84 36.06 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.9 tp -138.37 144.55 40.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 111.149 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.54 99.5 4.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.473 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' CE2' ' A' ' 36' ' ' PHE . 20.7 t -105.96 158.06 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.985 0.421 . . . . 0.0 111.774 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.13 149.76 26.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.667 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pt -144.51 126.92 8.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.0 Cg_endo -57.1 95.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.386 2.057 . . . . 0.0 111.568 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.7 t0 -59.17 160.63 6.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 3.9 t0 -145.86 45.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.152 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.55 89.63 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.885 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CZ ' ' CB ' ' A' ' 29' ' ' ASP . 20.0 m-85 -83.67 -170.03 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.266 0.555 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -129.82 -29.27 2.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.645 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.666 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.86 137.54 34.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.508 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 25.2 t80 -127.4 97.02 4.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.463 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.06 135.63 37.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.412 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 52' ' ' TRP . 9.6 t80 -121.28 125.85 48.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.491 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -123.8 123.37 40.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -157.43 139.28 6.31 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 118.816 -1.659 . . . . 0.0 114.442 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.86 148.38 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.343 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tp -100.03 120.15 39.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.8 t-20 61.76 54.83 2.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 51.0 tt0 174.06 109.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 36.0 mt-10 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.9 mt-10 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.834 0.35 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.85 -26.57 10.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.655 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.71 -121.63 7.01 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.435 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -137.88 -73.71 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.749 0.309 . . . . 0.0 110.547 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.5 m-90 -61.3 90.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.037 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.22 87.28 2.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.142 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -136.6 129.63 31.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.989 0.423 . . . . 0.0 111.919 -179.054 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -99.4 126.67 45.33 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -111.96 142.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 111.217 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -130.71 28.7 4.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.92 98.12 2.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 36.1 Cg_exo -57.29 169.14 2.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.477 2.118 . . . . 0.0 112.589 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' ARG . 11.9 tptp -105.18 34.64 3.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.91 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 82.06 88.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.48 -5.86 13.95 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.864 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.0 mtt180 -157.26 130.42 7.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.466 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 15.6 m95 -78.64 158.16 28.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.5 m -134.26 112.57 11.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 5.2 t80 -113.8 85.39 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.96 151.13 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -138.13 113.19 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.13 22.39 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -143.83 31.01 1.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.5 128.8 44.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.5 96.15 5.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.68 152.47 28.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.12 150.63 41.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.184 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD22 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.42 130.8 46.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.421 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' HD11 ' A' ' 75' ' ' LEU . . . 95.19 -25.15 25.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.598 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 101' ' ' VAL . 9.8 t70 -56.39 152.91 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 152.64 29.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.543 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.6 mp -112.72 146.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 m-85 -144.55 126.16 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.479 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 1.3 p90 -161.03 -176.72 5.65 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.491 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 61.2 p-90 -152.83 135.13 15.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.591 -1.64 . . . . 0.0 108.97 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 14.1 p -99.79 163.74 12.34 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.2 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HD13 ' A' ' 86' ' ' ILE . 17.0 t80 -145.1 113.8 6.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.667 0.27 . . . . 0.0 111.012 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -107.73 164.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.666 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 34.7 mm -138.99 104.48 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.4 59.66 1.86 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.573 0.545 . . . . 0.0 110.668 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 64.43 64.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.678 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.58 63.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -143.16 71.23 1.33 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.16 160.66 44.54 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.4 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -152.28 149.01 28.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' THR . 13.4 ptt180 -128.68 144.97 51.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -103.68 75.81 1.34 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.405 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.98 175.9 10.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.573 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.45 18.16 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.806 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.57 162.79 52.36 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.97 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -154.39 146.43 23.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.903 0.382 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 29.6 t90 -142.65 167.04 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.062 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.1 t -115.45 163.41 15.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.468 HG21 HD11 ' A' ' 79' ' ' ILE . 3.4 t -125.83 17.78 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.923 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -65.95 -13.04 59.06 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.25 162.25 39.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.276 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 16' ' ' ALA . 95.3 m-85 -130.47 140.69 50.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.704 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 121.166 0.507 . . . . 0.0 110.79 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.84 0.353 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 HG11 ' CA ' ' A' ' 94' ' ' GLN . 12.0 p -71.92 142.79 85.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' CD ' HG11 ' A' ' 85' ' ' VAL . 15.4 Cg_exo -68.36 -178.44 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -110.33 120.76 43.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -82.27 116.05 21.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.473 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.3 ttmt -103.78 101.75 11.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.459 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 1.1 mp -91.23 168.6 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 111.838 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 0.1 OUTLIER -155.92 154.09 30.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.473 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 104' ' ' PHE . . . -86.94 128.34 35.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 111.825 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 1.3 mp -112.66 115.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.715 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.487 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -78.85 143.7 62.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.6 Cg_endo -91.69 -4.11 49.93 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.037 -1.234 . . . . 0.0 112.491 -0.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -165.54 89.23 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -156.48 -174.52 26.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.691 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tp -158.24 131.8 7.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.713 0.292 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' CB ' HD13 ' A' ' 17' ' ' ILE . 12.7 ttt85 -129.24 114.74 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 25.6 t -122.93 158.47 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 111.541 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.01 144.88 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.871 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.468 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pp -138.22 127.04 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.101 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.0 Cg_endo -60.67 104.17 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.174 1.916 . . . . 0.0 111.693 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 14.5 t0 -66.82 158.12 31.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.49 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -142.78 45.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.673 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.88 46.12 47.28 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 6.5 m-85 -88.52 -172.64 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.519 0.676 . . . . 0.0 111.184 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 86' ' ' ILE . 9.7 m -133.19 -27.49 1.59 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.595 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.9 tp -141.5 131.05 23.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.121 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.468 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 16.3 t80 -122.63 101.66 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 55' ' ' ASP . . . -105.38 121.28 43.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 15.3 t80 -106.89 131.7 53.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.61 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.14 122.53 32.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -153.85 147.54 17.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 118.87 -1.633 . . . . 0.0 114.428 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.1 tmtt? -119.15 145.0 46.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 110.431 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.17 117.58 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.57 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 66.75 67.4 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.069 0.461 . . . . 0.0 110.491 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 80' ' ' TYR . 44.7 tt0 179.19 111.78 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . 20.3 mt-10 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.377 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -62.43 -19.03 63.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.059 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.04 -135.75 6.91 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -118.83 -76.8 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 10.2 m-90 -67.43 86.78 0.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -118.88 87.69 2.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.453 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.503 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.0 ttt180 -142.49 127.54 18.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 111.85 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.3 p30 -88.37 135.51 33.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 34' ' ' PHE . 1.9 mt -121.61 151.45 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.4 t -139.5 24.3 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.31 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -145.86 94.58 5.0 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.993 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.4 Cg_exo -53.53 -172.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.256 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.6 -48.69 2.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -178.79 83.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.432 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.43 -0.3 42.41 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 148.93 21.37 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 120.626 0.251 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.455 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 11.4 m95 -90.19 161.09 15.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.177 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.9 m -134.32 116.7 15.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 6.1 t80 -106.25 95.29 5.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -101.28 139.8 36.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.413 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.06 106.16 5.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -89.21 22.5 2.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.679 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.07 38.32 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.85 115.79 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -73.93 76.58 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -97.36 139.23 33.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.981 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 152.64 51.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.446 ' CD2' ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -55.43 137.83 47.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.8 -29.47 7.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.62 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.88 160.16 6.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.951 0.405 . . . . 0.0 111.213 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -124.35 159.3 30.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.628 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 1.4 mp -116.07 145.22 22.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 112.018 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CD1' ' HA ' ' A' ' 43' ' ' GLU . 98.0 m-85 -144.52 126.53 15.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 3.6 p90 -161.32 -173.12 3.67 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.125 0.964 . . . . 0.0 113.427 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 11.7 p-90 -154.34 133.64 12.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.62 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 5.6 p -99.68 163.49 12.46 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.079 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HD13 ' A' ' 86' ' ' ILE . 13.4 t80 -143.64 124.77 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.612 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -119.57 166.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.654 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 mm -141.34 106.28 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.921 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -103.63 64.49 0.81 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.711 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.3 t0 67.7 64.59 0.39 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.86 70.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.37 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.84 73.62 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.61 162.04 46.9 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.392 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -152.28 143.28 23.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 83' ' ' THR . 10.3 ptt85 -126.08 142.97 51.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.41 ' CA ' HG11 ' A' ' 9' ' ' VAL . 4.4 tt0 -101.0 75.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.657 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 33.8 p-10 -78.32 174.77 10.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.623 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 t30 60.25 18.31 7.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.38 159.93 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.07 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -154.65 161.69 41.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.0 0.428 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 70.7 t90 -147.6 166.26 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.434 ' O ' ' CH2' ' A' ' 99' ' ' TRP . 5.5 t -110.25 155.74 21.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.79 7.88 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.328 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 m -70.94 -9.9 58.71 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.752 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -123.47 163.97 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.447 ' CD1' ' HB1' ' A' ' 16' ' ' ALA . 23.2 m-85 -137.28 120.82 17.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 16' ' ' ALA . 6.2 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.963 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.788 0.327 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 43.1 t80 -86.03 175.12 8.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.097 0.475 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 18.8 t -118.99 159.9 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 94' ' ' GLN . 7.1 p -68.05 138.51 92.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD2' HG13 ' A' ' 85' ' ' VAL . 36.0 Cg_endo -67.41 -172.57 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.421 2.081 . . . . 0.0 112.665 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -111.41 124.4 52.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.408 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -84.44 106.82 16.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 13.3 mttp -93.32 112.65 24.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.359 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 2.0 mp -101.16 164.96 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 112.055 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.6 pt-20 -155.68 143.39 19.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.15 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.458 ' HB2' ' CG ' ' A' ' 104' ' ' PHE . . . -86.91 110.49 20.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 111.322 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 15.8 mm -81.5 145.25 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.321 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t80 -106.33 141.76 23.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.7 Cg_endo -93.14 -0.14 53.49 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.085 -1.214 . . . . 0.0 112.445 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -161.66 94.56 0.96 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -176.04 169.19 41.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.668 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.46 121.73 7.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -115.09 132.89 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 38.3 t -124.42 158.96 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.83 144.89 25.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.86 128.33 12.15 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.497 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 17.0 Cg_endo -58.01 95.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.513 2.142 . . . . 0.0 111.7 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.1 t0 -60.29 160.6 8.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -147.36 46.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.922 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.14 89.0 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.686 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.465 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 10.3 m-85 -84.15 -171.21 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.261 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -132.02 -28.33 1.76 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.66 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.4 tp -140.34 132.37 27.86 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.246 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 44.1 t80 -124.59 92.85 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 84' ' ' TYR . . . -86.83 132.08 33.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 52' ' ' TRP . 40.8 t80 -121.52 123.27 41.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.39 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.531 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.06 118.84 27.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -150.91 133.04 4.11 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.253 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -105.92 148.92 27.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.338 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.57 122.18 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.0 t-20 59.34 58.91 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.1 tt0 175.47 109.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 41.8 mt-10 -56.25 -168.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.13 148.49 13.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -134.53 45.4 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.01 -130.76 2.21 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.531 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.35 72.99 1.08 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 144.29 26.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.016 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.53 -25.21 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.633 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.29 -110.43 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.426 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -142.49 -80.09 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.735 0.303 . . . . 0.0 110.584 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.458 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 17.3 m-90 -61.05 94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.43 83.0 1.94 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.318 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -133.77 133.67 41.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.56 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.43 111.65 24.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG22 ' CZ3' ' A' ' 64' ' ' TRP . 9.7 mt -93.06 152.09 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 78.7 p -119.91 -23.59 6.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.71 121.0 27.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.59 0.233 . . . . 0.0 111.23 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 31.7 Cg_exo -58.66 -164.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.409 2.072 . . . . 0.0 112.086 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -45.65 2.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 179.18 80.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.499 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.88 0.59 34.68 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 8.0 mtm180 -156.99 131.23 8.47 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.389 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.474 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 15.0 m95 -77.09 155.62 32.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.92 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -134.72 118.95 17.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.394 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 49.6 t80 -110.62 89.45 3.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.079 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.93 137.45 32.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.274 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -138.11 100.91 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.591 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 22.44 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.597 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.65 26.79 5.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.315 . . . . 0.0 111.037 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.92 100.1 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -73.78 75.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -86.31 163.47 17.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.791 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -141.65 148.2 38.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.035 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -55.62 142.22 34.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.259 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.5 -32.43 6.26 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.83 151.19 26.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.912 0.387 . . . . 0.0 111.149 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -114.7 154.3 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.517 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.3 mp -109.25 146.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.061 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 97.6 m-85 -144.17 122.34 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.4 p90 -157.8 -174.9 5.08 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -154.77 131.6 10.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.816 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 76.5 p -110.35 151.87 26.91 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.434 ' CE2' HD13 ' A' ' 86' ' ' ILE . 19.9 t80 -135.76 129.43 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.105 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -113.73 164.08 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.375 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.661 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 24.4 mm -137.52 107.28 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.883 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -99.94 57.12 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.5 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 t0 68.95 69.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.771 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.75 25.29 75.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.31 73.72 1.39 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.201 0.524 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.25 161.08 29.92 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.552 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -152.13 146.56 25.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -124.37 150.55 45.41 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.451 ' N ' HG23 ' A' ' 9' ' ' VAL . 10.3 tt0 -106.6 72.27 0.9 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.665 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.3 p-10 -78.47 176.03 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.47 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 61.05 18.23 8.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.62 162.44 54.31 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.87 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 2.8 tt0 -154.39 155.28 34.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.895 0.379 . . . . 0.0 111.111 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.445 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 51.7 t90 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.423 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.4 t -108.52 159.75 16.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 t -121.42 -1.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.795 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.405 ' CG2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -66.82 -9.92 42.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.813 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.45 150.61 52.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CG ' ' HB2' ' A' ' 16' ' ' ALA . 8.9 m-85 -129.45 143.44 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.012 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -98.69 162.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 0.0 111.094 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.402 ' ND2' ' CB ' ' A' ' 112' ' ' ALA . 7.0 m-20 -86.21 152.15 23.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.31 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -18.08 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.55 -31.31 68.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.944 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.72 18.98 5.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.381 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.9 p -139.69 157.61 69.64 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-O 121.334 0.587 . . . . 0.0 111.366 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 51.2 Cg_exo -51.66 126.2 19.01 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.976 2.451 . . . . 0.0 113.083 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.402 ' CB ' ' ND2' ' A' ' 106' ' ' ASN . . . -114.74 42.69 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.654 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -128.25 100.82 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.768 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 t -115.64 43.8 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.003 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.0 m 60.56 54.1 3.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.88 79.94 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.37 112.61 49.28 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.399 2.066 . . . . 0.0 112.339 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.816 0.341 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 46.0 t80 -66.5 175.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.461 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 17.2 t -115.59 159.22 15.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.45 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' CG2' ' HD2' ' A' ' 10' ' ' PRO . 7.3 p -72.96 138.77 79.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CG2' ' A' ' 9' ' ' VAL . 41.1 Cg_endo -67.06 -167.89 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.601 2.2 . . . . 0.0 112.455 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -109.47 114.98 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.12 104.87 13.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.8 159.22 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.751 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HB2' ' CD2' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -150.37 150.9 32.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.193 0.521 . . . . 0.0 111.888 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.71 142.78 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.941 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 104' ' ' PHE . . . -86.83 115.73 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.495 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 17.0 mm -88.25 129.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.244 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.493 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 25.2 t80 -93.77 141.5 23.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -94.17 4.52 53.74 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.332 -1.112 . . . . 0.0 112.477 0.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.97 97.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.025 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.495 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.25 176.95 47.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.326 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tp -150.73 138.87 20.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 110.998 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 110.74 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 25' ' ' SER . 24.0 t -119.82 146.58 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.82 151.63 36.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -139.95 130.12 13.97 Favored Pre-proline 0 N--CA 1.467 0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.008 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.98 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.243 1.962 . . . . 0.0 111.567 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 22.5 t0 -61.98 160.7 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.691 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 30.0 t70 -150.46 45.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.757 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.48 92.34 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.336 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CD1' HG21 ' A' ' 85' ' ' VAL . 21.3 m-85 -76.81 -124.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.348 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -179.58 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.69 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.4 tp -140.8 131.21 25.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.703 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 24.1 t80 -120.01 108.34 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.142 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' TYR . . . -111.05 120.59 42.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 18.4 t80 -110.04 128.81 55.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -124.74 124.75 42.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.9 140.03 7.12 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.143 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -112.21 149.18 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 110.468 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 tp -98.09 119.46 36.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.078 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.5 t-20 62.53 57.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.06 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 52.7 tt0 177.24 109.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.35 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 32.3 mt-10 -57.9 -169.51 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.634 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.69 151.66 3.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.352 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 67.8 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.022 0.439 . . . . 0.0 110.759 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.16 -136.81 5.84 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 82' ' ' TRP . 22.0 mt -119.71 68.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.144 0.497 . . . . 0.0 110.895 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.73 156.82 23.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -60.88 -17.12 48.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 40.74 -131.56 3.06 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -129.8 -68.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 0.0 110.574 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.9 m-90 -77.13 90.87 3.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.992 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.07 88.54 2.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.931 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.2 tpm_? -133.81 127.63 33.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.93 118.86 32.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.04 146.76 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 p -132.77 36.21 3.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 91.4 1.72 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 43.2 Cg_exo -56.91 171.93 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.592 2.195 . . . . 0.0 112.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -109.15 32.84 4.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.792 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 79.46 89.5 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.04 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 73.16 -3.51 29.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.957 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 60' ' ' LYS . 9.1 ttt180 -157.67 127.26 6.0 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.796 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.46 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 13.2 m95 -79.85 157.58 26.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -134.33 118.71 17.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 11.6 t80 -116.57 84.97 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -94.66 146.41 24.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.142 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD1' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -138.0 109.78 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 22.24 2.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -144.03 36.55 1.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.08 126.71 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -79.46 75.86 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.735 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.7 mt -101.23 130.73 47.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.784 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -121.03 153.89 36.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.961 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.459 HD21 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.75 132.01 51.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.283 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -26.55 16.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.504 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -55.43 154.46 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 151.01 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.448 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.2 mp -110.42 147.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 112.162 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 37.6 m-85 -144.31 125.31 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.598 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.1 p90 -160.64 -174.27 4.37 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.495 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.9 p-90 -151.99 134.32 15.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.288 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -99.65 161.28 13.71 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.013 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 10.5 t80 -141.4 138.19 32.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.703 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.24 161.86 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.69 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 33.7 mm -136.79 111.19 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.722 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -105.7 67.93 0.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.26 55.86 2.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.82 28.17 43.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.7 mt -143.84 75.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.215 0.531 . . . . 0.0 110.212 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.08 160.56 40.71 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.376 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 29.3 m-85 -152.26 153.04 32.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -135.74 146.59 47.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.424 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.0 tt0 -104.68 75.42 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.461 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.9 p30 -78.2 175.22 10.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.565 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 60.47 18.54 8.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.61 161.6 52.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.005 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -154.46 145.49 22.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' A' ' 14' ' ' LEU . 42.0 t90 -141.12 165.95 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.079 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.8 t -111.15 162.02 15.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 101' ' ' VAL . 2.8 t -124.37 11.53 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -10.2 59.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.921 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.98 140.99 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.703 0.287 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' A' ' 75' ' ' LEU . 9.8 m-85 -122.15 129.42 52.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 110' ' ' THR . 28.5 m -98.8 166.8 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.206 0.527 . . . . 0.0 111.239 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 110' ' ' THR . 33.8 t30 -81.21 154.16 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.372 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.34 -16.35 5.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -31.93 63.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.033 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.62 22.57 3.98 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.368 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.552 ' O ' ' HB ' ' A' ' 105' ' ' VAL . 1.1 p -133.96 166.78 26.67 Favored Pre-proline 0 C--O 1.222 -0.353 0 CA-C-N 117.046 0.423 . . . . 0.0 110.915 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 36.6 Cg_endo -71.8 118.45 5.64 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.056 1.837 . . . . 0.0 112.13 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -174.04 74.58 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.558 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.07 145.62 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.7 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.8 p -64.97 -51.74 60.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -70.23 105.65 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -172.7 83.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.962 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 62.49 148.49 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.972 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.549 2.166 . . . . 0.0 112.295 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.905 0.383 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 50.2 t80 -93.73 174.59 7.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 111.031 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.462 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 16.3 t -112.53 162.01 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.224 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.74 130.4 94.02 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.267 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 24.2 Cg_exo -63.14 -170.25 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.72 2.28 . . . . 0.0 112.587 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -110.87 124.97 53.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.47 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -77.64 104.49 8.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.24 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.54 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.252 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 5.2 mp -106.18 162.44 13.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.93 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 24.9 mm-40 -152.96 145.3 24.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.945 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB2' ' CD1' ' A' ' 104' ' ' PHE . . . -87.07 120.85 28.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 111.567 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.6 mm -98.19 114.25 35.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.176 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 54.5 t80 -79.21 142.03 58.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 98.9 Cg_endo -96.73 4.99 40.44 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.603 0.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.76 95.63 0.9 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . 169.23 167.19 29.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.555 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -158.27 121.8 3.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.745 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -97.07 134.91 39.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.009 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.01 152.95 30.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.496 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pt -147.37 122.03 5.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.48 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 9.4 Cg_endo -55.24 99.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.105 1.87 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 20.1 t0 -62.68 161.48 12.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.597 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.448 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -145.39 44.69 1.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.671 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.58 42.69 62.7 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.736 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.2 m-85 -88.08 -171.19 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.401 0.62 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' ILE . 37.8 t -132.04 -27.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.697 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 8.0 tp -138.3 134.99 35.0 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.254 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.496 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 18.6 t80 -126.31 90.65 3.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.89 124.65 31.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.659 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 52' ' ' TRP . 78.8 t80 -114.59 117.59 31.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.4 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -122.57 125.46 45.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.65 141.88 8.14 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.927 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.0 148.54 40.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 110.447 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 126.16 45.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.09 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.7 t-20 58.1 53.49 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.1 tt0 176.69 109.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.167 0.508 . . . . 0.0 110.382 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 29.2 mt-10 -57.81 -168.13 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.442 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 154.04 24.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.186 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.84 85.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 111.06 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 99.48 99.17 2.21 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.617 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.2 mt 16.25 72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.618 0.767 . . . . 0.0 112.64 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -89.34 147.95 23.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -56.33 -20.31 18.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.599 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.52 -130.47 4.93 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.923 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -129.3 -70.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.8 m-90 -72.77 94.06 1.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -118.09 91.98 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.1 tpt85 -139.51 125.58 19.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -86.4 130.35 34.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.36 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.9 mt -110.42 152.97 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.344 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.9 p -144.48 27.78 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.05 87.38 4.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 21.6 Cg_exo -66.02 -170.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.816 2.344 . . . . 0.0 112.445 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -121.95 24.14 9.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.588 178.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 82.49 90.96 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.352 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 76.0 0.76 65.94 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.759 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.83 121.3 4.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.529 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 19.2 m95 -82.95 157.57 22.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 119.7 18.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.57 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 31.9 t80 -122.64 93.76 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 mmm-85 -95.49 143.35 26.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.345 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.13 94.25 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -89.27 22.6 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.597 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -126.67 28.66 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.71 110.79 20.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.01 76.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 mt -86.79 153.28 21.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.9 142.92 47.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.14 132.0 42.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.297 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.98 -28.37 12.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.84 161.77 12.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -121.07 158.4 27.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.465 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 1.3 mp -116.73 145.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.112 0.482 . . . . 0.0 112.176 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 31.1 m-85 -144.3 126.33 15.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.46 -174.18 4.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 47' ' ' LEU . 31.9 p-90 -156.7 128.27 7.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.449 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 6.5 p -106.9 152.63 23.66 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.43 ' CZ ' HD12 ' A' ' 86' ' ' ILE . 17.2 t80 -135.9 117.36 14.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -103.99 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.266 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.641 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.3 mm -137.16 109.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.845 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.89 68.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.875 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 63.31 65.53 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.0 27.01 73.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.399 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 mt -144.52 74.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.179 0.514 . . . . 0.0 110.097 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -89.54 162.11 30.28 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.375 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.05 147.71 26.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -126.06 141.23 52.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.26 76.44 2.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.237 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.5 p30 -83.43 179.69 7.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.232 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.0 t30 59.05 18.38 6.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.57 163.24 44.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.078 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.39 158.38 39.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.1 0.476 . . . . 0.0 111.476 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.429 ' CG ' ' N ' ' A' ' 100' ' ' THR . 49.7 t90 -147.66 165.69 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.8 t -107.75 157.44 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -119.69 -4.19 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.638 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.3 m -62.1 -15.97 49.05 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.607 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.93 159.19 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 21.0 m-85 -138.09 129.87 28.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 22.7 m -98.67 179.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.29 0.567 . . . . 0.0 111.956 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -92.34 152.94 19.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.411 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.94 -16.55 7.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.27 -30.75 65.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.179 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.6 18.46 5.27 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.452 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 p -138.01 154.95 74.71 Favored Pre-proline 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 111.512 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 31.4 Cg_exo -57.7 121.52 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.026 2.484 . . . . 0.0 112.388 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 171.28 79.97 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.56 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.414 ' CB ' ' HB2' ' A' ' 104' ' ' PHE . 35.9 t70 -116.85 90.82 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.641 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -61.14 90.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.231 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.62 -170.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tt -125.62 67.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -143.35 132.67 11.64 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.444 2.096 . . . . 0.0 112.367 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.803 0.335 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 34.8 t80 -95.75 176.06 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.235 0.54 . . . . 0.0 111.087 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 28.4 t -125.3 162.89 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.068 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG2' ' HD2' ' A' ' 10' ' ' PRO . 7.1 p -66.56 138.28 95.53 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD2' HG13 ' A' ' 85' ' ' VAL . 36.6 Cg_endo -66.01 -168.09 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.493 2.129 . . . . 0.0 112.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -109.55 116.99 32.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -80.45 107.9 13.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.401 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -81.86 156.81 24.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.74 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 99' ' ' TRP . 5.1 mp -146.69 149.9 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.45 . . . . 0.0 111.879 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -148.66 142.37 25.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.95 114.51 23.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.123 0.487 . . . . 0.0 111.465 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 24.3 mm -89.68 130.39 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.238 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.1 t80 -92.93 142.27 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 94.6 Cg_endo -92.49 -2.69 50.5 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.484 0.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -163.27 95.52 0.85 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.9 171.16 43.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.282 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.47 132.02 17.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.0 111.25 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.6 ttt180 -117.97 125.8 51.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.391 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 61.9 t -126.85 152.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.45 145.1 24.23 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.985 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.487 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pp -143.98 117.06 5.77 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.304 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HA ' ' CD ' ' A' ' 63' ' ' ARG . 84.1 Cg_exo -45.11 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.419 2.079 . . . . 0.0 112.284 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 43.0 t0 -80.14 143.52 33.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 111.361 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.96 48.88 2.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.608 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.91 38.49 96.11 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.889 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CD1' HG22 ' A' ' 85' ' ' VAL . 22.1 m-85 -68.65 -123.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.282 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 177.32 -35.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.736 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.5 tp -141.12 126.3 18.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.088 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 11.8 t80 -118.67 95.02 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.61 120.14 33.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.0 t80 -105.83 126.91 52.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.266 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.485 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.47 122.29 33.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -159.37 139.38 6.16 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.806 -1.664 . . . . 0.0 114.211 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 146.97 42.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.503 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.0 tp -89.3 133.09 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 44.76 63.08 1.82 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 177.49 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.38 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 50.9 mt-10 -56.0 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.383 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.0 mtp -147.47 144.25 28.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.656 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.42 77.67 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 84.13 101.93 0.58 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.429 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.8 mt 24.72 88.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.511 0.724 . . . . 0.0 112.527 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -109.65 143.0 40.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.547 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.56 -45.25 56.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.51 -122.44 28.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.17 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -137.96 -72.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.904 0.383 . . . . 0.0 110.451 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.444 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 9.1 m-90 -60.76 88.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.946 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.79 94.3 4.4 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.001 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 3.9 tpt85 -146.94 127.83 14.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.971 0.415 . . . . 0.0 112.117 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.22 123.93 35.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.386 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.15 151.47 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.363 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.5 p -141.11 30.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -153.15 92.16 3.3 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.2 Cg_exo -58.25 169.03 3.19 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.562 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.93 33.93 3.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.828 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 81.12 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.161 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.64 -2.74 21.46 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.846 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.409 ' CD ' ' HA ' ' A' ' 27' ' ' PRO . 1.2 tpp180 -157.61 124.2 4.93 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.619 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 12.1 m95 -76.62 154.94 33.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -134.67 120.52 19.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 32.7 t80 -121.41 106.08 11.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -110.17 141.4 43.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -138.09 111.17 7.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -89.37 22.34 2.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.347 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -125.52 36.8 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.82 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 81.23 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' HB3' HG11 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -78.97 169.9 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.599 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 145.22 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.411 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -55.22 136.86 48.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.18 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.31 -29.84 9.58 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.275 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.33 152.92 20.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 0.0 111.194 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -115.25 148.89 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.438 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.429 HD11 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -105.31 150.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.056 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.404 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 75.1 m-85 -144.07 128.04 17.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.161 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.9 p90 -161.07 -174.4 4.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.085 0.945 . . . . 0.0 113.361 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.485 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 52.4 p-90 -158.67 135.79 9.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.13 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 32.5 p -99.36 163.03 12.7 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.27 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.432 ' CE1' HD12 ' A' ' 86' ' ' ILE . 14.8 t80 -144.93 105.5 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.8 164.38 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 34.3 mm -141.03 109.65 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.598 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 67.4 0.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.31 65.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 28.53 71.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.43 73.27 1.39 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -83.18 160.64 38.64 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.501 -0.772 . . . . 0.0 114.233 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.24 147.85 26.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 83' ' ' THR . 12.4 ptt-85 -126.28 147.65 49.66 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.529 0.681 . . . . 0.0 112.701 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -106.01 74.07 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.439 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.0 p30 -82.27 176.21 9.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.703 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 60.05 19.76 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.625 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.86 162.15 42.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -154.34 162.7 41.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.963 0.411 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 14' ' ' LEU . 46.9 t90 -155.08 165.82 35.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.166 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.438 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.2 t -105.65 160.88 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 73' ' ' LEU . 21.4 t -121.89 -0.3 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.746 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.411 ' HA ' ' CD2' ' A' ' 75' ' ' LEU . 25.3 p -63.44 -14.06 46.66 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.17 154.55 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.704 0.288 . . . . 0.0 110.879 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.442 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 10.1 m-85 -135.54 144.63 46.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.77 168.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 110' ' ' THR . 9.7 m-20 -86.59 151.13 23.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.225 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -54.85 -17.44 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.09 -29.98 64.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.192 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.81 14.43 6.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.227 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.2 p -134.07 161.21 65.12 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.886 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 77.9 Cg_exo -46.48 130.55 14.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.861 2.374 . . . . 0.0 113.11 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.51 112.54 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.412 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -123.81 -169.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 65.9 37.74 5.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -147.06 90.66 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.813 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 tp 61.94 73.37 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.823 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.73 94.76 28.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.525 2.15 . . . . 0.0 112.397 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.776 0.322 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 37.1 t80 -95.58 177.23 5.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 23.0 t -124.77 162.27 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.293 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 92' ' ' TYR . 8.7 p -66.59 131.03 94.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 20.8 Cg_exo -65.47 -177.53 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.356 2.038 . . . . 0.0 111.988 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -107.79 129.73 55.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 111.674 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.45 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -81.0 101.17 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.224 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -83.26 100.63 10.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 3.7 mp -92.96 157.52 16.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.8 mm-40 -148.92 142.23 25.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.227 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.86 110.54 20.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.141 0.496 . . . . 0.0 111.29 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 19.0 mm -83.35 150.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.252 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -114.0 143.83 30.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.737 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 9.9 Cg_endo -89.55 3.5 69.26 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.285 0.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -170.18 98.39 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.501 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -172.42 -176.45 41.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.426 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.07 134.87 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -126.25 119.79 28.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.11 147.75 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.282 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.52 148.82 34.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.477 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -146.61 126.32 6.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.68 116.35 2.31 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.259 1.973 . . . . 0.0 111.681 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -83.06 112.11 19.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 0.0 111.335 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 24.2 t0 -101.43 43.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.813 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.03 31.84 80.1 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.882 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.444 ' CD2' HG12 ' A' ' 85' ' ' VAL . 95.5 m-85 -61.2 -113.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.799 0.299 . . . . 0.0 110.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . 6.7 t 176.87 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.718 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.4 132.02 28.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.793 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.477 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.0 t80 -122.32 98.0 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.732 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.3 119.03 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' ' CD2' ' A' ' 81' ' ' PHE . 40.1 t80 -106.01 128.36 53.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.589 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.64 122.11 35.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.582 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.98 145.95 12.0 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.863 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 161.6 21.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.456 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.51 118.19 32.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 52.7 t30 57.66 70.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 73.9 tt0 171.33 110.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.375 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 51.4 mt-10 -57.21 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.139 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.05 149.25 28.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.556 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -137.16 81.78 1.89 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 90.42 100.53 1.16 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.462 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 46' ' ' GLY . 2.0 mt 20.88 89.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.736 0.814 . . . . 0.0 112.742 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.83 138.54 40.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.723 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.589 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.54 -30.91 44.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.642 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.46 -137.44 15.67 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.584 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.1 -74.78 0.6 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.5 m-90 -60.43 90.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.069 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -117.96 85.22 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.868 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -130.63 127.63 39.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.735 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -94.43 110.89 22.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.517 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' ILE . 10.7 mm -92.1 133.75 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.298 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 t -129.79 36.65 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.05 90.35 1.23 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.9 Cg_exo -53.6 170.26 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.74 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 1.2 tmtm? -112.93 42.13 1.94 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.461 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 1.3 mp0 72.77 88.62 0.1 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.489 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.23 -3.47 22.73 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.052 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 7.1 ttt180 -157.84 125.52 5.25 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.847 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 11.9 m95 -76.3 154.7 34.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 m -134.63 120.64 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.505 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 14.7 t80 -120.5 115.7 23.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -111.14 145.1 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.243 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.08 104.34 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 22.49 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.64 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.03 40.72 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.349 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.53 93.11 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -73.95 75.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.691 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mt -97.69 168.01 10.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -142.02 143.82 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 133.2 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.352 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.96 -28.89 11.68 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.216 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.39 162.62 14.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.851 0.358 . . . . 0.0 111.244 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -121.47 158.42 28.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.207 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.3 mp -113.89 149.91 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.173 0.511 . . . . 0.0 112.17 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 m-85 -143.84 125.18 14.68 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -159.5 -175.3 5.11 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.275 1.035 . . . . 0.0 113.721 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.435 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 38.7 p-90 -153.46 133.95 13.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.483 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.94 155.48 17.66 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.163 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 14.1 t80 -135.6 109.66 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 0.0 111.168 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.81 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -102.91 168.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.393 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.718 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 45.7 mm -145.5 104.44 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 O-C-N 123.292 0.37 . . . . 0.0 111.03 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.64 75.85 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.328 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.25 57.88 1.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.355 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.27 17.76 77.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.277 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -143.97 69.58 1.28 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.423 0.63 . . . . 0.0 110.013 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.81 ' HA3' ' O ' ' A' ' 85' ' ' VAL . . . -83.58 -170.42 46.36 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.432 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 91' ' ' GLY . 21.2 m-85 -151.97 171.04 18.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.775 -0.712 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -144.18 143.7 31.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.404 ' HB2' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.13 74.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.519 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -77.9 174.21 11.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.37 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 59.56 19.42 7.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.35 162.79 53.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.198 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -154.4 147.46 24.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.432 ' CE2' ' O ' ' A' ' 100' ' ' THR . 54.2 t90 -141.49 165.23 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.366 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.5 t -106.06 156.7 18.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.86 -3.59 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.936 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 m -62.06 -16.1 49.57 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.935 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -125.09 150.75 46.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 7.7 m-85 -132.63 145.54 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 12.8 m -98.59 164.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 0.0 110.834 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 110' ' ' THR . 24.4 t30 -89.43 151.3 22.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.479 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.46 -17.93 6.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.4 -30.93 67.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.846 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.57 20.54 4.61 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.261 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -143.07 159.06 57.4 Favored Pre-proline 0 C--O 1.223 -0.319 0 CA-C-O 121.339 0.59 . . . . 0.0 111.44 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 77.3 Cg_exo -49.34 126.73 16.33 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.022 2.481 . . . . 0.0 113.31 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 96.86 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.318 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.51 169.99 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.17 90.69 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -164.97 121.75 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 84.1 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.04 116.07 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.888 0.375 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 41.2 t80 -91.24 175.92 6.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.186 0.517 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.453 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 19.4 t -117.24 160.74 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 94' ' ' GLN . 7.3 p -66.65 137.69 95.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . 43.5 Cg_endo -70.54 -171.01 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.51 2.14 . . . . 0.0 112.89 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -108.27 127.36 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.71 106.88 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.605 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 108.45 21.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 99' ' ' TRP . 3.8 mp -102.7 156.03 17.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 112.154 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -137.19 140.62 41.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.014 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . . . -86.49 100.87 12.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.176 0.512 . . . . 0.0 111.361 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 12.5 mm -74.73 141.95 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.309 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 26.2 t80 -104.16 141.05 21.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.57 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 77.3 Cg_endo -94.41 2.8 51.43 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.306 -1.122 . . . . 0.0 112.369 0.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.67 96.46 0.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.582 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -177.52 165.87 35.91 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 67' ' ' ARG . 4.8 tp -138.95 143.64 38.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -135.19 101.91 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -100.32 158.53 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -152.68 145.0 23.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.469 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -144.75 126.67 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.788 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 13.2 Cg_endo -56.67 95.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.454 2.103 . . . . 0.0 111.709 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.71 159.69 8.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.1 t0 -146.85 44.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.585 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.61 40.77 85.75 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.529 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 85' ' ' VAL . 9.7 m-85 -82.96 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.374 0.607 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -131.72 -27.53 1.9 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.515 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.69 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 6.7 tp -140.01 132.28 28.24 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.876 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.469 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 31.2 t80 -123.68 98.36 5.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.313 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 84' ' ' TYR . . . -91.88 124.85 36.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.7 t80 -116.95 122.69 45.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.352 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.585 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 51' ' ' HIS . . . -160.85 147.36 14.0 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 118.918 -1.611 . . . . 0.0 114.073 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 132.08 53.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.58 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.0 tp -79.82 105.69 11.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.557 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.1 t-20 76.59 65.39 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.6 tt0 171.98 109.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 32.4 mt-10 -53.36 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -172.34 122.99 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.413 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -118.47 70.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.381 . . . . 0.0 110.793 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.63 -129.15 2.83 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.416 HD21 ' CH2' ' A' ' 82' ' ' TRP . 35.5 mt -124.86 56.89 1.29 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.198 0.523 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -69.08 146.76 52.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.14 -24.38 10.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.672 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.43 -139.57 1.7 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.636 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 12.6 m170 -122.43 -74.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.163 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.7 m-90 -67.98 88.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.98 86.37 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 ttm180 -135.02 143.85 46.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.982 0.42 . . . . 0.0 111.707 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.76 118.62 37.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.627 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.1 151.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.7 p -140.24 42.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.133 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 98.19 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 58.8 Cg_exo -52.08 -176.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.506 2.138 . . . . 0.0 112.228 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -48.51 3.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.157 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.8 80.76 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.537 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . 70.81 2.05 42.86 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.7 mtt180 -156.79 133.43 10.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.711 -0.244 . . . . 0.0 110.597 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.456 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 10.4 m95 -79.77 153.97 28.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.3 m -135.2 120.26 18.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 44.0 t80 -110.55 82.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.521 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -92.3 126.94 37.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.291 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -138.04 111.44 8.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 22.29 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.345 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.59 31.24 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -108.48 127.0 53.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -87.24 75.86 9.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.0 mt -82.5 154.54 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -130.93 144.51 51.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.409 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 0.4 OUTLIER -67.35 131.46 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.386 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -24.69 25.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.622 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.36 159.97 7.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -108.36 164.83 11.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.634 HG13 ' CE3' ' A' ' 99' ' ' TRP . 5.1 mm -125.99 146.17 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 75.4 m-85 -144.44 130.92 19.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.413 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.467 ' CD1' HG22 ' A' ' 79' ' ' ILE . 4.0 p90 -161.57 -176.4 5.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 122.156 0.979 . . . . 0.0 113.607 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.557 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.5 p-90 -153.37 133.28 13.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.477 -1.692 . . . . 0.0 108.293 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 1.8 p -111.95 153.27 27.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.098 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 35' ' ' ALA . 17.5 t80 -136.39 141.02 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.277 0.361 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -128.85 163.25 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.69 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 25.6 mm -137.52 107.23 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.904 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.22 68.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t0 63.62 65.77 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 29.0 71.62 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.533 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.2 75.2 1.45 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.132 0.491 . . . . 0.0 110.146 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.23 159.08 27.21 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.505 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -152.43 150.47 29.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 83' ' ' THR . 18.1 ptt-85 -129.09 149.99 50.67 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.573 0.702 . . . . 0.0 112.87 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.404 ' N ' HG23 ' A' ' 9' ' ' VAL . 5.4 tt0 -105.58 75.22 1.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.768 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -74.92 172.44 12.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.396 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.1 t30 61.57 18.39 9.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.9 165.41 29.84 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.823 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -154.23 149.23 26.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.074 0.464 . . . . 0.0 111.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.634 ' CE3' HG13 ' A' ' 79' ' ' ILE . 28.6 t90 -151.99 164.57 36.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.984 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -114.21 163.05 15.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 1.7 t -129.67 15.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.715 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.6 p -56.29 -24.51 43.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.524 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -142.68 172.78 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CE1' HD21 ' A' ' 75' ' ' LEU . 13.8 m-85 -133.06 150.04 52.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.1 m -98.64 171.11 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.121 0.486 . . . . 0.0 110.928 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' THR . 19.3 t30 -92.21 151.23 20.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.08 -16.87 5.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.87 -29.35 64.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.275 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.65 15.03 6.52 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.129 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.3 p -139.47 163.28 46.46 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 110.822 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 89.0 Cg_exo -43.1 130.7 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.902 2.401 . . . . 0.0 113.328 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.0 112.97 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -113.56 148.72 35.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.795 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.57 38.55 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.0 m -59.04 167.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.31 79.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.12 94.68 6.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.845 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.441 2.094 . . . . 0.0 112.313 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.484 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 84.2 t80 -70.26 167.08 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.213 0.53 . . . . 0.0 110.911 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 41.6 t -140.3 160.61 25.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.191 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 85' ' ' VAL . 7.6 p -78.78 141.36 59.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' A' ' 27' ' ' PRO . 82.8 Cg_exo -51.66 -169.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.7 2.267 . . . . 0.0 112.291 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 t -107.29 139.73 41.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.236 0.541 . . . . 0.0 112.274 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 25' ' ' SER . . . -84.2 115.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.222 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.72 106.51 13.72 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 4.1 mp -97.98 152.03 19.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.244 0.545 . . . . 0.0 111.994 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -141.9 136.73 30.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.685 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.39 98.88 11.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.152 0.501 . . . . 0.0 111.188 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 27.1 mm -74.52 147.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.455 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -106.48 146.81 33.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.545 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 12.1 Cg_endo -90.59 3.6 67.81 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.159 -1.184 . . . . 0.0 112.353 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.86 79.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 68' ' ' ASP . . . -146.58 -172.12 16.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -154.69 142.62 20.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.12 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.7 99.31 4.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.42 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 18.4 t -116.95 142.2 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -146.15 141.75 27.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.464 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.533 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pp -135.9 120.15 12.97 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.762 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 10' ' ' PRO . 86.2 Cg_exo -46.27 123.09 6.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.115 1.877 . . . . 0.0 112.172 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.2 t0 -79.02 158.88 27.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.191 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -145.37 46.44 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.867 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.41 37.58 86.01 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.478 ' CD1' HG23 ' A' ' 85' ' ' VAL . 14.4 m-85 -82.94 -172.16 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.266 0.555 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ILE . 48.4 t -131.59 -26.47 2.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.799 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.728 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 12.2 tp -146.45 132.95 19.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.334 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.1 t80 -117.99 106.19 12.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 84' ' ' TYR . . . -103.79 118.4 36.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 52' ' ' TRP . 24.2 t80 -106.23 125.84 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -124.95 122.72 38.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.81 137.83 5.84 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 118.853 -1.642 . . . . 0.0 114.252 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -111.53 142.46 43.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.28 125.69 42.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.987 0.422 . . . . 0.0 111.192 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 63.78 50.94 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.9 tt0 176.42 109.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.578 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 44.8 mt-10 -57.49 -167.64 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.373 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.54 157.53 14.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -143.29 49.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.469 . . . . 0.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.67 -137.87 4.81 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.419 HD22 ' CH2' ' A' ' 82' ' ' TRP . 23.3 mt -121.02 67.11 0.86 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.264 0.554 . . . . 0.0 111.094 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 1.4 mt-10 -87.67 147.34 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.939 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.475 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -53.35 -26.04 17.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.813 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.32 -117.03 3.45 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.379 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 m80 -140.41 -73.4 0.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.437 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.7 m-90 -60.39 90.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.05 87.29 2.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CB ' ' CE1' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -131.77 118.08 19.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.007 0.432 . . . . 0.0 111.617 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -92.99 106.45 18.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.9 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.42 148.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.614 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 t -140.1 39.34 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.421 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.41 99.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.468 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.1 Cg_exo -51.73 -175.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.438 2.092 . . . . 0.0 112.362 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -116.82 -67.12 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.069 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.47 84.35 1.37 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.747 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.82 -0.73 34.98 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -157.81 160.38 37.71 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.69 0.281 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.468 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 5.7 m95 -94.92 156.2 16.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.855 0.359 . . . . 0.0 110.225 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -134.69 116.24 14.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 54' ' ' ARG . 11.1 t80 -110.94 112.7 24.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.393 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 2.4 t0 -138.06 107.88 6.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -89.21 22.59 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.53 33.09 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.12 105.27 16.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -73.82 75.89 1.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.6 mt -87.25 156.83 19.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.46 134.92 34.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 131.65 49.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.264 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.01 -29.92 9.22 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.05 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.517 ' HB3' HG23 ' A' ' 101' ' ' VAL . 7.3 t70 -69.22 162.45 27.08 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.08 172.5 6.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.988 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.537 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.7 mp -127.85 142.44 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.785 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 47.2 m-85 -144.31 128.18 17.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 3.7 p90 -161.13 -177.56 6.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.474 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 55.8 p-90 -149.12 131.19 15.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.151 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -100.48 155.47 17.82 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.823 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.439 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 8.2 t80 -134.87 148.15 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.763 0.316 . . . . 0.0 111.057 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -137.91 165.31 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.957 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.664 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 16.8 mm -141.4 107.7 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 O-C-N 123.069 0.231 . . . . 0.0 111.025 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.68 62.58 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.446 0.466 . . . . 0.0 110.56 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 t70 69.28 65.72 0.27 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.32 28.21 71.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.83 74.22 1.42 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.01 161.67 45.79 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.403 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -152.18 148.99 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -134.17 143.11 47.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.4 tt0 -102.54 76.52 1.54 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 5.0 p-10 -77.2 -179.06 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.27 16.23 8.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.657 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.41 162.49 49.79 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.004 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -154.42 152.59 30.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 0.0 111.251 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.537 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 26.7 t90 -155.07 164.94 38.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.061 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -108.48 158.57 17.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 77' ' ' ASP . 2.6 t -119.85 -7.11 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.98 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.4 t -66.04 -8.42 23.12 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -134.34 137.2 43.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.053 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 4.4 m-85 -122.08 154.99 36.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.67 151.75 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.112 0.482 . . . . 0.0 110.942 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 110' ' ' THR . 7.0 m-20 -82.16 153.48 25.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -55.49 -17.25 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.39 -30.72 64.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.047 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.24 5.28 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.416 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.7 p -142.84 161.48 48.75 Favored Pre-proline 0 CA--C 1.517 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.0 111.107 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 82.9 Cg_exo -44.95 128.43 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.935 2.424 . . . . 0.0 113.264 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.85 93.22 8.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.355 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -171.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -66.56 -33.67 76.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.7 t 61.98 179.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 pp -136.19 79.85 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.9 120.22 70.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.443 2.095 . . . . 0.0 112.304 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 65.6 t80 -61.74 170.22 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 110.773 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.481 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 11.2 t -104.93 157.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.7 p -68.66 138.41 90.86 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.473 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.0 -178.46 2.45 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.61 2.206 . . . . 0.0 111.893 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -103.71 120.9 41.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.471 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.0 109.23 16.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -90.05 130.18 36.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.365 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.422 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mp -121.98 154.79 36.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.145 0.498 . . . . 0.0 111.741 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 3.2 mp0 -147.54 144.62 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.111 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB2' ' CG ' ' A' ' 104' ' ' PHE . . . -86.98 130.61 34.39 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.006 0.432 . . . . 0.0 111.4 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.7 mm -109.55 134.55 51.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.306 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -98.26 144.1 27.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.452 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.459 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.4 Cg_endo -90.35 -7.18 45.47 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.423 0.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -159.11 93.08 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.07 165.33 38.66 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.632 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.84 137.03 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.87 121.89 39.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -121.28 151.86 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -155.03 144.88 21.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.497 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.5 127.64 12.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 52.8 Cg_exo -53.96 106.71 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.238 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 36.4 t0 -76.07 144.84 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.002 0.43 . . . . 0.0 111.296 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 1.8 m-20 -132.59 44.95 2.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.954 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.99 53.64 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 12.7 m-85 -82.04 -170.88 3.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.341 0.591 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 1.1 t -130.92 -29.32 1.89 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.449 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.6 tp -140.47 136.01 32.55 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.811 -0.755 . . . . 0.0 112.396 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.497 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 14.3 t80 -123.74 104.16 8.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.371 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.35 126.67 45.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.811 0.339 . . . . 0.0 110.746 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.3 t80 -113.51 124.07 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.433 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.582 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -126.97 115.48 19.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.24 139.09 6.95 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 118.572 -1.775 . . . . 0.0 114.571 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -122.18 126.86 49.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.7 141.32 28.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.71 40.62 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -176.9 109.55 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.4 mt-10 -50.71 -172.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.992 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.38 135.43 54.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.067 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -150.64 64.14 0.93 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . 113.99 129.24 4.84 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 82' ' ' TRP . 6.9 mt -43.03 91.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 111.675 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' GLY . 4.6 mt-10 -116.7 154.04 31.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.932 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -55.84 -22.91 27.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.9 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.58 -108.98 0.69 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.042 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t-80 -133.9 -73.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.947 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.46 ' O ' ' O ' ' A' ' 36' ' ' PHE . 27.9 m-90 -72.04 92.74 1.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.55 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.189 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.447 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 21.5 tpt180 -149.18 133.23 17.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.884 0.373 . . . . 0.0 111.947 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.75 143.35 26.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.713 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 mt -126.87 142.82 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.158 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -134.22 30.68 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.77 89.38 4.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 57.2 Cg_exo -51.89 171.85 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.578 2.186 . . . . 0.0 112.576 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.36 34.96 3.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.96 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.95 87.85 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.226 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.1 -5.82 12.47 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.818 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 9.4 mtt-85 -157.48 130.67 7.73 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.299 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.464 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 12.5 m95 -78.13 154.8 30.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.963 0.411 . . . . 0.0 110.02 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 97.1 m -134.76 118.54 17.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.217 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 82.5 t80 -120.81 91.8 3.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 146.19 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -138.04 106.89 5.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.25 22.35 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.651 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -134.65 43.45 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.09 123.24 42.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -73.94 76.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 142.42 30.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 158.78 38.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -68.87 133.37 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.93 -27.99 15.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.46 164.48 3.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.089 0.471 . . . . 0.0 111.084 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.1 153.58 42.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.419 ' CG2' ' CE1' ' A' ' 81' ' ' PHE . 1.4 mp -113.42 143.1 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.987 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.6 m-85 -144.18 125.71 14.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 5.0 p90 -161.09 -174.5 4.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 122.439 1.114 . . . . 0.0 113.939 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.464 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 16.4 p-90 -151.59 129.85 12.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.034 -1.894 . . . . 0.0 108.148 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.86 161.0 13.88 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.783 -178.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CZ ' HD13 ' A' ' 86' ' ' ILE . 18.3 t80 -141.59 137.87 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.622 0.248 . . . . 0.0 110.566 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -130.94 162.42 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.5 mm -135.16 105.79 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.855 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 66.81 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.529 0.518 . . . . 0.0 110.546 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.17 61.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.93 29.01 63.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 mt -143.82 74.16 1.42 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.134 0.492 . . . . 0.0 110.208 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.83 159.68 42.24 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.542 -0.753 . . . . 0.0 114.595 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -152.44 144.14 23.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.613 -0.793 . . . . 0.0 108.985 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -128.5 140.11 51.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.416 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.92 77.49 2.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.556 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 8.9 p-10 -80.8 176.28 9.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.417 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 60.57 18.31 8.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.36 162.02 50.77 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.131 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.42 158.72 40.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CE2' ' O ' ' A' ' 100' ' ' THR . 58.8 t90 -155.1 166.6 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.255 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 4.7 t -109.83 160.09 16.65 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.68 2.12 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -63.77 -13.44 43.95 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -131.33 150.87 51.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.034 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' A' ' 16' ' ' ALA . 9.3 m-85 -131.73 145.21 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.165 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.4 m -98.6 163.22 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' THR . 33.8 t30 -83.9 152.52 24.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -55.96 -17.11 5.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.31 -30.72 65.04 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.914 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.87 17.85 5.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.446 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 p -137.95 159.19 69.56 Favored Pre-proline 0 C--O 1.222 -0.342 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 77.6 Cg_exo -48.87 128.46 19.0 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.959 2.439 . . . . 0.0 113.286 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.96 124.28 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.94 133.69 48.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -59.55 93.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.82 161.71 37.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -85.22 57.46 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.98 130.31 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--O 1.251 1.146 0 C-N-CA 122.449 2.099 . . . . 0.0 112.387 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 68.2 t80 -61.05 169.68 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 3.3 p -105.57 179.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.379 0.609 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' H ' ' CG2' ' A' ' 8' ' ' VAL . 7.3 p -81.36 137.75 48.57 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.237 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.35 -174.49 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.586 2.191 . . . . 0.0 112.145 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.71 118.63 37.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.378 . . . . 0.0 111.888 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 26' ' ' ILE . . . -76.8 105.68 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.431 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.95 107.23 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.048 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD21 ' CE2' ' A' ' 36' ' ' PHE . 4.9 mp -96.45 159.22 15.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.232 0.539 . . . . 0.0 111.773 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.12 137.24 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.47 102.63 14.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.207 0.527 . . . . 0.0 111.058 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.472 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 25.2 mm -73.1 135.51 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.409 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 57.9 t80 -94.89 141.28 23.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.695 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.3 Cg_endo -92.31 -3.29 49.77 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.432 0.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.84 94.95 0.87 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -168.96 -171.08 34.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.387 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' ' CD1' ' A' ' 52' ' ' TRP . 13.3 tp -156.93 147.7 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.71 106.65 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.0 157.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -155.03 146.72 23.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 111.589 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.549 HG12 ' CE2' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -141.83 130.52 12.12 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.57 101.54 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.184 1.923 . . . . 0.0 111.052 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 22.8 t70 -69.14 149.8 48.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.298 0.57 . . . . 0.0 111.899 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 9.1 t70 -131.35 42.78 3.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.492 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.02 45.82 30.81 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.702 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 12.5 m-85 -87.5 -171.49 3.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.329 0.585 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ILE . 88.6 p -128.64 -29.18 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.498 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.661 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 9.0 tp -142.63 140.53 31.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.593 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 26' ' ' ILE . 46.1 t80 -133.23 99.75 4.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.61 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 54' ' ' ARG . . . -98.2 117.82 33.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.547 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.452 ' CE2' HD21 ' A' ' 14' ' ' LEU . 28.0 t80 -104.94 120.16 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.029 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.491 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -116.82 128.77 55.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.414 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -156.19 132.37 3.31 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.05 -1.548 . . . . 0.0 114.161 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -106.65 144.69 32.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.5 tp -98.97 124.79 44.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.016 0.436 . . . . 0.0 111.547 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 t-20 65.11 49.36 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 60.7 tt0 175.81 109.82 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 110.613 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.7 mt-10 -55.26 -175.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.766 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.11 156.82 43.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.438 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.57 44.11 1.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.247 0.546 . . . . 0.0 110.429 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.37 -134.02 3.14 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.439 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.439 ' CD2' ' CH2' ' A' ' 82' ' ' TRP . 18.0 mt -124.42 75.32 1.39 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 120.956 0.408 . . . . 0.0 111.026 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 4.7 mt-10 -98.85 145.73 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -49.16 -36.03 18.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.869 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.76 -112.33 3.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.026 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 66.0 t60 -145.19 -74.2 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.686 0.279 . . . . 0.0 110.919 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.49 ' CD1' ' CD2' ' A' ' 22' ' ' LEU . 7.7 m-90 -63.79 101.07 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.29 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.93 76.63 1.03 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -96.41 114.3 25.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.502 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.43 95.54 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.161 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -104.03 152.89 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.269 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -121.26 -8.53 9.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -135.38 120.09 13.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.484 0.183 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.466 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.6 Cg_exo -58.13 -165.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.456 2.104 . . . . 0.0 112.33 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -119.49 -44.9 2.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.223 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ARG . 1.5 tp10 -178.59 82.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.711 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 -7.18 19.79 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -157.38 149.75 22.84 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.504 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.47 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 4.8 m95 -88.21 150.83 23.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.89 0.376 . . . . 0.0 110.163 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -135.52 122.06 20.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.547 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 37.4 t80 -109.22 154.02 22.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 118.78 10.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 0.0 111.229 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.444 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.3 t70 -121.34 98.37 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 22.59 2.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.553 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.33 27.99 4.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.42 100.99 10.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -73.79 75.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.041 0.448 . . . . 0.0 110.67 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.401 ' HB3' ' CG1' ' A' ' 101' ' ' VAL . 57.3 mt -91.57 142.15 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -125.55 146.44 49.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.19 144.92 14.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.08 -35.05 4.44 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.244 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.53 ' HB3' HG22 ' A' ' 101' ' ' VAL . 11.1 t0 -62.15 149.54 41.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -108.31 168.28 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 3.0 mp -124.92 145.8 31.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.196 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.8 m-85 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -159.9 -177.53 6.4 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.488 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 57.4 p-90 -153.54 135.05 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.894 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 72.1 p -99.55 166.69 11.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.071 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 15.9 t80 -150.01 108.69 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.667 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.4 m -102.8 169.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.66 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.661 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 28.3 mm -144.53 101.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.537 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -96.16 62.26 2.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 t0 64.35 62.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.84 60.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mt -143.29 71.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.21 0.528 . . . . 0.0 110.157 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -75.84 160.53 51.71 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.333 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CZ ' ' O ' ' A' ' 7' ' ' TYR . 58.4 m-85 -152.19 140.79 20.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' THR . 8.0 ptt180 -121.84 144.59 48.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.443 ' CA ' HG12 ' A' ' 9' ' ' VAL . 12.4 tt0 -105.4 69.62 0.85 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.689 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.2 p30 -78.24 176.14 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.516 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.8 t30 61.42 17.57 8.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.38 164.75 53.59 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.12 152.03 29.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 26.8 t90 -148.63 164.06 35.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.976 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -107.26 159.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 77' ' ' ASP . 13.8 t -118.7 -5.22 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.814 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.4 p -69.12 -5.23 20.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.09 149.1 48.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.451 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 5.7 m-85 -133.83 148.47 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.038 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 7.8 m -98.64 168.04 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.262 0.553 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 110' ' ' THR . 9.4 m-20 -94.99 149.67 21.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.436 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -18.82 8.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.15 -30.86 70.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.879 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.68 23.4 3.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.323 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -149.44 159.07 37.33 Favored Pre-proline 0 CA--C 1.517 -0.322 0 CA-C-O 121.453 0.644 . . . . 0.0 111.758 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 76.8 Cg_exo -49.15 125.55 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.163 2.575 . . . . 0.0 113.236 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 69.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.191 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.3 173.1 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.2 p -100.86 34.76 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -127.48 144.1 51.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.65 66.7 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.89 120.36 81.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.429 2.086 . . . . 0.0 112.352 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 43.1 t80 -77.64 176.87 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 18.9 t -119.38 160.02 19.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 94' ' ' GLN . 8.2 p -70.37 138.05 86.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 9' ' ' VAL . 37.9 Cg_endo -67.18 -168.36 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.486 2.124 . . . . 0.0 112.662 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -105.22 117.66 34.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.451 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.92 99.42 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.616 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -82.16 152.26 26.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.586 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 mp -145.24 157.79 43.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.581 . . . . 0.0 112.07 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 8.8 mt-10 -150.03 142.92 24.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.977 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' CG ' ' A' ' 104' ' ' PHE . . . -86.26 101.68 13.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 111.547 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 26.7 mm -71.82 122.94 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.199 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.488 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 34.0 t80 -87.45 141.83 32.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 90.3 Cg_endo -96.27 5.15 42.91 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.512 0.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -164.65 96.69 0.75 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.765 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . 177.07 166.16 33.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.507 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.47 120.76 7.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.715 0.293 . . . . 0.0 110.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -109.88 133.1 53.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.985 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 22.1 t -121.74 155.06 26.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.339 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.408 ' N ' HG11 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.63 147.07 29.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.788 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.485 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pt -146.11 127.49 7.47 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.451 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 22.8 Cg_endo -60.72 96.94 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.456 2.104 . . . . 0.0 111.463 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 24.1 t0 -59.97 154.94 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.632 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.428 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t70 -139.37 43.6 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.571 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.28 41.51 52.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.709 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.5 m-85 -85.24 -170.83 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.375 0.607 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -131.83 -28.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.544 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.675 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 10.1 tp -139.68 135.67 33.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.378 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 29.9 t80 -126.95 103.3 7.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.387 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.36 118.2 36.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.643 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.4 t80 -105.91 128.47 53.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.505 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -119.28 129.37 54.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -147.07 142.37 10.24 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 118.765 -1.683 . . . . 0.0 114.615 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -119.64 124.55 46.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.347 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 tp -81.7 112.99 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.824 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.5 t-20 58.89 65.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.9 tt0 174.28 110.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 38.1 mt-10 -54.5 -168.93 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -152.05 145.54 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.686 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.63 44.57 2.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.187 0.518 . . . . 0.0 110.408 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.56 -140.75 7.41 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.42 HD23 ' CH2' ' A' ' 82' ' ' TRP . 18.4 mt -119.49 73.82 0.97 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.989 0.423 . . . . 0.0 110.977 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.25 143.71 26.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.093 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.25 -25.87 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.796 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.22 -107.9 0.31 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.47 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.2 t60 -138.38 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 15.8 m-90 -65.56 87.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.58 86.36 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -133.41 126.65 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.001 0.429 . . . . 0.0 111.964 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.6 109.55 21.45 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.363 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 56' ' ' ILE . 18.3 mt -93.3 141.01 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -129.58 23.79 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.91 87.61 7.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 53.6 Cg_exo -52.72 171.46 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.613 2.209 . . . . 0.0 112.538 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 63' ' ' ARG . 4.5 tptm -109.97 36.46 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.678 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 4.5 mt-10 76.64 88.99 0.08 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.22 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.6 -3.68 24.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.2 mtp180 -157.29 129.04 7.03 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.444 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.479 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 7.9 m95 -81.53 150.28 28.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -135.07 121.92 21.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.442 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 18.0 t80 -110.44 143.89 40.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.427 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -141.76 118.1 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.197 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 16.1 t70 -126.87 101.56 6.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.636 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.21 22.42 2.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.72 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -123.09 28.77 7.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.29 106.9 15.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -73.93 76.94 1.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.806 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -78.89 166.31 22.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.676 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.81 149.16 46.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD23 ' CE1' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -67.66 131.3 45.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.257 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.51 -26.23 16.89 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -58.26 158.73 6.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.229 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.96 14.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.592 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -122.66 150.95 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.296 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 78.1 m-85 -144.4 130.37 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -161.23 -178.45 6.72 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.15 0.976 . . . . 0.0 113.48 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.5 p-90 -155.03 132.35 11.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.91 163.01 12.63 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.417 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 40.9 t80 -144.26 122.39 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.772 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -117.75 163.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.675 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 32.9 mm -136.39 109.27 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.582 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -103.77 74.4 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.034 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 t0 58.05 48.21 13.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.27 30.18 20.3 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.332 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mt -143.94 75.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.157 0.503 . . . . 0.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.34 158.95 44.35 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.429 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -152.35 150.1 29.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.63 -0.785 . . . . 0.0 108.932 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.54 147.47 52.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.447 ' N ' HG22 ' A' ' 9' ' ' VAL . 4.1 tt0 -107.37 73.51 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.8 p30 -85.75 -179.88 6.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.523 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 t30 61.07 18.21 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.518 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.18 163.14 42.95 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.27 128.82 9.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 100' ' ' THR . 47.5 t90 -120.1 170.18 9.53 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 3.7 t -110.62 160.95 16.21 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.71 15.17 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.667 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.443 ' HA ' HD13 ' A' ' 75' ' ' LEU . 26.8 p -58.79 -24.55 61.99 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.892 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -137.31 161.33 36.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.856 0.36 . . . . 0.0 111.177 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.444 ' CE1' HD23 ' A' ' 75' ' ' LEU . 9.5 m-85 -130.18 145.86 51.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.796 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 m -98.53 167.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.093 0.473 . . . . 0.0 110.502 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 110' ' ' THR . 10.0 m-20 -89.2 150.36 22.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.423 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.87 -18.26 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.3 -30.57 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.079 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.72 18.25 5.29 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.245 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.4 p -141.89 162.25 47.12 Favored Pre-proline 0 C--O 1.222 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 80.2 Cg_exo -44.02 129.93 7.96 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.87 2.38 . . . . 0.0 113.445 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.09 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.365 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -132.58 -171.36 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.4 m -104.11 85.08 2.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -65.57 164.86 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.13 90.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.49 142.77 25.22 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.504 2.136 . . . . 0.0 112.324 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.79 0.329 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.1 t80 -90.72 174.26 7.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.464 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 15.8 t -111.84 159.56 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG12 ' CA ' ' A' ' 94' ' ' GLN . 7.6 p -68.63 135.32 90.41 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.499 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 16.5 Cg_exo -66.68 -173.6 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.618 2.212 . . . . 0.0 112.236 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.26 125.24 51.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -85.37 106.23 16.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.958 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 ttmt -92.32 119.84 32.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.621 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 5.1 mp -108.14 158.72 17.18 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -146.12 140.63 26.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.116 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CH2' ' A' ' 99' ' ' TRP . . . -86.34 120.27 27.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.305 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 19.8 mm -92.62 130.72 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.342 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -92.14 142.49 26.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.614 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.2 Cg_endo -93.23 -0.96 51.59 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.386 0.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.59 94.93 0.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.473 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.86 173.11 46.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.476 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.29 130.01 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 111.07 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.26 115.5 23.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.719 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 5.3 t -110.86 161.5 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -152.68 143.58 22.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.046 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.59 124.06 10.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.479 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 10.8 Cg_endo -56.61 99.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.058 1.838 . . . . 0.0 111.359 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.1 t0 -65.51 160.07 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.809 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 4.1 t0 -143.23 43.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.96 42.68 68.19 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.808 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CD1' HG22 ' A' ' 85' ' ' VAL . 12.2 m-85 -84.2 -170.53 3.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.282 0.563 . . . . 0.0 111.114 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -131.97 -28.01 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.645 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 9.6 tp -140.27 134.91 31.7 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.189 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 47.8 t80 -127.4 90.3 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.67 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.1 125.4 32.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 14.2 t80 -115.04 124.02 50.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.345 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.544 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.08 122.31 36.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.06 147.01 15.07 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.972 -1.585 . . . . 0.0 114.112 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.79 155.36 39.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.444 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -92.72 115.23 27.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER 59.88 71.9 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 74.2 tt0 174.31 110.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 31.4 mt-10 -56.31 -167.57 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.135 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.5 mtp -145.95 143.28 29.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -135.69 81.13 1.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 84.47 99.84 0.63 Allowed Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.4 mt 18.46 96.19 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.725 0.81 . . . . 0.0 112.824 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -109.3 140.97 42.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.642 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.81 -26.37 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.664 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.79 -160.2 0.12 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.635 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -100.6 -74.22 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 110.696 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 14.7 m-90 -63.49 91.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -118.15 91.28 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.255 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.468 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.8 tmm_? -145.85 125.34 13.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.679 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.72 128.25 35.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.853 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.99 159.51 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.842 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t -148.39 39.98 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 111.23 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -175.77 96.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 74.4 Cg_exo -49.75 179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.403 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -106.55 -58.43 1.93 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.194 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 82.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.382 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . 74.09 -2.42 43.49 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 33.6 mtt85 -156.66 147.25 21.59 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.354 0.261 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.45 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 9.9 m95 -83.91 159.11 21.37 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.64 118.02 16.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.409 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 36' ' ' PHE . 8.3 t80 -99.8 94.59 6.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.313 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -93.34 124.93 37.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.378 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.6 t70 -138.12 97.57 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.25 22.36 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -133.87 44.15 2.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.74 115.64 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.068 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.96 76.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mt -82.81 164.98 20.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -141.68 150.53 42.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.979 0.419 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.58 132.89 46.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.304 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.61 -26.4 16.24 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.5 165.95 3.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.66 163.32 16.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.383 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -117.6 148.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 3.9 m-85 -144.33 129.71 18.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.0 p90 -161.1 -175.51 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 122.0 0.905 . . . . 0.0 113.2 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.472 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 32.2 p-90 -157.03 124.65 5.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.859 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.6 p -107.2 151.26 25.66 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.981 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 86' ' ' ILE . 24.4 t80 -133.81 124.58 26.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.229 0.331 . . . . 0.0 111.043 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -108.28 163.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.65 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 22.4 mm -136.91 114.31 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.911 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 70.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.4 t0 66.45 62.38 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.2 28.64 72.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.637 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.4 mt -145.06 77.91 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.171 0.51 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -93.17 161.87 25.67 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.627 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -152.13 147.51 26.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -122.97 151.62 41.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' CA ' HG12 ' A' ' 9' ' ' VAL . 4.2 tt0 -106.49 73.98 0.99 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.504 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.6 p30 -84.96 179.59 7.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.442 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 58.55 19.53 6.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.916 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.85 163.46 33.47 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.279 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.27 161.58 41.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.521 ' CZ2' ' HA ' ' A' ' 15' ' ' GLU . 54.8 t90 -146.43 169.06 19.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.526 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' CZ3' ' A' ' 99' ' ' TRP . 5.1 t -105.22 154.81 19.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.25 17.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.295 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -70.49 -10.71 59.89 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -127.29 162.73 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 75' ' ' LEU . 6.3 m-85 -135.29 123.53 23.08 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.98 153.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 110.852 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.79 155.42 39.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.603 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.25 -16.87 6.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -73.25 -31.73 64.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.895 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.76 7.16 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.288 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 p -127.21 157.49 72.23 Favored Pre-proline 0 CA--C 1.515 -0.38 0 CA-C-O 121.252 0.548 . . . . 0.0 110.977 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.31 129.02 32.46 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.775 2.317 . . . . 0.0 112.955 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.28 62.84 1.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.015 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -57.22 122.62 12.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.2 p -137.54 -42.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.0 53.89 0.46 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.951 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 40.17 67.55 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.721 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 60.99 155.55 0.11 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.526 2.15 . . . . 0.0 112.189 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.843 0.354 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.0 t80 -77.64 173.16 12.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.177 0.513 . . . . 0.0 110.793 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 16.2 t -110.89 160.71 9.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.236 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 94' ' ' GLN . 12.5 p -66.39 132.15 94.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.492 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.492 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.6 Cg_exo -64.19 -177.13 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.549 2.166 . . . . 0.0 111.933 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.6 122.69 47.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -81.14 109.79 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -95.3 102.35 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.162 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 2.1 mp -90.29 162.65 15.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.102 0.477 . . . . 0.0 111.935 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HB3' HG13 ' A' ' 105' ' ' VAL . 37.9 mt-10 -146.58 140.28 25.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.09 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . . . -86.73 110.62 20.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.995 0.426 . . . . 0.0 111.448 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.519 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 16.9 mm -83.41 159.73 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.486 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 8.8 t80 -122.57 140.82 33.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.597 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 8.8 Cg_endo -88.96 1.78 68.97 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.4 -1.083 . . . . 0.0 112.419 0.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.8 98.21 0.3 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.929 0.395 . . . . 0.0 111.008 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -166.59 -173.13 34.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.437 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 52' ' ' TRP . 6.7 tp -155.81 137.61 14.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.63 106.72 7.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.37 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -114.26 155.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.416 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.86 145.01 25.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.643 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -138.21 127.02 14.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.6 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.4 Cg_endo -58.4 93.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.344 2.029 . . . . 0.0 111.706 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.6 t0 -58.6 160.82 5.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.628 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 6.0 t0 -145.62 44.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.39 44.06 60.13 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.961 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.2 m-85 -88.28 -170.88 3.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.465 0.65 . . . . 0.0 111.22 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -131.69 -28.94 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.476 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 8.7 tp -138.38 135.3 35.19 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.163 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 37.1 t80 -125.44 98.58 5.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.028 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.88 126.22 37.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 111.062 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 52' ' ' TRP . 25.3 t80 -115.86 123.05 47.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -127.07 120.64 29.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.83 135.23 4.93 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 118.587 -1.768 . . . . 0.0 114.792 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -105.89 147.75 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.126 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.1 tp -97.19 125.26 41.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.279 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 56.8 57.72 4.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 76.5 tt0 174.64 109.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.14 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' C ' ' HG2' ' A' ' 44' ' ' MET . 60.7 mt-10 -53.11 176.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.471 ' HG2' ' C ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -141.24 138.97 33.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.276 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -132.86 48.08 2.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.112 0.482 . . . . 0.0 110.761 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.36 -138.74 5.6 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.9 mt -119.26 69.41 0.82 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.189 0.519 . . . . 0.0 111.0 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -91.15 145.86 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.996 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.4 -25.65 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.9 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.71 -117.71 3.14 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.454 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' GLY . 1.1 t60 -137.48 -73.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.768 0.318 . . . . 0.0 110.555 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.8 m-90 -69.98 90.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.32 90.16 3.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.135 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.19 130.17 18.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 112.035 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.26 123.6 34.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.554 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -102.46 143.32 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.234 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -134.31 34.57 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.27 91.87 1.69 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 48.4 Cg_exo -55.88 170.03 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.57 2.18 . . . . 0.0 112.451 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.73 34.49 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.929 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 80.81 87.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.38 -1.75 25.37 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.735 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HG2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -157.14 125.3 5.55 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.393 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.46 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 18.4 m95 -77.48 156.6 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.2 m -134.59 118.93 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.41 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 54.0 t80 -111.24 93.13 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.6 139.7 30.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.408 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.1 t70 -138.02 106.12 5.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.23 22.43 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.667 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -135.31 31.78 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.99 108.71 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.01 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -73.71 83.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.5 mt -86.08 115.48 23.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.016 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.87 131.43 52.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.02 133.57 32.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.432 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.94 -29.71 11.61 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 101' ' ' VAL . 30.9 t0 -65.85 160.9 22.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -119.37 160.23 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.2 mp -114.75 146.79 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.786 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 33.7 m-85 -144.23 125.05 14.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.598 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.8 p90 -161.08 -174.29 4.29 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.208 1.004 . . . . 0.0 113.404 -178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -151.01 127.43 10.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.378 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 24.4 p -107.07 149.7 27.32 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.461 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.429 ' CE2' HD13 ' A' ' 86' ' ' ILE . 17.4 t80 -131.51 146.4 52.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.306 0.379 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.55 162.52 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.103 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.634 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 31.1 mm -134.52 117.13 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.813 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -114.6 65.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t0 66.87 64.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.39 71.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.407 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.1 mt -144.96 77.9 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.233 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.81 161.25 28.11 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.47 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -152.18 139.7 19.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -123.3 145.07 49.0 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.434 ' N ' HG22 ' A' ' 9' ' ' VAL . 28.1 tt0 -100.35 75.74 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.923 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.8 p-10 -79.97 176.5 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.06 19.65 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.809 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.07 165.81 52.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.264 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.15 161.09 42.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.962 0.411 . . . . 0.0 111.225 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.447 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 55.7 t90 -155.21 166.25 34.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 5.6 t -107.03 158.01 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 77' ' ' ASP . 3.8 t -122.33 -3.26 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.099 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -62.02 -16.08 49.07 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.28 161.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.628 0.251 . . . . 0.0 110.574 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 16' ' ' ALA . 45.5 m-85 -137.99 138.01 38.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.447 ' HA ' ' N ' ' A' ' 112' ' ' ALA . 3.2 m -98.27 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.298 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 110' ' ' THR . 18.3 m-20 -114.7 145.81 41.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.674 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.37 -19.87 10.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -67.2 -29.35 69.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.857 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.63 25.57 3.09 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.615 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.4 p -145.14 151.76 49.2 Favored Pre-proline 0 CA--C 1.514 -0.416 0 CA-C-O 121.497 0.665 . . . . 0.0 112.42 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 37.7 Cg_exo -59.65 69.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.56 2.84 . . . . 0.0 114.293 -178.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.447 ' N ' ' HA ' ' A' ' 105' ' ' VAL . . . 68.62 155.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.549 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.4 109.01 6.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -135.49 71.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.6 -171.21 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.14 78.62 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -118.54 127.51 26.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.759 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.413 2.075 . . . . 0.0 112.313 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.762 0.315 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 46.9 t80 -60.0 173.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.071 0.462 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 17.6 t -117.21 159.89 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.393 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 94' ' ' GLN . 7.5 p -70.36 137.93 86.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD2' HG12 ' A' ' 85' ' ' VAL . 26.0 Cg_endo -63.64 -174.71 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.428 2.085 . . . . 0.0 112.554 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -110.1 116.48 31.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.546 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -73.38 99.58 2.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -87.45 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.991 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 4.0 mp -105.7 163.84 12.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.268 0.556 . . . . 0.0 112.16 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -151.06 140.27 21.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.893 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 104' ' ' PHE . . . -86.64 119.14 26.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.374 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.511 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.5 mm -93.42 152.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -116.44 149.18 43.26 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 3.2 Cg_exo -81.06 -6.99 44.27 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.221 0.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -168.36 93.46 0.35 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 111.0 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.511 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -158.47 -167.92 19.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.366 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 tp -158.19 148.3 20.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.082 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.19 104.79 4.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.647 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 17.2 t -113.28 159.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 111.476 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.08 145.01 21.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -142.35 115.9 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.953 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 85.0 Cg_exo -47.13 105.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.166 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 32.4 t0 -71.51 148.9 46.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.205 0.526 . . . . 0.0 111.21 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.2 t0 -134.72 45.34 2.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.488 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.67 36.98 76.55 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.282 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.5 m-85 -78.14 -172.19 2.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 86' ' ' ILE . 95.7 p -133.08 -26.91 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.771 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.8 tp -140.57 128.12 21.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.386 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 13.6 t80 -120.6 93.78 4.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.936 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.82 120.35 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.975 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 52' ' ' TRP . 37.9 t80 -106.18 130.36 54.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.465 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.98 116.41 20.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -155.61 139.79 6.87 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.551 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' A' ' 51' ' ' HIS . 9.6 tptp -117.04 145.56 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.6 tp -93.43 122.6 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 111.146 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.8 t-20 57.25 66.46 1.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 42.8 tt0 170.27 111.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -54.9 -168.92 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.9 mtp -143.47 120.37 11.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.053 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 57.79 3.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 85.17 103.75 0.66 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.536 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.4 mt 29.04 77.38 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.405 0.682 . . . . 0.0 112.6 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 19.1 mm-40 -95.26 155.71 16.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.56 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -44.85 -40.18 5.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.6 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.32 176.23 0.07 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 53' ' ' ALA . 6.3 m-70 -79.84 -78.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.534 0.207 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.2 m-90 -57.21 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.49 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 51' ' ' HIS . . . -118.5 90.09 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.252 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 4.4 ttp180 -149.12 133.21 17.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 111.955 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -91.04 136.56 32.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.8 148.62 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 111.193 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.1 p -137.84 22.55 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -146.79 88.49 5.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 56.0 Cg_exo -52.17 171.44 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.587 2.191 . . . . 0.0 112.641 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.72 39.8 1.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.657 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 74.01 89.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.432 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.71 -5.26 17.77 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.5 mtp180 -157.56 132.69 8.83 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.621 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.472 ' CZ2' ' HG3' ' A' ' 59' ' ' PRO . 12.3 m95 -81.81 156.45 24.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -134.62 119.38 18.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.393 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 3.1 t80 -112.86 89.62 3.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.508 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.25 148.99 25.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -138.1 115.56 11.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.771 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.1 22.01 2.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -145.32 27.02 1.28 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.31 30.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.1 76.03 10.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mt -103.31 132.3 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.567 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -122.76 152.68 40.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -54.16 131.82 41.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.297 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 75' ' ' LEU . . . 93.72 -27.0 13.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 9.9 t70 -57.8 149.79 21.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.981 0.419 . . . . 0.0 111.097 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 149.8 32.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.488 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.494 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.1 mp -109.22 148.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.207 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.408 ' N ' HG22 ' A' ' 79' ' ' ILE . 83.6 m-85 -144.45 125.39 14.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.494 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 2.7 p90 -161.2 -174.35 4.29 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 51.2 p-90 -157.97 134.33 9.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.153 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 24.6 p -99.74 161.99 13.27 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.118 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CZ ' ' CD1' ' A' ' 86' ' ' ILE . 23.8 t80 -144.18 106.05 4.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.645 0.259 . . . . 0.0 110.871 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.739 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.54 164.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.372 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.638 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 23.9 mm -140.58 106.62 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.875 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.5 74.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.661 0.601 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 57.61 62.28 2.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.74 31.37 62.61 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.217 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 mt -142.59 70.36 1.32 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.21 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -77.68 157.84 46.18 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 114.361 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.42 143.86 23.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -126.51 146.29 50.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 3.0 tt0 -105.38 73.82 1.05 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.232 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 19.0 p-10 -85.14 176.78 8.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.72 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 60.05 19.97 9.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.455 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.95 162.87 41.23 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.077 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -154.29 138.97 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.947 0.404 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 31.6 t90 -129.67 166.17 20.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.048 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.9 t -111.58 162.69 14.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 79' ' ' ILE . 11.7 t -123.83 5.4 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.401 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -62.01 -16.97 55.57 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.349 -0.387 . . . . 0.0 112.008 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -136.7 157.31 47.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.342 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 16.3 m-85 -135.83 145.57 46.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.037 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.4 m -98.71 157.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -82.62 153.48 25.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.543 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -55.81 -16.94 5.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -73.07 -30.71 63.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.957 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.01 5.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.329 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -139.35 159.08 67.49 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-O 121.303 0.573 . . . . 0.0 111.299 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.1 127.25 16.95 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.041 2.494 . . . . 0.0 113.179 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.82 73.54 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -75.45 86.87 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.8 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.27 81.36 1.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -113.49 73.9 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.6 75.76 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.44 125.42 91.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.776 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.382 2.055 . . . . 0.0 112.289 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 61.9 t80 -59.47 168.53 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 21.3 t -123.41 159.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.635 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 94' ' ' GLN . 2.7 p -66.95 145.82 98.98 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.072 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.2 Cg_exo -65.22 -166.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.605 2.203 . . . . 0.0 111.995 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.53 123.65 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -88.0 111.67 21.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.717 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 tptt -81.99 156.88 24.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.686 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 81' ' ' PHE . 4.9 mp -147.4 143.9 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.981 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -142.1 144.7 33.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.959 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 104' ' ' PHE . . . -87.13 110.03 19.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 28.7 mm -80.6 127.61 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.333 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -89.73 143.01 29.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 60.7 Cg_endo -93.28 2.68 57.12 Favored 'Cis proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.444 0.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -167.55 96.64 0.47 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.469 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.54 -178.2 45.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.433 HD21 ' CD1' ' A' ' 52' ' ' TRP . 5.4 tp -156.09 138.41 14.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 110.972 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 120.59 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.477 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 42.8 t -123.59 150.44 27.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.553 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -153.16 144.49 23.19 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.474 ' CD1' ' CD1' ' A' ' 64' ' ' TRP . 0.8 OUTLIER -137.54 125.84 14.49 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.542 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.2 Cg_endo -64.49 89.55 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.012 1.808 . . . . 0.0 111.414 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 16.5 t0 -50.87 160.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.332 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 36.0 t0 -140.05 41.5 1.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.46 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.96 49.5 7.6 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.088 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CD1' HG23 ' A' ' 85' ' ' VAL . 7.7 m-85 -94.41 -173.58 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.473 0.654 . . . . 0.0 111.169 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 86' ' ' ILE . 12.6 m -127.66 -29.98 2.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.105 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.1 tp -141.36 141.74 33.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.728 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 83' ' ' THR . 51.6 t80 -128.13 103.32 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.299 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.87 121.6 38.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 52' ' ' TRP . 18.8 t80 -112.17 123.04 49.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.524 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.59 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -123.71 122.67 38.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -152.24 136.51 5.46 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 118.836 -1.649 . . . . 0.0 114.463 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 127.12 46.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.42 HD21 ' CH2' ' A' ' 52' ' ' TRP . 0.8 OUTLIER -89.98 140.75 29.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.873 0.368 . . . . 0.0 110.937 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.56 6.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.786 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -179.9 109.05 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.193 0.521 . . . . 0.0 110.445 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.3 mt-10 -59.88 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.596 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.06 144.09 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.315 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.83 47.39 2.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.914 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.79 -128.15 1.57 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.42 HD22 ' CH2' ' A' ' 82' ' ' TRP . 23.9 mt -124.2 66.27 1.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -79.66 144.35 33.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.912 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -52.84 -24.89 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.67 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.56 -130.83 11.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.541 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -127.95 -77.4 0.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.81 0.338 . . . . 0.0 110.531 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.433 ' CD1' HD21 ' A' ' 22' ' ' LEU . 28.9 m-90 -62.85 94.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.206 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.5 87.88 2.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.9 tpm_? -136.81 127.68 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.953 0.406 . . . . 0.0 112.029 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.87 107.01 18.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.458 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mp -89.04 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.444 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 t -129.58 28.23 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.28 88.07 4.8 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 51.4 Cg_exo -54.99 170.46 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.3 tpmp? -108.41 31.34 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.698 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 81.42 93.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.678 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.31 -6.8 7.04 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 60' ' ' LYS . 11.6 ptt180 -157.53 134.95 10.44 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.893 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.495 ' CD1' ' HB2' ' A' ' 28' ' ' ASP . 6.1 m95 -85.23 154.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -134.6 100.06 4.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.557 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 39.9 t80 -95.88 143.13 27.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.919 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -144.87 145.03 31.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.406 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 47.5 t0 -138.03 100.19 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.476 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -89.17 22.44 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.683 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -138.67 32.52 2.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 0.0 110.811 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.425 ' HB1' ' CZ2' ' A' ' 52' ' ' TRP . . . -104.43 129.56 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.21 83.25 6.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.73 121.33 42.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.68 145.93 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 133.4 56.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.968 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.72 -28.85 14.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.045 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.77 163.25 7.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -122.49 156.75 33.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.493 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 1.2 mp -113.05 145.83 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.207 0.527 . . . . 0.0 112.125 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 15.9 m-85 -144.32 120.35 10.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -152.51 -176.27 5.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.203 1.001 . . . . 0.0 113.674 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 60.1 p-90 -152.38 125.29 8.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.318 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 45.1 p -100.0 149.0 23.9 Favored 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.793 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HD13 ' A' ' 86' ' ' ILE . 9.0 t80 -127.26 157.13 40.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 123.334 0.396 . . . . 0.0 110.849 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.628 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 20.8 mm -138.53 106.29 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.808 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -104.01 62.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.544 0.527 . . . . 0.0 110.72 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 t0 71.71 65.4 0.15 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.78 71.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.579 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mt -144.35 77.71 1.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.267 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -84.35 158.63 34.47 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.562 -0.745 . . . . 0.0 114.568 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -152.54 148.79 27.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.169 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.98 152.4 51.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.512 ' N ' HG13 ' A' ' 9' ' ' VAL . 3.2 tt0 -107.6 76.3 1.06 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.449 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.3 p30 -77.96 178.29 7.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.334 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 63.18 15.04 8.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.2 162.39 54.66 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.978 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.4 157.63 38.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.641 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.432 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 40.3 t90 -155.17 164.41 38.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.061 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.7 t -105.57 158.91 16.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 79' ' ' ILE . 10.3 t -120.33 -4.35 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.047 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.6 t -66.49 -8.59 27.36 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.24 139.37 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.426 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 82.9 m-85 -130.42 131.62 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 19.7 m -98.73 159.6 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 0.0 110.835 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -79.59 153.36 29.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.309 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -17.5 5.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.23 -31.5 65.88 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.921 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.79 18.74 5.1 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.484 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 p -135.08 156.17 78.49 Favored Pre-proline 0 C--O 1.222 -0.376 0 CA-C-O 121.385 0.612 . . . . 0.0 111.28 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 42.7 Cg_exo -55.1 126.15 21.58 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.832 2.354 . . . . 0.0 113.104 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.19 44.48 2.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.853 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -56.55 -177.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 t -79.65 66.17 5.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 t 63.89 130.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -114.76 66.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -162.36 104.72 1.1 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.497 2.131 . . . . 0.0 112.274 179.963 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 51.6 t80 -85.81 173.24 10.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.459 . . . . 0.0 110.76 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 17.1 t -111.68 158.98 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.429 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.81 127.36 93.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.29 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.41 -178.64 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.477 2.118 . . . . 0.0 112.212 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.3 135.19 47.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.267 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -88.63 111.05 21.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.842 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -92.18 94.14 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 99' ' ' TRP . 1.8 mp -83.83 163.2 20.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 0.0 112.315 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -150.71 138.86 20.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.526 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB1' ' CG ' ' A' ' 104' ' ' PHE . . . -86.39 114.89 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.242 0.544 . . . . 0.0 111.683 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 20.1 mm -96.45 108.65 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.44 ' CE1' ' CB ' ' A' ' 112' ' ' ALA . 35.6 p90 -78.92 150.78 75.65 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.01 2.58 69.66 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.962 -1.266 . . . . 0.0 112.282 0.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.59 93.18 0.26 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -171.07 175.25 44.78 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.447 HD21 ' CD1' ' A' ' 52' ' ' TRP . 7.7 tp -150.14 138.87 20.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 110.828 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 -137.11 107.31 6.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.724 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 21.1 t -116.95 155.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.409 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' TRP . 0.9 OUTLIER -143.12 144.01 32.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.679 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -136.74 128.07 16.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.394 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.92 102.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.346 2.031 . . . . 0.0 111.785 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -67.76 151.44 47.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.403 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -139.91 45.95 1.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.717 179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.31 92.58 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 29' ' ' ASP . 14.1 m-85 -78.48 -171.52 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.368 0.604 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 86' ' ' ILE . 40.4 m -131.8 -27.16 1.91 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.3 tp -143.36 132.19 22.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.627 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.47 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 39.0 t80 -122.32 101.64 7.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.906 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.44 126.73 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 10.6 t80 -112.72 130.49 56.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.1 119.13 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.75 139.32 6.64 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 118.586 -1.768 . . . . 0.0 114.676 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.25 142.93 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.233 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.4 tp -96.01 143.04 27.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 p30 44.36 48.98 8.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.363 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 179.44 109.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 110.398 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.49 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 56.0 mt-10 -57.4 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.639 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.97 156.33 12.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.358 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -143.15 65.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.024 0.44 . . . . 0.0 110.802 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.99 8.73 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.414 HD23 ' CE2' ' A' ' 82' ' ' TRP . 27.8 mt -118.1 65.22 0.75 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.43 150.55 23.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.533 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -54.48 -24.34 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.745 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.53 -115.58 1.93 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.544 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' GLY . 6.3 t-160 -137.61 -72.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 9.6 m-90 -68.38 88.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.34 88.99 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.486 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 39.7 ttt-85 -146.94 130.37 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.632 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.11 136.49 34.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mt -111.81 157.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.2 t -144.54 41.96 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.41 102.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.1 Cg_exo -54.27 -169.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.427 2.085 . . . . 0.0 112.366 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -119.03 -53.55 2.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.1 83.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.563 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.79 -2.17 34.3 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -156.92 145.64 19.91 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.769 -0.215 . . . . 0.0 110.473 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.457 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 10.7 m95 -81.97 161.94 22.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -134.11 116.95 16.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.48 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 24.2 t80 -99.94 84.12 2.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.353 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.96 124.92 36.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.46 110.13 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.755 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 22.15 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.439 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -135.18 40.22 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.89 111.57 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.207 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -73.96 75.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.92 134.03 39.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.22 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.04 141.45 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.44 132.22 34.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.68 -27.77 18.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.38 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -62.18 151.24 36.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.815 0.341 . . . . 0.0 111.104 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -110.93 152.95 26.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.84 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.552 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -112.21 145.34 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.561 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.49 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.5 m-85 -144.59 124.92 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.5 p90 -161.22 -173.83 4.04 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.49 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 63.5 p-90 -153.44 128.24 9.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.662 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 23.0 p -106.82 148.96 27.89 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.754 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 93' ' ' ARG . 5.1 t80 -129.61 145.0 51.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.365 0.415 . . . . 0.0 111.063 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -131.18 160.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.373 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.672 ' O ' ' N ' ' A' ' 32' ' ' SER . 37.8 mm -129.63 117.58 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.594 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 55.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 t0 71.87 67.19 0.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.34 23.37 77.47 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.371 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 mt -145.89 79.15 1.55 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -97.61 165.93 22.58 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.48 -0.782 . . . . 0.0 114.399 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -152.05 150.87 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 83' ' ' THR . 13.2 ptt-85 -128.88 145.37 51.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -99.5 77.63 2.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.808 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.49 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.1 p30 -81.77 178.74 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 59.54 19.1 7.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.63 166.4 53.27 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.102 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.11 156.59 37.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.552 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 29.6 t90 -154.67 165.45 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -110.82 161.97 15.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 79' ' ' ILE . 21.3 t -120.44 -3.13 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.805 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.0 m -62.26 -14.34 37.6 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.885 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -131.49 148.54 52.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CG ' ' HB1' ' A' ' 16' ' ' ALA . 4.8 m-85 -130.41 161.42 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 m -118.67 152.8 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 111.051 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 110' ' ' THR . 36.1 t30 -76.53 155.25 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.397 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.13 -16.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.2 -30.87 62.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.02 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 15.58 6.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.347 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.7 p -132.61 159.01 74.22 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 121.252 0.549 . . . . 0.0 110.853 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -50.01 128.84 23.19 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 113.056 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' CB ' ' CE1' ' A' ' 18' ' ' TYR . . . -89.24 105.51 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.248 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 112' ' ' ALA . 1.7 t70 52.53 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.584 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.2 p 51.48 52.51 14.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.124 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.4 p -158.52 174.92 14.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.61 47.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.1 155.13 80.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.559 2.173 . . . . 0.0 112.296 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.755 0.312 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 37.5 t80 -74.08 175.78 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.154 0.502 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 22.0 t -121.91 161.69 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.301 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 ' N ' ' A' ' 93' ' ' ARG . 13.2 t -66.08 129.78 94.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.993 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD2' HG11 ' A' ' 9' ' ' VAL . 27.6 Cg_endo -63.32 -171.13 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.354 2.036 . . . . 0.0 111.974 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -114.61 113.57 24.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -88.17 106.39 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.526 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -90.77 163.7 14.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.124 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.406 HD13 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -147.91 159.76 43.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.976 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -148.92 141.43 24.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.095 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . . . -87.07 104.44 16.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.968 0.413 . . . . 0.0 111.512 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.497 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 42.8 mm -72.19 146.36 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.439 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -105.08 142.22 24.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.739 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 97.7 Cg_endo -89.47 -7.79 46.05 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.848 -1.314 . . . . 0.0 112.222 -0.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 94.13 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.497 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -160.72 -165.85 18.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.492 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.0 tp -155.54 145.73 21.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.33 96.34 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.84 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 45.8 t -107.38 151.45 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -153.58 144.32 22.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.926 0.393 . . . . 0.0 111.612 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' CG2' ' HA ' ' A' ' 12' ' ' ALA . 1.5 pp -137.25 131.75 17.72 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.597 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 104.75 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.148 1.899 . . . . 0.0 111.477 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.3 t0 -70.53 157.99 36.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.367 0.603 . . . . 0.0 111.737 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 2.8 m-20 -146.97 42.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.329 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 45.43 9.49 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.744 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 29' ' ' ASP . 5.9 m-85 -86.05 -173.29 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.447 0.641 . . . . 0.0 111.102 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -133.59 -26.54 1.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.684 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.753 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.4 tp -142.05 129.49 21.28 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.234 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.461 ' HB3' ' CE3' ' A' ' 64' ' ' TRP . 6.0 t80 -120.58 91.34 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.173 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.63 132.82 35.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TRP . 38.8 t80 -116.94 126.5 53.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.982 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.584 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -128.24 117.91 22.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.26 138.4 6.55 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.737 -1.697 . . . . 0.0 114.631 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.4 OUTLIER -109.78 147.17 33.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.202 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -99.46 127.52 45.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 t30 57.45 54.81 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 175.55 109.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.244 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 35.3 mt-10 -56.96 -171.93 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.365 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.1 mtt -129.8 157.91 40.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.348 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -162.67 43.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.47 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . 145.35 125.89 1.8 Allowed Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.417 HD21 ' CZ2' ' A' ' 82' ' ' TRP . 5.9 mt -39.21 89.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.087 0.47 . . . . 0.0 112.066 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' GLY . 5.7 mm-40 -110.67 152.34 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -55.37 -22.05 17.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.085 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.51 4.39 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.245 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -131.64 -79.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.661 0.267 . . . . 0.0 110.347 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 36' ' ' PHE . 13.2 m-90 -61.53 91.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.64 88.65 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.168 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -143.57 124.07 13.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.025 0.44 . . . . 0.0 111.861 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.8 128.67 35.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.663 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 34' ' ' PHE . 11.2 mt -103.65 154.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 45.06 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.009 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.5 93.18 0.25 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.5 Cg_exo -52.06 -176.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.462 2.108 . . . . 0.0 112.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -113.95 -44.86 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.233 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.02 84.37 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.651 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.97 -2.8 32.17 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.424 -0.894 . . . . 0.0 110.923 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -157.11 148.51 22.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.461 ' CE3' ' HB3' ' A' ' 34' ' ' PHE . 5.1 m95 -90.12 157.28 17.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -134.64 114.73 13.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 32.6 t80 -107.41 89.37 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -94.69 144.87 25.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.099 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -138.0 108.44 6.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.582 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.18 22.39 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.522 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -141.26 28.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 115.66 27.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -73.91 75.97 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.629 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -96.75 142.12 29.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 142.27 49.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.782 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 1.4 tt -56.85 130.2 44.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.01 -28.39 14.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.133 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' HB3' HG23 ' A' ' 101' ' ' VAL . 8.9 t70 -66.56 153.09 43.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.95 0.405 . . . . 0.0 110.877 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.68 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.1 mp -114.83 144.58 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.861 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.0 m-85 -144.53 121.28 11.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.3 p90 -158.5 -172.37 3.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.13 0.967 . . . . 0.0 113.572 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.6 p-90 -155.54 134.25 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.979 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 17.8 p -99.92 165.45 11.55 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.721 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 86' ' ' ILE . 14.2 t80 -147.08 108.13 4.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.66 164.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 32' ' ' SER . 12.1 mm -145.23 106.84 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' CG ' ' HB2' ' A' ' 90' ' ' LEU . 11.9 ptmt -99.63 46.43 0.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 13.7 t0 81.1 77.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.474 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 21.51 75.48 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.265 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.421 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . 6.3 mt -145.64 79.37 1.57 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.332 0.586 . . . . 0.0 110.274 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.04 161.71 41.92 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.325 -0.852 . . . . 0.0 114.44 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.48 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 49.3 m-85 -144.8 134.38 23.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.569 ' N ' HG21 ' A' ' 9' ' ' VAL . 5.7 ptt180 -123.81 140.17 53.25 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.4 OUTLIER -100.8 73.15 1.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.83 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.6 p-10 -81.48 173.33 12.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.689 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 59.65 20.34 8.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.4 162.7 44.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.059 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -154.46 145.95 23.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.263 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.412 ' CG ' ' N ' ' A' ' 100' ' ' THR . 38.7 t90 -140.2 164.29 30.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.5 t -105.01 158.11 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 101' ' ' VAL . 4.0 t -121.12 -3.97 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.768 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -62.63 -14.33 41.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -125.3 149.16 48.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -134.32 146.4 49.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.261 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.1 m -102.81 166.01 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.718 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -79.26 153.69 29.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -15.59 3.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -76.48 -28.33 56.43 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.353 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 3.27 16.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.15 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.4 p -119.29 164.63 20.43 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.368 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 83.3 Cg_exo -43.24 133.57 6.43 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.732 2.288 . . . . 0.0 113.215 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 161.11 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.11 179.99 6.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.6 t -84.93 -35.45 22.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.64 169.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 61.36 98.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -134.83 148.05 65.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.474 2.116 . . . . 0.0 112.401 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 52.8 t80 -89.22 173.71 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.458 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 15.2 t -110.09 159.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.481 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG11 ' CA ' ' A' ' 94' ' ' GLN . 4.5 p -66.9 132.86 93.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.085 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.5 Cg_exo -64.41 -168.48 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.645 2.23 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.46 124.73 50.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -83.75 104.52 13.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.488 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -93.16 103.9 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.379 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 81' ' ' PHE . 5.5 mp -97.07 161.53 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 31.3 mt-10 -147.04 136.59 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.893 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . . . -86.55 102.6 14.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 28.1 mm -74.82 156.81 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.541 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -119.0 145.54 38.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.534 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -84.18 -2.66 56.92 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.302 0.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.12 98.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -163.35 -171.31 29.43 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.374 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.82 139.13 18.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.05 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 101.52 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.638 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.36 156.47 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.98 146.27 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.666 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pt -143.95 122.04 6.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.497 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 13.1 Cg_endo -57.72 101.18 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.092 1.861 . . . . 0.0 111.436 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.3 t0 -63.06 159.53 17.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -140.71 43.48 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.568 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.94 46.04 47.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.59 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 10.5 m-85 -90.4 -171.51 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.409 0.623 . . . . 0.0 111.419 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 86' ' ' ILE . 27.7 t -130.8 -28.26 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.552 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.68 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.1 tp -139.43 135.45 33.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.205 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 26.2 t80 -124.72 106.51 10.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.878 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.15 117.51 34.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 111.017 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 52' ' ' TRP . 56.2 t80 -106.55 124.57 49.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -125.59 129.35 49.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -159.52 139.99 6.54 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 114.438 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.7 tmtp? -116.78 135.79 53.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.214 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 tp -91.05 125.83 35.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 16.6 t-20 65.46 50.06 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.528 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.8 tt0 170.27 110.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.021 0.439 . . . . 0.0 110.337 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.3 mt-10 -53.65 -173.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.508 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.7 mmm -128.85 112.66 14.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.23 58.24 3.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.675 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 89.2 100.87 1.03 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.507 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.8 mt 24.45 78.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.624 0.77 . . . . 0.0 112.731 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.66 157.73 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.725 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -51.92 -25.72 8.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 42.64 -124.96 4.18 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.088 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -137.36 -73.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.302 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.598 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 5.6 m-90 -63.61 82.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.717 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.26 93.04 3.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.212 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 4.3 tpm_? -141.46 125.77 17.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.945 0.402 . . . . 0.0 111.874 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.46 131.96 35.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.826 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.44 143.86 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.983 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.42 26.6 4.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -153.42 92.52 3.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 52.7 Cg_exo -52.72 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.252 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.8 -49.67 2.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.826 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -179.99 82.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.303 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.11 2.72 49.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -157.61 140.49 15.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.523 0.201 . . . . 0.0 111.001 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.457 ' CZ2' ' HG3' ' A' ' 59' ' ' PRO . 7.6 m95 -89.18 154.48 20.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.98 0.419 . . . . 0.0 110.311 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -134.73 119.89 18.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 17.0 t80 -113.65 106.8 14.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.614 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 139.39 38.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -137.37 105.37 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.729 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.29 22.77 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.632 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -134.06 29.87 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.51 99.16 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.073 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -74.09 75.93 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.764 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.65 146.43 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.935 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -130.92 139.82 50.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -52.69 132.55 36.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.2 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.92 -29.17 12.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.067 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 101' ' ' VAL . 7.8 t0 -66.35 153.87 41.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.019 0.438 . . . . 0.0 111.158 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 160.35 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.543 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -118.88 147.11 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.066 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 42.2 m-85 -144.55 129.43 18.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.468 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -161.11 -177.87 6.37 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.557 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.8 p-90 -151.02 133.06 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.481 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.7 OUTLIER -99.98 156.98 16.86 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -178.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 12.0 t80 -139.24 138.8 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.62 0.247 . . . . 0.0 110.838 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -134.25 161.08 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.0 mm -135.85 107.19 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.968 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -100.35 57.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.538 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 68.55 68.7 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.741 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.97 25.47 75.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.392 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.94 73.02 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 110.33 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -87.63 160.96 31.9 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.289 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -152.22 153.1 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -132.84 147.84 52.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.425 ' CA ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -104.05 76.75 1.37 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.399 177.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.458 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.19 177.27 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 61.78 17.28 8.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.801 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.18 163.91 54.9 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.951 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.47 153.84 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.459 . . . . 0.0 111.166 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.543 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 26.6 t90 -153.1 166.75 31.5 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -112.12 162.75 15.08 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 79' ' ' ILE . 20.3 t -121.9 -9.26 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.668 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.426 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 25.6 p -60.36 -14.35 18.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.718 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.45 162.36 22.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 16' ' ' ALA . 89.9 m-85 -140.88 148.07 39.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.436 ' HB ' ' C ' ' A' ' 110' ' ' THR . 4.7 m -98.15 -161.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.81 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 110' ' ' THR . 17.8 t30 -108.73 145.39 35.16 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 111.607 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.24 -19.89 6.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.47 -30.02 70.27 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.935 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 17.63 5.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.208 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.4 p -140.79 156.13 68.96 Favored Pre-proline 0 CA--C 1.514 -0.432 0 CA-C-O 121.372 0.606 . . . . 0.0 111.736 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 53.0 Cg_exo -52.3 78.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.511 2.807 . . . . 0.0 114.011 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 110' ' ' THR . . . 80.74 -174.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.419 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -119.45 98.74 6.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -28.01 67.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.63 -175.34 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.39 88.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.84 143.38 15.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.527 2.151 . . . . 0.0 112.242 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.868 0.366 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 39.5 t80 -74.15 176.33 6.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' N ' ' CG ' ' A' ' 7' ' ' TYR . 20.6 t -117.67 161.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.368 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 92' ' ' TYR . 11.0 t -66.29 127.26 93.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.77 -177.12 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.467 2.112 . . . . 0.0 112.331 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 t -110.93 111.43 22.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.506 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -82.82 109.61 17.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.521 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -84.23 164.45 19.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.187 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mp -154.12 138.62 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.074 0.464 . . . . 0.0 112.094 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -135.2 136.7 41.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.496 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' CB ' ' CD2' ' A' ' 104' ' ' PHE . . . -86.75 114.52 23.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.7 mm -91.67 111.61 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -83.07 147.01 52.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.438 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 91.2 Cg_endo -92.23 -3.69 49.06 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.897 -1.293 . . . . 0.0 112.606 0.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 91.68 1.18 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.66 173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.574 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.44 144.51 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -133.72 109.88 9.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.86 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 30.0 t -122.76 142.88 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.357 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -143.52 146.94 33.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.473 ' CD1' ' CD1' ' A' ' 64' ' ' TRP . 1.2 pp -136.41 122.92 13.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.303 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 72.1 Cg_exo -47.61 108.68 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.494 2.129 . . . . 0.0 112.026 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 27.5 t0 -76.64 151.03 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 0.0 111.399 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t0 -140.89 46.09 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.752 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.98 69.85 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.404 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 10.1 m-85 -73.64 -170.97 0.94 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.637 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -132.94 -27.76 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 5.8 tp -139.87 127.25 21.39 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.251 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.471 ' CE1' HG12 ' A' ' 26' ' ' ILE . 2.4 t80 -118.49 94.36 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.78 29.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' TRP . 32.5 t80 -105.91 126.36 52.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.473 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.44 132.47 3.52 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.152 -1.499 . . . . 0.0 114.04 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.62 141.63 40.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.4 tp -92.24 117.16 29.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 57.8 t-20 63.92 65.17 0.72 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 36.1 tt0 172.86 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.163 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 78.1 mt-10 -54.09 -169.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.436 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.3 mtp -143.22 142.34 31.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.05 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -140.07 42.4 1.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.932 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.57 -143.31 9.54 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.169 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 mt -116.86 80.28 1.45 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.048 0.451 . . . . 0.0 110.978 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -101.03 150.05 23.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.099 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.455 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -57.44 -32.14 66.6 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.713 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.16 -103.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.279 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -148.59 -78.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 110.546 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 36' ' ' PHE . 10.6 m-90 -59.25 89.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.4 88.86 3.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.223 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -132.45 125.71 31.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.042 0.449 . . . . 0.0 111.776 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -105.74 94.31 5.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.45 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mt -81.49 146.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.142 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.17 22.71 6.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -154.89 100.54 2.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.1 Cg_exo -52.1 171.56 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.426 2.084 . . . . 0.0 112.542 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -114.66 40.9 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 63' ' ' ARG . 6.4 tt0 84.0 86.65 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.845 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.96 -5.72 6.0 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.954 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 1.1 mtt180 -157.25 137.52 12.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.582 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.473 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 12.4 m95 -83.36 154.28 24.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.406 ' CB ' ' HG3' ' A' ' 60' ' ' LYS . 4.9 m -134.71 119.48 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.397 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 11.4 t80 -108.28 87.54 2.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.242 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 132.85 36.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.184 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -138.1 103.12 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -89.18 22.41 2.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.698 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -133.1 42.07 3.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.5 100.76 7.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.93 99.82 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -122.01 164.19 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -138.52 144.38 39.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.553 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -62.64 126.75 28.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.572 . . . . 0.0 110.724 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.37 -31.09 4.32 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.354 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.91 149.62 43.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 111.008 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 164.23 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.483 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.8 mp -118.87 147.81 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.13 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 63.5 m-85 -144.46 125.77 14.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -157.5 -178.62 7.47 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.0 p-90 -155.7 134.6 12.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.671 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -99.81 160.97 13.9 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.941 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.435 ' CE1' HD12 ' A' ' 86' ' ' ILE . 16.3 t80 -145.33 105.46 4.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 111.06 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.61 165.17 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.659 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 19.7 mm -142.51 105.99 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.877 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.7 ttpt -96.05 70.01 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.427 0.454 . . . . 0.0 111.104 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 56.72 46.02 20.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.263 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.68 7.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.729 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 7.4 mt -142.9 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -64.85 155.98 47.61 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.191 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.498 ' HB3' HG21 ' A' ' 9' ' ' VAL . 69.9 m-85 -152.52 134.24 14.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.34 -0.93 . . . . 0.0 108.677 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.9 140.7 49.15 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.562 0.696 . . . . 0.0 112.687 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 2.5 tt0 -104.33 73.8 1.14 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.452 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.5 p30 -81.32 174.33 11.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.564 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.18 18.82 9.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.07 163.29 52.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.911 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -152.55 150.67 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 27.8 t90 -149.18 164.45 34.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -106.4 158.56 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 21.5 t -119.86 -10.6 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.178 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.532 ' HA ' HD13 ' A' ' 75' ' ' LEU . 20.9 p -60.24 -11.51 6.53 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.47 148.12 52.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.456 ' CD2' ' CB ' ' A' ' 16' ' ' ALA . 40.9 m-85 -135.32 149.95 49.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.362 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 m -98.87 155.25 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.083 0.468 . . . . 0.0 110.491 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 7.1 m-20 -83.99 152.02 24.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.275 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -17.84 4.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -30.98 66.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.901 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.67 21.79 4.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.365 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.9 p -147.05 159.8 41.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.177 0.513 . . . . 0.0 111.394 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 79.4 Cg_exo -47.38 126.88 12.57 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.113 2.542 . . . . 0.0 113.063 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.08 53.4 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.001 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -171.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.49 32.9 16.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 p -109.63 -176.89 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.95 92.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.04 89.74 2.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.55 2.167 . . . . 0.0 112.367 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.1 t80 -89.28 172.71 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.462 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 14.8 t -108.9 160.05 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.27 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 7.2 p -66.89 130.38 93.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.206 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 38.8 Cg_exo -60.35 -175.26 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.688 2.259 . . . . 0.0 112.383 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.83 125.81 52.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -82.58 105.7 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.726 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -95.87 109.78 22.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.009 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 4.3 mp -105.76 157.01 17.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.265 0.555 . . . . 0.0 112.266 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 38.4 mt-10 -140.69 141.44 34.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.512 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . . . -86.13 122.78 30.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.157 0.503 . . . . 0.0 111.367 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.495 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.8 mm -104.69 109.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -79.0 150.55 75.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.883 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.59 -1.62 61.82 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.188 0.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.75 98.12 0.31 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.4 164.84 36.06 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.9 tp -138.37 144.55 40.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 111.149 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.54 99.5 4.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.473 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' CE2' ' A' ' 36' ' ' PHE . 20.7 t -105.96 158.06 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.985 0.421 . . . . 0.0 111.774 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.13 149.76 26.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.667 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.2 pt -144.51 126.92 8.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.0 Cg_endo -57.1 95.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.386 2.057 . . . . 0.0 111.568 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.7 t0 -59.17 160.63 6.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 3.9 t0 -145.86 45.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.152 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.55 89.63 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.885 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CZ ' ' CB ' ' A' ' 29' ' ' ASP . 20.0 m-85 -83.67 -170.03 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.266 0.555 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -129.82 -29.27 2.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.645 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.666 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.86 137.54 34.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.508 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 25.2 t80 -127.4 97.02 4.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.463 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.06 135.63 37.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.412 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 52' ' ' TRP . 9.6 t80 -121.28 125.85 48.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.491 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -123.8 123.37 40.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -157.43 139.28 6.31 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 118.816 -1.659 . . . . 0.0 114.442 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.86 148.38 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.343 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tp -100.03 120.15 39.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.8 t-20 61.76 54.83 2.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 51.0 tt0 174.06 109.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 36.0 mt-10 -55.76 -168.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.465 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.47 120.66 7.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.643 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.96 57.6 4.25 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.013 0.435 . . . . 0.0 110.518 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.91 -120.18 3.37 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' A' ' 82' ' ' TRP . 14.4 mt -124.95 75.47 1.44 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.049 0.452 . . . . 0.0 110.985 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.9 mt-10 -88.38 155.28 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.157 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.85 -26.57 10.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.655 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.71 -121.63 7.01 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.435 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -137.88 -73.71 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.749 0.309 . . . . 0.0 110.547 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.5 m-90 -61.3 90.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.037 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.22 87.28 2.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.142 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -136.6 129.63 31.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.989 0.423 . . . . 0.0 111.919 -179.054 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -99.4 126.67 45.33 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -111.96 142.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 111.217 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -130.71 28.7 4.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.92 98.12 2.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 36.1 Cg_exo -57.29 169.14 2.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.477 2.118 . . . . 0.0 112.589 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' ARG . 11.9 tptp -105.18 34.64 3.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.91 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 82.06 88.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.48 -5.86 13.95 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.864 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.0 mtt180 -157.26 130.42 7.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.466 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 15.6 m95 -78.64 158.16 28.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.5 m -134.26 112.57 11.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 5.2 t80 -113.8 85.39 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.96 151.13 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -138.13 113.19 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.13 22.39 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -143.83 31.01 1.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.5 128.8 44.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.5 96.15 5.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.68 152.47 28.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.12 150.63 41.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.184 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.412 HD22 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.42 130.8 46.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.421 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' HD11 ' A' ' 75' ' ' LEU . . . 95.19 -25.15 25.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.598 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 101' ' ' VAL . 9.8 t70 -56.39 152.91 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 152.64 29.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.543 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 99' ' ' TRP . 2.6 mp -112.72 146.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 m-85 -144.55 126.16 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.479 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 1.3 p90 -161.03 -176.72 5.65 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.491 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 61.2 p-90 -152.83 135.13 15.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.591 -1.64 . . . . 0.0 108.97 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 14.1 p -99.79 163.74 12.34 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.2 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HD13 ' A' ' 86' ' ' ILE . 17.0 t80 -145.1 113.8 6.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.667 0.27 . . . . 0.0 111.012 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -107.73 164.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.666 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 34.7 mm -138.99 104.48 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.4 59.66 1.86 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.573 0.545 . . . . 0.0 110.668 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 64.43 64.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.678 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.01 25.58 63.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -143.16 71.23 1.33 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.16 160.66 44.54 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.4 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -152.28 149.01 28.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' THR . 13.4 ptt180 -128.68 144.97 51.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -103.68 75.81 1.34 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.405 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.98 175.9 10.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.573 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.45 18.16 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.806 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.57 162.79 52.36 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.97 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -154.39 146.43 23.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.903 0.382 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 79' ' ' ILE . 29.6 t90 -142.65 167.04 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.062 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.1 t -115.45 163.41 15.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.468 HG21 HD11 ' A' ' 79' ' ' ILE . 3.4 t -125.83 17.78 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.923 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -65.95 -13.04 59.06 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.25 162.25 39.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.276 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 16' ' ' ALA . 95.3 m-85 -130.47 140.69 50.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.704 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 m -98.54 161.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.166 0.507 . . . . 0.0 110.79 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' THR . 6.3 m-80 -82.74 152.13 25.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.378 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.17 -17.39 4.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.05 -31.28 65.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.975 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.55 5.18 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.384 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.6 p -136.29 158.17 74.07 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.387 0.613 . . . . 0.0 111.128 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.56 128.01 24.56 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.926 2.417 . . . . 0.0 113.244 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 113.67 14.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.23 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.21 147.72 48.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.2 -53.75 3.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -149.8 124.36 9.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.32 91.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 60.76 89.67 0.1 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.248 1.024 0 C-N-CA 122.553 2.169 . . . . 0.0 112.339 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.85 0.357 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 52.6 t80 -79.2 173.3 12.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.783 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.467 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 16.6 t -115.36 159.43 15.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.492 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 HG11 ' CA ' ' A' ' 94' ' ' GLN . 12.0 p -71.92 142.79 85.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' CD ' HG11 ' A' ' 85' ' ' VAL . 15.4 Cg_exo -68.36 -178.44 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -110.33 120.76 43.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . . . -82.27 116.05 21.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.473 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.3 ttmt -103.78 101.75 11.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.459 ' CD1' ' CZ ' ' A' ' 81' ' ' PHE . 1.1 mp -91.23 168.6 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 111.838 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 0.1 OUTLIER -155.92 154.09 30.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.473 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 104' ' ' PHE . . . -86.94 128.34 35.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 111.825 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 1.3 mp -112.66 115.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.715 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.487 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -78.85 143.7 62.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.6 Cg_endo -91.69 -4.11 49.93 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.037 -1.234 . . . . 0.0 112.491 -0.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -165.54 89.23 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -156.48 -174.52 26.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.691 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tp -158.24 131.8 7.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.713 0.292 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' CB ' HD13 ' A' ' 17' ' ' ILE . 12.7 ttt85 -129.24 114.74 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 25.6 t -122.93 158.47 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 111.541 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.01 144.88 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.871 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.468 HG12 ' CZ ' ' A' ' 34' ' ' PHE . 1.1 pp -138.22 127.04 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.101 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.0 Cg_endo -60.67 104.17 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.174 1.916 . . . . 0.0 111.693 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 14.5 t0 -66.82 158.12 31.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.49 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -142.78 45.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.673 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.88 46.12 47.28 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' CD2' ' OD1' ' A' ' 28' ' ' ASP . 6.5 m-85 -88.52 -172.64 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.519 0.676 . . . . 0.0 111.184 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 86' ' ' ILE . 9.7 m -133.19 -27.49 1.59 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.595 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.9 tp -141.5 131.05 23.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.121 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.468 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 16.3 t80 -122.63 101.66 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 55' ' ' ASP . . . -105.38 121.28 43.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 15.3 t80 -106.89 131.7 53.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.61 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.14 122.53 32.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -153.85 147.54 17.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 118.87 -1.633 . . . . 0.0 114.428 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.1 tmtt? -119.15 145.0 46.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 110.431 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.17 117.58 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.57 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 66.75 67.4 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.069 0.461 . . . . 0.0 110.491 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 44' ' ' MET . 44.7 tt0 179.19 111.78 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' MET . 20.3 mt-10 -69.3 30.93 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.377 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.589 ' H ' ' C ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER 52.5 149.86 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.207 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -142.05 60.75 1.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.708 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.23 127.17 5.71 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 82' ' ' TRP . 4.5 mt -39.87 97.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 111.39 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.97 -178.16 3.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.167 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -62.43 -19.03 63.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.059 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.04 -135.75 6.91 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -118.83 -76.8 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 10.2 m-90 -67.43 86.78 0.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' CB ' ' CD2' ' A' ' 37' ' ' HIS . . . -118.88 87.69 2.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.453 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.503 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.0 ttt180 -142.49 127.54 18.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 111.85 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.3 p30 -88.37 135.51 33.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 34' ' ' PHE . 1.9 mt -121.61 151.45 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.4 t -139.5 24.3 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.31 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -145.86 94.58 5.0 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.993 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.4 Cg_exo -53.53 -172.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.256 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.6 -48.69 2.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -178.79 83.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.432 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.43 -0.3 42.41 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 148.93 21.37 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 120.626 0.251 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.455 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 11.4 m95 -90.19 161.09 15.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.177 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.9 m -134.32 116.7 15.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 6.1 t80 -106.25 95.29 5.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -101.28 139.8 36.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.413 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.06 106.16 5.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -89.21 22.5 2.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.679 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.07 38.32 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.85 115.79 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -73.93 76.58 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -97.36 139.23 33.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.981 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 152.64 51.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.446 ' CD2' ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -55.43 137.83 47.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.8 -29.47 7.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.62 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.88 160.16 6.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.951 0.405 . . . . 0.0 111.213 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -124.35 159.3 30.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.628 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 1.4 mp -116.07 145.22 22.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 112.018 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CD1' ' HA ' ' A' ' 43' ' ' GLU . 98.0 m-85 -144.52 126.53 15.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 3.6 p90 -161.32 -173.12 3.67 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.125 0.964 . . . . 0.0 113.427 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 11.7 p-90 -154.34 133.64 12.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.62 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 5.6 p -99.68 163.49 12.46 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.079 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' CZ ' HD13 ' A' ' 86' ' ' ILE . 13.4 t80 -143.64 124.77 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.612 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -119.57 166.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.654 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 mm -141.34 106.28 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.921 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -103.63 64.49 0.81 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.711 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.3 t0 67.7 64.59 0.39 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.86 70.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.37 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 mt -143.84 73.62 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.61 162.04 46.9 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.392 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -152.28 143.28 23.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 83' ' ' THR . 10.3 ptt85 -126.08 142.97 51.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.41 ' CA ' HG11 ' A' ' 9' ' ' VAL . 4.4 tt0 -101.0 75.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.657 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 33.8 p-10 -78.32 174.77 10.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.623 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 t30 60.25 18.31 7.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.38 159.93 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.07 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -154.65 161.69 41.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.0 0.428 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 70.7 t90 -147.6 166.26 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.434 ' O ' ' CH2' ' A' ' 99' ' ' TRP . 5.5 t -110.25 155.74 21.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.79 7.88 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.328 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 m -70.94 -9.9 58.71 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.752 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -123.47 163.97 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.447 ' CD1' ' HB1' ' A' ' 16' ' ' ALA . 23.2 m-85 -137.28 120.82 17.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 6.2 m -98.39 -168.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.963 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 110' ' ' THR . 14.0 t30 -109.2 145.33 36.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -54.42 -18.87 4.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.78 -28.99 68.08 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.62 22.61 3.96 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.705 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.6 p -143.55 152.17 55.89 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-O 121.51 0.671 . . . . 0.0 112.085 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 31.7 Cg_exo -58.84 76.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.447 2.765 . . . . 0.0 113.538 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 120.54 3.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.225 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' OD2' ' CD2' ' A' ' 18' ' ' TYR . 24.4 t0 -124.33 88.71 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.816 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.16 89.57 6.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 50.59 2.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.774 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.53 83.8 1.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -127.08 147.05 60.09 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.883 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.471 2.114 . . . . 0.0 112.37 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.8 t . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.955 0.407 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -68.05 138.51 92.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' HG11 ' A' ' 85' ' ' VAL . 36.0 Cg_endo -67.41 -172.57 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.421 2.081 . . . . 0.0 112.665 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -111.41 124.4 52.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.408 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.59 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -84.44 106.82 16.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 13.3 mttp -93.32 112.65 24.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.359 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 mp -101.16 164.96 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 112.055 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.648 ' O ' HD22 ' A' ' 22' ' ' LEU . 5.6 pt-20 -155.68 143.39 19.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.15 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.91 110.49 20.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 111.322 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 15.8 mm -81.5 145.25 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.321 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t80 -106.33 141.76 23.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.7 Cg_endo -93.14 -0.14 53.49 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.085 -1.214 . . . . 0.0 112.445 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -161.66 94.56 0.96 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -176.04 169.19 41.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.668 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -151.46 121.73 7.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.587 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.572 ' N ' HD13 ' A' ' 22' ' ' LEU . 45.3 ttp85 -115.09 132.89 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 25' ' ' SER . 38.3 t -124.42 158.96 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.83 144.89 25.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.7 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.86 128.33 12.15 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.497 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 17.0 Cg_endo -58.01 95.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.513 2.142 . . . . 0.0 111.7 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.1 t0 -60.29 160.6 8.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -147.36 46.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.922 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.14 89.0 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.686 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' CD1' HG21 ' A' ' 85' ' ' VAL . 10.3 m-85 -84.15 -171.21 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.261 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -132.02 -28.33 1.76 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.66 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.4 tp -140.34 132.37 27.86 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.246 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 26' ' ' ILE . 44.1 t80 -124.59 92.85 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.612 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -86.83 132.08 33.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' HG22 ' A' ' 83' ' ' THR . 40.8 t80 -121.52 123.27 41.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.39 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -125.06 118.84 27.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -150.91 133.04 4.11 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.253 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -105.92 148.92 27.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.338 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD13 ' HH2' ' A' ' 52' ' ' TRP . 17.6 tp -99.57 122.18 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.0 t-20 59.34 58.91 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.1 tt0 175.47 109.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 41.8 mt-10 . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.36 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.53 -25.21 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.633 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.29 -110.43 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.426 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -142.49 -80.09 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.735 0.303 . . . . 0.0 110.584 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.663 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 17.3 m-90 -61.05 94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.43 83.0 1.94 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.318 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -133.77 133.67 41.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.56 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.612 ' OD1' ' HB2' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -106.43 111.65 24.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.893 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.694 HD12 ' HD2' ' A' ' 34' ' ' PHE . 9.7 mt -93.06 152.09 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 33' ' ' LEU . 78.7 p -119.91 -23.59 6.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.71 121.0 27.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.59 0.233 . . . . 0.0 111.23 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.469 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 31.7 Cg_exo -58.66 -164.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.409 2.072 . . . . 0.0 112.086 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -45.65 2.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 179.18 80.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.499 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.88 0.59 34.68 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 8.0 mtm180 -156.99 131.23 8.47 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.389 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.573 ' CG ' HD11 ' A' ' 26' ' ' ILE . 15.0 m95 -77.09 155.62 32.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.92 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -134.72 118.95 17.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.394 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 49.6 t80 -110.62 89.45 3.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.079 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.93 137.45 32.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.274 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -138.11 100.91 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.591 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 22.44 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.597 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.65 26.79 5.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.315 . . . . 0.0 111.037 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.92 100.1 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -73.78 75.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.803 ' CD1' HD23 ' A' ' 22' ' ' LEU . 4.1 mt -86.31 163.47 17.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.791 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -141.65 148.2 38.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.035 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -55.62 142.22 34.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.259 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.5 -32.43 6.26 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.4 t70 -59.83 151.19 26.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.912 0.387 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -114.7 154.3 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.517 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.3 mp -109.25 146.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.061 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 97.6 m-85 -144.17 122.34 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.907 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.4 p90 -157.8 -174.9 5.08 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -154.77 131.6 10.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.816 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 76.5 p -110.35 151.87 26.91 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.81 ' CE2' HD11 ' A' ' 86' ' ' ILE . 19.9 t80 -135.76 129.43 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.105 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -113.73 164.08 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.375 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' CE2' ' A' ' 84' ' ' TYR . 24.4 mm -137.52 107.28 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.883 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -99.94 57.12 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.5 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 t0 68.95 69.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.771 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.816 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.75 25.29 75.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.31 73.72 1.39 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.201 0.524 . . . . 0.0 110.233 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.25 161.08 29.92 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.552 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -152.13 146.56 25.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.741 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -124.37 150.55 45.41 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -106.6 72.27 0.9 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.665 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.3 p-10 -78.47 176.03 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.47 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 61.05 18.23 8.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.62 162.44 54.31 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.87 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 2.8 tt0 -154.39 155.28 34.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.895 0.379 . . . . 0.0 111.111 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.634 ' HB2' HD13 ' A' ' 14' ' ' LEU . 51.7 t90 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.423 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.4 t -108.52 159.75 16.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 101' ' ' VAL . 17.5 t -121.42 -1.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.795 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.405 ' CG2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -66.82 -9.92 42.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.813 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.7 pt-20 -131.45 150.61 52.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.9 m-85 -129.45 143.44 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.012 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 15' ' ' GLU . 11.2 m . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 0.0 111.094 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.2 t . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.97 0.415 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -72.96 138.77 79.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.57 ' HD2' HG11 ' A' ' 85' ' ' VAL . 41.1 Cg_endo -67.06 -167.89 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.601 2.2 . . . . 0.0 112.455 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -109.47 114.98 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.887 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.12 104.87 13.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.8 159.22 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.751 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.37 150.9 32.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.193 0.521 . . . . 0.0 111.888 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -145.71 142.78 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.941 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.83 115.73 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 23' ' ' ARG . 17.0 mm -88.25 129.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.244 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 25.2 t80 -93.77 141.5 23.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -94.17 4.52 53.74 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.332 -1.112 . . . . 0.0 112.477 0.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.97 97.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.025 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.25 176.95 47.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.326 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -150.73 138.87 20.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 110.998 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.804 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.44 110.74 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.491 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 13' ' ' LYS . 24.0 t -119.82 146.58 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.82 151.63 36.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.548 HD11 ' CG ' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -139.95 130.12 13.97 Favored Pre-proline 0 N--CA 1.467 0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.008 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.98 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.243 1.962 . . . . 0.0 111.567 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 22.5 t0 -61.98 160.7 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.691 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 30.0 t70 -150.46 45.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.757 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.48 92.34 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.336 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 85' ' ' VAL . 21.3 m-85 -76.81 -124.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.348 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -179.58 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.4 tp -140.8 131.21 25.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.703 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 24.1 t80 -120.01 108.34 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.142 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -111.05 120.59 42.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 18.4 t80 -110.04 128.81 55.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.635 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -124.74 124.75 42.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.9 140.03 7.12 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.143 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.0 ttmt -112.21 149.18 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 110.468 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD1' HD23 ' A' ' 73' ' ' LEU . 4.8 tp -98.09 119.46 36.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.078 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.5 t-20 62.53 57.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.06 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 52.7 tt0 177.24 109.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.35 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 32.3 mt-10 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.634 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.917 0.389 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -60.88 -17.12 48.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 40.74 -131.56 3.06 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 3.0 t60 -129.8 -68.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 0.0 110.574 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.9 m-90 -77.13 90.87 3.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.992 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.07 88.54 2.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.931 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.2 tpm_? -133.81 127.63 33.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.93 118.86 32.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 58' ' ' LYS . 26.7 mt -100.04 146.76 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.352 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.721 HG22 ' CD1' ' A' ' 33' ' ' LEU . 8.9 p -132.77 36.21 3.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.564 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.21 91.4 1.72 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 43.2 Cg_exo -56.91 171.93 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.592 2.195 . . . . 0.0 112.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.15 32.84 4.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.792 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 79.46 89.5 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.04 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 73.16 -3.51 29.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.957 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -157.67 127.26 6.0 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.796 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.548 ' CG ' HD11 ' A' ' 26' ' ' ILE . 13.2 m95 -79.85 157.58 26.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -134.33 118.71 17.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 11.6 t80 -116.57 84.97 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -94.66 146.41 24.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.142 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD1' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -138.0 109.78 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 22.24 2.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -144.03 36.55 1.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.08 126.71 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -79.46 75.86 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.735 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 40' ' ' LEU . 39.7 mt -101.23 130.73 47.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.784 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -121.03 153.89 36.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.961 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.75 132.01 51.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.283 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -26.55 16.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.504 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.3 t70 -55.43 154.46 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 151.01 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.536 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -110.42 147.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 112.162 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 37.6 m-85 -144.31 125.31 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.1 p90 -160.64 -174.27 4.37 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.513 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.9 p-90 -151.99 134.32 15.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.288 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.65 161.28 13.71 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.013 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.791 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 10.5 t80 -141.4 138.19 32.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.703 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.24 161.86 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.722 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 33.7 mm -136.79 111.19 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.722 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.8 tttt -105.7 67.93 0.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.26 55.86 2.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.808 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 81.82 28.17 43.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.7 mt -143.84 75.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.215 0.531 . . . . 0.0 110.212 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.08 160.56 40.71 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.376 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 29.3 m-85 -152.26 153.04 32.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.675 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -135.74 146.59 47.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.452 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.0 tt0 -104.68 75.42 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.461 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.9 p30 -78.2 175.22 10.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.565 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 60.47 18.54 8.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.61 161.6 52.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.005 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -154.46 145.49 22.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.536 ' CE3' HD13 ' A' ' 79' ' ' ILE . 42.0 t90 -141.12 165.95 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.079 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.8 t -111.15 162.02 15.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.56 ' O ' HD22 ' A' ' 75' ' ' LEU . 2.8 t -124.37 11.53 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -73.1 -10.2 59.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.921 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.827 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.6 mt-10 -122.98 140.99 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.703 0.287 . . . . 0.0 110.799 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 75' ' ' LEU . 9.8 m-85 -122.15 129.42 52.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' HD13 ' A' ' 17' ' ' ILE . 28.5 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.206 0.527 . . . . 0.0 111.239 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.3 t . . . . . 0 CA--C 1.526 0.054 0 CA-C-O 120.813 0.34 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.642 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.7 p -66.74 130.4 94.02 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.267 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 24.2 Cg_exo -63.14 -170.25 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.72 2.28 . . . . 0.0 112.587 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -110.87 124.97 53.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.47 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -77.64 104.49 8.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.24 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.54 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.252 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.661 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.2 mp -106.18 162.44 13.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.93 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 24.9 mm-40 -152.96 145.3 24.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.945 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.893 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -87.07 120.85 28.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 111.567 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' CG2' ' A' ' 105' ' ' VAL . 18.6 mm -98.19 114.25 35.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.176 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 54.5 t80 -79.21 142.03 58.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 98.9 Cg_endo -96.73 4.99 40.44 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.603 0.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.76 95.63 0.9 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . 169.23 167.19 29.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.555 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB3' HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -158.27 121.8 3.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.745 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 tmm_? -97.07 134.91 39.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 ' HG ' ' A' ' 14' ' ' LEU . 39.8 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.009 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.01 152.95 30.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.553 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.2 pt -147.37 122.03 5.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.48 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 9.4 Cg_endo -55.24 99.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.105 1.87 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 20.1 t0 -62.68 161.48 12.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.597 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -145.39 44.69 1.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.671 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.58 42.69 62.7 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.736 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.2 m-85 -88.08 -171.19 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.401 0.62 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' ILE . 37.8 t -132.04 -27.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.697 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.717 HD12 HG22 ' A' ' 57' ' ' THR . 8.0 tp -138.3 134.99 35.0 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.254 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.756 ' HD2' HD12 ' A' ' 56' ' ' ILE . 18.6 t80 -126.31 90.65 3.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -84.89 124.65 31.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.659 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 52' ' ' TRP . 78.8 t80 -114.59 117.59 31.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.4 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.808 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -122.57 125.46 45.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -157.65 141.88 8.14 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.927 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.0 148.54 40.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 110.447 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.444 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.7 tp -99.46 126.16 45.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.7 t-20 58.1 53.49 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.1 tt0 176.69 109.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.167 0.508 . . . . 0.0 110.382 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 29.2 mt-10 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.442 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.88 0.371 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -56.33 -20.31 18.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.599 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.52 -130.47 4.93 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.923 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -129.3 -70.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.8 m-90 -72.77 94.06 1.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.808 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.09 91.98 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.1 tpt85 -139.51 125.58 19.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -86.4 130.35 34.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.36 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.756 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.9 mt -110.42 152.97 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.344 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.717 HG22 HD12 ' A' ' 33' ' ' LEU . 32.9 p -144.48 27.78 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -151.05 87.38 4.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 21.6 Cg_exo -66.02 -170.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.816 2.344 . . . . 0.0 112.445 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -121.95 24.14 9.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.588 178.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 82.49 90.96 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.352 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 76.0 0.76 65.94 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.759 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -157.83 121.3 4.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.553 ' CD1' HD11 ' A' ' 26' ' ' ILE . 19.2 m95 -82.95 157.57 22.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 119.7 18.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.57 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 56' ' ' ILE . 31.9 t80 -122.64 93.76 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 mmm-85 -95.49 143.35 26.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.345 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.13 94.25 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -89.27 22.6 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.597 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -126.67 28.66 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.71 110.79 20.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.01 76.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 22' ' ' LEU . 6.8 mt -86.79 153.28 21.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.9 142.92 47.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.6 OUTLIER -54.14 132.0 42.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.297 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.98 -28.37 12.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.2 t70 -62.84 161.77 12.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 111.079 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -121.07 158.4 27.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG21 ' CE2' ' A' ' 81' ' ' PHE . 1.3 mp -116.73 145.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.112 0.482 . . . . 0.0 112.176 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 31.1 m-85 -144.3 126.33 15.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.46 -174.18 4.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.17 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 31.9 p-90 -156.7 128.27 7.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.449 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 6.5 p -106.9 152.63 23.66 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.2 t80 -135.9 117.36 14.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -103.99 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.266 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.771 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.3 mm -137.16 109.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.845 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.89 68.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.875 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 63.31 65.53 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.799 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.0 27.01 73.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.399 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -144.52 74.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.179 0.514 . . . . 0.0 110.097 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.54 162.11 30.28 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.375 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.05 147.71 26.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.642 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -126.06 141.23 52.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.488 ' N ' HG21 ' A' ' 9' ' ' VAL . 2.6 tt0 -99.26 76.44 2.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.237 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.5 p30 -83.43 179.69 7.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.232 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.0 t30 59.05 18.38 6.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.57 163.24 44.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.078 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.39 158.38 39.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.1 0.476 . . . . 0.0 111.476 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CE3' HD13 ' A' ' 79' ' ' ILE . 49.7 t90 -147.66 165.69 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.8 t -107.75 157.44 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.9 t -119.69 -4.19 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.638 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' CD2' ' A' ' 75' ' ' LEU . 27.3 m -62.1 -15.97 49.05 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.607 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -108.93 159.19 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -138.09 129.87 28.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.001 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 16' ' ' ALA . 22.7 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 121.29 0.567 . . . . 0.0 111.956 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 9' ' ' VAL . 28.4 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -66.56 138.28 95.53 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 9' ' ' VAL . 36.6 Cg_endo -66.01 -168.09 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.493 2.129 . . . . 0.0 112.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -109.55 116.99 32.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -80.45 107.9 13.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.401 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' C ' HD12 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -81.86 156.81 24.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.74 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 5.1 mp -146.69 149.9 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.45 . . . . 0.0 111.879 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -148.66 142.37 25.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.95 114.51 23.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.123 0.487 . . . . 0.0 111.465 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 105' ' ' VAL . 24.3 mm -89.68 130.39 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.238 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.1 t80 -92.93 142.27 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 94.6 Cg_endo -92.49 -2.69 50.5 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.484 0.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -163.27 95.52 0.85 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.9 171.16 43.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.282 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -147.47 132.02 17.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.0 111.25 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.692 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.6 ttt180 -117.97 125.8 51.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.391 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.487 HG23 HD12 ' A' ' 22' ' ' LEU . 61.9 t -126.85 152.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -152.45 145.1 24.23 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.985 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.1 pp -143.98 117.06 5.77 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.304 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.11 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.419 2.079 . . . . 0.0 112.284 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 43.0 t0 -80.14 143.52 33.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 111.361 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.96 48.88 2.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.608 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.91 38.49 96.11 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.889 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CD1' HG21 ' A' ' 85' ' ' VAL . 22.1 m-85 -68.65 -123.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.282 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 177.32 -35.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 57' ' ' THR . 7.5 tp -141.12 126.3 18.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.088 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.704 ' HD2' HD12 ' A' ' 56' ' ' ILE . 11.8 t80 -118.67 95.02 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -93.61 120.14 33.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.0 t80 -105.83 126.91 52.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.266 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.47 122.29 33.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.37 139.38 6.16 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.806 -1.664 . . . . 0.0 114.211 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -117.23 146.97 42.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.503 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.0 tp -89.3 133.09 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 44.76 63.08 1.82 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 177.49 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.38 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 50.9 mt-10 . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.383 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.56 -45.25 56.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.51 -122.44 28.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.17 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -137.96 -72.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.904 0.383 . . . . 0.0 110.451 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.459 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.1 m-90 -60.76 88.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.946 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.79 94.3 4.4 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.001 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 3.9 tpt85 -146.94 127.83 14.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.971 0.415 . . . . 0.0 112.117 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.22 123.93 35.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.386 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.704 HD12 ' HD2' ' A' ' 34' ' ' PHE . 14.5 mt -108.15 151.47 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.363 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.858 HG22 HD12 ' A' ' 33' ' ' LEU . 28.5 p -141.11 30.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.8 pttm -153.15 92.16 3.3 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.2 Cg_exo -58.25 169.03 3.19 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.562 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.93 33.93 3.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.828 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 81.12 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.161 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.64 -2.74 21.46 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.846 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -157.61 124.2 4.93 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.619 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.1 m95 -76.62 154.94 33.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -134.67 120.52 19.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.658 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.7 t80 -121.41 106.08 11.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -110.17 141.4 43.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -138.09 111.17 7.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -89.37 22.34 2.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.347 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -125.52 36.8 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.82 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 81.23 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.654 HD11 HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -78.97 169.9 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.599 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 145.22 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -55.22 136.86 48.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.18 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.31 -29.84 9.58 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.275 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.3 t70 -59.33 152.92 20.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -115.25 148.89 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.438 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.544 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -105.31 150.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.056 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 75.1 m-85 -144.07 128.04 17.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.161 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.9 p90 -161.07 -174.4 4.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.085 0.945 . . . . 0.0 113.361 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 52.4 p-90 -158.67 135.79 9.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.13 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 12' ' ' ALA . 32.5 p -99.36 163.03 12.7 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.27 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.87 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 14.8 t80 -144.93 105.5 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.8 164.38 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.87 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.3 mm -141.03 109.65 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.598 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 67.4 0.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.31 65.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.17 28.53 71.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.43 73.27 1.39 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.177 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -83.18 160.64 38.64 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.501 -0.772 . . . . 0.0 114.233 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.24 147.85 26.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.604 ' C ' HG11 ' A' ' 9' ' ' VAL . 12.4 ptt-85 -126.28 147.65 49.66 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.529 0.681 . . . . 0.0 112.701 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -106.01 74.07 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.439 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.0 p30 -82.27 176.21 9.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.703 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 60.05 19.76 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.625 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.86 162.15 42.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -154.34 162.7 41.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.963 0.411 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CE3' HD13 ' A' ' 79' ' ' ILE . 46.9 t90 -155.08 165.82 35.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.166 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.438 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.2 t -105.65 160.88 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.4 t -121.89 -0.3 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.746 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 p -63.44 -14.06 46.66 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -129.17 154.55 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.704 0.288 . . . . 0.0 110.879 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.589 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -135.54 144.63 46.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 17' ' ' ILE . 17.3 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 23.0 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.763 0.316 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.791 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.7 p -66.59 131.03 94.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 20.8 Cg_exo -65.47 -177.53 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.356 2.038 . . . . 0.0 111.988 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -107.79 129.73 55.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 111.674 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.682 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -81.0 101.17 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.224 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -83.26 100.63 10.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 3.7 mp -92.96 157.52 16.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.8 mm-40 -148.92 142.23 25.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.227 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.86 110.54 20.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.141 0.496 . . . . 0.0 111.29 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 23' ' ' ARG . 19.0 mm -83.35 150.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.252 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.422 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -114.0 143.83 30.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.737 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 9.9 Cg_endo -89.55 3.5 69.26 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.285 0.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -170.18 98.39 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.514 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -172.42 -176.45 41.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.426 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -158.07 134.87 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 17' ' ' ILE . 4.1 tmm_? -126.25 119.79 28.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.11 147.75 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.282 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.52 148.82 34.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -146.61 126.32 6.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.68 116.35 2.31 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.259 1.973 . . . . 0.0 111.681 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 46.3 t0 -83.06 112.11 19.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 0.0 111.335 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -101.43 43.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.813 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.03 31.84 80.1 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.882 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CD2' HG11 ' A' ' 85' ' ' VAL . 95.5 m-85 -61.2 -113.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.799 0.299 . . . . 0.0 110.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . 6.7 t 176.87 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.749 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.4 132.02 28.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.793 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CD1' HD13 ' A' ' 26' ' ' ILE . 17.0 t80 -122.32 98.0 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.732 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -102.3 119.03 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 40.1 t80 -106.01 128.36 53.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.64 122.11 35.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.582 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.98 145.95 12.0 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.863 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 161.6 21.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.456 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 HD22 ' A' ' 73' ' ' LEU . 21.3 tp -96.51 118.19 32.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 52.7 t30 57.66 70.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 73.9 tt0 171.33 110.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.375 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 51.4 mt-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.793 0.33 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.54 -30.91 44.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.642 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.46 -137.44 15.67 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.584 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.1 -74.78 0.6 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.5 m-90 -60.43 90.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.069 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.96 85.22 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.868 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -130.63 127.63 39.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.735 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -94.43 110.89 22.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.517 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mm -92.1 133.75 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 t -129.79 36.65 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.05 90.35 1.23 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.9 Cg_exo -53.6 170.26 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.74 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 1.2 tmtm? -112.93 42.13 1.94 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.461 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 1.3 mp0 72.77 88.62 0.1 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.489 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.23 -3.47 22.73 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.052 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 7.1 ttt180 -157.84 125.52 5.25 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.847 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.465 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 11.9 m95 -76.3 154.7 34.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 m -134.63 120.64 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.505 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 14.7 t80 -120.5 115.7 23.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -111.14 145.1 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.243 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.08 104.34 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 22.49 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.64 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.03 40.72 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.349 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.53 93.11 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -73.95 75.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.691 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 22' ' ' LEU . 4.6 mt -97.69 168.01 10.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -142.02 143.82 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.3 OUTLIER -52.57 133.2 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.352 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.96 -28.89 11.68 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.216 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' A' ' 101' ' ' VAL . 8.5 t70 -64.39 162.62 14.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.851 0.358 . . . . 0.0 111.244 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -121.47 158.42 28.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.207 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.3 mp -113.89 149.91 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.173 0.511 . . . . 0.0 112.17 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 m-85 -143.84 125.18 14.68 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.682 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 1.7 p90 -159.5 -175.3 5.11 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.275 1.035 . . . . 0.0 113.721 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.439 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 38.7 p-90 -153.46 133.95 13.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.483 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.94 155.48 17.66 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.163 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.1 t80 -135.6 109.66 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 0.0 111.168 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.834 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -102.91 168.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.393 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.749 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 45.7 mm -145.5 104.44 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 O-C-N 123.292 0.37 . . . . 0.0 111.03 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -98.64 75.85 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.328 179.213 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.25 57.88 1.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.355 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.862 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.27 17.76 77.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.277 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.97 69.58 1.28 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.423 0.63 . . . . 0.0 110.013 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 85' ' ' VAL . . . -83.58 -170.42 46.36 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.432 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.2 m-85 -151.97 171.04 18.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.775 -0.712 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.791 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -144.18 143.7 31.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.442 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.13 74.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.519 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -77.9 174.21 11.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.37 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 59.56 19.42 7.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.35 162.79 53.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.198 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 2.9 tt0 -154.4 147.46 24.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 54.2 t90 -141.49 165.23 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.366 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.5 t -106.06 156.7 18.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 77' ' ' ASP . 4.6 t -119.86 -3.59 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.936 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 75' ' ' LEU . 18.7 m -62.06 -16.1 49.57 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.935 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.657 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.1 mt-10 -125.09 150.75 46.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 7.7 m-85 -132.63 145.54 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 0.0 110.834 179.742 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 19.4 t . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.817 0.341 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.748 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -66.65 137.69 95.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD2' HG11 ' A' ' 85' ' ' VAL . 43.5 Cg_endo -70.54 -171.01 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.51 2.14 . . . . 0.0 112.89 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -108.27 127.36 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -85.71 106.88 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.605 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 108.45 21.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.67 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.8 mp -102.7 156.03 17.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 112.154 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.418 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -137.19 140.62 41.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.014 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.49 100.87 12.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.176 0.512 . . . . 0.0 111.361 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 12.5 mm -74.73 141.95 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.309 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 26.2 t80 -104.16 141.05 21.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.57 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 77.3 Cg_endo -94.41 2.8 51.43 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.306 -1.122 . . . . 0.0 112.369 0.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.67 96.46 0.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.582 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.5 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -177.52 165.87 35.91 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 23' ' ' ARG . 4.8 tp -138.95 143.64 38.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.746 ' N ' HD12 ' A' ' 22' ' ' LEU . 4.3 ttt180 -135.19 101.91 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.856 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.67 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.9 t -100.32 158.53 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.407 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -152.68 145.0 23.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.681 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -144.75 126.67 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.788 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 13.2 Cg_endo -56.67 95.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.454 2.103 . . . . 0.0 111.709 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.71 159.69 8.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.1 t0 -146.85 44.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.585 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.61 40.77 85.75 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.529 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.7 m-85 -82.96 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.374 0.607 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -131.72 -27.53 1.9 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.515 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 6.7 tp -140.01 132.28 28.24 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.876 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.703 ' HD2' HD12 ' A' ' 56' ' ' ILE . 31.2 t80 -123.68 98.36 5.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.313 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -91.88 124.85 36.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 36.7 t80 -116.95 122.69 45.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.352 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -160.85 147.36 14.0 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 118.918 -1.611 . . . . 0.0 114.073 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 132.08 53.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.58 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 101' ' ' VAL . 11.0 tp -79.82 105.69 11.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.1 t-20 76.59 65.39 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.6 tt0 171.98 109.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 32.4 mt-10 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.672 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' HE2' ' A' ' 37' ' ' HIS . . . -53.14 -24.38 10.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.672 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.43 -139.57 1.7 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.636 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 12.6 m170 -122.43 -74.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.163 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.652 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -67.98 88.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.98 86.37 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 ttm180 -135.02 143.85 46.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.982 0.42 . . . . 0.0 111.707 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -107.76 118.62 37.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.627 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.8 mt -95.1 151.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.069 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 44.7 p -140.24 42.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.133 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 98.19 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 58.8 Cg_exo -52.08 -176.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.506 2.138 . . . . 0.0 112.228 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -48.51 3.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.157 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.8 80.76 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.537 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . 70.81 2.05 42.86 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.7 mtt180 -156.79 133.43 10.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.711 -0.244 . . . . 0.0 110.597 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.562 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.4 m95 -79.77 153.97 28.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.3 m -135.2 120.26 18.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 44.0 t80 -110.55 82.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.521 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -92.3 126.94 37.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.291 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -138.04 111.44 8.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 22.29 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.345 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.59 31.24 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -108.48 127.0 53.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.052 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -87.24 75.86 9.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.652 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 56.0 mt -82.5 154.54 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -130.93 144.51 51.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.409 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -67.35 131.46 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.386 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.88 -24.69 25.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.622 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 40' ' ' LEU . 8.9 t70 -59.36 159.97 7.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -108.36 164.83 11.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.636 HG13 ' CE3' ' A' ' 99' ' ' TRP . 5.1 mm -125.99 146.17 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 75.4 m-85 -144.44 130.92 19.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.413 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 4.0 p90 -161.57 -176.4 5.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 122.156 0.979 . . . . 0.0 113.607 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.577 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.5 p-90 -153.37 133.28 13.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.477 -1.692 . . . . 0.0 108.293 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.701 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.8 p -111.95 153.27 27.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.098 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.817 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.5 t80 -136.39 141.02 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.277 0.361 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -128.85 163.25 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.804 HD11 ' CE2' ' A' ' 84' ' ' TYR . 25.6 mm -137.52 107.23 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.904 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.22 68.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t0 63.62 65.77 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.804 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.6 29.0 71.62 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.533 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.2 75.2 1.45 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.132 0.491 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.23 159.08 27.21 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.505 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -152.43 150.47 29.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.748 ' C ' HG11 ' A' ' 9' ' ' VAL . 18.1 ptt-85 -129.09 149.99 50.67 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.573 0.702 . . . . 0.0 112.87 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -105.58 75.22 1.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.768 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -74.92 172.44 12.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.396 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.1 t30 61.57 18.39 9.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.9 165.41 29.84 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.823 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -154.23 149.23 26.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.074 0.464 . . . . 0.0 111.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.636 ' CE3' HG13 ' A' ' 79' ' ' ILE . 28.6 t90 -151.99 164.57 36.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.984 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -114.21 163.05 15.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 40' ' ' LEU . 1.7 t -129.67 15.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.715 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.527 ' O ' HD21 ' A' ' 75' ' ' LEU . 6.6 p -56.29 -24.51 43.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 66.9 mt-10 -142.68 172.78 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 13.8 m-85 -133.06 150.04 52.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.121 0.486 . . . . 0.0 110.928 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 9' ' ' VAL . 41.6 t . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 94' ' ' GLN . 7.6 p -78.78 141.36 59.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 82.8 Cg_exo -51.66 -169.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.7 2.267 . . . . 0.0 112.291 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 t -107.29 139.73 41.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.236 0.541 . . . . 0.0 112.274 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 24' ' ' VAL . . . -84.2 115.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.222 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.72 106.51 13.72 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.574 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.1 mp -97.98 152.03 19.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.244 0.545 . . . . 0.0 111.994 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 105' ' ' VAL . 17.5 mt-10 -141.9 136.73 30.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.685 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.733 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.39 98.88 11.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.152 0.501 . . . . 0.0 111.188 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 27.1 mm -74.52 147.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.455 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -106.48 146.81 33.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.545 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 12.1 Cg_endo -90.59 3.6 67.81 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.159 -1.184 . . . . 0.0 112.353 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.86 79.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 68' ' ' ASP . . . -146.58 -172.12 16.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 23' ' ' ARG . 19.5 tp -154.69 142.62 20.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.12 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.688 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -135.7 99.31 4.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.42 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.752 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 18.4 t -116.95 142.2 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -146.15 141.75 27.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.464 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.591 ' CG2' ' HB2' ' A' ' 12' ' ' ALA . 1.2 pp -135.9 120.15 12.97 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.762 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 10' ' ' PRO . 86.2 Cg_exo -46.27 123.09 6.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.115 1.877 . . . . 0.0 112.172 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 15.2 t0 -79.02 158.88 27.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.191 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -145.37 46.44 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.867 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.41 37.58 86.01 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.4 m-85 -82.94 -172.16 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.266 0.555 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ILE . 48.4 t -131.59 -26.47 2.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.799 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 12.2 tp -146.45 132.95 19.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.334 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.1 t80 -117.99 106.19 12.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -103.79 118.4 36.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 24.2 t80 -106.23 125.84 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -124.95 122.72 38.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.81 137.83 5.84 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 118.853 -1.642 . . . . 0.0 114.252 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -111.53 142.46 43.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 101' ' ' VAL . 36.5 tp -97.28 125.69 42.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.987 0.422 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 63.78 50.94 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.9 tt0 176.42 109.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.578 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 44.8 mt-10 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.373 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 1.4 mt-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -53.35 -26.04 17.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.813 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.32 -117.03 3.45 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.379 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.6 m80 -140.41 -73.4 0.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.728 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 6.7 m-90 -60.39 90.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.05 87.29 2.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 118.08 19.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.007 0.432 . . . . 0.0 111.617 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -92.99 106.45 18.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.9 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 9.1 mm -86.42 148.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.614 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 t -140.1 39.34 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.421 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.41 99.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.1 Cg_exo -51.73 -175.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.438 2.092 . . . . 0.0 112.362 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -116.82 -67.12 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.069 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.47 84.35 1.37 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.747 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.82 -0.73 34.98 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 5.6 ptp85 -157.81 160.38 37.71 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.69 0.281 . . . . 0.0 110.908 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.47 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 5.7 m95 -94.92 156.2 16.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.855 0.359 . . . . 0.0 110.225 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -134.69 116.24 14.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 54' ' ' ARG . 11.1 t80 -110.94 112.7 24.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.393 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 2.4 t0 -138.06 107.88 6.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -89.21 22.59 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.53 33.09 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.12 105.27 16.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -73.82 75.89 1.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.728 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 61.6 mt -87.25 156.83 19.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.078 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.46 134.92 34.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.424 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.6 OUTLIER -56.8 131.65 49.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.264 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.01 -29.92 9.22 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.05 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 101' ' ' VAL . 7.3 t70 -69.22 162.45 27.08 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -114.08 172.5 6.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.988 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.791 HD11 HG22 ' A' ' 101' ' ' VAL . 2.7 mp -127.85 142.44 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.785 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 47.2 m-85 -144.31 128.18 17.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.7 p90 -161.13 -177.56 6.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.492 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 55.8 p-90 -149.12 131.19 15.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.151 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -100.48 155.47 17.82 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.823 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.867 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 8.2 t80 -134.87 148.15 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.763 0.316 . . . . 0.0 111.057 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -137.91 165.31 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.957 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.698 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 16.8 mm -141.4 107.7 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 O-C-N 123.069 0.231 . . . . 0.0 111.025 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.68 62.58 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.446 0.466 . . . . 0.0 110.56 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 t70 69.28 65.72 0.27 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.811 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.32 28.21 71.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.518 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.83 74.22 1.42 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.01 161.67 45.79 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.403 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' O ' HG13 ' A' ' 85' ' ' VAL . 83.7 m-85 -152.18 148.99 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -134.17 143.11 47.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.729 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 tt0 -102.54 76.52 1.54 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 5.0 p-10 -77.2 -179.06 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.27 16.23 8.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.657 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.41 162.49 49.79 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.004 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -154.42 152.59 30.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 0.0 111.251 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.708 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.7 t90 -155.07 164.94 38.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.061 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.781 ' OG1' HG22 ' A' ' 102' ' ' THR . 5.7 t -108.48 158.57 17.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.791 HG22 HD11 ' A' ' 79' ' ' ILE . 2.6 t -119.85 -7.11 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.98 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.781 HG22 ' OG1' ' A' ' 100' ' ' THR . 2.4 t -66.04 -8.42 23.12 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.9 tt0 -134.34 137.2 43.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.053 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.4 m-85 -122.08 154.99 36.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 17' ' ' ILE . 6.2 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.112 0.482 . . . . 0.0 110.942 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 9' ' ' VAL . 11.2 t . . . . . 0 N--CA 1.46 0.065 0 CA-C-O 120.974 0.416 . . . . 0.0 111.558 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.561 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.7 p -68.66 138.41 90.86 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.473 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 11.9 Cg_exo -70.0 -178.46 2.45 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.61 2.206 . . . . 0.0 111.893 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -103.71 120.9 41.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.471 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.0 109.23 16.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.8 mmtm -90.05 130.18 36.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.365 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HG ' HG22 ' A' ' 24' ' ' VAL . 6.1 mp -121.98 154.79 36.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.145 0.498 . . . . 0.0 111.741 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' HG11 ' A' ' 105' ' ' VAL . 3.2 mp0 -147.54 144.62 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.111 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.98 130.61 34.39 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.006 0.432 . . . . 0.0 111.4 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 23' ' ' ARG . 9.7 mm -109.55 134.55 51.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.306 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -98.26 144.1 27.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.452 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.4 Cg_endo -90.35 -7.18 45.47 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.423 0.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -159.11 93.08 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.493 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.07 165.33 38.66 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.632 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -146.84 137.03 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -120.87 121.89 39.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG22 ' HG ' ' A' ' 14' ' ' LEU . 31.2 t -121.28 151.86 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -155.03 144.88 21.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -140.5 127.64 12.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 52.8 Cg_exo -53.96 106.71 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.238 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 36.4 t0 -76.07 144.84 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.002 0.43 . . . . 0.0 111.296 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 1.8 m-20 -132.59 44.95 2.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.954 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.99 53.64 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.7 m-85 -82.04 -170.88 3.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.341 0.591 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 1.1 t -130.92 -29.32 1.89 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.449 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.672 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.6 tp -140.47 136.01 32.55 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.811 -0.755 . . . . 0.0 112.396 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.65 ' HD2' HD12 ' A' ' 56' ' ' ILE . 14.3 t80 -123.74 104.16 8.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.371 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -99.35 126.67 45.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.811 0.339 . . . . 0.0 110.746 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.3 t80 -113.51 124.07 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.433 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -126.97 115.48 19.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -151.24 139.09 6.95 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 118.572 -1.775 . . . . 0.0 114.571 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -122.18 126.86 49.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 ' CH2' ' A' ' 52' ' ' TRP . 0.5 OUTLIER -91.7 141.32 28.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.71 40.62 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -176.9 109.55 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.4 mt-10 . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.992 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -55.84 -22.91 27.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.9 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.58 -108.98 0.69 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.042 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t-80 -133.9 -73.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.947 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 40' ' ' LEU . 27.9 m-90 -72.04 92.74 1.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.55 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.189 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 21.5 tpt180 -149.18 133.23 17.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.884 0.373 . . . . 0.0 111.947 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.75 143.35 26.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.713 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.65 HD12 ' HD2' ' A' ' 34' ' ' PHE . 11.7 mt -126.87 142.82 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.158 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 32' ' ' SER . 3.4 m -134.22 30.68 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -151.77 89.38 4.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.437 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 57.2 Cg_exo -51.89 171.85 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.578 2.186 . . . . 0.0 112.576 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.36 34.96 3.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.96 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.95 87.85 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.226 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.1 -5.82 12.47 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.818 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 9.4 mtt-85 -157.48 130.67 7.73 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.299 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.5 m95 -78.13 154.8 30.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.963 0.411 . . . . 0.0 110.02 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 97.1 m -134.76 118.54 17.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.217 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' HD11 ' A' ' 56' ' ' ILE . 82.5 t80 -120.81 91.8 3.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 146.19 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 26.4 t0 -138.04 106.89 5.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.673 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.25 22.35 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.651 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -134.65 43.45 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.09 123.24 42.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -73.94 76.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.695 HD13 HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -98.43 142.42 30.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 158.78 38.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 3.3 tt -68.87 133.37 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.015 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 105.93 -27.99 15.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' VAL . 10.9 t70 -59.46 164.48 3.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.089 0.471 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.1 153.58 42.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.438 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.4 mp -113.42 143.1 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.987 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.6 m-85 -144.18 125.71 14.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.618 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 5.0 p90 -161.09 -174.5 4.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 122.439 1.114 . . . . 0.0 113.939 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.467 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 16.4 p-90 -151.59 129.85 12.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.034 -1.894 . . . . 0.0 108.148 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -99.86 161.0 13.88 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.783 -178.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.939 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 18.3 t80 -141.59 137.87 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.622 0.248 . . . . 0.0 110.566 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -130.94 162.42 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.5 mm -135.16 105.79 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.855 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 66.81 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.529 0.518 . . . . 0.0 110.546 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.17 61.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 73.93 29.01 63.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -143.82 74.16 1.42 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.134 0.492 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.83 159.68 42.24 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.542 -0.753 . . . . 0.0 114.595 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -152.44 144.14 23.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.613 -0.793 . . . . 0.0 108.985 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -128.5 140.11 51.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.561 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.92 77.49 2.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.556 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 8.9 p-10 -80.8 176.28 9.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.417 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 60.57 18.31 8.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.36 162.02 50.77 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.131 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.42 158.72 40.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CE2' ' O ' ' A' ' 100' ' ' THR . 58.8 t90 -155.1 166.6 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.255 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 4.7 t -109.83 160.09 16.65 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.6 t -122.68 2.12 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.58 HG22 ' HA2' ' A' ' 76' ' ' GLY . 44.6 p -63.77 -13.44 43.95 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.752 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.6 tt0 -131.33 150.87 51.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.034 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 9.3 m-85 -131.73 145.21 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.165 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.448 HG11 ' HG2' ' A' ' 15' ' ' GLU . 25.4 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 9' ' ' VAL . 3.3 p . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 121.379 0.609 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.793 ' H ' HG22 ' A' ' 8' ' ' VAL . 7.3 p -81.36 137.75 48.57 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.237 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 14.2 Cg_exo -68.35 -174.49 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.586 2.191 . . . . 0.0 112.145 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.71 118.63 37.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.378 . . . . 0.0 111.888 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -76.8 105.68 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.431 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.95 107.23 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.048 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.753 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.9 mp -96.45 159.22 15.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.232 0.539 . . . . 0.0 111.773 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.12 137.24 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.47 102.63 14.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.207 0.527 . . . . 0.0 111.058 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 23' ' ' ARG . 25.2 mm -73.1 135.51 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.409 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 57.9 t80 -94.89 141.28 23.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.695 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.3 Cg_endo -92.31 -3.29 49.77 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.432 0.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.84 94.95 0.87 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -168.96 -171.08 34.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.387 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD12 ' H ' ' A' ' 23' ' ' ARG . 13.3 tp -156.93 147.7 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB2' HD11 ' A' ' 17' ' ' ILE . 6.8 ttm180 -144.71 106.65 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.673 HG22 ' HG ' ' A' ' 14' ' ' LEU . 21.4 t -109.0 157.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.03 146.72 23.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 111.589 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.799 HG21 ' CZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -141.83 130.52 12.12 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.57 101.54 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.184 1.923 . . . . 0.0 111.052 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.453 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.8 t70 -69.14 149.8 48.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.298 0.57 . . . . 0.0 111.899 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.447 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 9.1 t70 -131.35 42.78 3.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.492 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.02 45.82 30.81 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.702 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 12.5 m-85 -87.5 -171.49 3.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.329 0.585 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ILE . 88.6 p -128.64 -29.18 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.498 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.845 ' CD1' HG22 ' A' ' 57' ' ' THR . 9.0 tp -142.63 140.53 31.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.593 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 26' ' ' ILE . 46.1 t80 -133.23 99.75 4.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.61 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -98.2 117.82 33.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.547 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.753 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 28.0 t80 -104.94 120.16 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.029 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.514 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -116.82 128.77 55.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.414 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -156.19 132.37 3.31 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.05 -1.548 . . . . 0.0 114.161 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 11.7 ttpt -106.65 144.69 32.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.5 tp -98.97 124.79 44.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.016 0.436 . . . . 0.0 111.547 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 t-20 65.11 49.36 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 60.7 tt0 175.81 109.82 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 110.613 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 45.7 mt-10 . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.766 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 4.7 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -49.16 -36.03 18.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.869 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.76 -112.33 3.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.026 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 66.0 t60 -145.19 -74.2 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.686 0.279 . . . . 0.0 110.919 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.666 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -63.79 101.07 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.29 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -115.93 76.63 1.03 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -96.41 114.3 25.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.502 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.43 95.54 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.161 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 58' ' ' LYS . 6.6 mt -104.03 152.89 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.269 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 33' ' ' LEU . 9.1 p -121.26 -8.53 9.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.4 mttp -135.38 120.09 13.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.484 0.183 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.6 Cg_exo -58.13 -165.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.456 2.104 . . . . 0.0 112.33 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -119.49 -44.9 2.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.223 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -178.59 82.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.711 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 -7.18 19.79 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.38 149.75 22.84 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.504 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 4.8 m95 -88.21 150.83 23.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.89 0.376 . . . . 0.0 110.163 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -135.52 122.06 20.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.547 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 37.4 t80 -109.22 154.02 22.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 118.78 10.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 0.0 111.229 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.3 t70 -121.34 98.37 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.406 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -89.16 22.59 2.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.553 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.33 27.99 4.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.42 100.99 10.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -73.79 75.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.041 0.448 . . . . 0.0 110.67 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.666 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 57.3 mt -91.57 142.15 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -125.55 146.44 49.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.19 144.92 14.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 95.08 -35.05 4.44 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.244 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.1 t0 -62.15 149.54 41.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -108.31 168.28 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HG22 ' A' ' 101' ' ' VAL . 3.0 mp -124.92 145.8 31.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.196 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 57.8 m-85 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -159.9 -177.53 6.4 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 57.4 p-90 -153.54 135.05 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.894 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 72.1 p -99.55 166.69 11.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.071 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.661 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 15.9 t80 -150.01 108.69 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.667 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.75 ' O ' HD13 ' A' ' 86' ' ' ILE . 1.4 m -102.8 169.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.66 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -144.53 101.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.537 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -96.16 62.26 2.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 t0 64.35 62.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.836 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.53 26.84 60.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.265 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.4 mt -143.29 71.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.21 0.528 . . . . 0.0 110.157 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -75.84 160.53 51.71 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.333 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 85' ' ' VAL . 58.4 m-85 -152.19 140.79 20.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.67 ' C ' HG11 ' A' ' 9' ' ' VAL . 8.0 ptt180 -121.84 144.59 48.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' N ' HG21 ' A' ' 9' ' ' VAL . 12.4 tt0 -105.4 69.62 0.85 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.689 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.2 p30 -78.24 176.14 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.516 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.8 t30 61.42 17.57 8.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.38 164.75 53.59 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.12 152.03 29.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.8 t90 -148.63 164.06 35.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.976 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -107.26 159.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.665 HG22 HD11 ' A' ' 79' ' ' ILE . 13.8 t -118.7 -5.22 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.814 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HD21 ' A' ' 75' ' ' LEU . 4.4 p -69.12 -5.23 20.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.959 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -136.09 149.1 48.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.703 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 m-85 -133.83 148.47 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.038 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.262 0.553 . . . . 0.0 110.92 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.9 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.979 0.419 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.614 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -70.37 138.05 86.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 9' ' ' VAL . 37.9 Cg_endo -67.18 -168.36 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.486 2.124 . . . . 0.0 112.662 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -105.22 117.66 34.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.451 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.92 99.42 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.616 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -82.16 152.26 26.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.586 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.463 HD22 ' CE2' ' A' ' 81' ' ' PHE . 3.6 mp -145.24 157.79 43.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.581 . . . . 0.0 112.07 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.538 ' O ' HD22 ' A' ' 22' ' ' LEU . 8.8 mt-10 -150.03 142.92 24.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.977 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . . . -86.26 101.68 13.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 111.547 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 23' ' ' ARG . 26.7 mm -71.82 122.94 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.199 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 34.0 t80 -87.45 141.83 32.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 90.3 Cg_endo -96.27 5.15 42.91 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.512 0.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -164.65 96.69 0.75 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.765 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . 177.07 166.16 33.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.507 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.634 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -149.47 120.76 7.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.715 0.293 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HG2' HD11 ' A' ' 17' ' ' ILE . 9.9 ptm180 -109.88 133.1 53.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 22.1 t -121.74 155.06 26.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.339 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.63 147.07 29.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.788 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -146.11 127.49 7.47 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.451 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 22.8 Cg_endo -60.72 96.94 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.456 2.104 . . . . 0.0 111.463 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 24.1 t0 -59.97 154.94 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.632 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t70 -139.37 43.6 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.571 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.28 41.51 52.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.709 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 85' ' ' VAL . 11.5 m-85 -85.24 -170.83 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.375 0.607 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -131.83 -28.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.544 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 57' ' ' THR . 10.1 tp -139.68 135.67 33.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.378 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 29.9 t80 -126.95 103.3 7.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.387 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.36 118.2 36.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.643 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.4 t80 -105.91 128.47 53.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.718 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -119.28 129.37 54.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -147.07 142.37 10.24 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 118.765 -1.683 . . . . 0.0 114.615 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.2 mttp -119.64 124.55 46.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.347 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD13 HD23 ' A' ' 73' ' ' LEU . 46.3 tp -81.7 112.99 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.824 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.5 t-20 58.89 65.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.9 tt0 174.28 110.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 38.1 mt-10 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.422 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.718 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.25 -25.87 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.796 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 48.22 -107.9 0.31 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.47 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.2 t60 -138.38 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.738 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 15.8 m-90 -65.56 87.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.58 86.36 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -133.41 126.65 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.001 0.429 . . . . 0.0 111.964 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.6 109.55 21.45 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.363 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 18.3 mt -93.3 141.01 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.813 HG22 HD12 ' A' ' 33' ' ' LEU . 9.8 p -129.58 23.79 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.91 87.61 7.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 53.6 Cg_exo -52.72 171.46 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.613 2.209 . . . . 0.0 112.538 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 63' ' ' ARG . 4.5 tptm -109.97 36.46 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.678 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 4.5 mt-10 76.64 88.99 0.08 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.22 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.6 -3.68 24.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.002 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 10.2 mtp180 -157.29 129.04 7.03 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.444 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.531 ' CD1' HD11 ' A' ' 26' ' ' ILE . 7.9 m95 -81.53 150.28 28.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -135.07 121.92 21.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 56' ' ' ILE . 18.0 t80 -110.44 143.89 40.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.427 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -141.76 118.1 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.197 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 16.1 t70 -126.87 101.56 6.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.636 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.21 22.42 2.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.72 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -123.09 28.77 7.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.29 106.9 15.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -73.93 76.94 1.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.806 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 4.1 mt -78.89 166.31 22.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.676 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.81 149.16 46.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -67.66 131.3 45.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.257 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.604 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.51 -26.23 16.89 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.7 t70 -58.26 158.73 6.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.96 14.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.592 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -122.66 150.95 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.296 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 78.1 m-85 -144.4 130.37 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -161.23 -178.45 6.72 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.15 0.976 . . . . 0.0 113.48 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.5 p-90 -155.03 132.35 11.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -99.91 163.01 12.63 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.417 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.82 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 40.9 t80 -144.26 122.39 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.772 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -117.75 163.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.82 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 32.9 mm -136.39 109.27 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.582 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -103.77 74.4 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.034 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 t0 58.05 48.21 13.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.788 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 87.27 30.18 20.3 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.332 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.8 mt -143.94 75.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.157 0.503 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.34 158.95 44.35 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.429 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -152.35 150.1 29.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.63 -0.785 . . . . 0.0 108.932 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.614 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.54 147.47 52.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 4.1 tt0 -107.37 73.51 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.8 p30 -85.75 -179.88 6.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.523 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 t30 61.07 18.21 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.518 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.18 163.14 42.95 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.27 128.82 9.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 47.5 t90 -120.1 170.18 9.53 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 3.7 t -110.62 160.95 16.21 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 77' ' ' ASP . 2.1 t -126.71 15.17 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.667 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.593 ' O ' HD21 ' A' ' 75' ' ' LEU . 26.8 p -58.79 -24.55 61.99 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.892 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 81.7 mt-10 -137.31 161.33 36.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.856 0.36 . . . . 0.0 111.177 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 9.5 m-85 -130.18 145.86 51.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.796 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 17' ' ' ILE . 25.5 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.093 0.473 . . . . 0.0 110.502 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.8 t . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.78 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.6 p -68.63 135.32 90.41 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.499 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' HG11 ' A' ' 85' ' ' VAL . 16.5 Cg_exo -66.68 -173.6 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.618 2.212 . . . . 0.0 112.236 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.26 125.24 51.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -85.37 106.23 16.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.958 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 ttmt -92.32 119.84 32.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.621 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.717 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.1 mp -108.14 158.72 17.18 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.818 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.12 140.63 26.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.116 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.34 120.27 27.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.305 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 105' ' ' VAL . 19.8 mm -92.62 130.72 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.342 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -92.14 142.49 26.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.614 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.2 Cg_endo -93.23 -0.96 51.59 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.386 0.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.59 94.93 0.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.485 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.86 173.11 46.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.476 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -152.29 130.01 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 111.07 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' N ' HD13 ' A' ' 22' ' ' LEU . 9.8 ttt180 -120.26 115.5 23.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.719 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.717 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.3 t -110.86 161.5 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.453 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -152.68 143.58 22.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.046 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.683 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.59 124.06 10.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 10.8 Cg_endo -56.61 99.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.058 1.838 . . . . 0.0 111.359 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.1 t0 -65.51 160.07 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.809 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 4.1 t0 -143.23 43.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.96 42.68 68.19 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.808 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.2 m-85 -84.2 -170.53 3.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.282 0.563 . . . . 0.0 111.114 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -131.97 -28.01 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.645 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 9.6 tp -140.27 134.91 31.7 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.189 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.69 ' HD2' HD12 ' A' ' 56' ' ' ILE . 47.8 t80 -127.4 90.3 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.67 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -85.1 125.4 32.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.487 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 14.2 t80 -115.04 124.02 50.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.345 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.612 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -125.08 122.31 36.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -156.06 147.01 15.07 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.972 -1.585 . . . . 0.0 114.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.79 155.36 39.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.444 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -92.72 115.23 27.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER 59.88 71.9 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 74.2 tt0 174.31 110.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 31.4 mt-10 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.135 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.81 -26.37 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.664 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.79 -160.2 0.12 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.635 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -100.6 -74.22 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 110.696 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.621 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 m-90 -63.49 91.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.15 91.28 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.255 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.8 tmm_? -145.85 125.34 13.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.679 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.72 128.25 35.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.853 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.8 mt -102.99 159.51 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 56' ' ' ILE . 10.6 t -148.39 39.98 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 111.23 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -175.77 96.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.447 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 74.4 Cg_exo -49.75 179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.403 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -106.55 -58.43 1.93 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.194 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 82.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.382 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . 74.09 -2.42 43.49 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 33.6 mtt85 -156.66 147.25 21.59 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.354 0.261 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.609 ' CG ' HD11 ' A' ' 26' ' ' ILE . 9.9 m95 -83.91 159.11 21.37 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.64 118.02 16.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.409 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 36' ' ' PHE . 8.3 t80 -99.8 94.59 6.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.313 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -93.34 124.93 37.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.378 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.421 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.6 t70 -138.12 97.57 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.25 22.36 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -133.87 44.15 2.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -118.74 115.64 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.068 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.96 76.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 22' ' ' LEU . 6.4 mt -82.81 164.98 20.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -141.68 150.53 42.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.979 0.419 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -70.58 132.89 46.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.304 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.47 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.61 -26.4 16.24 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.9 t70 -60.5 165.95 3.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.66 163.32 16.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.383 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -117.6 148.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 3.9 m-85 -144.33 129.71 18.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 3.0 p90 -161.1 -175.51 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 122.0 0.905 . . . . 0.0 113.2 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 32.2 p-90 -157.03 124.65 5.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.859 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.6 p -107.2 151.26 25.66 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.981 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 86' ' ' ILE . 24.4 t80 -133.81 124.58 26.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.229 0.331 . . . . 0.0 111.043 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -108.28 163.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.797 HD11 ' CE2' ' A' ' 84' ' ' TYR . 22.4 mm -136.91 114.31 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.911 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 70.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.4 t0 66.45 62.38 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.768 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.2 28.64 72.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.637 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -145.06 77.91 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.171 0.51 . . . . 0.0 109.981 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -93.17 161.87 25.67 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.627 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -152.13 147.51 26.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.78 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -122.97 151.62 41.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.466 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -106.49 73.98 0.99 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.504 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.6 p30 -84.96 179.59 7.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.442 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 58.55 19.53 6.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.916 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.85 163.46 33.47 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.279 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.27 161.58 41.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.515 ' CZ2' ' HA ' ' A' ' 15' ' ' GLU . 54.8 t90 -146.43 169.06 19.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.526 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' CZ3' ' A' ' 99' ' ' TRP . 5.1 t -105.22 154.81 19.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.634 ' O ' HD22 ' A' ' 75' ' ' LEU . 1.9 t -124.25 17.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.295 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -70.49 -10.71 59.89 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -127.29 162.73 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.549 ' CE2' HD23 ' A' ' 75' ' ' LEU . 6.3 m-85 -135.29 123.53 23.08 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.7 m . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 110.852 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.2 t . . . . . 0 N--CA 1.46 0.044 0 CA-C-O 120.932 0.396 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.622 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.5 p -66.39 132.15 94.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.492 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.6 Cg_exo -64.19 -177.13 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.549 2.166 . . . . 0.0 111.933 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.6 122.69 47.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -81.14 109.79 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -95.3 102.35 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.162 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.1 mp -90.29 162.65 15.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.102 0.477 . . . . 0.0 111.935 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 105' ' ' VAL . 37.9 mt-10 -146.58 140.28 25.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.09 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.73 110.62 20.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.995 0.426 . . . . 0.0 111.448 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 16.9 mm -83.41 159.73 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 8.8 t80 -122.57 140.82 33.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.597 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 8.8 Cg_endo -88.96 1.78 68.97 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.4 -1.083 . . . . 0.0 112.419 0.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.8 98.21 0.3 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.929 0.395 . . . . 0.0 111.008 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.668 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -166.59 -173.13 34.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.437 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -155.81 137.61 14.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.803 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -133.63 106.72 7.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.37 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 22' ' ' LEU . 16.4 t -114.26 155.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.86 145.01 25.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.643 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.674 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -138.21 127.02 14.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.6 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.4 Cg_endo -58.4 93.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.344 2.029 . . . . 0.0 111.706 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.6 t0 -58.6 160.82 5.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.628 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 6.0 t0 -145.62 44.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.39 44.06 60.13 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.961 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.2 m-85 -88.28 -170.88 3.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.465 0.65 . . . . 0.0 111.22 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -131.69 -28.94 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.476 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 8.7 tp -138.38 135.3 35.19 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.163 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.706 ' HD2' HD12 ' A' ' 56' ' ' ILE . 37.1 t80 -125.44 98.58 5.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.028 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -92.88 126.22 37.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 111.062 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' CD2' HG22 ' A' ' 83' ' ' THR . 25.3 t80 -115.86 123.05 47.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.632 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -127.07 120.64 29.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.83 135.23 4.93 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 118.587 -1.768 . . . . 0.0 114.792 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -105.89 147.75 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.126 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.1 tp -97.19 125.26 41.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.279 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.3 t-20 56.8 57.72 4.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 76.5 tt0 174.64 109.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.14 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 60.7 mt-10 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 0.0 111.783 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.4 -25.65 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.9 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.71 -117.71 3.14 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.454 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 38' ' ' GLY . 1.1 t60 -137.48 -73.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.768 0.318 . . . . 0.0 110.555 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 12.8 m-90 -69.98 90.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.32 90.16 3.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.135 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.19 130.17 18.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 112.035 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.26 123.6 34.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.554 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 34' ' ' PHE . 13.3 mt -102.46 143.32 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.234 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 19.9 p -134.31 34.57 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.27 91.87 1.69 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 48.4 Cg_exo -55.88 170.03 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.57 2.18 . . . . 0.0 112.451 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.73 34.49 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.929 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 80.81 87.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.38 -1.75 25.37 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.735 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -157.14 125.3 5.55 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.393 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.566 ' CG ' HD11 ' A' ' 26' ' ' ILE . 18.4 m95 -77.48 156.6 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.2 m -134.59 118.93 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.41 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 56' ' ' ILE . 54.0 t80 -111.24 93.13 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.6 139.7 30.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.1 t70 -138.02 106.12 5.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.23 22.43 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.667 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -135.31 31.78 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.516 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -112.99 108.71 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.01 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -73.71 83.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 21' ' ' GLY . 37.5 mt -86.08 115.48 23.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.87 131.43 52.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -52.02 133.57 32.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.432 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.62 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.94 -29.71 11.61 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 101' ' ' VAL . 30.9 t0 -65.85 160.9 22.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -119.37 160.23 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.2 mp -114.75 146.79 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.786 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 33.7 m-85 -144.23 125.05 14.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.8 p90 -161.08 -174.29 4.29 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.208 1.004 . . . . 0.0 113.404 -178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.518 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.9 p-90 -151.01 127.43 10.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.378 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 24.4 p -107.07 149.7 27.32 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.461 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.773 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.4 t80 -131.51 146.4 52.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.306 0.379 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.55 162.52 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.103 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.773 HD11 ' CE2' ' A' ' 84' ' ' TYR . 31.1 mm -134.52 117.13 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.813 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -114.6 65.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t0 66.87 64.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.779 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.27 28.39 71.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.1 mt -144.96 77.9 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.233 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.81 161.25 28.11 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.47 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.6 m-85 -152.18 139.7 19.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -123.3 145.07 49.0 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.622 ' N ' HG21 ' A' ' 9' ' ' VAL . 28.1 tt0 -100.35 75.74 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.923 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.8 p-10 -79.97 176.5 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.06 19.65 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.809 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.07 165.81 52.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.264 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.15 161.09 42.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.962 0.411 . . . . 0.0 111.225 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.624 ' HB2' HD13 ' A' ' 14' ' ' LEU . 55.7 t90 -155.21 166.25 34.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 5.6 t -107.03 158.01 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' ASP . 3.8 t -122.33 -3.26 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.099 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.62 HG22 ' HA2' ' A' ' 76' ' ' GLY . 76.1 p -62.02 -16.08 49.07 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -114.28 161.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.628 0.251 . . . . 0.0 110.574 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 75' ' ' LEU . 45.5 m-85 -137.99 138.01 38.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 15' ' ' GLU . 3.2 m . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.298 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.6 t . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.943 0.402 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.65 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.5 p -70.36 137.93 86.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 26.0 Cg_endo -63.64 -174.71 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.428 2.085 . . . . 0.0 112.554 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -110.1 116.48 31.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.546 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -73.38 99.58 2.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -87.45 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.991 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.0 mp -105.7 163.84 12.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.268 0.556 . . . . 0.0 112.16 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HG2' HG11 ' A' ' 105' ' ' VAL . 2.0 mp0 -151.06 140.27 21.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.893 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.653 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.64 119.14 26.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.374 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.5 mm -93.42 152.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -116.44 149.18 43.26 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 3.2 Cg_exo -81.06 -6.99 44.27 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.221 0.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -168.36 93.46 0.35 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 111.0 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -158.47 -167.92 19.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.366 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.586 HD12 ' H ' ' A' ' 23' ' ' ARG . 43.3 tp -158.19 148.3 20.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -143.19 104.79 4.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.647 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.752 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.2 t -113.28 159.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 111.476 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.08 145.01 21.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -142.35 115.9 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.953 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 85.0 Cg_exo -47.13 105.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.166 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 32.4 t0 -71.51 148.9 46.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.205 0.526 . . . . 0.0 111.21 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.2 t0 -134.72 45.34 2.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.488 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.67 36.98 76.55 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.282 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.5 m-85 -78.14 -172.19 2.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 86' ' ' ILE . 95.7 p -133.08 -26.91 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.771 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.8 tp -140.57 128.12 21.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.386 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.656 ' HD2' HD12 ' A' ' 56' ' ' ILE . 13.6 t80 -120.6 93.78 4.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.936 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -95.82 120.35 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.975 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 52' ' ' TRP . 37.9 t80 -106.18 130.36 54.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -127.98 116.41 20.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -155.61 139.79 6.87 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.551 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 9.6 tptp -117.04 145.56 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 HD23 ' A' ' 73' ' ' LEU . 21.6 tp -93.43 122.6 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 111.146 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.8 t-20 57.25 66.46 1.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 42.8 tt0 170.27 111.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.735 0.303 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -44.85 -40.18 5.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.6 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.32 176.23 0.07 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 53' ' ' ALA . 1.9 m80 -79.84 -78.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.534 0.207 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.688 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 8.2 m-90 -57.21 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.49 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 51' ' ' HIS . . . -118.5 90.09 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.252 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 4.4 ttp180 -149.12 133.21 17.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 111.955 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -91.04 136.56 32.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.0 mt -115.8 148.62 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 111.193 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.581 HG22 HD12 ' A' ' 33' ' ' LEU . 48.1 p -137.84 22.55 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.3 mmpt? -146.79 88.49 5.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 56.0 Cg_exo -52.17 171.44 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.587 2.191 . . . . 0.0 112.641 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.72 39.8 1.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.657 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 3.2 mt-10 74.01 89.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.432 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.71 -5.26 17.77 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.5 mtp180 -157.56 132.69 8.83 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.621 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.61 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.3 m95 -81.81 156.45 24.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 ' CD ' ' A' ' 67' ' ' ARG . 1.1 m -134.62 119.38 18.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.393 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 3.1 t80 -112.86 89.62 3.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.508 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.431 ' CD ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -104.25 148.99 25.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 22' ' ' LEU . 1.9 m-20 -138.1 115.56 11.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.771 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.1 22.01 2.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -145.32 27.02 1.28 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.31 30.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.1 76.03 10.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.3 mt -103.31 132.3 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.437 ' N ' HG11 ' A' ' 101' ' ' VAL . 13.2 mttt -122.76 152.68 40.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 111.553 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -54.16 131.82 41.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.297 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.72 -27.0 13.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.9 t70 -57.8 149.79 21.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.981 0.419 . . . . 0.0 111.097 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 149.8 32.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.488 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.735 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -109.22 148.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.207 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -144.45 125.39 14.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.547 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.7 p90 -161.2 -174.35 4.29 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 51.2 p-90 -157.97 134.33 9.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.153 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 24.6 p -99.74 161.99 13.27 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.118 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.888 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 23.8 t80 -144.18 106.05 4.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.645 0.259 . . . . 0.0 110.871 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.54 164.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.372 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 23.9 mm -140.58 106.62 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.875 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -102.5 74.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.661 0.601 . . . . 0.0 110.589 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 57.61 62.28 2.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.814 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.74 31.37 62.61 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.217 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.6 mt -142.59 70.36 1.32 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.21 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -77.68 157.84 46.18 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 114.361 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.42 143.86 23.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.65 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -126.51 146.29 50.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 3.0 tt0 -105.38 73.82 1.05 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.232 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 19.0 p-10 -85.14 176.78 8.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.72 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 60.05 19.97 9.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.455 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.95 162.87 41.23 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.077 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -154.29 138.97 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.947 0.404 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.735 ' CE3' HD13 ' A' ' 79' ' ' ILE . 31.6 t90 -129.67 166.17 20.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.048 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.9 t -111.58 162.69 14.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 77' ' ' ASP . 11.7 t -123.83 5.4 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.401 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 3.2 p -62.01 -16.97 55.57 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.349 -0.387 . . . . 0.0 112.008 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 mm-40 -136.7 157.31 47.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.342 . . . . 0.0 111.025 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 16.3 m-85 -135.83 145.57 46.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.037 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' ' 15' ' ' GLU . 14.4 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 9' ' ' VAL . 21.3 t . . . . . 0 C--O 1.228 -0.075 0 CA-C-O 121.093 0.473 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.67 HG11 ' N ' ' A' ' 94' ' ' GLN . 2.7 p -66.95 145.82 98.98 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.072 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 9' ' ' VAL . 21.2 Cg_exo -65.22 -166.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.605 2.203 . . . . 0.0 111.995 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.53 123.65 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.0 111.67 21.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.717 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 tptt -81.99 156.88 24.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.686 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' A' ' 24' ' ' VAL . 4.9 mp -147.4 143.9 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.981 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -142.1 144.7 33.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.959 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.13 110.03 19.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.7 mm -80.6 127.61 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.333 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -89.73 143.01 29.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 60.7 Cg_endo -93.28 2.68 57.12 Favored 'Cis proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.444 0.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -167.55 96.64 0.47 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.54 -178.2 45.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 23' ' ' ARG . 5.4 tp -156.09 138.41 14.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 110.972 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.837 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.44 120.59 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.477 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 42.8 t -123.59 150.44 27.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.553 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -153.16 144.49 23.19 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -137.54 125.84 14.49 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.2 Cg_endo -64.49 89.55 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.012 1.808 . . . . 0.0 111.414 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 16.5 t0 -50.87 160.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.332 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 36.0 t0 -140.05 41.5 1.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.46 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.96 49.5 7.6 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.088 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' HG21 ' A' ' 85' ' ' VAL . 7.7 m-85 -94.41 -173.58 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.473 0.654 . . . . 0.0 111.169 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 86' ' ' ILE . 12.6 m -127.66 -29.98 2.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.105 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.1 tp -141.36 141.74 33.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.728 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.613 ' CD1' HD13 ' A' ' 26' ' ' ILE . 51.6 t80 -128.13 103.32 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.299 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.87 121.6 38.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 0.0 110.982 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HG22 ' A' ' 83' ' ' THR . 18.8 t80 -112.17 123.04 49.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.524 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -123.71 122.67 38.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -152.24 136.51 5.46 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 118.836 -1.649 . . . . 0.0 114.463 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.45 127.12 46.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.619 HD12 ' CG ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -89.98 140.75 29.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.873 0.368 . . . . 0.0 110.937 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.56 6.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.786 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 36.4 tt0 -179.9 109.05 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.193 0.521 . . . . 0.0 110.445 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.3 mt-10 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.596 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.748 0.309 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.616 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -52.84 -24.89 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.67 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.56 -130.83 11.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.541 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -127.95 -77.4 0.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.81 0.338 . . . . 0.0 110.531 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.639 ' NE1' HD23 ' A' ' 22' ' ' LEU . 28.9 m-90 -62.85 94.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.206 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.5 87.88 2.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.9 tpm_? -136.81 127.68 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.953 0.406 . . . . 0.0 112.029 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.87 107.01 18.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.458 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 3.1 mp -89.04 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.444 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 t -129.58 28.23 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -150.28 88.07 4.8 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 51.4 Cg_exo -54.99 170.46 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.3 tpmp? -108.41 31.34 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.698 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 81.42 93.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.678 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.31 -6.8 7.04 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.456 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 11.6 ptt180 -157.53 134.95 10.44 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.893 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' A' ' 26' ' ' ILE . 6.1 m95 -85.23 154.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -134.6 100.06 4.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.557 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 39.9 t80 -95.88 143.13 27.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.919 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -144.87 145.03 31.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.406 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 47.5 t0 -138.03 100.19 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.476 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -89.17 22.44 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.683 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -138.67 32.52 2.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 0.0 110.811 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB1' ' CZ2' ' A' ' 52' ' ' TRP . . . -104.43 129.56 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.21 83.25 6.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.596 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.0 OUTLIER -102.73 121.33 42.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.68 145.93 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -59.0 133.4 56.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.968 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.72 -28.85 14.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.045 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.619 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 t70 -61.77 163.25 7.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 111.115 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -122.49 156.75 33.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.493 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.506 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -113.05 145.83 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.207 0.527 . . . . 0.0 112.125 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 15.9 m-85 -144.32 120.35 10.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -152.51 -176.27 5.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.203 1.001 . . . . 0.0 113.674 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.504 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 60.1 p-90 -152.38 125.29 8.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.318 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 45.1 p -100.0 149.0 23.9 Favored 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.793 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.888 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.0 t80 -127.26 157.13 40.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 123.334 0.396 . . . . 0.0 110.849 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.662 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 20.8 mm -138.53 106.29 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.808 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -104.01 62.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.544 0.527 . . . . 0.0 110.72 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 t0 71.71 65.4 0.15 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.771 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.72 28.78 71.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.579 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.6 mt -144.35 77.71 1.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.267 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -84.35 158.63 34.47 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.562 -0.745 . . . . 0.0 114.568 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -152.54 148.79 27.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.169 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.98 152.4 51.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.67 ' N ' HG11 ' A' ' 9' ' ' VAL . 3.2 tt0 -107.6 76.3 1.06 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.449 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.3 p30 -77.96 178.29 7.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.334 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 63.18 15.04 8.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.2 162.39 54.66 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.978 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.4 157.63 38.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.641 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.506 ' CE3' HD13 ' A' ' 79' ' ' ILE . 40.3 t90 -155.17 164.41 38.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.061 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 102' ' ' THR . 6.7 t -105.57 158.91 16.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.561 HG21 ' HB3' ' A' ' 77' ' ' ASP . 10.3 t -120.33 -4.35 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.047 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 100' ' ' THR . 9.6 t -66.49 -8.59 27.36 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.0 mt-10 -124.24 139.37 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 82.9 m-85 -130.42 131.62 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 0.0 110.835 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.99 0.424 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -66.81 127.36 93.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.29 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.9 Cg_exo -67.41 -178.64 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.477 2.118 . . . . 0.0 112.212 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.3 135.19 47.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.267 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.606 ' HB1' HG11 ' A' ' 24' ' ' VAL . . . -88.63 111.05 21.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.842 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -92.18 94.14 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.845 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -83.83 163.2 20.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 0.0 112.315 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.618 ' CD ' HG11 ' A' ' 105' ' ' VAL . 28.7 mt-10 -150.71 138.86 20.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.526 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.39 114.89 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.242 0.544 . . . . 0.0 111.683 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.532 HD13 HG22 ' A' ' 105' ' ' VAL . 20.1 mm -96.45 108.65 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -78.92 150.78 75.65 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.01 2.58 69.66 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.962 -1.266 . . . . 0.0 112.282 0.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.59 93.18 0.26 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -171.07 175.25 44.78 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 23' ' ' ARG . 7.7 tp -150.14 138.87 20.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 110.828 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 22' ' ' LEU . 22.0 ttt85 -137.11 107.31 6.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.724 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.606 HG11 ' HB1' ' A' ' 12' ' ' ALA . 21.1 t -116.95 155.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.409 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.442 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -143.12 144.01 32.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.679 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.644 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -136.74 128.07 16.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.394 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.92 102.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.346 2.031 . . . . 0.0 111.785 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.5 t0 -67.76 151.44 47.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.403 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -139.91 45.95 1.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.717 179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.31 92.58 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.1 m-85 -78.48 -171.52 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.368 0.604 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 86' ' ' ILE . 40.4 m -131.8 -27.16 1.91 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 56' ' ' ILE . 10.3 tp -143.36 132.19 22.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.627 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.726 ' HD2' HD12 ' A' ' 56' ' ' ILE . 39.0 t80 -122.32 101.64 7.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.906 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.44 126.73 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.615 ' CD2' HG22 ' A' ' 83' ' ' THR . 10.6 t80 -112.72 130.49 56.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.1 119.13 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.518 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.75 139.32 6.64 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 118.586 -1.768 . . . . 0.0 114.676 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.25 142.93 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.233 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.424 HD22 HD23 ' A' ' 73' ' ' LEU . 30.4 tp -96.01 143.04 27.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 1.3 p-10 44.36 48.98 8.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.363 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 179.44 109.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 110.398 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 56.0 mt-10 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.639 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.825 0.345 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -54.48 -24.34 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.745 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.53 -115.58 1.93 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.544 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' GLY . 6.3 t-160 -137.61 -72.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.649 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.6 m-90 -68.38 88.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.34 88.99 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 39.7 ttt-85 -146.94 130.37 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.632 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.11 136.49 34.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.2 mt -111.81 157.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 56' ' ' ILE . 12.2 t -144.54 41.96 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.41 102.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.1 Cg_exo -54.27 -169.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.427 2.085 . . . . 0.0 112.366 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -119.03 -53.55 2.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.1 83.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.563 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.79 -2.17 34.3 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 3.0 mtt180 -156.92 145.64 19.91 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.769 -0.215 . . . . 0.0 110.473 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.493 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.7 m95 -81.97 161.94 22.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -134.11 116.95 16.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.48 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 24.2 t80 -99.94 84.12 2.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.353 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.96 124.92 36.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.46 110.13 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.755 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 22.15 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.439 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -135.18 40.22 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -107.89 111.57 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.207 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -73.96 75.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 78.7 mt -95.92 134.03 39.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.22 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.512 ' N ' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -128.04 141.45 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.625 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.5 OUTLIER -52.44 132.22 34.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.68 -27.77 18.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.38 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.1 t0 -62.18 151.24 36.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.815 0.341 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -110.93 152.95 26.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.84 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.737 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -112.21 145.34 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.561 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.5 m-85 -144.59 124.92 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.845 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.5 p90 -161.22 -173.83 4.04 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.496 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 63.5 p-90 -153.44 128.24 9.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.662 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 23.0 p -106.82 148.96 27.89 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.754 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 93' ' ' ARG . 5.1 t80 -129.61 145.0 51.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.365 0.415 . . . . 0.0 111.063 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -131.18 160.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.373 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 37.8 mm -129.63 117.58 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.594 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 55.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 t0 71.87 67.19 0.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.786 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.34 23.37 77.47 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.371 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.7 mt -145.89 79.15 1.55 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.208 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -97.61 165.93 22.58 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.48 -0.782 . . . . 0.0 114.399 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -152.05 150.87 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.631 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.2 ptt-85 -128.88 145.37 51.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.576 ' N ' HG21 ' A' ' 9' ' ' VAL . 5.8 tt0 -99.5 77.63 2.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.808 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.1 p30 -81.77 178.74 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 59.54 19.1 7.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.63 166.4 53.27 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.102 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.11 156.59 37.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.737 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -154.67 165.45 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -110.82 161.97 15.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 79' ' ' ILE . 21.3 t -120.44 -3.13 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.805 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.625 HG23 ' CD2' ' A' ' 75' ' ' LEU . 9.0 m -62.26 -14.34 37.6 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.885 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tt0 -131.49 148.54 52.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.8 m-85 -130.41 161.42 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.618 HG11 ' CD ' ' A' ' 15' ' ' GLU . 12.0 m . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 111.051 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 9' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.857 HG22 ' HB3' ' A' ' 92' ' ' TYR . 13.2 t -66.08 129.78 94.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.993 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.32 -171.13 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.354 2.036 . . . . 0.0 111.974 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -114.61 113.57 24.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.73 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.17 106.39 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.526 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' C ' HD12 ' A' ' 14' ' ' LEU . 7.2 tttt -90.77 163.7 14.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.124 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.692 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -147.91 159.76 43.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.976 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -148.92 141.43 24.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.095 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.07 104.44 16.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.968 0.413 . . . . 0.0 111.512 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 23' ' ' ARG . 42.8 mm -72.19 146.36 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.427 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -105.08 142.22 24.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.739 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 97.7 Cg_endo -89.47 -7.79 46.05 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.848 -1.314 . . . . 0.0 112.222 -0.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 94.13 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -160.72 -165.85 18.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.492 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 23' ' ' ARG . 27.0 tp -155.54 145.73 21.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.773 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -140.33 96.34 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 45.8 t -107.38 151.45 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.58 144.32 22.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.926 0.393 . . . . 0.0 111.612 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.5 pp -137.25 131.75 17.72 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.597 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 104.75 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.148 1.899 . . . . 0.0 111.477 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.445 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 t0 -70.53 157.99 36.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.367 0.603 . . . . 0.0 111.737 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 2.8 m-20 -146.97 42.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.329 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 45.43 9.49 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.744 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m-85 -86.05 -173.29 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.447 0.641 . . . . 0.0 111.102 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -133.59 -26.54 1.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.684 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.756 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.4 tp -142.05 129.49 21.28 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.234 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.843 ' CD2' HD12 ' A' ' 56' ' ' ILE . 6.0 t80 -120.58 91.34 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.173 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -90.63 132.82 35.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.989 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TRP . 38.8 t80 -116.94 126.5 53.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.982 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -128.24 117.91 22.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.26 138.4 6.55 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.737 -1.697 . . . . 0.0 114.631 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.4 OUTLIER -109.78 147.17 33.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.202 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' HH2' ' A' ' 52' ' ' TRP . 15.0 tp -99.46 127.52 45.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.202 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.0 t30 57.45 54.81 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 66.6 tt0 175.55 109.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.244 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 35.3 mt-10 . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.365 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 5.7 mm-40 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.9 0.381 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -55.37 -22.05 17.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.085 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.51 4.39 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.245 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -131.64 -79.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.661 0.267 . . . . 0.0 110.347 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.623 ' HH2' HD13 ' A' ' 40' ' ' LEU . 13.2 m-90 -61.53 91.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.64 88.65 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.168 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -143.57 124.07 13.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.025 0.44 . . . . 0.0 111.861 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 4.2 p-10 -87.8 128.67 35.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.663 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.843 HD12 ' CD2' ' A' ' 34' ' ' PHE . 11.2 mt -103.65 154.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 45.06 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.009 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.5 93.18 0.25 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.5 Cg_exo -52.06 -176.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.462 2.108 . . . . 0.0 112.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -113.95 -44.86 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.233 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.02 84.37 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.651 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.97 -2.8 32.17 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.424 -0.894 . . . . 0.0 110.923 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -157.11 148.51 22.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.771 ' CD1' HD11 ' A' ' 26' ' ' ILE . 5.1 m95 -90.12 157.28 17.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -134.64 114.73 13.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.6 t80 -107.41 89.37 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -94.69 144.87 25.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.099 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -138.0 108.44 6.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.582 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -89.18 22.39 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.522 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -141.26 28.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 115.66 27.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -73.91 75.97 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.629 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 96.2 mt -96.75 142.12 29.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 142.27 49.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.782 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 102' ' ' THR . 1.4 tt -56.85 130.2 44.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.631 ' HA2' HG23 ' A' ' 102' ' ' THR . . . 106.01 -28.39 14.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.133 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 101' ' ' VAL . 8.9 t70 -66.56 153.09 43.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.95 0.405 . . . . 0.0 110.877 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.68 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.615 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -114.83 144.58 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.861 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.0 m-85 -144.53 121.28 11.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.692 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.3 p90 -158.5 -172.37 3.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.13 0.967 . . . . 0.0 113.572 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.6 p-90 -155.54 134.25 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.979 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 12' ' ' ALA . 17.8 p -99.92 165.45 11.55 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.721 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.859 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.2 t80 -147.08 108.13 4.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.66 164.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.791 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 12.1 mm -145.23 106.84 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 90' ' ' LEU . 11.9 ptmt -99.63 46.43 0.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 13.7 t0 81.1 77.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.474 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.807 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.02 21.51 75.48 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.265 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.3 mt -145.64 79.37 1.57 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.332 0.586 . . . . 0.0 110.274 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.04 161.71 41.92 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.325 -0.852 . . . . 0.0 114.44 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.857 ' HB3' HG22 ' A' ' 9' ' ' VAL . 49.3 m-85 -144.8 134.38 23.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.838 ' C ' HG11 ' A' ' 9' ' ' VAL . 5.7 ptt180 -123.81 140.17 53.25 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.71 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.8 73.15 1.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.83 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.6 p-10 -81.48 173.33 12.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.689 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 59.65 20.34 8.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.4 162.7 44.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.059 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -154.46 145.95 23.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.263 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 79' ' ' ILE . 38.7 t90 -140.2 164.29 30.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.5 t -105.01 158.11 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ASP . 4.0 t -121.12 -3.97 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.768 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -62.63 -14.33 41.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.628 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.9 tt0 -125.3 149.16 48.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 110.846 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.596 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -134.32 146.4 49.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.261 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG2' HD13 ' A' ' 17' ' ' ILE . 15.1 m . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.718 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.2 t . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 120.958 0.409 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 ' C ' ' A' ' 93' ' ' ARG . 4.5 p -66.9 132.86 93.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.085 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' HG11 ' A' ' 85' ' ' VAL . 22.5 Cg_exo -64.41 -168.48 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.645 2.23 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.46 124.73 50.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.804 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.75 104.52 13.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.488 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -93.16 103.9 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.379 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.5 mp -97.07 161.53 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.567 ' HB3' HG11 ' A' ' 105' ' ' VAL . 31.3 mt-10 -147.04 136.59 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.893 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.55 102.6 14.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.1 mm -74.82 156.81 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.541 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -119.0 145.54 38.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.534 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -84.18 -2.66 56.92 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.302 0.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.12 98.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -163.35 -171.31 29.43 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.374 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.633 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.82 139.13 18.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.05 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.873 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -133.9 101.52 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.638 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 14' ' ' LEU . 14.0 t -109.36 156.47 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -154.98 146.27 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.666 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -143.95 122.04 6.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.497 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 13.1 Cg_endo -57.72 101.18 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.092 1.861 . . . . 0.0 111.436 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.3 t0 -63.06 159.53 17.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -140.71 43.48 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.568 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.94 46.04 47.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.59 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 29' ' ' ASP . 10.5 m-85 -90.4 -171.51 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.409 0.623 . . . . 0.0 111.419 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 86' ' ' ILE . 27.7 t -130.8 -28.26 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.552 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.711 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.1 tp -139.43 135.45 33.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.205 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' ILE . 26.2 t80 -124.72 106.51 10.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.878 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.15 117.51 34.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 111.017 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.703 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 56.2 t80 -106.55 124.57 49.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -125.59 129.35 49.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -159.52 139.99 6.54 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 114.438 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.7 tmtp? -116.78 135.79 53.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.214 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 HG21 ' A' ' 101' ' ' VAL . 5.6 tp -91.05 125.83 35.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 16.6 t-20 65.46 50.06 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.528 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.8 tt0 170.27 110.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.021 0.439 . . . . 0.0 110.337 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.3 mt-10 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.508 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.83 0.347 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.92 -25.72 8.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 42.64 -124.96 4.18 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.088 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -137.36 -73.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.302 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 5.6 m-90 -63.61 82.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.717 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.26 93.04 3.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.212 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 4.3 tpm_? -141.46 125.77 17.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.945 0.402 . . . . 0.0 111.874 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.46 131.96 35.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.826 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.588 HD12 ' HD2' ' A' ' 34' ' ' PHE . 7.7 mt -117.44 143.86 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.983 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.42 26.6 4.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.0 mmmt -153.42 92.52 3.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.163 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 52.7 Cg_exo -52.72 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.252 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.8 -49.67 2.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.826 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -179.99 82.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.303 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.11 2.72 49.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HD3' ' CB ' ' A' ' 25' ' ' SER . 20.9 ttm-85 -157.61 140.49 15.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.523 0.201 . . . . 0.0 111.001 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.474 ' CG ' HD11 ' A' ' 26' ' ' ILE . 7.6 m95 -89.18 154.48 20.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.98 0.419 . . . . 0.0 110.311 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -134.73 119.89 18.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 17.0 t80 -113.65 106.8 14.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.614 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 139.39 38.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.428 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -137.37 105.37 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.729 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.29 22.77 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.632 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -134.06 29.87 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.51 99.16 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.073 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -74.09 75.93 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.764 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.633 HD11 ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -91.65 146.43 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.935 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.421 ' N ' HG11 ' A' ' 101' ' ' VAL . 9.6 ttpp -130.92 139.82 50.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -52.69 132.55 36.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.2 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.92 -29.17 12.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.067 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 7.8 t0 -66.35 153.87 41.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.019 0.438 . . . . 0.0 111.158 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 160.35 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.792 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -118.88 147.11 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.066 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 42.2 m-85 -144.55 129.43 18.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -161.11 -177.87 6.37 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.602 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.577 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.8 p-90 -151.02 133.06 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.481 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -99.98 156.98 16.86 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -178.599 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 12.0 t80 -139.24 138.8 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.62 0.247 . . . . 0.0 110.838 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -134.25 161.08 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.56 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.711 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.0 mm -135.85 107.19 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.968 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -100.35 57.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.538 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 68.55 68.7 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.741 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.831 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.97 25.47 75.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.392 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.94 73.02 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -87.63 160.96 31.9 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.289 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -152.22 153.1 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.749 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -132.84 147.84 52.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -104.05 76.75 1.37 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.399 177.472 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.19 177.27 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 61.78 17.28 8.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.801 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.18 163.91 54.9 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.951 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.47 153.84 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.459 . . . . 0.0 111.166 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.792 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.6 t90 -153.1 166.75 31.5 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -112.12 162.75 15.08 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.69 HG22 HD11 ' A' ' 79' ' ' ILE . 20.3 t -121.9 -9.26 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.668 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 76' ' ' GLY . 25.6 p -60.36 -14.35 18.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.718 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.45 162.36 22.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 89.9 m-85 -140.88 148.07 39.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 15' ' ' GLU . 4.7 m . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.81 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 20.6 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.924 0.392 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 93' ' ' ARG . 11.0 t -66.29 127.26 93.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.77 -177.12 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.467 2.112 . . . . 0.0 112.331 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 t -110.93 111.43 22.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.506 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.82 109.61 17.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.521 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.778 ' O ' HG13 ' A' ' 24' ' ' VAL . 9.4 mttt -84.23 164.45 19.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.187 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.727 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.2 mp -154.12 138.62 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.074 0.464 . . . . 0.0 112.094 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -135.2 136.7 41.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.496 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.745 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.75 114.52 23.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.7 mm -91.67 111.61 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -83.07 147.01 52.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.438 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 91.2 Cg_endo -92.23 -3.69 49.06 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.897 -1.293 . . . . 0.0 112.606 0.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 91.68 1.18 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.66 173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.574 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -153.44 144.51 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.507 ' H ' HD13 ' A' ' 22' ' ' LEU . 19.7 ttt180 -133.72 109.88 9.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 13' ' ' LYS . 30.0 t -122.76 142.88 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.357 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.52 146.94 33.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.2 pp -136.41 122.92 13.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.303 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 72.1 Cg_exo -47.61 108.68 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.494 2.129 . . . . 0.0 112.026 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 27.5 t0 -76.64 151.03 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 0.0 111.399 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t0 -140.89 46.09 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.752 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.98 69.85 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.404 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 10.1 m-85 -73.64 -170.97 0.94 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.637 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -132.94 -27.76 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.768 HD21 ' OD2' ' A' ' 55' ' ' ASP . 5.8 tp -139.87 127.25 21.39 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.251 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' HD12 ' A' ' 56' ' ' ILE . 2.4 t80 -118.49 94.36 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -101.82 114.78 29.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' TRP . 32.5 t80 -105.91 126.36 52.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.49 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.44 132.47 3.52 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.152 -1.499 . . . . 0.0 114.04 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 18.1 tptm -108.62 141.63 40.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 73' ' ' LEU . 62.4 tp -92.24 117.16 29.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.889 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 57.8 t-20 63.92 65.17 0.72 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 36.1 tt0 172.86 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.163 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 78.1 mt-10 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.436 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -57.44 -32.14 66.6 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.713 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.16 -103.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.279 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -148.59 -78.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 110.546 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 36' ' ' PHE . 10.6 m-90 -59.25 89.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.4 88.86 3.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.223 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -132.45 125.71 31.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.042 0.449 . . . . 0.0 111.776 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD21 ' A' ' 33' ' ' LEU . 10.2 t0 -105.74 94.31 5.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.45 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 58' ' ' LYS . 16.6 mt -81.49 146.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.142 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.17 22.71 6.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.678 ' H ' HG22 ' A' ' 56' ' ' ILE . 7.2 ptpt -154.89 100.54 2.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.1 Cg_exo -52.1 171.56 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.426 2.084 . . . . 0.0 112.542 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -114.66 40.9 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 6.4 tt0 84.0 86.65 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.845 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.96 -5.72 6.0 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.954 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 1.1 mtt180 -157.25 137.52 12.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.582 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.641 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.4 m95 -83.36 154.28 24.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -134.71 119.48 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 11.4 t80 -108.28 87.54 2.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.242 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 132.85 36.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.184 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.0 t0 -138.1 103.12 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 7.0 ptt-85 -89.18 22.41 2.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -133.1 42.07 3.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.5 100.76 7.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.93 99.82 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.655 HD11 HD23 ' A' ' 22' ' ' LEU . 2.5 mt -122.01 164.19 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -138.52 144.38 39.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.85 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -62.64 126.75 28.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.572 . . . . 0.0 110.724 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.757 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 125.37 -31.09 4.32 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.354 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.5 t0 -72.91 149.62 43.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 164.23 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 101' ' ' VAL . 2.8 mp -118.87 147.81 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.13 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 63.5 m-85 -144.46 125.77 14.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.579 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -157.5 -178.62 7.47 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.498 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.0 p-90 -155.7 134.6 12.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.671 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.733 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.81 160.97 13.9 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.941 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.916 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 16.3 t80 -145.33 105.46 4.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 111.06 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.61 165.17 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 19.7 mm -142.51 105.99 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.877 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.7 ttpt -96.05 70.01 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.427 0.454 . . . . 0.0 111.104 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 56.72 46.02 20.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.263 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.796 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 98.45 28.68 7.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.729 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -142.9 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -64.85 155.98 47.61 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.191 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.749 ' HB3' HG22 ' A' ' 9' ' ' VAL . 69.9 m-85 -152.52 134.24 14.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.34 -0.93 . . . . 0.0 108.677 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.869 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.9 140.7 49.15 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.562 0.696 . . . . 0.0 112.687 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.7 ' N ' HG11 ' A' ' 9' ' ' VAL . 2.5 tt0 -104.33 73.8 1.14 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.452 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.5 p30 -81.32 174.33 11.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.564 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.18 18.82 9.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.07 163.29 52.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.911 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -152.55 150.67 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.646 ' CE3' HD13 ' A' ' 79' ' ' ILE . 27.8 t90 -149.18 164.45 34.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -106.4 158.56 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 79' ' ' ILE . 21.5 t -119.86 -10.6 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.178 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.757 HG22 ' HA2' ' A' ' 76' ' ' GLY . 20.9 p -60.24 -11.51 6.53 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -132.47 148.12 52.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.745 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 40.9 m-85 -135.32 149.95 49.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.362 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.083 0.468 . . . . 0.0 110.491 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 9' ' ' VAL . 14.8 t . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.856 0.36 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.681 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.2 p -66.89 130.38 93.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.206 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' CD ' HG11 ' A' ' 85' ' ' VAL . 38.8 Cg_exo -60.35 -175.26 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.688 2.259 . . . . 0.0 112.383 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.83 125.81 52.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.58 105.7 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.726 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -95.87 109.78 22.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.009 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.3 mp -105.76 157.01 17.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.265 0.555 . . . . 0.0 112.266 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 38.4 mt-10 -140.69 141.44 34.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.512 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.13 122.78 30.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.157 0.503 . . . . 0.0 111.367 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.494 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.8 mm -104.69 109.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -79.0 150.55 75.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.883 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.59 -1.62 61.82 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.188 0.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.75 98.12 0.31 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.4 164.84 36.06 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 23' ' ' ARG . 22.9 tp -138.37 144.55 40.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 111.149 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.678 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -135.54 99.5 4.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.473 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.7 t -105.96 158.06 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.985 0.421 . . . . 0.0 111.774 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -155.13 149.76 26.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.667 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -144.51 126.92 8.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.0 Cg_endo -57.1 95.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.386 2.057 . . . . 0.0 111.568 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.7 t0 -59.17 160.63 6.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 3.9 t0 -145.86 45.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.152 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.55 89.63 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.885 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 85' ' ' VAL . 20.0 m-85 -83.67 -170.03 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.266 0.555 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -129.82 -29.27 2.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.645 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.7 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.86 137.54 34.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.508 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.709 ' HD2' HD12 ' A' ' 56' ' ' ILE . 25.2 t80 -127.4 97.02 4.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.463 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.832 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.06 135.63 37.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.412 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 52' ' ' TRP . 9.6 t80 -121.28 125.85 48.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -123.8 123.37 40.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -157.43 139.28 6.31 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 118.816 -1.659 . . . . 0.0 114.442 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -111.86 148.38 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.343 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tp -100.03 120.15 39.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.8 t-20 61.76 54.83 2.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 51.0 tt0 174.06 109.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 36.0 mt-10 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.9 mt-10 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.834 0.35 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.85 -26.57 10.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.655 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.71 -121.63 7.01 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.435 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -137.88 -73.71 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.749 0.309 . . . . 0.0 110.547 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.5 m-90 -61.3 90.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.037 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.22 87.28 2.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.142 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -136.6 129.63 31.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.989 0.423 . . . . 0.0 111.919 -179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -99.4 126.67 45.33 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.709 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.7 mt -111.96 142.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -130.71 28.7 4.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -155.92 98.12 2.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 36.1 Cg_exo -57.29 169.14 2.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.477 2.118 . . . . 0.0 112.589 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' ARG . 11.9 tptp -105.18 34.64 3.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.91 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 82.06 88.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.48 -5.86 13.95 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.864 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.0 mtt180 -157.26 130.42 7.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.563 ' CD1' HD11 ' A' ' 26' ' ' ILE . 15.6 m95 -78.64 158.16 28.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 67' ' ' ARG . 9.5 m -134.26 112.57 11.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' ILE . 5.2 t80 -113.8 85.39 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.599 ' HD2' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -103.96 151.13 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.45 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -138.13 113.19 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.13 22.39 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -143.83 31.01 1.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.5 128.8 44.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.5 96.15 5.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.68 152.47 28.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.12 150.63 41.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.184 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.622 HD23 ' HE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.42 130.8 46.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.421 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.15 25.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.8 t70 -56.39 152.91 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 152.64 29.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.543 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.71 HD11 HG22 ' A' ' 101' ' ' VAL . 2.6 mp -112.72 146.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 m-85 -144.55 126.16 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 79' ' ' ILE . 1.3 p90 -161.03 -176.72 5.65 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.509 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 61.2 p-90 -152.83 135.13 15.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.591 -1.64 . . . . 0.0 108.97 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 12' ' ' ALA . 14.1 p -99.79 163.74 12.34 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.2 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.832 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.0 t80 -145.1 113.8 6.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.667 0.27 . . . . 0.0 111.012 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -107.73 164.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.7 mm -138.99 104.48 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.4 59.66 1.86 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.573 0.545 . . . . 0.0 110.668 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 64.43 64.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.678 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.01 25.58 63.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.315 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.16 71.23 1.33 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.16 160.66 44.54 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.4 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -152.28 149.01 28.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.681 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.4 ptt180 -128.68 144.97 51.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.496 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.68 75.81 1.34 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.405 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.487 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.98 175.9 10.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.573 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.45 18.16 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.806 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.57 162.79 52.36 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.97 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -154.39 146.43 23.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.903 0.382 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -142.65 167.04 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.062 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.1 t -115.45 163.41 15.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 79' ' ' ILE . 3.4 t -125.83 17.78 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.923 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.537 ' HA ' HD13 ' A' ' 75' ' ' LEU . 1.2 p -65.95 -13.04 59.06 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.701 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.4 mt-10 -147.25 162.25 39.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.622 ' HE2' HD23 ' A' ' 75' ' ' LEU . 95.3 m-85 -130.47 140.69 50.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.704 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 121.166 0.507 . . . . 0.0 110.79 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.6 t . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.84 0.353 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 ' C ' ' A' ' 93' ' ' ARG . 12.0 p -71.92 142.79 85.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.4 Cg_exo -68.36 -178.44 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -110.33 120.76 43.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -82.27 116.05 21.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.473 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.3 ttmt -103.78 101.75 11.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.1 mp -91.23 168.6 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 111.838 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -155.92 154.09 30.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.473 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.94 128.34 35.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 111.825 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 16' ' ' ALA . 1.3 mp -112.66 115.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.715 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -78.85 143.7 62.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.6 Cg_endo -91.69 -4.11 49.93 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.037 -1.234 . . . . 0.0 112.491 -0.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -165.54 89.23 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.435 ' C ' ' HB ' ' A' ' 17' ' ' ILE . . . -156.48 -174.52 26.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.691 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -158.24 131.8 7.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.713 0.292 . . . . 0.0 110.829 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.713 ' N ' HD12 ' A' ' 22' ' ' LEU . 12.7 ttt85 -129.24 114.74 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 25' ' ' SER . 25.6 t -122.93 158.47 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 111.541 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.01 144.88 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.871 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.695 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.1 pp -138.22 127.04 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.101 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 18.0 Cg_endo -60.67 104.17 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.174 1.916 . . . . 0.0 111.693 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 14.5 t0 -66.82 158.12 31.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.49 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -142.78 45.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.673 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.88 46.12 47.28 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 6.5 m-85 -88.52 -172.64 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.519 0.676 . . . . 0.0 111.184 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 86' ' ' ILE . 9.7 m -133.19 -27.49 1.59 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.595 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.9 tp -141.5 131.05 23.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.121 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.624 ' O ' HD12 ' A' ' 56' ' ' ILE . 16.3 t80 -122.63 101.66 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -105.38 121.28 43.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 15.3 t80 -106.89 131.7 53.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -128.14 122.53 32.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -153.85 147.54 17.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 118.87 -1.633 . . . . 0.0 114.428 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.1 tmtt? -119.15 145.0 46.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 110.431 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 79' ' ' ILE . 11.9 tp -94.17 117.58 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.57 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 66.75 67.4 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.069 0.461 . . . . 0.0 110.491 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 80' ' ' TYR . 44.7 tt0 179.19 111.78 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . 20.3 mt-10 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.377 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -62.43 -19.03 63.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.059 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.04 -135.75 6.91 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -118.83 -76.8 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.708 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 10.2 m-90 -67.43 86.78 0.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.88 87.69 2.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.453 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.0 ttt180 -142.49 127.54 18.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 111.85 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.3 p30 -88.37 135.51 33.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' PHE . 1.9 mt -121.61 151.45 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.4 t -139.5 24.3 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.31 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 3.9 mtmp? -145.86 94.58 5.0 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.4 Cg_exo -53.53 -172.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.256 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.6 -48.69 2.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -178.79 83.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.432 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.43 -0.3 42.41 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.76 148.93 21.37 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 120.626 0.251 . . . . 0.0 110.803 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' A' ' 26' ' ' ILE . 11.4 m95 -90.19 161.09 15.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.177 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.9 m -134.32 116.7 15.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.516 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 6.1 t80 -106.25 95.29 5.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -101.28 139.8 36.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.413 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.06 106.16 5.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -89.21 22.5 2.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.679 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.07 38.32 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -104.85 115.79 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -73.93 76.58 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.708 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 10.5 mt -97.36 139.23 33.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.981 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 152.64 51.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.897 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -55.43 137.83 47.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.8 -29.47 7.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.62 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 12.4 t70 -58.88 160.16 6.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.951 0.405 . . . . 0.0 111.213 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -124.35 159.3 30.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.628 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 1.4 mp -116.07 145.22 22.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 112.018 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 43' ' ' GLU . 98.0 m-85 -144.52 126.53 15.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.917 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.6 p90 -161.32 -173.12 3.67 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.125 0.964 . . . . 0.0 113.427 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.508 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 11.7 p-90 -154.34 133.64 12.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.62 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 5.6 p -99.68 163.49 12.46 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.079 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 13.4 t80 -143.64 124.77 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.612 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -119.57 166.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.686 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 mm -141.34 106.28 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.921 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -103.63 64.49 0.81 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.711 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.3 t0 67.7 64.59 0.39 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.41 28.86 70.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.37 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.84 73.62 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 0.0 110.189 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.61 162.04 46.9 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.392 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 85' ' ' VAL . 28.5 m-85 -152.28 143.28 23.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.628 ' C ' HG11 ' A' ' 9' ' ' VAL . 10.3 ptt85 -126.08 142.97 51.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.4 tt0 -101.0 75.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.657 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 33.8 p-10 -78.32 174.77 10.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.623 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 t30 60.25 18.31 7.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.38 159.93 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.07 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -154.65 161.69 41.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.0 0.428 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.822 ' HB2' HD13 ' A' ' 14' ' ' LEU . 70.7 t90 -147.6 166.26 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.434 ' O ' ' CH2' ' A' ' 99' ' ' TRP . 5.5 t -110.25 155.74 21.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.615 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.0 t -118.79 7.88 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.328 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 19.1 m -70.94 -9.9 58.71 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.752 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -123.47 163.97 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.897 ' CE2' HD23 ' A' ' 75' ' ' LEU . 23.2 m-85 -137.28 120.82 17.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.862 HG11 ' HG2' ' A' ' 15' ' ' GLU . 6.2 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.963 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.788 0.327 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 43.1 t80 -86.03 175.12 8.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.097 0.475 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.8 t -118.99 159.9 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -68.05 138.51 92.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' HG11 ' A' ' 85' ' ' VAL . 36.0 Cg_endo -67.41 -172.57 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.421 2.081 . . . . 0.0 112.665 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -111.41 124.4 52.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.408 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.59 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -84.44 106.82 16.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 13.3 mttp -93.32 112.65 24.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.359 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 mp -101.16 164.96 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 112.055 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.648 ' O ' HD22 ' A' ' 22' ' ' LEU . 5.6 pt-20 -155.68 143.39 19.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.15 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.91 110.49 20.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 111.322 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 15.8 mm -81.5 145.25 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.321 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t80 -106.33 141.76 23.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.7 Cg_endo -93.14 -0.14 53.49 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.085 -1.214 . . . . 0.0 112.445 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -161.66 94.56 0.96 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -176.04 169.19 41.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.668 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -151.46 121.73 7.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.587 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.572 ' N ' HD13 ' A' ' 22' ' ' LEU . 45.3 ttp85 -115.09 132.89 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 25' ' ' SER . 38.3 t -124.42 158.96 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.83 144.89 25.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.7 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.86 128.33 12.15 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.497 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 17.0 Cg_endo -58.01 95.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.513 2.142 . . . . 0.0 111.7 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.1 t0 -60.29 160.6 8.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -147.36 46.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.922 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.14 89.0 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.686 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' CD1' HG21 ' A' ' 85' ' ' VAL . 10.3 m-85 -84.15 -171.21 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.261 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -132.02 -28.33 1.76 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.66 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.4 tp -140.34 132.37 27.86 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.246 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 26' ' ' ILE . 44.1 t80 -124.59 92.85 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.612 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -86.83 132.08 33.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' HG22 ' A' ' 83' ' ' THR . 40.8 t80 -121.52 123.27 41.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.39 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -125.06 118.84 27.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -150.91 133.04 4.11 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.253 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -105.92 148.92 27.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.338 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD13 ' HH2' ' A' ' 52' ' ' TRP . 17.6 tp -99.57 122.18 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.0 t-20 59.34 58.91 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.1 tt0 175.47 109.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 41.8 mt-10 -56.25 -168.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.13 148.49 13.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -134.53 45.4 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.01 -130.76 2.21 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.531 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.35 72.99 1.08 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 144.29 26.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.016 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.53 -25.21 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.633 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.29 -110.43 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.426 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -142.49 -80.09 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.735 0.303 . . . . 0.0 110.584 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.663 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 17.3 m-90 -61.05 94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.43 83.0 1.94 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.318 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -133.77 133.67 41.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.56 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.612 ' OD1' ' HB2' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -106.43 111.65 24.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.893 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.694 HD12 ' HD2' ' A' ' 34' ' ' PHE . 9.7 mt -93.06 152.09 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 33' ' ' LEU . 78.7 p -119.91 -23.59 6.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.71 121.0 27.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.59 0.233 . . . . 0.0 111.23 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.469 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 31.7 Cg_exo -58.66 -164.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.409 2.072 . . . . 0.0 112.086 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -45.65 2.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 179.18 80.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.499 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.88 0.59 34.68 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 8.0 mtm180 -156.99 131.23 8.47 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.389 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.573 ' CG ' HD11 ' A' ' 26' ' ' ILE . 15.0 m95 -77.09 155.62 32.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.92 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -134.72 118.95 17.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.394 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 49.6 t80 -110.62 89.45 3.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.079 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.93 137.45 32.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.274 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -138.11 100.91 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.591 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 22.44 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.597 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.65 26.79 5.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.315 . . . . 0.0 111.037 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.92 100.1 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -73.78 75.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.803 ' CD1' HD23 ' A' ' 22' ' ' LEU . 4.1 mt -86.31 163.47 17.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.791 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -141.65 148.2 38.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.035 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -55.62 142.22 34.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.259 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.5 -32.43 6.26 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.4 t70 -59.83 151.19 26.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.912 0.387 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -114.7 154.3 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.517 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.3 mp -109.25 146.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.061 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 97.6 m-85 -144.17 122.34 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.907 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.4 p90 -157.8 -174.9 5.08 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -154.77 131.6 10.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.816 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 76.5 p -110.35 151.87 26.91 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.81 ' CE2' HD11 ' A' ' 86' ' ' ILE . 19.9 t80 -135.76 129.43 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.105 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -113.73 164.08 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.375 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' CE2' ' A' ' 84' ' ' TYR . 24.4 mm -137.52 107.28 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.883 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -99.94 57.12 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.5 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 t0 68.95 69.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.771 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.816 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.75 25.29 75.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.31 73.72 1.39 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.201 0.524 . . . . 0.0 110.233 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.25 161.08 29.92 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.552 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -152.13 146.56 25.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.741 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -124.37 150.55 45.41 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -106.6 72.27 0.9 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.665 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.3 p-10 -78.47 176.03 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.47 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 61.05 18.23 8.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.62 162.44 54.31 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.87 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 2.8 tt0 -154.39 155.28 34.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.895 0.379 . . . . 0.0 111.111 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.634 ' HB2' HD13 ' A' ' 14' ' ' LEU . 51.7 t90 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.423 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.4 t -108.52 159.75 16.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 101' ' ' VAL . 17.5 t -121.42 -1.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.795 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.405 ' CG2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -66.82 -9.92 42.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.813 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.7 pt-20 -131.45 150.61 52.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.9 m-85 -129.45 143.44 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.012 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -98.69 162.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 0.0 111.094 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.651 ' CG ' ' HB2' ' A' ' 112' ' ' ALA . 1.3 m120 -86.21 152.15 23.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.31 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -18.08 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.55 -31.31 68.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.944 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.72 18.98 5.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.381 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.9 p -139.69 157.61 69.64 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-O 121.334 0.587 . . . . 0.0 111.366 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 51.2 Cg_exo -51.66 126.2 19.01 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.976 2.451 . . . . 0.0 113.083 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.651 ' HB2' ' CG ' ' A' ' 106' ' ' ASN . . . -114.74 42.69 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.654 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -128.25 100.82 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.768 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.836 HG23 HD12 ' A' ' 116' ' ' LEU . 6.0 t -115.64 43.8 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.003 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.0 m 60.56 54.1 3.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.836 HD12 HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -138.88 79.94 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.37 112.61 49.28 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.399 2.066 . . . . 0.0 112.339 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.816 0.341 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 46.0 t80 -66.5 175.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.2 t -115.59 159.22 15.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.45 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -72.96 138.77 79.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.57 ' HD2' HG11 ' A' ' 85' ' ' VAL . 41.1 Cg_endo -67.06 -167.89 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.601 2.2 . . . . 0.0 112.455 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -109.47 114.98 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.887 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.12 104.87 13.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.8 159.22 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.751 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.37 150.9 32.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.193 0.521 . . . . 0.0 111.888 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -145.71 142.78 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.941 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.83 115.73 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 23' ' ' ARG . 17.0 mm -88.25 129.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.244 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 25.2 t80 -93.77 141.5 23.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -94.17 4.52 53.74 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.332 -1.112 . . . . 0.0 112.477 0.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.97 97.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.025 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.25 176.95 47.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.326 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -150.73 138.87 20.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 110.998 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.804 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.44 110.74 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.491 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 13' ' ' LYS . 24.0 t -119.82 146.58 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.82 151.63 36.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.548 HD11 ' CG ' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -139.95 130.12 13.97 Favored Pre-proline 0 N--CA 1.467 0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.008 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.98 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.243 1.962 . . . . 0.0 111.567 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 22.5 t0 -61.98 160.7 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.691 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 30.0 t70 -150.46 45.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.757 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.48 92.34 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.336 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 85' ' ' VAL . 21.3 m-85 -76.81 -124.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.348 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -179.58 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.4 tp -140.8 131.21 25.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.703 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 24.1 t80 -120.01 108.34 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.142 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -111.05 120.59 42.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 18.4 t80 -110.04 128.81 55.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.635 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -124.74 124.75 42.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.9 140.03 7.12 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.143 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.0 ttmt -112.21 149.18 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 110.468 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD1' HD23 ' A' ' 73' ' ' LEU . 4.8 tp -98.09 119.46 36.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.078 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.5 t-20 62.53 57.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.06 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 52.7 tt0 177.24 109.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.35 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 32.3 mt-10 -57.9 -169.51 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.634 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.69 151.66 3.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.352 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 67.8 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.022 0.439 . . . . 0.0 110.759 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.16 -136.81 5.84 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.689 HD22 ' CH2' ' A' ' 82' ' ' TRP . 22.0 mt -119.71 68.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.144 0.497 . . . . 0.0 110.895 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.73 156.82 23.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -60.88 -17.12 48.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 40.74 -131.56 3.06 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 3.0 t60 -129.8 -68.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 0.0 110.574 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.9 m-90 -77.13 90.87 3.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.992 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.07 88.54 2.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.931 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.2 tpm_? -133.81 127.63 33.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.93 118.86 32.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 58' ' ' LYS . 26.7 mt -100.04 146.76 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.352 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.721 HG22 ' CD1' ' A' ' 33' ' ' LEU . 8.9 p -132.77 36.21 3.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.564 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.21 91.4 1.72 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 43.2 Cg_exo -56.91 171.93 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.592 2.195 . . . . 0.0 112.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.15 32.84 4.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.792 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 79.46 89.5 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.04 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 73.16 -3.51 29.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.957 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -157.67 127.26 6.0 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.796 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.548 ' CG ' HD11 ' A' ' 26' ' ' ILE . 13.2 m95 -79.85 157.58 26.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -134.33 118.71 17.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 11.6 t80 -116.57 84.97 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -94.66 146.41 24.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.142 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD1' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -138.0 109.78 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 22.24 2.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -144.03 36.55 1.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.08 126.71 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -79.46 75.86 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.735 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 40' ' ' LEU . 39.7 mt -101.23 130.73 47.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.784 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -121.03 153.89 36.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.961 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.75 132.01 51.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.283 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -26.55 16.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.504 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.3 t70 -55.43 154.46 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 151.01 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.536 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -110.42 147.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 112.162 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 37.6 m-85 -144.31 125.31 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.1 p90 -160.64 -174.27 4.37 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.689 ' CH2' HD22 ' A' ' 47' ' ' LEU . 57.9 p-90 -151.99 134.32 15.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.288 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.65 161.28 13.71 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.013 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.791 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 10.5 t80 -141.4 138.19 32.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.703 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.24 161.86 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.722 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 33.7 mm -136.79 111.19 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.722 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.8 tttt -105.7 67.93 0.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.26 55.86 2.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.808 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 81.82 28.17 43.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.7 mt -143.84 75.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.215 0.531 . . . . 0.0 110.212 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.08 160.56 40.71 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.376 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 29.3 m-85 -152.26 153.04 32.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.675 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -135.74 146.59 47.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.452 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.0 tt0 -104.68 75.42 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.461 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.9 p30 -78.2 175.22 10.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.565 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 60.47 18.54 8.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.61 161.6 52.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.005 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -154.46 145.49 22.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.536 ' CE3' HD13 ' A' ' 79' ' ' ILE . 42.0 t90 -141.12 165.95 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.079 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.8 t -111.15 162.02 15.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.56 ' O ' HD22 ' A' ' 75' ' ' LEU . 2.8 t -124.37 11.53 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -73.1 -10.2 59.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.921 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.827 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.6 mt-10 -122.98 140.99 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.703 0.287 . . . . 0.0 110.799 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 75' ' ' LEU . 9.8 m-85 -122.15 129.42 52.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 110' ' ' THR . 28.5 m -98.8 166.8 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.206 0.527 . . . . 0.0 111.239 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 110' ' ' THR . 2.4 t-20 -81.21 154.16 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.372 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.34 -16.35 5.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -31.93 63.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.033 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.62 22.57 3.98 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.368 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 p -133.96 166.78 26.67 Favored Pre-proline 0 C--O 1.222 -0.353 0 CA-C-N 117.046 0.423 . . . . 0.0 110.915 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 36.6 Cg_endo -71.8 118.45 5.64 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.056 1.837 . . . . 0.0 112.13 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -174.04 74.58 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.558 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.07 145.62 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.7 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.8 p -64.97 -51.74 60.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -70.23 105.65 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -172.7 83.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.962 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 62.49 148.49 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.972 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.549 2.166 . . . . 0.0 112.295 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.905 0.383 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 50.2 t80 -93.73 174.59 7.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 111.031 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.3 t -112.53 162.01 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.224 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.642 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.7 p -66.74 130.4 94.02 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.267 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 24.2 Cg_exo -63.14 -170.25 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.72 2.28 . . . . 0.0 112.587 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -110.87 124.97 53.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.47 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -77.64 104.49 8.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.24 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.54 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.252 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.661 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.2 mp -106.18 162.44 13.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.93 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 24.9 mm-40 -152.96 145.3 24.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.945 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.893 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -87.07 120.85 28.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 111.567 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' CG2' ' A' ' 105' ' ' VAL . 18.6 mm -98.19 114.25 35.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.176 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 54.5 t80 -79.21 142.03 58.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 98.9 Cg_endo -96.73 4.99 40.44 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.603 0.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.76 95.63 0.9 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . 169.23 167.19 29.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.555 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB3' HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -158.27 121.8 3.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.745 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 tmm_? -97.07 134.91 39.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 ' HG ' ' A' ' 14' ' ' LEU . 39.8 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.009 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.01 152.95 30.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.553 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.2 pt -147.37 122.03 5.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.48 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 9.4 Cg_endo -55.24 99.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.105 1.87 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 20.1 t0 -62.68 161.48 12.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.597 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -145.39 44.69 1.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.671 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.58 42.69 62.7 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.736 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.2 m-85 -88.08 -171.19 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.401 0.62 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' ILE . 37.8 t -132.04 -27.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.697 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.717 HD12 HG22 ' A' ' 57' ' ' THR . 8.0 tp -138.3 134.99 35.0 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.254 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.756 ' HD2' HD12 ' A' ' 56' ' ' ILE . 18.6 t80 -126.31 90.65 3.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -84.89 124.65 31.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.659 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 52' ' ' TRP . 78.8 t80 -114.59 117.59 31.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.4 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.808 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -122.57 125.46 45.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -157.65 141.88 8.14 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.927 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.0 148.54 40.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 110.447 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.444 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.7 tp -99.46 126.16 45.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.7 t-20 58.1 53.49 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.1 tt0 176.69 109.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.167 0.508 . . . . 0.0 110.382 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 29.2 mt-10 -57.81 -168.13 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.442 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 154.04 24.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.186 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.84 85.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 111.06 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 99.48 99.17 2.21 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.617 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' CZ3' ' A' ' 82' ' ' TRP . 1.2 mt 16.25 72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.618 0.767 . . . . 0.0 112.64 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -89.34 147.95 23.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -56.33 -20.31 18.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.599 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.52 -130.47 4.93 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.923 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -129.3 -70.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.8 m-90 -72.77 94.06 1.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.808 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.09 91.98 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.1 tpt85 -139.51 125.58 19.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -86.4 130.35 34.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.36 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.756 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.9 mt -110.42 152.97 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.344 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.717 HG22 HD12 ' A' ' 33' ' ' LEU . 32.9 p -144.48 27.78 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -151.05 87.38 4.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 21.6 Cg_exo -66.02 -170.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.816 2.344 . . . . 0.0 112.445 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -121.95 24.14 9.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.588 178.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 82.49 90.96 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.352 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 76.0 0.76 65.94 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.759 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -157.83 121.3 4.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.553 ' CD1' HD11 ' A' ' 26' ' ' ILE . 19.2 m95 -82.95 157.57 22.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 119.7 18.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.57 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 56' ' ' ILE . 31.9 t80 -122.64 93.76 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 mmm-85 -95.49 143.35 26.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.345 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.13 94.25 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -89.27 22.6 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.597 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -126.67 28.66 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.71 110.79 20.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.01 76.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 22' ' ' LEU . 6.8 mt -86.79 153.28 21.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.9 142.92 47.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.6 OUTLIER -54.14 132.0 42.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.297 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.98 -28.37 12.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.2 t70 -62.84 161.77 12.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 111.079 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -121.07 158.4 27.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG21 ' CE2' ' A' ' 81' ' ' PHE . 1.3 mp -116.73 145.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.112 0.482 . . . . 0.0 112.176 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 31.1 m-85 -144.3 126.33 15.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.46 -174.18 4.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.17 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.517 ' CZ3' HD22 ' A' ' 47' ' ' LEU . 31.9 p-90 -156.7 128.27 7.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.449 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 6.5 p -106.9 152.63 23.66 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.2 t80 -135.9 117.36 14.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -103.99 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.266 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.771 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.3 mm -137.16 109.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.845 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.89 68.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.875 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 63.31 65.53 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.799 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.0 27.01 73.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.399 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -144.52 74.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.179 0.514 . . . . 0.0 110.097 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.54 162.11 30.28 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.375 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.05 147.71 26.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.642 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -126.06 141.23 52.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.488 ' N ' HG21 ' A' ' 9' ' ' VAL . 2.6 tt0 -99.26 76.44 2.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.237 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.5 p30 -83.43 179.69 7.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.232 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.0 t30 59.05 18.38 6.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.57 163.24 44.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.078 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.39 158.38 39.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.1 0.476 . . . . 0.0 111.476 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CE3' HD13 ' A' ' 79' ' ' ILE . 49.7 t90 -147.66 165.69 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.8 t -107.75 157.44 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.9 t -119.69 -4.19 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.638 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' CD2' ' A' ' 75' ' ' LEU . 27.3 m -62.1 -15.97 49.05 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.607 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -108.93 159.19 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.444 ' HB2' ' CB ' ' A' ' 113' ' ' ASP . 21.0 m-85 -138.09 129.87 28.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 16' ' ' ALA . 22.7 m -98.67 179.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.29 0.567 . . . . 0.0 111.956 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -92.34 152.94 19.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.411 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.94 -16.55 7.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.27 -30.75 65.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.179 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.6 18.46 5.27 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.452 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 p -138.01 154.95 74.71 Favored Pre-proline 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 111.512 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 31.4 Cg_exo -57.7 121.52 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.026 2.484 . . . . 0.0 112.388 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 111' ' ' PRO . . . 171.28 79.97 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.56 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.444 ' CB ' ' HB2' ' A' ' 104' ' ' PHE . 35.9 t70 -116.85 90.82 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.641 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 114' ' ' THR . 8.8 t -61.14 90.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.231 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.62 -170.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tt -125.62 67.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -143.35 132.67 11.64 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.444 2.096 . . . . 0.0 112.367 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.803 0.335 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 34.8 t80 -95.75 176.06 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.235 0.54 . . . . 0.0 111.087 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 9' ' ' VAL . 28.4 t -125.3 162.89 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.068 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -66.56 138.28 95.53 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 9' ' ' VAL . 36.6 Cg_endo -66.01 -168.09 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.493 2.129 . . . . 0.0 112.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -109.55 116.99 32.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -80.45 107.9 13.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.401 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' C ' HD12 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -81.86 156.81 24.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.74 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 5.1 mp -146.69 149.9 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.45 . . . . 0.0 111.879 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -148.66 142.37 25.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.95 114.51 23.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.123 0.487 . . . . 0.0 111.465 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 105' ' ' VAL . 24.3 mm -89.68 130.39 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.238 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.1 t80 -92.93 142.27 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 94.6 Cg_endo -92.49 -2.69 50.5 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.484 0.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -163.27 95.52 0.85 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.9 171.16 43.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.282 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -147.47 132.02 17.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.0 111.25 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.692 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.6 ttt180 -117.97 125.8 51.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.391 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.487 HG23 HD12 ' A' ' 22' ' ' LEU . 61.9 t -126.85 152.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -152.45 145.1 24.23 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.985 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.1 pp -143.98 117.06 5.77 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.304 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.11 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.419 2.079 . . . . 0.0 112.284 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 43.0 t0 -80.14 143.52 33.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 111.361 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.96 48.88 2.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.608 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.91 38.49 96.11 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.889 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CD1' HG21 ' A' ' 85' ' ' VAL . 22.1 m-85 -68.65 -123.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.282 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 177.32 -35.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 57' ' ' THR . 7.5 tp -141.12 126.3 18.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.088 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.704 ' HD2' HD12 ' A' ' 56' ' ' ILE . 11.8 t80 -118.67 95.02 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -93.61 120.14 33.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.0 t80 -105.83 126.91 52.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.266 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.47 122.29 33.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.37 139.38 6.16 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.806 -1.664 . . . . 0.0 114.211 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -117.23 146.97 42.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.503 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.0 tp -89.3 133.09 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 44.76 63.08 1.82 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 177.49 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.38 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 50.9 mt-10 -56.0 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.383 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 81' ' ' PHE . 2.0 mtp -147.47 144.25 28.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.656 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.42 77.67 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 84.13 101.93 0.58 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.429 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.8 mt 24.72 88.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.511 0.724 . . . . 0.0 112.527 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -109.65 143.0 40.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.547 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.56 -45.25 56.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.51 -122.44 28.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.17 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -137.96 -72.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.904 0.383 . . . . 0.0 110.451 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.459 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.1 m-90 -60.76 88.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.946 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.79 94.3 4.4 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.001 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 3.9 tpt85 -146.94 127.83 14.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.971 0.415 . . . . 0.0 112.117 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.22 123.93 35.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.386 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.704 HD12 ' HD2' ' A' ' 34' ' ' PHE . 14.5 mt -108.15 151.47 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.363 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.858 HG22 HD12 ' A' ' 33' ' ' LEU . 28.5 p -141.11 30.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.8 pttm -153.15 92.16 3.3 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.2 Cg_exo -58.25 169.03 3.19 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.562 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.93 33.93 3.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.828 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 81.12 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.161 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.64 -2.74 21.46 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.846 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -157.61 124.2 4.93 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.619 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.1 m95 -76.62 154.94 33.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -134.67 120.52 19.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.658 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.7 t80 -121.41 106.08 11.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -110.17 141.4 43.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -138.09 111.17 7.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -89.37 22.34 2.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.347 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -125.52 36.8 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.82 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 81.23 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.654 HD11 HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -78.97 169.9 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.599 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 145.22 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -55.22 136.86 48.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.18 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.31 -29.84 9.58 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.275 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.3 t70 -59.33 152.92 20.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -115.25 148.89 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.438 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.544 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -105.31 150.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.056 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 75.1 m-85 -144.07 128.04 17.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.161 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.9 p90 -161.07 -174.4 4.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.085 0.945 . . . . 0.0 113.361 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 52.4 p-90 -158.67 135.79 9.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.13 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 12' ' ' ALA . 32.5 p -99.36 163.03 12.7 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.27 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.87 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 14.8 t80 -144.93 105.5 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.8 164.38 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.87 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.3 mm -141.03 109.65 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.598 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 67.4 0.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.31 65.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.17 28.53 71.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.43 73.27 1.39 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.177 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -83.18 160.64 38.64 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.501 -0.772 . . . . 0.0 114.233 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.24 147.85 26.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.604 ' C ' HG11 ' A' ' 9' ' ' VAL . 12.4 ptt-85 -126.28 147.65 49.66 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.529 0.681 . . . . 0.0 112.701 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -106.01 74.07 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.439 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.0 p30 -82.27 176.21 9.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.703 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 60.05 19.76 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.625 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.86 162.15 42.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -154.34 162.7 41.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.963 0.411 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CE3' HD13 ' A' ' 79' ' ' ILE . 46.9 t90 -155.08 165.82 35.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.166 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.438 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.2 t -105.65 160.88 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.4 t -121.89 -0.3 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.746 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 p -63.44 -14.06 46.66 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -129.17 154.55 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.704 0.288 . . . . 0.0 110.879 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.589 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -135.54 144.63 46.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 17' ' ' ILE . 17.3 m -98.77 168.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 110' ' ' THR . 9.7 m-20 -86.59 151.13 23.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.225 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -54.85 -17.44 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.09 -29.98 64.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.192 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.81 14.43 6.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.227 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.2 p -134.07 161.21 65.12 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.886 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 77.9 Cg_exo -46.48 130.55 14.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.861 2.374 . . . . 0.0 113.11 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.51 112.54 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.412 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -123.81 -169.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 65.9 37.74 5.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -147.06 90.66 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.813 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 tp 61.94 73.37 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.823 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.73 94.76 28.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.525 2.15 . . . . 0.0 112.397 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.776 0.322 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 37.1 t80 -95.58 177.23 5.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 23.0 t -124.77 162.27 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.293 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.791 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.7 p -66.59 131.03 94.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 20.8 Cg_exo -65.47 -177.53 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.356 2.038 . . . . 0.0 111.988 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -107.79 129.73 55.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 111.674 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.682 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -81.0 101.17 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.224 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -83.26 100.63 10.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 3.7 mp -92.96 157.52 16.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.8 mm-40 -148.92 142.23 25.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.227 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.86 110.54 20.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.141 0.496 . . . . 0.0 111.29 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 23' ' ' ARG . 19.0 mm -83.35 150.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.252 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -114.0 143.83 30.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.737 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 9.9 Cg_endo -89.55 3.5 69.26 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.285 0.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -170.18 98.39 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -172.42 -176.45 41.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.426 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -158.07 134.87 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 17' ' ' ILE . 4.1 tmm_? -126.25 119.79 28.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.11 147.75 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.282 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.52 148.82 34.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -146.61 126.32 6.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.68 116.35 2.31 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.259 1.973 . . . . 0.0 111.681 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 46.3 t0 -83.06 112.11 19.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 0.0 111.335 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 24.2 t0 -101.43 43.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.813 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.03 31.84 80.1 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.882 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CD2' HG11 ' A' ' 85' ' ' VAL . 95.5 m-85 -61.2 -113.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.799 0.299 . . . . 0.0 110.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . 6.7 t 176.87 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.749 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.4 132.02 28.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.793 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CD1' HD13 ' A' ' 26' ' ' ILE . 17.0 t80 -122.32 98.0 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.732 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -102.3 119.03 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 40.1 t80 -106.01 128.36 53.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.64 122.11 35.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.582 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.98 145.95 12.0 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.863 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 161.6 21.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.456 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 HD22 ' A' ' 73' ' ' LEU . 21.3 tp -96.51 118.19 32.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 52.7 t30 57.66 70.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 73.9 tt0 171.33 110.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.375 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 51.4 mt-10 -57.21 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.139 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -152.05 149.25 28.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.556 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -137.16 81.78 1.89 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 90.42 100.53 1.16 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.462 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 46' ' ' GLY . 2.0 mt 20.88 89.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.736 0.814 . . . . 0.0 112.742 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.83 138.54 40.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.723 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.54 -30.91 44.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.642 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.46 -137.44 15.67 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.584 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.1 -74.78 0.6 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.5 m-90 -60.43 90.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.069 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.96 85.22 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.868 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -130.63 127.63 39.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.735 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -94.43 110.89 22.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.517 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mm -92.1 133.75 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 t -129.79 36.65 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.05 90.35 1.23 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.9 Cg_exo -53.6 170.26 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.74 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 1.2 tmtm? -112.93 42.13 1.94 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.461 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 1.3 mp0 72.77 88.62 0.1 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.489 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.23 -3.47 22.73 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.052 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 7.1 ttt180 -157.84 125.52 5.25 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.847 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.465 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 11.9 m95 -76.3 154.7 34.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 m -134.63 120.64 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.505 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 14.7 t80 -120.5 115.7 23.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -111.14 145.1 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.243 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.08 104.34 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 22.49 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.64 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.03 40.72 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.349 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.53 93.11 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -73.95 75.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.691 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 22' ' ' LEU . 4.6 mt -97.69 168.01 10.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -142.02 143.82 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.3 OUTLIER -52.57 133.2 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.352 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.96 -28.89 11.68 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.216 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' A' ' 101' ' ' VAL . 8.5 t70 -64.39 162.62 14.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.851 0.358 . . . . 0.0 111.244 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -121.47 158.42 28.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.207 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.3 mp -113.89 149.91 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.173 0.511 . . . . 0.0 112.17 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 m-85 -143.84 125.18 14.68 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.682 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 1.7 p90 -159.5 -175.3 5.11 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.275 1.035 . . . . 0.0 113.721 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.439 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 38.7 p-90 -153.46 133.95 13.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.483 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.94 155.48 17.66 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.163 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.1 t80 -135.6 109.66 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 0.0 111.168 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.834 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -102.91 168.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.393 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.749 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 45.7 mm -145.5 104.44 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 O-C-N 123.292 0.37 . . . . 0.0 111.03 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -98.64 75.85 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.328 179.213 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.25 57.88 1.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.355 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.862 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.27 17.76 77.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.277 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.97 69.58 1.28 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.423 0.63 . . . . 0.0 110.013 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 85' ' ' VAL . . . -83.58 -170.42 46.36 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.432 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.2 m-85 -151.97 171.04 18.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.775 -0.712 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.791 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -144.18 143.7 31.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.442 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.13 74.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.519 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -77.9 174.21 11.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.37 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 59.56 19.42 7.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.35 162.79 53.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.198 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 2.9 tt0 -154.4 147.46 24.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 54.2 t90 -141.49 165.23 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.366 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.5 t -106.06 156.7 18.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 77' ' ' ASP . 4.6 t -119.86 -3.59 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.936 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 75' ' ' LEU . 18.7 m -62.06 -16.1 49.57 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.935 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.657 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.1 mt-10 -125.09 150.75 46.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 7.7 m-85 -132.63 145.54 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 12.8 m -98.59 164.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 0.0 110.834 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 110' ' ' THR . 24.4 t30 -89.43 151.3 22.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.479 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.46 -17.93 6.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.4 -30.93 67.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.846 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.57 20.54 4.61 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.261 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -143.07 159.06 57.4 Favored Pre-proline 0 C--O 1.223 -0.319 0 CA-C-O 121.339 0.59 . . . . 0.0 111.44 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 77.3 Cg_exo -49.34 126.73 16.33 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.022 2.481 . . . . 0.0 113.31 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 96.86 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.318 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.51 169.99 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.17 90.69 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -164.97 121.75 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 84.1 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.04 116.07 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.888 0.375 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 41.2 t80 -91.24 175.92 6.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.186 0.517 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 19.4 t -117.24 160.74 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.748 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -66.65 137.69 95.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD2' HG11 ' A' ' 85' ' ' VAL . 43.5 Cg_endo -70.54 -171.01 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.51 2.14 . . . . 0.0 112.89 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -108.27 127.36 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -85.71 106.88 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.605 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 108.45 21.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.67 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.8 mp -102.7 156.03 17.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 112.154 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -137.19 140.62 41.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.014 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.49 100.87 12.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.176 0.512 . . . . 0.0 111.361 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 12.5 mm -74.73 141.95 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.309 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 26.2 t80 -104.16 141.05 21.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.57 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 77.3 Cg_endo -94.41 2.8 51.43 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.306 -1.122 . . . . 0.0 112.369 0.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.67 96.46 0.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.582 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.5 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -177.52 165.87 35.91 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 23' ' ' ARG . 4.8 tp -138.95 143.64 38.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.746 ' N ' HD12 ' A' ' 22' ' ' LEU . 4.3 ttt180 -135.19 101.91 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.856 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.67 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.9 t -100.32 158.53 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.407 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -152.68 145.0 23.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.681 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -144.75 126.67 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.788 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 13.2 Cg_endo -56.67 95.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.454 2.103 . . . . 0.0 111.709 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.71 159.69 8.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.1 t0 -146.85 44.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.585 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.61 40.77 85.75 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.529 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.7 m-85 -82.96 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.374 0.607 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -131.72 -27.53 1.9 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.515 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 6.7 tp -140.01 132.28 28.24 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.876 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.703 ' HD2' HD12 ' A' ' 56' ' ' ILE . 31.2 t80 -123.68 98.36 5.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.313 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -91.88 124.85 36.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 36.7 t80 -116.95 122.69 45.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.352 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -160.85 147.36 14.0 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 118.918 -1.611 . . . . 0.0 114.073 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 132.08 53.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.58 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 101' ' ' VAL . 11.0 tp -79.82 105.69 11.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.1 t-20 76.59 65.39 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.6 tt0 171.98 109.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 32.4 mt-10 -53.36 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -172.34 122.99 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.413 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -118.47 70.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.381 . . . . 0.0 110.793 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.63 -129.15 2.83 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.671 HD22 ' CH2' ' A' ' 82' ' ' TRP . 35.5 mt -124.86 56.89 1.29 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.198 0.523 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -69.08 146.76 52.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' HE2' ' A' ' 37' ' ' HIS . . . -53.14 -24.38 10.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.672 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.43 -139.57 1.7 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.636 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 12.6 m170 -122.43 -74.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.163 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.652 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -67.98 88.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.98 86.37 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 ttm180 -135.02 143.85 46.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.982 0.42 . . . . 0.0 111.707 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -107.76 118.62 37.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.627 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.8 mt -95.1 151.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.069 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 44.7 p -140.24 42.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.133 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 98.19 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 58.8 Cg_exo -52.08 -176.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.506 2.138 . . . . 0.0 112.228 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -48.51 3.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.157 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.8 80.76 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.537 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . 70.81 2.05 42.86 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.7 mtt180 -156.79 133.43 10.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.711 -0.244 . . . . 0.0 110.597 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.562 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.4 m95 -79.77 153.97 28.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.3 m -135.2 120.26 18.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 44.0 t80 -110.55 82.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.521 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -92.3 126.94 37.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.291 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -138.04 111.44 8.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 22.29 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.345 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.59 31.24 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -108.48 127.0 53.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.052 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -87.24 75.86 9.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.652 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 56.0 mt -82.5 154.54 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -130.93 144.51 51.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.409 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -67.35 131.46 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.386 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.88 -24.69 25.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.622 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 40' ' ' LEU . 8.9 t70 -59.36 159.97 7.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -108.36 164.83 11.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.636 HG13 ' CE3' ' A' ' 99' ' ' TRP . 5.1 mm -125.99 146.17 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 75.4 m-85 -144.44 130.92 19.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.413 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 4.0 p90 -161.57 -176.4 5.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 122.156 0.979 . . . . 0.0 113.607 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.671 ' CH2' HD22 ' A' ' 47' ' ' LEU . 66.5 p-90 -153.37 133.28 13.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.477 -1.692 . . . . 0.0 108.293 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.701 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.8 p -111.95 153.27 27.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.098 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.817 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.5 t80 -136.39 141.02 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.277 0.361 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -128.85 163.25 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.804 HD11 ' CE2' ' A' ' 84' ' ' TYR . 25.6 mm -137.52 107.23 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.904 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.22 68.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t0 63.62 65.77 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.804 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.6 29.0 71.62 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.533 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.2 75.2 1.45 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.132 0.491 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.23 159.08 27.21 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.505 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -152.43 150.47 29.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.748 ' C ' HG11 ' A' ' 9' ' ' VAL . 18.1 ptt-85 -129.09 149.99 50.67 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.573 0.702 . . . . 0.0 112.87 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -105.58 75.22 1.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.768 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -74.92 172.44 12.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.396 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.1 t30 61.57 18.39 9.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.9 165.41 29.84 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.823 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -154.23 149.23 26.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.074 0.464 . . . . 0.0 111.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.636 ' CE3' HG13 ' A' ' 79' ' ' ILE . 28.6 t90 -151.99 164.57 36.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.984 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -114.21 163.05 15.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 40' ' ' LEU . 1.7 t -129.67 15.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.715 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.527 ' O ' HD21 ' A' ' 75' ' ' LEU . 6.6 p -56.29 -24.51 43.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 66.9 mt-10 -142.68 172.78 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 13.8 m-85 -133.06 150.04 52.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 12.1 m -98.64 171.11 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.121 0.486 . . . . 0.0 110.928 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 110' ' ' THR . 19.3 t30 -92.21 151.23 20.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.08 -16.87 5.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.87 -29.35 64.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.275 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.65 15.03 6.52 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.129 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.3 p -139.47 163.28 46.46 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 110.822 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 89.0 Cg_exo -43.1 130.7 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.902 2.401 . . . . 0.0 113.328 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.0 112.97 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -113.56 148.72 35.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.795 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.57 38.55 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.0 m -59.04 167.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.31 79.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.12 94.68 6.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.845 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.441 2.094 . . . . 0.0 112.313 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.484 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 84.2 t80 -70.26 167.08 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.213 0.53 . . . . 0.0 110.911 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 9' ' ' VAL . 41.6 t -140.3 160.61 25.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.191 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 94' ' ' GLN . 7.6 p -78.78 141.36 59.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 82.8 Cg_exo -51.66 -169.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.7 2.267 . . . . 0.0 112.291 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 t -107.29 139.73 41.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.236 0.541 . . . . 0.0 112.274 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 24' ' ' VAL . . . -84.2 115.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.222 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.72 106.51 13.72 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.574 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.1 mp -97.98 152.03 19.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.244 0.545 . . . . 0.0 111.994 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 105' ' ' VAL . 17.5 mt-10 -141.9 136.73 30.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.685 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.733 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.39 98.88 11.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.152 0.501 . . . . 0.0 111.188 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 27.1 mm -74.52 147.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.455 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -106.48 146.81 33.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.545 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 12.1 Cg_endo -90.59 3.6 67.81 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.159 -1.184 . . . . 0.0 112.353 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.86 79.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 68' ' ' ASP . . . -146.58 -172.12 16.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 23' ' ' ARG . 19.5 tp -154.69 142.62 20.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.12 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.688 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -135.7 99.31 4.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.42 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.752 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 18.4 t -116.95 142.2 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -146.15 141.75 27.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.464 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.591 ' CG2' ' HB2' ' A' ' 12' ' ' ALA . 1.2 pp -135.9 120.15 12.97 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.762 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 10' ' ' PRO . 86.2 Cg_exo -46.27 123.09 6.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.115 1.877 . . . . 0.0 112.172 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 15.2 t0 -79.02 158.88 27.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.191 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -145.37 46.44 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.867 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.41 37.58 86.01 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.4 m-85 -82.94 -172.16 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.266 0.555 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ILE . 48.4 t -131.59 -26.47 2.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.799 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 12.2 tp -146.45 132.95 19.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.334 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.1 t80 -117.99 106.19 12.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -103.79 118.4 36.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 24.2 t80 -106.23 125.84 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -124.95 122.72 38.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.81 137.83 5.84 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 118.853 -1.642 . . . . 0.0 114.252 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -111.53 142.46 43.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 101' ' ' VAL . 36.5 tp -97.28 125.69 42.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.987 0.422 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 63.78 50.94 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.9 tt0 176.42 109.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.578 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 44.8 mt-10 -57.49 -167.64 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.373 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.54 157.53 14.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -143.29 49.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.469 . . . . 0.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.67 -137.87 4.81 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD22 ' CH2' ' A' ' 82' ' ' TRP . 23.3 mt -121.02 67.11 0.86 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.264 0.554 . . . . 0.0 111.094 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 1.4 mt-10 -87.67 147.34 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.939 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -53.35 -26.04 17.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.813 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.32 -117.03 3.45 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.379 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.6 m80 -140.41 -73.4 0.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.728 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 6.7 m-90 -60.39 90.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.05 87.29 2.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 118.08 19.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.007 0.432 . . . . 0.0 111.617 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -92.99 106.45 18.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.9 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 9.1 mm -86.42 148.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.614 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 t -140.1 39.34 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.421 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.41 99.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.1 Cg_exo -51.73 -175.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.438 2.092 . . . . 0.0 112.362 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -116.82 -67.12 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.069 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.47 84.35 1.37 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.747 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.82 -0.73 34.98 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 5.6 ptp85 -157.81 160.38 37.71 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.69 0.281 . . . . 0.0 110.908 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.47 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 5.7 m95 -94.92 156.2 16.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.855 0.359 . . . . 0.0 110.225 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -134.69 116.24 14.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 54' ' ' ARG . 11.1 t80 -110.94 112.7 24.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.393 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 2.4 t0 -138.06 107.88 6.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -89.21 22.59 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.53 33.09 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.12 105.27 16.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -73.82 75.89 1.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.728 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 61.6 mt -87.25 156.83 19.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.078 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.46 134.92 34.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.424 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.6 OUTLIER -56.8 131.65 49.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.264 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.01 -29.92 9.22 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.05 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 101' ' ' VAL . 7.3 t70 -69.22 162.45 27.08 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -114.08 172.5 6.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.988 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.791 HD11 HG22 ' A' ' 101' ' ' VAL . 2.7 mp -127.85 142.44 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.785 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 47.2 m-85 -144.31 128.18 17.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.7 p90 -161.13 -177.56 6.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.649 ' CH2' HD22 ' A' ' 47' ' ' LEU . 55.8 p-90 -149.12 131.19 15.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.151 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -100.48 155.47 17.82 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.823 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.867 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 8.2 t80 -134.87 148.15 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.763 0.316 . . . . 0.0 111.057 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -137.91 165.31 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.957 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.698 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 16.8 mm -141.4 107.7 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 O-C-N 123.069 0.231 . . . . 0.0 111.025 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.68 62.58 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.446 0.466 . . . . 0.0 110.56 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 t70 69.28 65.72 0.27 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.811 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.32 28.21 71.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.518 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.83 74.22 1.42 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.01 161.67 45.79 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.403 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' O ' HG13 ' A' ' 85' ' ' VAL . 83.7 m-85 -152.18 148.99 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -134.17 143.11 47.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.729 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 tt0 -102.54 76.52 1.54 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 5.0 p-10 -77.2 -179.06 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.27 16.23 8.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.657 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.41 162.49 49.79 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.004 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -154.42 152.59 30.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 0.0 111.251 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.708 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.7 t90 -155.07 164.94 38.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.061 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.781 ' OG1' HG22 ' A' ' 102' ' ' THR . 5.7 t -108.48 158.57 17.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.791 HG22 HD11 ' A' ' 79' ' ' ILE . 2.6 t -119.85 -7.11 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.98 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.781 HG22 ' OG1' ' A' ' 100' ' ' THR . 2.4 t -66.04 -8.42 23.12 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.9 tt0 -134.34 137.2 43.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.053 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.4 m-85 -122.08 154.99 36.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 17' ' ' ILE . 6.2 m -109.67 151.75 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.112 0.482 . . . . 0.0 110.942 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 110' ' ' THR . 1.0 OUTLIER -82.16 153.48 25.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.397 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -55.49 -17.25 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.39 -30.72 64.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.047 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.24 5.28 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.416 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.7 p -142.84 161.48 48.75 Favored Pre-proline 0 CA--C 1.517 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.0 111.107 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 82.9 Cg_exo -44.95 128.43 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.935 2.424 . . . . 0.0 113.264 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.85 93.22 8.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.355 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -171.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -66.56 -33.67 76.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.7 t 61.98 179.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 116' ' ' LEU . 1.1 pp -136.19 79.85 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.9 120.22 70.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.443 2.095 . . . . 0.0 112.304 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 65.6 t80 -61.74 170.22 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 110.773 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.481 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 11.2 t -104.93 157.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.7 p -68.66 138.41 90.86 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.473 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 11.9 Cg_exo -70.0 -178.46 2.45 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.61 2.206 . . . . 0.0 111.893 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -103.71 120.9 41.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.471 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.0 109.23 16.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.8 mmtm -90.05 130.18 36.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.365 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HG ' HG22 ' A' ' 24' ' ' VAL . 6.1 mp -121.98 154.79 36.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.145 0.498 . . . . 0.0 111.741 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' HG11 ' A' ' 105' ' ' VAL . 3.2 mp0 -147.54 144.62 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.111 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.98 130.61 34.39 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.006 0.432 . . . . 0.0 111.4 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 23' ' ' ARG . 9.7 mm -109.55 134.55 51.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.306 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -98.26 144.1 27.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.452 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.4 Cg_endo -90.35 -7.18 45.47 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.423 0.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -159.11 93.08 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.493 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.07 165.33 38.66 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.632 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -146.84 137.03 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -120.87 121.89 39.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG22 ' HG ' ' A' ' 14' ' ' LEU . 31.2 t -121.28 151.86 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -155.03 144.88 21.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -140.5 127.64 12.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 52.8 Cg_exo -53.96 106.71 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.238 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 36.4 t0 -76.07 144.84 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.002 0.43 . . . . 0.0 111.296 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 1.8 m-20 -132.59 44.95 2.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.954 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.99 53.64 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.7 m-85 -82.04 -170.88 3.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.341 0.591 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 1.1 t -130.92 -29.32 1.89 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.449 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.672 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.6 tp -140.47 136.01 32.55 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.811 -0.755 . . . . 0.0 112.396 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.65 ' HD2' HD12 ' A' ' 56' ' ' ILE . 14.3 t80 -123.74 104.16 8.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.371 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -99.35 126.67 45.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.811 0.339 . . . . 0.0 110.746 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.3 t80 -113.51 124.07 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.433 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -126.97 115.48 19.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -151.24 139.09 6.95 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 118.572 -1.775 . . . . 0.0 114.571 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -122.18 126.86 49.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 ' CH2' ' A' ' 52' ' ' TRP . 0.5 OUTLIER -91.7 141.32 28.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.71 40.62 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -176.9 109.55 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.4 mt-10 -50.71 -172.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.992 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.413 ' CE ' ' HA ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -119.38 135.43 54.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.067 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -150.64 64.14 0.93 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . 113.99 129.24 4.84 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.716 HD22 ' CH2' ' A' ' 82' ' ' TRP . 6.9 mt -43.03 91.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 111.675 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' GLY . 4.6 mt-10 -116.7 154.04 31.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.932 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -55.84 -22.91 27.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.9 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.58 -108.98 0.69 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.042 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t-80 -133.9 -73.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.947 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 40' ' ' LEU . 27.9 m-90 -72.04 92.74 1.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.55 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.189 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 21.5 tpt180 -149.18 133.23 17.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.884 0.373 . . . . 0.0 111.947 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.75 143.35 26.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.713 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.65 HD12 ' HD2' ' A' ' 34' ' ' PHE . 11.7 mt -126.87 142.82 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.158 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 32' ' ' SER . 3.4 m -134.22 30.68 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -151.77 89.38 4.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.437 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 57.2 Cg_exo -51.89 171.85 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.578 2.186 . . . . 0.0 112.576 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.36 34.96 3.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.96 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.95 87.85 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.226 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.1 -5.82 12.47 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.818 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 9.4 mtt-85 -157.48 130.67 7.73 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.299 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.5 m95 -78.13 154.8 30.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.963 0.411 . . . . 0.0 110.02 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 97.1 m -134.76 118.54 17.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.217 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' HD11 ' A' ' 56' ' ' ILE . 82.5 t80 -120.81 91.8 3.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 146.19 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 26.4 t0 -138.04 106.89 5.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.673 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.25 22.35 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.651 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -134.65 43.45 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.09 123.24 42.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -73.94 76.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.695 HD13 HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -98.43 142.42 30.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 158.78 38.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 3.3 tt -68.87 133.37 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.015 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 105.93 -27.99 15.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' VAL . 10.9 t70 -59.46 164.48 3.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.089 0.471 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.1 153.58 42.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.438 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.4 mp -113.42 143.1 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.987 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.6 m-85 -144.18 125.71 14.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.618 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 5.0 p90 -161.09 -174.5 4.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 122.439 1.114 . . . . 0.0 113.939 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.716 ' CH2' HD22 ' A' ' 47' ' ' LEU . 16.4 p-90 -151.59 129.85 12.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.034 -1.894 . . . . 0.0 108.148 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -99.86 161.0 13.88 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.783 -178.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.939 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 18.3 t80 -141.59 137.87 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.622 0.248 . . . . 0.0 110.566 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -130.94 162.42 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.5 mm -135.16 105.79 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.855 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 66.81 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.529 0.518 . . . . 0.0 110.546 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.17 61.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 73.93 29.01 63.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -143.82 74.16 1.42 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.134 0.492 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.83 159.68 42.24 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.542 -0.753 . . . . 0.0 114.595 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -152.44 144.14 23.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.613 -0.793 . . . . 0.0 108.985 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -128.5 140.11 51.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.561 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.92 77.49 2.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.556 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 8.9 p-10 -80.8 176.28 9.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.417 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 60.57 18.31 8.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.36 162.02 50.77 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.131 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.42 158.72 40.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CE2' ' O ' ' A' ' 100' ' ' THR . 58.8 t90 -155.1 166.6 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.255 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 4.7 t -109.83 160.09 16.65 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.6 t -122.68 2.12 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.58 HG22 ' HA2' ' A' ' 76' ' ' GLY . 44.6 p -63.77 -13.44 43.95 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.752 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.6 tt0 -131.33 150.87 51.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.034 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 9.3 m-85 -131.73 145.21 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.165 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.448 HG11 ' HG2' ' A' ' 15' ' ' GLU . 25.4 m -98.6 163.22 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' THR . 33.8 t30 -83.9 152.52 24.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -55.96 -17.11 5.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.31 -30.72 65.04 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.914 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.87 17.85 5.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.446 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -137.95 159.19 69.56 Favored Pre-proline 0 C--O 1.222 -0.342 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 77.6 Cg_exo -48.87 128.46 19.0 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.959 2.439 . . . . 0.0 113.286 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.96 124.28 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.94 133.69 48.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -59.55 93.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.82 161.71 37.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -85.22 57.46 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.98 130.31 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--O 1.251 1.146 0 C-N-CA 122.449 2.099 . . . . 0.0 112.387 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 68.2 t80 -61.05 169.68 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 9' ' ' VAL . 3.3 p -105.57 179.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.379 0.609 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.793 ' H ' HG22 ' A' ' 8' ' ' VAL . 7.3 p -81.36 137.75 48.57 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.237 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 14.2 Cg_exo -68.35 -174.49 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.586 2.191 . . . . 0.0 112.145 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.71 118.63 37.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.378 . . . . 0.0 111.888 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -76.8 105.68 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.431 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.95 107.23 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.048 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.753 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.9 mp -96.45 159.22 15.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.232 0.539 . . . . 0.0 111.773 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.12 137.24 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.47 102.63 14.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.207 0.527 . . . . 0.0 111.058 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 23' ' ' ARG . 25.2 mm -73.1 135.51 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.409 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 57.9 t80 -94.89 141.28 23.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.695 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.3 Cg_endo -92.31 -3.29 49.77 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.432 0.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.84 94.95 0.87 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -168.96 -171.08 34.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.387 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD12 ' H ' ' A' ' 23' ' ' ARG . 13.3 tp -156.93 147.7 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB2' HD11 ' A' ' 17' ' ' ILE . 6.8 ttm180 -144.71 106.65 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.673 HG22 ' HG ' ' A' ' 14' ' ' LEU . 21.4 t -109.0 157.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.03 146.72 23.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 111.589 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.799 HG21 ' CZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -141.83 130.52 12.12 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.57 101.54 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.184 1.923 . . . . 0.0 111.052 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.453 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.8 t70 -69.14 149.8 48.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.298 0.57 . . . . 0.0 111.899 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.447 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 9.1 t70 -131.35 42.78 3.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.492 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.02 45.82 30.81 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.702 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 12.5 m-85 -87.5 -171.49 3.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.329 0.585 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ILE . 88.6 p -128.64 -29.18 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.498 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.845 ' CD1' HG22 ' A' ' 57' ' ' THR . 9.0 tp -142.63 140.53 31.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.593 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 26' ' ' ILE . 46.1 t80 -133.23 99.75 4.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.61 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -98.2 117.82 33.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.547 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.753 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 28.0 t80 -104.94 120.16 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.029 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.514 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -116.82 128.77 55.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.414 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -156.19 132.37 3.31 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.05 -1.548 . . . . 0.0 114.161 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 11.7 ttpt -106.65 144.69 32.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.5 tp -98.97 124.79 44.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.016 0.436 . . . . 0.0 111.547 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 t-20 65.11 49.36 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 60.7 tt0 175.81 109.82 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 110.613 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 45.7 mt-10 -55.26 -175.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.766 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.11 156.82 43.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.438 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.57 44.11 1.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.247 0.546 . . . . 0.0 110.429 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.37 -134.02 3.14 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.439 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.812 HD22 ' CH2' ' A' ' 82' ' ' TRP . 18.0 mt -124.42 75.32 1.39 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 120.956 0.408 . . . . 0.0 111.026 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 4.7 mt-10 -98.85 145.73 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -49.16 -36.03 18.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.869 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.76 -112.33 3.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.026 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 66.0 t60 -145.19 -74.2 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.686 0.279 . . . . 0.0 110.919 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.666 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -63.79 101.07 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.29 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -115.93 76.63 1.03 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -96.41 114.3 25.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.502 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.43 95.54 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.161 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 58' ' ' LYS . 6.6 mt -104.03 152.89 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.269 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 33' ' ' LEU . 9.1 p -121.26 -8.53 9.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.4 mttp -135.38 120.09 13.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.484 0.183 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.6 Cg_exo -58.13 -165.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.456 2.104 . . . . 0.0 112.33 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -119.49 -44.9 2.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.223 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -178.59 82.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.711 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 -7.18 19.79 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.38 149.75 22.84 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.504 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 4.8 m95 -88.21 150.83 23.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.89 0.376 . . . . 0.0 110.163 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -135.52 122.06 20.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.547 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 37.4 t80 -109.22 154.02 22.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 118.78 10.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 0.0 111.229 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.3 t70 -121.34 98.37 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.406 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -89.16 22.59 2.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.553 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.33 27.99 4.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.42 100.99 10.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -73.79 75.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.041 0.448 . . . . 0.0 110.67 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.666 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 57.3 mt -91.57 142.15 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -125.55 146.44 49.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.19 144.92 14.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 95.08 -35.05 4.44 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.244 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.1 t0 -62.15 149.54 41.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -108.31 168.28 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HG22 ' A' ' 101' ' ' VAL . 3.0 mp -124.92 145.8 31.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.196 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 57.8 m-85 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -159.9 -177.53 6.4 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.812 ' CH2' HD22 ' A' ' 47' ' ' LEU . 57.4 p-90 -153.54 135.05 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.894 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 72.1 p -99.55 166.69 11.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.071 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.661 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 15.9 t80 -150.01 108.69 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.667 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.75 ' O ' HD13 ' A' ' 86' ' ' ILE . 1.4 m -102.8 169.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.66 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -144.53 101.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.537 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -96.16 62.26 2.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 t0 64.35 62.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.836 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.53 26.84 60.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.265 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.4 mt -143.29 71.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.21 0.528 . . . . 0.0 110.157 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -75.84 160.53 51.71 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.333 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 85' ' ' VAL . 58.4 m-85 -152.19 140.79 20.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.67 ' C ' HG11 ' A' ' 9' ' ' VAL . 8.0 ptt180 -121.84 144.59 48.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' N ' HG21 ' A' ' 9' ' ' VAL . 12.4 tt0 -105.4 69.62 0.85 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.689 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.2 p30 -78.24 176.14 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.516 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.8 t30 61.42 17.57 8.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.38 164.75 53.59 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.12 152.03 29.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.8 t90 -148.63 164.06 35.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.976 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -107.26 159.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.665 HG22 HD11 ' A' ' 79' ' ' ILE . 13.8 t -118.7 -5.22 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.814 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HD21 ' A' ' 75' ' ' LEU . 4.4 p -69.12 -5.23 20.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.959 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -136.09 149.1 48.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.703 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 m-85 -133.83 148.47 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.038 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 7.8 m -98.64 168.04 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.262 0.553 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 110' ' ' THR . 1.4 m120 -94.99 149.67 21.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.436 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -18.82 8.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.15 -30.86 70.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.879 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.68 23.4 3.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.323 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -149.44 159.07 37.33 Favored Pre-proline 0 CA--C 1.517 -0.322 0 CA-C-O 121.453 0.644 . . . . 0.0 111.758 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 76.8 Cg_exo -49.15 125.55 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.163 2.575 . . . . 0.0 113.236 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 69.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.191 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.3 173.1 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.2 p -100.86 34.76 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -127.48 144.1 51.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 116' ' ' LEU . 8.3 mp -107.65 66.7 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.89 120.36 81.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.429 2.086 . . . . 0.0 112.352 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 43.1 t80 -77.64 176.87 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.9 t -119.38 160.02 19.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.614 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -70.37 138.05 86.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 9' ' ' VAL . 37.9 Cg_endo -67.18 -168.36 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.486 2.124 . . . . 0.0 112.662 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -105.22 117.66 34.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.451 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.92 99.42 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.616 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -82.16 152.26 26.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.586 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.463 HD22 ' CE2' ' A' ' 81' ' ' PHE . 3.6 mp -145.24 157.79 43.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.581 . . . . 0.0 112.07 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.538 ' O ' HD22 ' A' ' 22' ' ' LEU . 8.8 mt-10 -150.03 142.92 24.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.977 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . . . -86.26 101.68 13.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 111.547 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 23' ' ' ARG . 26.7 mm -71.82 122.94 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.199 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 34.0 t80 -87.45 141.83 32.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 90.3 Cg_endo -96.27 5.15 42.91 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.512 0.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -164.65 96.69 0.75 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.765 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . 177.07 166.16 33.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.507 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.634 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -149.47 120.76 7.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.715 0.293 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HG2' HD11 ' A' ' 17' ' ' ILE . 9.9 ptm180 -109.88 133.1 53.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 22.1 t -121.74 155.06 26.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.339 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.63 147.07 29.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.788 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -146.11 127.49 7.47 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.451 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 22.8 Cg_endo -60.72 96.94 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.456 2.104 . . . . 0.0 111.463 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 24.1 t0 -59.97 154.94 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.632 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t70 -139.37 43.6 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.571 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.28 41.51 52.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.709 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 85' ' ' VAL . 11.5 m-85 -85.24 -170.83 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.375 0.607 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -131.83 -28.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.544 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 57' ' ' THR . 10.1 tp -139.68 135.67 33.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.378 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 29.9 t80 -126.95 103.3 7.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.387 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.36 118.2 36.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.643 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.4 t80 -105.91 128.47 53.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.718 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -119.28 129.37 54.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -147.07 142.37 10.24 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 118.765 -1.683 . . . . 0.0 114.615 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.2 mttp -119.64 124.55 46.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.347 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD13 HD23 ' A' ' 73' ' ' LEU . 46.3 tp -81.7 112.99 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.824 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.5 t-20 58.89 65.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.9 tt0 174.28 110.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 38.1 mt-10 -54.5 -168.93 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -152.05 145.54 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.686 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.63 44.57 2.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.187 0.518 . . . . 0.0 110.408 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.56 -140.75 7.41 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.726 HD22 ' CH2' ' A' ' 82' ' ' TRP . 18.4 mt -119.49 73.82 0.97 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.989 0.423 . . . . 0.0 110.977 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.25 143.71 26.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.093 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.718 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.25 -25.87 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.796 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 48.22 -107.9 0.31 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.47 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.2 t60 -138.38 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.738 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 15.8 m-90 -65.56 87.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.58 86.36 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -133.41 126.65 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.001 0.429 . . . . 0.0 111.964 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.6 109.55 21.45 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.363 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 18.3 mt -93.3 141.01 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.813 HG22 HD12 ' A' ' 33' ' ' LEU . 9.8 p -129.58 23.79 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.91 87.61 7.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 53.6 Cg_exo -52.72 171.46 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.613 2.209 . . . . 0.0 112.538 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 63' ' ' ARG . 4.5 tptm -109.97 36.46 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.678 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 4.5 mt-10 76.64 88.99 0.08 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.22 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.6 -3.68 24.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.002 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 10.2 mtp180 -157.29 129.04 7.03 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.444 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.531 ' CD1' HD11 ' A' ' 26' ' ' ILE . 7.9 m95 -81.53 150.28 28.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -135.07 121.92 21.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 56' ' ' ILE . 18.0 t80 -110.44 143.89 40.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.427 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -141.76 118.1 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.197 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 16.1 t70 -126.87 101.56 6.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.636 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.21 22.42 2.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.72 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -123.09 28.77 7.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.29 106.9 15.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -73.93 76.94 1.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.806 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 4.1 mt -78.89 166.31 22.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.676 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.81 149.16 46.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -67.66 131.3 45.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.257 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.604 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.51 -26.23 16.89 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.7 t70 -58.26 158.73 6.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.96 14.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.592 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -122.66 150.95 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.296 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 78.1 m-85 -144.4 130.37 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -161.23 -178.45 6.72 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.15 0.976 . . . . 0.0 113.48 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.726 ' CH2' HD22 ' A' ' 47' ' ' LEU . 53.5 p-90 -155.03 132.35 11.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -99.91 163.01 12.63 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.417 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.82 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 40.9 t80 -144.26 122.39 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.772 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -117.75 163.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.82 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 32.9 mm -136.39 109.27 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.582 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -103.77 74.4 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.034 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 t0 58.05 48.21 13.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.788 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 87.27 30.18 20.3 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.332 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.8 mt -143.94 75.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.157 0.503 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.34 158.95 44.35 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.429 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -152.35 150.1 29.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.63 -0.785 . . . . 0.0 108.932 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.614 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.54 147.47 52.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 4.1 tt0 -107.37 73.51 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.8 p30 -85.75 -179.88 6.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.523 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 t30 61.07 18.21 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.518 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.18 163.14 42.95 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.27 128.82 9.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 47.5 t90 -120.1 170.18 9.53 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 3.7 t -110.62 160.95 16.21 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 77' ' ' ASP . 2.1 t -126.71 15.17 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.667 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.593 ' O ' HD21 ' A' ' 75' ' ' LEU . 26.8 p -58.79 -24.55 61.99 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.892 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 81.7 mt-10 -137.31 161.33 36.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.856 0.36 . . . . 0.0 111.177 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 9.5 m-85 -130.18 145.86 51.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.796 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 17' ' ' ILE . 25.5 m -98.53 167.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.093 0.473 . . . . 0.0 110.502 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 110' ' ' THR . 10.0 m-20 -89.2 150.36 22.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.423 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.87 -18.26 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.3 -30.57 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.079 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.72 18.25 5.29 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.245 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.4 p -141.89 162.25 47.12 Favored Pre-proline 0 C--O 1.222 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 80.2 Cg_exo -44.02 129.93 7.96 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.87 2.38 . . . . 0.0 113.445 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.09 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.365 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -132.58 -171.36 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.4 m -104.11 85.08 2.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -65.57 164.86 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.13 90.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.49 142.77 25.22 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.504 2.136 . . . . 0.0 112.324 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.79 0.329 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.1 t80 -90.72 174.26 7.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.8 t -111.84 159.56 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.78 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.6 p -68.63 135.32 90.41 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.499 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' HG11 ' A' ' 85' ' ' VAL . 16.5 Cg_exo -66.68 -173.6 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.618 2.212 . . . . 0.0 112.236 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.26 125.24 51.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -85.37 106.23 16.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.958 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 ttmt -92.32 119.84 32.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.621 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.717 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.1 mp -108.14 158.72 17.18 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.818 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.12 140.63 26.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.116 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.34 120.27 27.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.305 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 105' ' ' VAL . 19.8 mm -92.62 130.72 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.342 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -92.14 142.49 26.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.614 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.2 Cg_endo -93.23 -0.96 51.59 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.386 0.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.59 94.93 0.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.485 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.86 173.11 46.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.476 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -152.29 130.01 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 111.07 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' N ' HD13 ' A' ' 22' ' ' LEU . 9.8 ttt180 -120.26 115.5 23.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.719 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.717 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.3 t -110.86 161.5 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.453 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -152.68 143.58 22.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.046 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.683 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.59 124.06 10.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 10.8 Cg_endo -56.61 99.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.058 1.838 . . . . 0.0 111.359 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.1 t0 -65.51 160.07 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.809 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 4.1 t0 -143.23 43.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.96 42.68 68.19 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.808 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.2 m-85 -84.2 -170.53 3.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.282 0.563 . . . . 0.0 111.114 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -131.97 -28.01 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.645 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 9.6 tp -140.27 134.91 31.7 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.189 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.69 ' HD2' HD12 ' A' ' 56' ' ' ILE . 47.8 t80 -127.4 90.3 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.67 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -85.1 125.4 32.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.487 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 14.2 t80 -115.04 124.02 50.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.345 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.612 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -125.08 122.31 36.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -156.06 147.01 15.07 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.972 -1.585 . . . . 0.0 114.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.79 155.36 39.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.444 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -92.72 115.23 27.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER 59.88 71.9 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 74.2 tt0 174.31 110.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 31.4 mt-10 -56.31 -167.57 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.135 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.5 mtp -145.95 143.28 29.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -135.69 81.13 1.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 84.47 99.84 0.63 Allowed Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.4 mt 18.46 96.19 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.725 0.81 . . . . 0.0 112.824 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -109.3 140.97 42.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.642 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.81 -26.37 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.664 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.79 -160.2 0.12 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.635 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -100.6 -74.22 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 110.696 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.621 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 m-90 -63.49 91.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.15 91.28 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.255 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.8 tmm_? -145.85 125.34 13.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.679 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.72 128.25 35.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.853 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.8 mt -102.99 159.51 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 56' ' ' ILE . 10.6 t -148.39 39.98 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 111.23 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -175.77 96.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.447 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 74.4 Cg_exo -49.75 179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.403 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -106.55 -58.43 1.93 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.194 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 82.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.382 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . 74.09 -2.42 43.49 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 33.6 mtt85 -156.66 147.25 21.59 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.354 0.261 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.609 ' CG ' HD11 ' A' ' 26' ' ' ILE . 9.9 m95 -83.91 159.11 21.37 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.64 118.02 16.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.409 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 36' ' ' PHE . 8.3 t80 -99.8 94.59 6.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.313 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -93.34 124.93 37.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.378 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.421 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.6 t70 -138.12 97.57 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.25 22.36 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -133.87 44.15 2.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -118.74 115.64 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.068 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.96 76.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 22' ' ' LEU . 6.4 mt -82.81 164.98 20.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -141.68 150.53 42.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.979 0.419 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -70.58 132.89 46.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.304 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.47 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.61 -26.4 16.24 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.9 t70 -60.5 165.95 3.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.66 163.32 16.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.383 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -117.6 148.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 3.9 m-85 -144.33 129.71 18.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 3.0 p90 -161.1 -175.51 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 122.0 0.905 . . . . 0.0 113.2 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 32.2 p-90 -157.03 124.65 5.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.859 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.6 p -107.2 151.26 25.66 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.981 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 86' ' ' ILE . 24.4 t80 -133.81 124.58 26.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.229 0.331 . . . . 0.0 111.043 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -108.28 163.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.797 HD11 ' CE2' ' A' ' 84' ' ' TYR . 22.4 mm -136.91 114.31 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.911 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 70.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.4 t0 66.45 62.38 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.768 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.2 28.64 72.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.637 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -145.06 77.91 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.171 0.51 . . . . 0.0 109.981 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -93.17 161.87 25.67 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.627 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -152.13 147.51 26.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.78 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -122.97 151.62 41.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.466 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -106.49 73.98 0.99 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.504 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.6 p30 -84.96 179.59 7.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.442 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 58.55 19.53 6.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.916 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.85 163.46 33.47 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.279 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.27 161.58 41.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.515 ' CZ2' ' HA ' ' A' ' 15' ' ' GLU . 54.8 t90 -146.43 169.06 19.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.526 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' CZ3' ' A' ' 99' ' ' TRP . 5.1 t -105.22 154.81 19.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.634 ' O ' HD22 ' A' ' 75' ' ' LEU . 1.9 t -124.25 17.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.295 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -70.49 -10.71 59.89 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -127.29 162.73 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.549 ' CE2' HD23 ' A' ' 75' ' ' LEU . 6.3 m-85 -135.29 123.53 23.08 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.7 m -97.98 153.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 110.852 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 110' ' ' THR . 24.4 t30 -72.79 155.42 39.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.603 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.25 -16.87 6.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -73.25 -31.73 64.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.895 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.76 7.16 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.288 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 106' ' ' ASN . 4.4 p -127.21 157.49 72.23 Favored Pre-proline 0 CA--C 1.515 -0.38 0 CA-C-O 121.252 0.548 . . . . 0.0 110.977 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 41.8 Cg_exo -54.31 129.02 32.46 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.775 2.317 . . . . 0.0 112.955 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 114' ' ' THR . . . -99.28 62.84 1.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -57.22 122.62 12.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 112' ' ' ALA . 70.2 p -137.54 -42.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.654 ' C ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER 69.0 53.89 0.46 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.951 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 115' ' ' SER . 1.0 OUTLIER 40.17 67.55 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.721 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 60.99 155.55 0.11 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.526 2.15 . . . . 0.0 112.189 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.843 0.354 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.0 t80 -77.64 173.16 12.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.177 0.513 . . . . 0.0 110.793 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.2 t -110.89 160.71 9.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.236 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.622 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.5 p -66.39 132.15 94.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.492 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.6 Cg_exo -64.19 -177.13 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.549 2.166 . . . . 0.0 111.933 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.6 122.69 47.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -81.14 109.79 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -95.3 102.35 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.162 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.1 mp -90.29 162.65 15.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.102 0.477 . . . . 0.0 111.935 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 105' ' ' VAL . 37.9 mt-10 -146.58 140.28 25.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.09 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.73 110.62 20.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.995 0.426 . . . . 0.0 111.448 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 16.9 mm -83.41 159.73 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 8.8 t80 -122.57 140.82 33.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.597 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 8.8 Cg_endo -88.96 1.78 68.97 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.4 -1.083 . . . . 0.0 112.419 0.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.8 98.21 0.3 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.929 0.395 . . . . 0.0 111.008 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.668 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -166.59 -173.13 34.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.437 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -155.81 137.61 14.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.803 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -133.63 106.72 7.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.37 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 22' ' ' LEU . 16.4 t -114.26 155.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.86 145.01 25.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.643 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.674 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -138.21 127.02 14.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.6 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.4 Cg_endo -58.4 93.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.344 2.029 . . . . 0.0 111.706 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.6 t0 -58.6 160.82 5.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.628 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 6.0 t0 -145.62 44.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.39 44.06 60.13 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.961 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.2 m-85 -88.28 -170.88 3.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.465 0.65 . . . . 0.0 111.22 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -131.69 -28.94 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.476 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 8.7 tp -138.38 135.3 35.19 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.163 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.706 ' HD2' HD12 ' A' ' 56' ' ' ILE . 37.1 t80 -125.44 98.58 5.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.028 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -92.88 126.22 37.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 111.062 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' CD2' HG22 ' A' ' 83' ' ' THR . 25.3 t80 -115.86 123.05 47.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.632 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -127.07 120.64 29.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.83 135.23 4.93 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 118.587 -1.768 . . . . 0.0 114.792 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -105.89 147.75 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.126 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.1 tp -97.19 125.26 41.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.279 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.3 t-20 56.8 57.72 4.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 76.5 tt0 174.64 109.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.14 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 60.7 mt-10 -53.11 176.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.48 ' HG2' ' C ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -141.24 138.97 33.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.276 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -132.86 48.08 2.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.112 0.482 . . . . 0.0 110.761 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.36 -138.74 5.6 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD22 ' CH2' ' A' ' 82' ' ' TRP . 20.9 mt -119.26 69.41 0.82 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.189 0.519 . . . . 0.0 111.0 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -91.15 145.86 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.996 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.4 -25.65 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.9 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.71 -117.71 3.14 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.454 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 38' ' ' GLY . 1.1 t60 -137.48 -73.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.768 0.318 . . . . 0.0 110.555 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 12.8 m-90 -69.98 90.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.32 90.16 3.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.135 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.19 130.17 18.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 112.035 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.26 123.6 34.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.554 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 34' ' ' PHE . 13.3 mt -102.46 143.32 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.234 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 19.9 p -134.31 34.57 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.27 91.87 1.69 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 48.4 Cg_exo -55.88 170.03 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.57 2.18 . . . . 0.0 112.451 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.73 34.49 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.929 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 80.81 87.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.38 -1.75 25.37 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.735 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -157.14 125.3 5.55 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.393 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.566 ' CG ' HD11 ' A' ' 26' ' ' ILE . 18.4 m95 -77.48 156.6 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.2 m -134.59 118.93 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.41 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 56' ' ' ILE . 54.0 t80 -111.24 93.13 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.6 139.7 30.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.1 t70 -138.02 106.12 5.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.23 22.43 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.667 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -135.31 31.78 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.516 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -112.99 108.71 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.01 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -73.71 83.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 21' ' ' GLY . 37.5 mt -86.08 115.48 23.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.87 131.43 52.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -52.02 133.57 32.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.432 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.62 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.94 -29.71 11.61 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 101' ' ' VAL . 30.9 t0 -65.85 160.9 22.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -119.37 160.23 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.2 mp -114.75 146.79 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.786 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 33.7 m-85 -144.23 125.05 14.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.8 p90 -161.08 -174.29 4.29 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.208 1.004 . . . . 0.0 113.404 -178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.518 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.9 p-90 -151.01 127.43 10.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.378 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 24.4 p -107.07 149.7 27.32 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.461 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.773 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.4 t80 -131.51 146.4 52.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.306 0.379 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.55 162.52 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.103 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.773 HD11 ' CE2' ' A' ' 84' ' ' TYR . 31.1 mm -134.52 117.13 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.813 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -114.6 65.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t0 66.87 64.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.779 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.27 28.39 71.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.1 mt -144.96 77.9 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.233 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.81 161.25 28.11 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.47 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.6 m-85 -152.18 139.7 19.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -123.3 145.07 49.0 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.622 ' N ' HG21 ' A' ' 9' ' ' VAL . 28.1 tt0 -100.35 75.74 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.923 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.8 p-10 -79.97 176.5 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.06 19.65 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.809 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.07 165.81 52.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.264 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.15 161.09 42.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.962 0.411 . . . . 0.0 111.225 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.624 ' HB2' HD13 ' A' ' 14' ' ' LEU . 55.7 t90 -155.21 166.25 34.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 5.6 t -107.03 158.01 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' ASP . 3.8 t -122.33 -3.26 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.099 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.62 HG22 ' HA2' ' A' ' 76' ' ' GLY . 76.1 p -62.02 -16.08 49.07 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -114.28 161.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.628 0.251 . . . . 0.0 110.574 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 75' ' ' LEU . 45.5 m-85 -137.99 138.01 38.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 15' ' ' GLU . 3.2 m -98.27 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.298 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -114.7 145.81 41.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.674 -178.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.37 -19.87 10.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -67.2 -29.35 69.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.857 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.63 25.57 3.09 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.615 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.4 p -145.14 151.76 49.2 Favored Pre-proline 0 CA--C 1.514 -0.416 0 CA-C-O 121.497 0.665 . . . . 0.0 112.42 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.588 ' HA ' HG12 ' A' ' 105' ' ' VAL . 37.7 Cg_exo -59.65 69.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.56 2.84 . . . . 0.0 114.293 -178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . 68.62 155.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.549 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.4 109.01 6.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -135.49 71.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.6 -171.21 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.14 78.62 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -118.54 127.51 26.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.759 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.413 2.075 . . . . 0.0 112.313 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.762 0.315 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 46.9 t80 -60.0 173.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.071 0.462 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.6 t -117.21 159.89 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.393 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.65 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.5 p -70.36 137.93 86.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 26.0 Cg_endo -63.64 -174.71 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.428 2.085 . . . . 0.0 112.554 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -110.1 116.48 31.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.546 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -73.38 99.58 2.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -87.45 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.991 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.0 mp -105.7 163.84 12.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.268 0.556 . . . . 0.0 112.16 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HG2' HG11 ' A' ' 105' ' ' VAL . 2.0 mp0 -151.06 140.27 21.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.893 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.653 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.64 119.14 26.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.374 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.5 mm -93.42 152.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -116.44 149.18 43.26 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 3.2 Cg_exo -81.06 -6.99 44.27 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.221 0.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -168.36 93.46 0.35 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 111.0 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -158.47 -167.92 19.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.366 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.586 HD12 ' H ' ' A' ' 23' ' ' ARG . 43.3 tp -158.19 148.3 20.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -143.19 104.79 4.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.647 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.752 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.2 t -113.28 159.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 111.476 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.08 145.01 21.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -142.35 115.9 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.953 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 85.0 Cg_exo -47.13 105.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.166 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 32.4 t0 -71.51 148.9 46.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.205 0.526 . . . . 0.0 111.21 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.2 t0 -134.72 45.34 2.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.488 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.67 36.98 76.55 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.282 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.5 m-85 -78.14 -172.19 2.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 86' ' ' ILE . 95.7 p -133.08 -26.91 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.771 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.8 tp -140.57 128.12 21.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.386 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.656 ' HD2' HD12 ' A' ' 56' ' ' ILE . 13.6 t80 -120.6 93.78 4.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.936 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -95.82 120.35 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.975 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 52' ' ' TRP . 37.9 t80 -106.18 130.36 54.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -127.98 116.41 20.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -155.61 139.79 6.87 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.551 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 9.6 tptp -117.04 145.56 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 HD23 ' A' ' 73' ' ' LEU . 21.6 tp -93.43 122.6 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 111.146 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.8 t-20 57.25 66.46 1.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 42.8 tt0 170.27 111.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -54.9 -168.92 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.9 mtp -143.47 120.37 11.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.053 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 57.79 3.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 85.17 103.75 0.66 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.536 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.4 mt 29.04 77.38 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.405 0.682 . . . . 0.0 112.6 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -95.26 155.71 16.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.56 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -44.85 -40.18 5.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.6 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.32 176.23 0.07 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 53' ' ' ALA . 1.9 m80 -79.84 -78.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.534 0.207 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.688 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 8.2 m-90 -57.21 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.49 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 51' ' ' HIS . . . -118.5 90.09 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.252 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 4.4 ttp180 -149.12 133.21 17.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 111.955 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -91.04 136.56 32.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.0 mt -115.8 148.62 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 111.193 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.581 HG22 HD12 ' A' ' 33' ' ' LEU . 48.1 p -137.84 22.55 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.3 mmpt? -146.79 88.49 5.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 56.0 Cg_exo -52.17 171.44 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.587 2.191 . . . . 0.0 112.641 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.72 39.8 1.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.657 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 3.2 mt-10 74.01 89.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.432 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.71 -5.26 17.77 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.5 mtp180 -157.56 132.69 8.83 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.621 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.61 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.3 m95 -81.81 156.45 24.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 ' CD ' ' A' ' 67' ' ' ARG . 1.1 m -134.62 119.38 18.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.393 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 3.1 t80 -112.86 89.62 3.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.508 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.431 ' CD ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -104.25 148.99 25.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 22' ' ' LEU . 1.9 m-20 -138.1 115.56 11.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.771 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.1 22.01 2.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -145.32 27.02 1.28 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.31 30.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.1 76.03 10.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.3 mt -103.31 132.3 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.437 ' N ' HG11 ' A' ' 101' ' ' VAL . 13.2 mttt -122.76 152.68 40.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 111.553 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -54.16 131.82 41.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.297 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.72 -27.0 13.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.9 t70 -57.8 149.79 21.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.981 0.419 . . . . 0.0 111.097 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 149.8 32.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.488 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.735 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -109.22 148.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.207 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -144.45 125.39 14.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.547 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.7 p90 -161.2 -174.35 4.29 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 51.2 p-90 -157.97 134.33 9.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.153 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 24.6 p -99.74 161.99 13.27 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.118 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.888 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 23.8 t80 -144.18 106.05 4.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.645 0.259 . . . . 0.0 110.871 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.54 164.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.372 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 23.9 mm -140.58 106.62 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.875 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -102.5 74.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.661 0.601 . . . . 0.0 110.589 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 57.61 62.28 2.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.814 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.74 31.37 62.61 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.217 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.6 mt -142.59 70.36 1.32 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.21 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -77.68 157.84 46.18 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 114.361 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.42 143.86 23.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.65 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -126.51 146.29 50.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 3.0 tt0 -105.38 73.82 1.05 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.232 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 19.0 p-10 -85.14 176.78 8.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.72 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 60.05 19.97 9.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.455 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.95 162.87 41.23 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.077 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -154.29 138.97 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.947 0.404 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.735 ' CE3' HD13 ' A' ' 79' ' ' ILE . 31.6 t90 -129.67 166.17 20.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.048 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.9 t -111.58 162.69 14.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 77' ' ' ASP . 11.7 t -123.83 5.4 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.401 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 3.2 p -62.01 -16.97 55.57 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.349 -0.387 . . . . 0.0 112.008 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 mm-40 -136.7 157.31 47.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.342 . . . . 0.0 111.025 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 16.3 m-85 -135.83 145.57 46.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.037 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 14.4 m -98.71 157.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 110' ' ' THR . 34.9 t30 -82.62 153.48 25.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.543 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -55.81 -16.94 5.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -73.07 -30.71 63.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.957 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.01 5.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.329 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 p -139.35 159.08 67.49 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-O 121.303 0.573 . . . . 0.0 111.299 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 77.8 Cg_exo -49.1 127.25 16.95 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.041 2.494 . . . . 0.0 113.179 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.82 73.54 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -75.45 86.87 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.8 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.27 81.36 1.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -113.49 73.9 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.6 75.76 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.44 125.42 91.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.776 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.382 2.055 . . . . 0.0 112.289 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 61.9 t80 -59.47 168.53 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 21.3 t -123.41 159.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.635 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.67 HG11 ' N ' ' A' ' 94' ' ' GLN . 2.7 p -66.95 145.82 98.98 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.072 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 9' ' ' VAL . 21.2 Cg_exo -65.22 -166.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.605 2.203 . . . . 0.0 111.995 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.53 123.65 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.0 111.67 21.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.717 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 tptt -81.99 156.88 24.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.686 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' A' ' 24' ' ' VAL . 4.9 mp -147.4 143.9 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.981 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -142.1 144.7 33.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.959 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.13 110.03 19.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.7 mm -80.6 127.61 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.333 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -89.73 143.01 29.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 60.7 Cg_endo -93.28 2.68 57.12 Favored 'Cis proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.444 0.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -167.55 96.64 0.47 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.54 -178.2 45.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 23' ' ' ARG . 5.4 tp -156.09 138.41 14.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 110.972 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.837 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.44 120.59 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.477 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 42.8 t -123.59 150.44 27.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.553 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -153.16 144.49 23.19 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -137.54 125.84 14.49 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.2 Cg_endo -64.49 89.55 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.012 1.808 . . . . 0.0 111.414 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 16.5 t0 -50.87 160.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.332 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 36.0 t0 -140.05 41.5 1.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.46 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.96 49.5 7.6 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.088 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' HG21 ' A' ' 85' ' ' VAL . 7.7 m-85 -94.41 -173.58 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.473 0.654 . . . . 0.0 111.169 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 86' ' ' ILE . 12.6 m -127.66 -29.98 2.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.105 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.1 tp -141.36 141.74 33.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.728 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.613 ' CD1' HD13 ' A' ' 26' ' ' ILE . 51.6 t80 -128.13 103.32 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.299 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.87 121.6 38.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 0.0 110.982 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HG22 ' A' ' 83' ' ' THR . 18.8 t80 -112.17 123.04 49.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.524 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -123.71 122.67 38.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -152.24 136.51 5.46 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 118.836 -1.649 . . . . 0.0 114.463 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.45 127.12 46.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.619 HD12 ' CG ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -89.98 140.75 29.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.873 0.368 . . . . 0.0 110.937 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.56 6.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.786 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 36.4 tt0 -179.9 109.05 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.193 0.521 . . . . 0.0 110.445 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.3 mt-10 -59.88 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.596 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.06 144.09 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.315 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.83 47.39 2.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.914 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.79 -128.15 1.57 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.64 HD22 ' CH2' ' A' ' 82' ' ' TRP . 23.9 mt -124.2 66.27 1.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -79.66 144.35 33.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.912 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.616 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -52.84 -24.89 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.67 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.56 -130.83 11.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.541 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -127.95 -77.4 0.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.81 0.338 . . . . 0.0 110.531 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.639 ' NE1' HD23 ' A' ' 22' ' ' LEU . 28.9 m-90 -62.85 94.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.206 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.5 87.88 2.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.9 tpm_? -136.81 127.68 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.953 0.406 . . . . 0.0 112.029 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.87 107.01 18.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.458 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 3.1 mp -89.04 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.444 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 t -129.58 28.23 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -150.28 88.07 4.8 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 51.4 Cg_exo -54.99 170.46 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.3 tpmp? -108.41 31.34 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.698 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 81.42 93.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.678 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.31 -6.8 7.04 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.456 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 11.6 ptt180 -157.53 134.95 10.44 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.893 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' A' ' 26' ' ' ILE . 6.1 m95 -85.23 154.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -134.6 100.06 4.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.557 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 39.9 t80 -95.88 143.13 27.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.919 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -144.87 145.03 31.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.406 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 47.5 t0 -138.03 100.19 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.476 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -89.17 22.44 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.683 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -138.67 32.52 2.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 0.0 110.811 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB1' ' CZ2' ' A' ' 52' ' ' TRP . . . -104.43 129.56 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.21 83.25 6.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.596 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.0 OUTLIER -102.73 121.33 42.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.68 145.93 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.552 HD11 ' OD1' ' A' ' 113' ' ' ASP . 0.3 OUTLIER -59.0 133.4 56.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.968 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.72 -28.85 14.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.045 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.619 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 t70 -61.77 163.25 7.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 111.115 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -122.49 156.75 33.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.493 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.506 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -113.05 145.83 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.207 0.527 . . . . 0.0 112.125 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 15.9 m-85 -144.32 120.35 10.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -152.51 -176.27 5.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.203 1.001 . . . . 0.0 113.674 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CH2' HD22 ' A' ' 47' ' ' LEU . 60.1 p-90 -152.38 125.29 8.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.318 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 45.1 p -100.0 149.0 23.9 Favored 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.793 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.888 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.0 t80 -127.26 157.13 40.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 123.334 0.396 . . . . 0.0 110.849 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.662 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 20.8 mm -138.53 106.29 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.808 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -104.01 62.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.544 0.527 . . . . 0.0 110.72 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 t0 71.71 65.4 0.15 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.771 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.72 28.78 71.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.579 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.6 mt -144.35 77.71 1.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.267 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -84.35 158.63 34.47 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.562 -0.745 . . . . 0.0 114.568 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -152.54 148.79 27.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.169 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.98 152.4 51.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.67 ' N ' HG11 ' A' ' 9' ' ' VAL . 3.2 tt0 -107.6 76.3 1.06 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.449 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.3 p30 -77.96 178.29 7.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.334 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 63.18 15.04 8.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.2 162.39 54.66 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.978 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.4 157.63 38.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.641 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.506 ' CE3' HD13 ' A' ' 79' ' ' ILE . 40.3 t90 -155.17 164.41 38.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.061 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 102' ' ' THR . 6.7 t -105.57 158.91 16.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.561 HG21 ' HB3' ' A' ' 77' ' ' ASP . 10.3 t -120.33 -4.35 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.047 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 100' ' ' THR . 9.6 t -66.49 -8.59 27.36 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.0 mt-10 -124.24 139.37 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 82.9 m-85 -130.42 131.62 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 19.7 m -98.73 159.6 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 0.0 110.835 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.677 ' ND2' ' HB2' ' A' ' 112' ' ' ALA . 7.1 m-20 -79.59 153.36 29.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.309 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -17.5 5.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.23 -31.5 65.88 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.921 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.79 18.74 5.1 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.484 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.8 p -135.08 156.17 78.49 Favored Pre-proline 0 C--O 1.222 -0.376 0 CA-C-O 121.385 0.612 . . . . 0.0 111.28 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 42.7 Cg_exo -55.1 126.15 21.58 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.832 2.354 . . . . 0.0 113.104 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.677 ' HB2' ' ND2' ' A' ' 106' ' ' ASN . . . -139.19 44.48 2.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.853 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.552 ' OD1' HD11 ' A' ' 75' ' ' LEU . 6.5 t0 -56.55 -177.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 t -79.65 66.17 5.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 t 63.89 130.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -114.76 66.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -162.36 104.72 1.1 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.497 2.131 . . . . 0.0 112.274 179.963 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 51.6 t80 -85.81 173.24 10.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.459 . . . . 0.0 110.76 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.1 t -111.68 158.98 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.429 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -66.81 127.36 93.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.29 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.9 Cg_exo -67.41 -178.64 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.477 2.118 . . . . 0.0 112.212 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.3 135.19 47.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.267 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.606 ' HB1' HG11 ' A' ' 24' ' ' VAL . . . -88.63 111.05 21.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.842 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -92.18 94.14 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.845 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -83.83 163.2 20.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 0.0 112.315 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.618 ' CD ' HG11 ' A' ' 105' ' ' VAL . 28.7 mt-10 -150.71 138.86 20.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.526 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.39 114.89 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.242 0.544 . . . . 0.0 111.683 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.532 HD13 HG22 ' A' ' 105' ' ' VAL . 20.1 mm -96.45 108.65 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.44 ' CE1' ' CB ' ' A' ' 112' ' ' ALA . 35.6 p90 -78.92 150.78 75.65 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.01 2.58 69.66 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.962 -1.266 . . . . 0.0 112.282 0.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.59 93.18 0.26 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -171.07 175.25 44.78 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 23' ' ' ARG . 7.7 tp -150.14 138.87 20.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 110.828 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 22' ' ' LEU . 22.0 ttt85 -137.11 107.31 6.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.724 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.606 HG11 ' HB1' ' A' ' 12' ' ' ALA . 21.1 t -116.95 155.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.409 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.442 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -143.12 144.01 32.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.679 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.644 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -136.74 128.07 16.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.394 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.92 102.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.346 2.031 . . . . 0.0 111.785 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.5 t0 -67.76 151.44 47.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.403 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -139.91 45.95 1.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.717 179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.31 92.58 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.1 m-85 -78.48 -171.52 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.368 0.604 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 86' ' ' ILE . 40.4 m -131.8 -27.16 1.91 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 56' ' ' ILE . 10.3 tp -143.36 132.19 22.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.627 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.726 ' HD2' HD12 ' A' ' 56' ' ' ILE . 39.0 t80 -122.32 101.64 7.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.906 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.44 126.73 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.615 ' CD2' HG22 ' A' ' 83' ' ' THR . 10.6 t80 -112.72 130.49 56.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.1 119.13 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.518 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.75 139.32 6.64 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 118.586 -1.768 . . . . 0.0 114.676 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.25 142.93 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.233 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.424 HD22 HD23 ' A' ' 73' ' ' LEU . 30.4 tp -96.01 143.04 27.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 1.3 p-10 44.36 48.98 8.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.363 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 179.44 109.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 110.398 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 56.0 mt-10 -57.4 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.639 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.97 156.33 12.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.358 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -143.15 65.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.024 0.44 . . . . 0.0 110.802 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.99 8.73 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD22 ' CH2' ' A' ' 82' ' ' TRP . 27.8 mt -118.1 65.22 0.75 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.43 150.55 23.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -54.48 -24.34 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.745 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.53 -115.58 1.93 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.544 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' GLY . 6.3 t-160 -137.61 -72.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.649 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.6 m-90 -68.38 88.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.34 88.99 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 39.7 ttt-85 -146.94 130.37 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.632 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.11 136.49 34.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.2 mt -111.81 157.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 56' ' ' ILE . 12.2 t -144.54 41.96 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.41 102.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.1 Cg_exo -54.27 -169.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.427 2.085 . . . . 0.0 112.366 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -119.03 -53.55 2.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.1 83.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.563 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.79 -2.17 34.3 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 3.0 mtt180 -156.92 145.64 19.91 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.769 -0.215 . . . . 0.0 110.473 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.493 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.7 m95 -81.97 161.94 22.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -134.11 116.95 16.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.48 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 24.2 t80 -99.94 84.12 2.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.353 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.96 124.92 36.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.46 110.13 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.755 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 22.15 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.439 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -135.18 40.22 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -107.89 111.57 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.207 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -73.96 75.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 78.7 mt -95.92 134.03 39.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.22 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.512 ' N ' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -128.04 141.45 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.625 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.5 OUTLIER -52.44 132.22 34.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.68 -27.77 18.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.38 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.1 t0 -62.18 151.24 36.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.815 0.341 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -110.93 152.95 26.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.84 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.737 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -112.21 145.34 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.561 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.5 m-85 -144.59 124.92 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.845 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.5 p90 -161.22 -173.83 4.04 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.533 ' CH2' HD22 ' A' ' 47' ' ' LEU . 63.5 p-90 -153.44 128.24 9.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.662 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 23.0 p -106.82 148.96 27.89 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.754 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 93' ' ' ARG . 5.1 t80 -129.61 145.0 51.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.365 0.415 . . . . 0.0 111.063 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -131.18 160.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.373 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 37.8 mm -129.63 117.58 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.594 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 55.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 t0 71.87 67.19 0.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.786 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.34 23.37 77.47 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.371 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.7 mt -145.89 79.15 1.55 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.208 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -97.61 165.93 22.58 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.48 -0.782 . . . . 0.0 114.399 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -152.05 150.87 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.631 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.2 ptt-85 -128.88 145.37 51.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.576 ' N ' HG21 ' A' ' 9' ' ' VAL . 5.8 tt0 -99.5 77.63 2.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.808 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.1 p30 -81.77 178.74 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 59.54 19.1 7.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.63 166.4 53.27 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.102 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.11 156.59 37.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.737 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -154.67 165.45 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -110.82 161.97 15.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 79' ' ' ILE . 21.3 t -120.44 -3.13 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.805 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.625 HG23 ' CD2' ' A' ' 75' ' ' LEU . 9.0 m -62.26 -14.34 37.6 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.885 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tt0 -131.49 148.54 52.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.8 m-85 -130.41 161.42 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.618 HG11 ' CD ' ' A' ' 15' ' ' GLU . 12.0 m -118.67 152.8 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 111.051 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 110' ' ' THR . 36.1 t30 -76.53 155.25 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.397 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.13 -16.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.2 -30.87 62.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.02 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 15.58 6.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.347 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.7 p -132.61 159.01 74.22 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 121.252 0.549 . . . . 0.0 110.853 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 59.8 Cg_exo -50.01 128.84 23.19 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 113.056 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' CB ' ' CE1' ' A' ' 18' ' ' TYR . . . -89.24 105.51 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.248 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 112' ' ' ALA . 1.7 t70 52.53 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.584 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.2 p 51.48 52.51 14.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.124 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.4 p -158.52 174.92 14.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.61 47.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.1 155.13 80.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.559 2.173 . . . . 0.0 112.296 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.755 0.312 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 37.5 t80 -74.08 175.78 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.154 0.502 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 9' ' ' VAL . 22.0 t -121.91 161.69 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.301 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.857 HG22 ' HB3' ' A' ' 92' ' ' TYR . 13.2 t -66.08 129.78 94.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.993 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.32 -171.13 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.354 2.036 . . . . 0.0 111.974 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -114.61 113.57 24.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.73 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.17 106.39 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.526 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' C ' HD12 ' A' ' 14' ' ' LEU . 7.2 tttt -90.77 163.7 14.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.124 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.692 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -147.91 159.76 43.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.976 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -148.92 141.43 24.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.095 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.07 104.44 16.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.968 0.413 . . . . 0.0 111.512 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 23' ' ' ARG . 42.8 mm -72.19 146.36 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.427 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -105.08 142.22 24.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.739 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 97.7 Cg_endo -89.47 -7.79 46.05 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.848 -1.314 . . . . 0.0 112.222 -0.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 94.13 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -160.72 -165.85 18.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.492 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 23' ' ' ARG . 27.0 tp -155.54 145.73 21.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.773 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -140.33 96.34 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 45.8 t -107.38 151.45 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.58 144.32 22.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.926 0.393 . . . . 0.0 111.612 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.5 pp -137.25 131.75 17.72 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.597 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 104.75 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.148 1.899 . . . . 0.0 111.477 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 t0 -70.53 157.99 36.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.367 0.603 . . . . 0.0 111.737 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 2.8 m-20 -146.97 42.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.329 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 45.43 9.49 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.744 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m-85 -86.05 -173.29 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.447 0.641 . . . . 0.0 111.102 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -133.59 -26.54 1.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.684 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.756 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.4 tp -142.05 129.49 21.28 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.234 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.843 ' CD2' HD12 ' A' ' 56' ' ' ILE . 6.0 t80 -120.58 91.34 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.173 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -90.63 132.82 35.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.989 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TRP . 38.8 t80 -116.94 126.5 53.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.982 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -128.24 117.91 22.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.26 138.4 6.55 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.737 -1.697 . . . . 0.0 114.631 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.4 OUTLIER -109.78 147.17 33.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.202 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' HH2' ' A' ' 52' ' ' TRP . 15.0 tp -99.46 127.52 45.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.202 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.0 t30 57.45 54.81 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 66.6 tt0 175.55 109.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.244 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 35.3 mt-10 -56.96 -171.93 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.365 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.1 mtt -129.8 157.91 40.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.348 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -162.67 43.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.47 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . 145.35 125.89 1.8 Allowed Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' CH2' ' A' ' 82' ' ' TRP . 5.9 mt -39.21 89.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.087 0.47 . . . . 0.0 112.066 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' GLY . 5.7 mm-40 -110.67 152.34 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -55.37 -22.05 17.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.085 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.51 4.39 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.245 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -131.64 -79.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.661 0.267 . . . . 0.0 110.347 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.623 ' HH2' HD13 ' A' ' 40' ' ' LEU . 13.2 m-90 -61.53 91.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.64 88.65 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.168 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -143.57 124.07 13.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.025 0.44 . . . . 0.0 111.861 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 4.2 p-10 -87.8 128.67 35.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.663 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.843 HD12 ' CD2' ' A' ' 34' ' ' PHE . 11.2 mt -103.65 154.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 45.06 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.009 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.5 93.18 0.25 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.5 Cg_exo -52.06 -176.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.462 2.108 . . . . 0.0 112.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -113.95 -44.86 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.233 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.02 84.37 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.651 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.97 -2.8 32.17 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.424 -0.894 . . . . 0.0 110.923 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -157.11 148.51 22.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.771 ' CD1' HD11 ' A' ' 26' ' ' ILE . 5.1 m95 -90.12 157.28 17.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -134.64 114.73 13.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.6 t80 -107.41 89.37 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -94.69 144.87 25.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.099 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -138.0 108.44 6.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.582 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -89.18 22.39 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.522 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -141.26 28.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 115.66 27.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -73.91 75.97 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.629 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 96.2 mt -96.75 142.12 29.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 142.27 49.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.782 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 102' ' ' THR . 1.4 tt -56.85 130.2 44.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.631 ' HA2' HG23 ' A' ' 102' ' ' THR . . . 106.01 -28.39 14.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.133 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 101' ' ' VAL . 8.9 t70 -66.56 153.09 43.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.95 0.405 . . . . 0.0 110.877 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.68 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.615 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -114.83 144.58 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.861 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.0 m-85 -144.53 121.28 11.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.692 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.3 p90 -158.5 -172.37 3.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.13 0.967 . . . . 0.0 113.572 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.6 p-90 -155.54 134.25 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.979 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 12' ' ' ALA . 17.8 p -99.92 165.45 11.55 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.721 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.859 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.2 t80 -147.08 108.13 4.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.66 164.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.791 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 12.1 mm -145.23 106.84 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 90' ' ' LEU . 11.9 ptmt -99.63 46.43 0.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 13.7 t0 81.1 77.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.474 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.807 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.02 21.51 75.48 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.265 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.3 mt -145.64 79.37 1.57 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.332 0.586 . . . . 0.0 110.274 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.04 161.71 41.92 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.325 -0.852 . . . . 0.0 114.44 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.857 ' HB3' HG22 ' A' ' 9' ' ' VAL . 49.3 m-85 -144.8 134.38 23.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.838 ' C ' HG11 ' A' ' 9' ' ' VAL . 5.7 ptt180 -123.81 140.17 53.25 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.71 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.8 73.15 1.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.83 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.6 p-10 -81.48 173.33 12.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.689 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 59.65 20.34 8.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.4 162.7 44.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.059 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -154.46 145.95 23.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.263 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 79' ' ' ILE . 38.7 t90 -140.2 164.29 30.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.5 t -105.01 158.11 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ASP . 4.0 t -121.12 -3.97 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.768 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -62.63 -14.33 41.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.628 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.9 tt0 -125.3 149.16 48.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 110.846 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.596 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -134.32 146.4 49.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.261 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG2' HD13 ' A' ' 17' ' ' ILE . 15.1 m -102.81 166.01 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 110' ' ' THR . 20.8 t30 -79.26 153.69 29.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -15.59 3.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -76.48 -28.33 56.43 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.353 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 3.27 16.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.15 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.4 p -119.29 164.63 20.43 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.368 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 83.3 Cg_exo -43.24 133.57 6.43 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.732 2.288 . . . . 0.0 113.215 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 161.11 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.11 179.99 6.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.6 t -84.93 -35.45 22.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.64 169.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 61.36 98.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -134.83 148.05 65.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.474 2.116 . . . . 0.0 112.401 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 52.8 t80 -89.22 173.71 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.2 t -110.09 159.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.481 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 ' C ' ' A' ' 93' ' ' ARG . 4.5 p -66.9 132.86 93.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.085 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' HG11 ' A' ' 85' ' ' VAL . 22.5 Cg_exo -64.41 -168.48 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.645 2.23 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.46 124.73 50.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.804 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.75 104.52 13.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.488 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -93.16 103.9 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.379 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.5 mp -97.07 161.53 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.567 ' HB3' HG11 ' A' ' 105' ' ' VAL . 31.3 mt-10 -147.04 136.59 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.893 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.55 102.6 14.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.1 mm -74.82 156.81 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.541 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -119.0 145.54 38.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.534 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -84.18 -2.66 56.92 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.302 0.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.12 98.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -163.35 -171.31 29.43 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.374 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.633 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.82 139.13 18.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.05 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.873 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -133.9 101.52 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.638 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 14' ' ' LEU . 14.0 t -109.36 156.47 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -154.98 146.27 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.666 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -143.95 122.04 6.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.497 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 13.1 Cg_endo -57.72 101.18 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.092 1.861 . . . . 0.0 111.436 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.3 t0 -63.06 159.53 17.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -140.71 43.48 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.568 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.94 46.04 47.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.59 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 29' ' ' ASP . 10.5 m-85 -90.4 -171.51 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.409 0.623 . . . . 0.0 111.419 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 86' ' ' ILE . 27.7 t -130.8 -28.26 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.552 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.711 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.1 tp -139.43 135.45 33.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.205 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' ILE . 26.2 t80 -124.72 106.51 10.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.878 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.15 117.51 34.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 111.017 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.703 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 56.2 t80 -106.55 124.57 49.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -125.59 129.35 49.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -159.52 139.99 6.54 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 114.438 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.7 tmtp? -116.78 135.79 53.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.214 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 HG21 ' A' ' 101' ' ' VAL . 5.6 tp -91.05 125.83 35.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 16.6 t-20 65.46 50.06 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.528 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.8 tt0 170.27 110.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.021 0.439 . . . . 0.0 110.337 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.3 mt-10 -53.65 -173.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.508 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.7 mmm -128.85 112.66 14.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.23 58.24 3.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.675 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 89.2 100.87 1.03 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.507 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.8 mt 24.45 78.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.624 0.77 . . . . 0.0 112.731 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.66 157.73 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.725 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.92 -25.72 8.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 42.64 -124.96 4.18 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.088 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -137.36 -73.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.302 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 5.6 m-90 -63.61 82.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.717 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.26 93.04 3.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.212 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 4.3 tpm_? -141.46 125.77 17.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.945 0.402 . . . . 0.0 111.874 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.46 131.96 35.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.826 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.588 HD12 ' HD2' ' A' ' 34' ' ' PHE . 7.7 mt -117.44 143.86 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.983 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.42 26.6 4.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.0 mmmt -153.42 92.52 3.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.163 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 52.7 Cg_exo -52.72 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.252 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.8 -49.67 2.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.826 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -179.99 82.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.303 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.11 2.72 49.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HD3' ' CB ' ' A' ' 25' ' ' SER . 20.9 ttm-85 -157.61 140.49 15.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.523 0.201 . . . . 0.0 111.001 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.474 ' CG ' HD11 ' A' ' 26' ' ' ILE . 7.6 m95 -89.18 154.48 20.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.98 0.419 . . . . 0.0 110.311 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -134.73 119.89 18.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 17.0 t80 -113.65 106.8 14.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.614 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 139.39 38.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.428 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -137.37 105.37 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.729 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.29 22.77 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.632 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -134.06 29.87 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.51 99.16 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.073 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -74.09 75.93 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.764 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.633 HD11 ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -91.65 146.43 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.935 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.421 ' N ' HG11 ' A' ' 101' ' ' VAL . 9.6 ttpp -130.92 139.82 50.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -52.69 132.55 36.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.2 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.92 -29.17 12.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.067 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 7.8 t0 -66.35 153.87 41.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.019 0.438 . . . . 0.0 111.158 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 160.35 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.792 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -118.88 147.11 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.066 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 42.2 m-85 -144.55 129.43 18.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -161.11 -177.87 6.37 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.577 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.8 p-90 -151.02 133.06 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.481 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -99.98 156.98 16.86 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -178.599 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 12.0 t80 -139.24 138.8 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.62 0.247 . . . . 0.0 110.838 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -134.25 161.08 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.56 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.711 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.0 mm -135.85 107.19 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.968 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -100.35 57.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.538 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 68.55 68.7 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.741 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.831 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.97 25.47 75.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.392 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.94 73.02 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -87.63 160.96 31.9 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.289 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -152.22 153.1 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.749 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -132.84 147.84 52.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -104.05 76.75 1.37 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.399 177.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.19 177.27 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 61.78 17.28 8.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.801 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.18 163.91 54.9 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.951 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.47 153.84 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.459 . . . . 0.0 111.166 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.792 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.6 t90 -153.1 166.75 31.5 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -112.12 162.75 15.08 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.69 HG22 HD11 ' A' ' 79' ' ' ILE . 20.3 t -121.9 -9.26 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.668 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 76' ' ' GLY . 25.6 p -60.36 -14.35 18.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.718 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.45 162.36 22.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 89.9 m-85 -140.88 148.07 39.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 15' ' ' GLU . 4.7 m -98.15 -161.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.81 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 110' ' ' THR . 17.8 t30 -108.73 145.39 35.16 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 111.607 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.24 -19.89 6.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.47 -30.02 70.27 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.935 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 17.63 5.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.208 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.4 p -140.79 156.13 68.96 Favored Pre-proline 0 CA--C 1.514 -0.432 0 CA-C-O 121.372 0.606 . . . . 0.0 111.736 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 53.0 Cg_exo -52.3 78.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.511 2.807 . . . . 0.0 114.011 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . 80.74 -174.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.419 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -119.45 98.74 6.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -28.01 67.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.63 -175.34 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.39 88.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.84 143.38 15.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.527 2.151 . . . . 0.0 112.242 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.868 0.366 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 39.5 t80 -74.15 176.33 6.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 20.6 t -117.67 161.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.368 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 93' ' ' ARG . 11.0 t -66.29 127.26 93.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.77 -177.12 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.467 2.112 . . . . 0.0 112.331 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 t -110.93 111.43 22.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.506 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.82 109.61 17.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.521 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.778 ' O ' HG13 ' A' ' 24' ' ' VAL . 9.4 mttt -84.23 164.45 19.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.187 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.727 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.2 mp -154.12 138.62 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.074 0.464 . . . . 0.0 112.094 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -135.2 136.7 41.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.496 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.745 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.75 114.52 23.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.7 mm -91.67 111.61 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -83.07 147.01 52.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.438 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 91.2 Cg_endo -92.23 -3.69 49.06 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.897 -1.293 . . . . 0.0 112.606 0.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 91.68 1.18 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.66 173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.574 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -153.44 144.51 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.507 ' H ' HD13 ' A' ' 22' ' ' LEU . 19.7 ttt180 -133.72 109.88 9.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 13' ' ' LYS . 30.0 t -122.76 142.88 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.357 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.52 146.94 33.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.2 pp -136.41 122.92 13.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.303 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 72.1 Cg_exo -47.61 108.68 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.494 2.129 . . . . 0.0 112.026 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 27.5 t0 -76.64 151.03 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 0.0 111.399 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t0 -140.89 46.09 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.752 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.98 69.85 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.404 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 10.1 m-85 -73.64 -170.97 0.94 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.637 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -132.94 -27.76 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.768 HD21 ' OD2' ' A' ' 55' ' ' ASP . 5.8 tp -139.87 127.25 21.39 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.251 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' HD12 ' A' ' 56' ' ' ILE . 2.4 t80 -118.49 94.36 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -101.82 114.78 29.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' TRP . 32.5 t80 -105.91 126.36 52.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.49 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.44 132.47 3.52 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.152 -1.499 . . . . 0.0 114.04 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 18.1 tptm -108.62 141.63 40.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 73' ' ' LEU . 62.4 tp -92.24 117.16 29.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.889 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 57.8 t-20 63.92 65.17 0.72 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 36.1 tt0 172.86 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.163 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 78.1 mt-10 -54.09 -169.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.436 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 81' ' ' PHE . 8.3 mtp -143.22 142.34 31.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.05 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -140.07 42.4 1.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.932 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.57 -143.31 9.54 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.169 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.51 HD22 ' CH2' ' A' ' 82' ' ' TRP . 13.3 mt -116.86 80.28 1.45 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.048 0.451 . . . . 0.0 110.978 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -101.03 150.05 23.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.099 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -57.44 -32.14 66.6 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.713 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.16 -103.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.279 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -148.59 -78.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 110.546 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 36' ' ' PHE . 10.6 m-90 -59.25 89.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.4 88.86 3.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.223 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -132.45 125.71 31.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.042 0.449 . . . . 0.0 111.776 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD21 ' A' ' 33' ' ' LEU . 10.2 t0 -105.74 94.31 5.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.45 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 58' ' ' LYS . 16.6 mt -81.49 146.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.142 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.17 22.71 6.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.678 ' H ' HG22 ' A' ' 56' ' ' ILE . 7.2 ptpt -154.89 100.54 2.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.1 Cg_exo -52.1 171.56 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.426 2.084 . . . . 0.0 112.542 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -114.66 40.9 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 6.4 tt0 84.0 86.65 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.845 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.96 -5.72 6.0 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.954 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 1.1 mtt180 -157.25 137.52 12.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.582 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.641 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.4 m95 -83.36 154.28 24.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -134.71 119.48 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 11.4 t80 -108.28 87.54 2.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.242 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 132.85 36.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.184 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.0 t0 -138.1 103.12 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 7.0 ptt-85 -89.18 22.41 2.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -133.1 42.07 3.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.5 100.76 7.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.93 99.82 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.655 HD11 HD23 ' A' ' 22' ' ' LEU . 2.5 mt -122.01 164.19 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -138.52 144.38 39.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.85 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -62.64 126.75 28.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.572 . . . . 0.0 110.724 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.757 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 125.37 -31.09 4.32 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.354 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.5 t0 -72.91 149.62 43.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 164.23 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 101' ' ' VAL . 2.8 mp -118.87 147.81 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.13 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 63.5 m-85 -144.46 125.77 14.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.579 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -157.5 -178.62 7.47 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.51 ' CH2' HD22 ' A' ' 47' ' ' LEU . 52.0 p-90 -155.7 134.6 12.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.671 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.733 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.81 160.97 13.9 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.941 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.916 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 16.3 t80 -145.33 105.46 4.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 111.06 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.61 165.17 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 19.7 mm -142.51 105.99 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.877 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.7 ttpt -96.05 70.01 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.427 0.454 . . . . 0.0 111.104 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 56.72 46.02 20.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.263 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.796 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 98.45 28.68 7.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.729 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -142.9 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -64.85 155.98 47.61 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.191 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.749 ' HB3' HG22 ' A' ' 9' ' ' VAL . 69.9 m-85 -152.52 134.24 14.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.34 -0.93 . . . . 0.0 108.677 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.869 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.9 140.7 49.15 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.562 0.696 . . . . 0.0 112.687 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.7 ' N ' HG11 ' A' ' 9' ' ' VAL . 2.5 tt0 -104.33 73.8 1.14 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.452 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.5 p30 -81.32 174.33 11.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.564 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.18 18.82 9.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.07 163.29 52.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.911 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -152.55 150.67 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.646 ' CE3' HD13 ' A' ' 79' ' ' ILE . 27.8 t90 -149.18 164.45 34.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -106.4 158.56 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 79' ' ' ILE . 21.5 t -119.86 -10.6 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.178 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.757 HG22 ' HA2' ' A' ' 76' ' ' GLY . 20.9 p -60.24 -11.51 6.53 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -132.47 148.12 52.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.745 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 40.9 m-85 -135.32 149.95 49.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.362 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m -98.87 155.25 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.083 0.468 . . . . 0.0 110.491 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' CG ' ' HB2' ' A' ' 112' ' ' ALA . 1.3 m120 -83.99 152.02 24.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.275 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -17.84 4.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -30.98 66.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.901 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.67 21.79 4.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.365 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.469 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.9 p -147.05 159.8 41.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.177 0.513 . . . . 0.0 111.394 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 79.4 Cg_exo -47.38 126.88 12.57 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.113 2.542 . . . . 0.0 113.063 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB2' ' CG ' ' A' ' 106' ' ' ASN . . . -101.08 53.4 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.001 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -171.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.49 32.9 16.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 p -109.63 -176.89 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.95 92.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.04 89.74 2.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.55 2.167 . . . . 0.0 112.367 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.1 t80 -89.28 172.71 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 9' ' ' VAL . 14.8 t -108.9 160.05 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.27 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.681 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.2 p -66.89 130.38 93.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.206 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' CD ' HG11 ' A' ' 85' ' ' VAL . 38.8 Cg_exo -60.35 -175.26 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.688 2.259 . . . . 0.0 112.383 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.83 125.81 52.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.58 105.7 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.726 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -95.87 109.78 22.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.009 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.3 mp -105.76 157.01 17.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.265 0.555 . . . . 0.0 112.266 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 38.4 mt-10 -140.69 141.44 34.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.512 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.13 122.78 30.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.157 0.503 . . . . 0.0 111.367 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.494 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.8 mm -104.69 109.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -79.0 150.55 75.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.883 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.59 -1.62 61.82 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.188 0.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.75 98.12 0.31 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.4 164.84 36.06 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 23' ' ' ARG . 22.9 tp -138.37 144.55 40.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 111.149 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.678 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -135.54 99.5 4.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.473 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.7 t -105.96 158.06 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.985 0.421 . . . . 0.0 111.774 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -155.13 149.76 26.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.667 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -144.51 126.92 8.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.0 Cg_endo -57.1 95.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.386 2.057 . . . . 0.0 111.568 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.7 t0 -59.17 160.63 6.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 3.9 t0 -145.86 45.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.152 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.55 89.63 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.885 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 85' ' ' VAL . 20.0 m-85 -83.67 -170.03 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.266 0.555 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -129.82 -29.27 2.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.645 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.7 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.86 137.54 34.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.508 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.709 ' HD2' HD12 ' A' ' 56' ' ' ILE . 25.2 t80 -127.4 97.02 4.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.463 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.832 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.06 135.63 37.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.412 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 52' ' ' TRP . 9.6 t80 -121.28 125.85 48.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -123.8 123.37 40.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -157.43 139.28 6.31 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 118.816 -1.659 . . . . 0.0 114.442 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -111.86 148.38 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.343 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tp -100.03 120.15 39.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.8 t-20 61.76 54.83 2.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 51.0 tt0 174.06 109.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 36.0 mt-10 -55.76 -168.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.465 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.47 120.66 7.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.643 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.96 57.6 4.25 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.013 0.435 . . . . 0.0 110.518 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.91 -120.18 3.37 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD22 ' CE3' ' A' ' 82' ' ' TRP . 14.4 mt -124.95 75.47 1.44 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.049 0.452 . . . . 0.0 110.985 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.9 mt-10 -88.38 155.28 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.157 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.85 -26.57 10.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.655 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.71 -121.63 7.01 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.435 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -137.88 -73.71 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.749 0.309 . . . . 0.0 110.547 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.5 m-90 -61.3 90.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.037 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.22 87.28 2.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.142 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -136.6 129.63 31.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.989 0.423 . . . . 0.0 111.919 -179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -99.4 126.67 45.33 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.709 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.7 mt -111.96 142.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -130.71 28.7 4.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -155.92 98.12 2.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 36.1 Cg_exo -57.29 169.14 2.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.477 2.118 . . . . 0.0 112.589 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' ARG . 11.9 tptp -105.18 34.64 3.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.91 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 82.06 88.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.48 -5.86 13.95 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.864 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.0 mtt180 -157.26 130.42 7.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.563 ' CD1' HD11 ' A' ' 26' ' ' ILE . 15.6 m95 -78.64 158.16 28.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 67' ' ' ARG . 9.5 m -134.26 112.57 11.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' ILE . 5.2 t80 -113.8 85.39 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.599 ' HD2' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -103.96 151.13 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.45 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -138.13 113.19 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.13 22.39 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -143.83 31.01 1.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.5 128.8 44.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.5 96.15 5.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.68 152.47 28.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.12 150.63 41.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.184 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.622 HD23 ' HE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.42 130.8 46.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.421 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.15 25.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.8 t70 -56.39 152.91 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 152.64 29.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.543 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.71 HD11 HG22 ' A' ' 101' ' ' VAL . 2.6 mp -112.72 146.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 m-85 -144.55 126.16 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 79' ' ' ILE . 1.3 p90 -161.03 -176.72 5.65 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.509 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 61.2 p-90 -152.83 135.13 15.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.591 -1.64 . . . . 0.0 108.97 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 12' ' ' ALA . 14.1 p -99.79 163.74 12.34 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.2 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.832 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.0 t80 -145.1 113.8 6.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.667 0.27 . . . . 0.0 111.012 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -107.73 164.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.7 mm -138.99 104.48 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.4 59.66 1.86 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.573 0.545 . . . . 0.0 110.668 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 64.43 64.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.678 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.01 25.58 63.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.315 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.16 71.23 1.33 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.16 160.66 44.54 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.4 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -152.28 149.01 28.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.681 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.4 ptt180 -128.68 144.97 51.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.496 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.68 75.81 1.34 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.405 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.487 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.98 175.9 10.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.573 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.45 18.16 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.806 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.57 162.79 52.36 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.97 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -154.39 146.43 23.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.903 0.382 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -142.65 167.04 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.062 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.1 t -115.45 163.41 15.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 79' ' ' ILE . 3.4 t -125.83 17.78 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.923 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.537 ' HA ' HD13 ' A' ' 75' ' ' LEU . 1.2 p -65.95 -13.04 59.06 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.701 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.4 mt-10 -147.25 162.25 39.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.622 ' HE2' HD23 ' A' ' 75' ' ' LEU . 95.3 m-85 -130.47 140.69 50.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.704 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m -98.54 161.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.166 0.507 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 110' ' ' THR . 6.3 m-80 -82.74 152.13 25.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.378 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.17 -17.39 4.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.05 -31.28 65.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.975 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.55 5.18 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.384 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.6 p -136.29 158.17 74.07 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.387 0.613 . . . . 0.0 111.128 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 51.0 Cg_exo -51.56 128.01 24.56 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.926 2.417 . . . . 0.0 113.244 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 113.67 14.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.23 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.21 147.72 48.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.2 -53.75 3.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -149.8 124.36 9.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.32 91.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 60.76 89.67 0.1 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.248 1.024 0 C-N-CA 122.553 2.169 . . . . 0.0 112.339 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.85 0.357 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 52.6 t80 -79.2 173.3 12.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.783 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.6 t -115.36 159.43 15.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.492 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 ' C ' ' A' ' 93' ' ' ARG . 12.0 p -71.92 142.79 85.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.4 Cg_exo -68.36 -178.44 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -110.33 120.76 43.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -82.27 116.05 21.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.473 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.3 ttmt -103.78 101.75 11.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.1 mp -91.23 168.6 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 111.838 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -155.92 154.09 30.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.473 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.94 128.34 35.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 111.825 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 16' ' ' ALA . 1.3 mp -112.66 115.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.715 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -78.85 143.7 62.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.6 Cg_endo -91.69 -4.11 49.93 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.037 -1.234 . . . . 0.0 112.491 -0.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -165.54 89.23 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' C ' ' HB ' ' A' ' 17' ' ' ILE . . . -156.48 -174.52 26.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.691 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -158.24 131.8 7.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.713 0.292 . . . . 0.0 110.829 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.713 ' N ' HD12 ' A' ' 22' ' ' LEU . 12.7 ttt85 -129.24 114.74 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 25' ' ' SER . 25.6 t -122.93 158.47 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 111.541 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.01 144.88 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.871 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.695 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.1 pp -138.22 127.04 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.101 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 18.0 Cg_endo -60.67 104.17 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.174 1.916 . . . . 0.0 111.693 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 14.5 t0 -66.82 158.12 31.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.49 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -142.78 45.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.673 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.88 46.12 47.28 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 6.5 m-85 -88.52 -172.64 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.519 0.676 . . . . 0.0 111.184 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 86' ' ' ILE . 9.7 m -133.19 -27.49 1.59 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.595 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.9 tp -141.5 131.05 23.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.121 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.624 ' O ' HD12 ' A' ' 56' ' ' ILE . 16.3 t80 -122.63 101.66 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -105.38 121.28 43.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 15.3 t80 -106.89 131.7 53.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -128.14 122.53 32.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -153.85 147.54 17.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 118.87 -1.633 . . . . 0.0 114.428 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.1 tmtt? -119.15 145.0 46.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 110.431 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 79' ' ' ILE . 11.9 tp -94.17 117.58 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.57 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 66.75 67.4 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.069 0.461 . . . . 0.0 110.491 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 44' ' ' MET . 44.7 tt0 179.19 111.78 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' MET . 20.3 mt-10 -69.3 30.93 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.377 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.568 ' H ' ' C ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER 52.5 149.86 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.207 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -142.05 60.75 1.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.708 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.23 127.17 5.71 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.523 HD22 ' CZ3' ' A' ' 82' ' ' TRP . 4.5 mt -39.87 97.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 111.39 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.97 -178.16 3.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.167 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -62.43 -19.03 63.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.059 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.04 -135.75 6.91 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -118.83 -76.8 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.708 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 10.2 m-90 -67.43 86.78 0.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.88 87.69 2.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.453 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.0 ttt180 -142.49 127.54 18.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 111.85 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.3 p30 -88.37 135.51 33.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' PHE . 1.9 mt -121.61 151.45 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.4 t -139.5 24.3 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.31 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 3.9 mtmp? -145.86 94.58 5.0 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.4 Cg_exo -53.53 -172.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.256 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.6 -48.69 2.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -178.79 83.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.432 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.43 -0.3 42.41 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.76 148.93 21.37 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 120.626 0.251 . . . . 0.0 110.803 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' A' ' 26' ' ' ILE . 11.4 m95 -90.19 161.09 15.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.177 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.9 m -134.32 116.7 15.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.516 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 6.1 t80 -106.25 95.29 5.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -101.28 139.8 36.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.413 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.06 106.16 5.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -89.21 22.5 2.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.679 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.07 38.32 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -104.85 115.79 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -73.93 76.58 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.708 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 10.5 mt -97.36 139.23 33.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.981 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 152.64 51.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.897 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -55.43 137.83 47.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.8 -29.47 7.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.62 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 12.4 t70 -58.88 160.16 6.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.951 0.405 . . . . 0.0 111.213 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -124.35 159.3 30.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.628 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 1.4 mp -116.07 145.22 22.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 112.018 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 43' ' ' GLU . 98.0 m-85 -144.52 126.53 15.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.917 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.6 p90 -161.32 -173.12 3.67 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.125 0.964 . . . . 0.0 113.427 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.523 ' CZ3' HD22 ' A' ' 47' ' ' LEU . 11.7 p-90 -154.34 133.64 12.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.62 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 5.6 p -99.68 163.49 12.46 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.079 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 13.4 t80 -143.64 124.77 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.612 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -119.57 166.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.686 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 mm -141.34 106.28 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.921 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -103.63 64.49 0.81 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.711 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.3 t0 67.7 64.59 0.39 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.41 28.86 70.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.37 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.84 73.62 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 0.0 110.189 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.61 162.04 46.9 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.392 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 85' ' ' VAL . 28.5 m-85 -152.28 143.28 23.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.628 ' C ' HG11 ' A' ' 9' ' ' VAL . 10.3 ptt85 -126.08 142.97 51.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.4 tt0 -101.0 75.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.657 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 33.8 p-10 -78.32 174.77 10.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.623 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 t30 60.25 18.31 7.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.38 159.93 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.07 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -154.65 161.69 41.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.0 0.428 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.822 ' HB2' HD13 ' A' ' 14' ' ' LEU . 70.7 t90 -147.6 166.26 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.434 ' O ' ' CH2' ' A' ' 99' ' ' TRP . 5.5 t -110.25 155.74 21.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.615 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.0 t -118.79 7.88 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.328 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 19.1 m -70.94 -9.9 58.71 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.752 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -123.47 163.97 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.897 ' CE2' HD23 ' A' ' 75' ' ' LEU . 23.2 m-85 -137.28 120.82 17.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.862 HG11 ' HG2' ' A' ' 15' ' ' GLU . 6.2 m -98.39 -168.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.963 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 110' ' ' THR . 14.0 t30 -109.2 145.33 36.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.415 ' HG3' HG23 ' A' ' 17' ' ' ILE . 16.8 mt-10 -54.42 -18.87 4.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.78 -28.99 68.08 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.62 22.61 3.96 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.705 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.6 p -143.55 152.17 55.89 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-O 121.51 0.671 . . . . 0.0 112.085 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 31.7 Cg_exo -58.84 76.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.447 2.765 . . . . 0.0 113.538 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 120.54 3.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.225 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' OD2' ' CD2' ' A' ' 18' ' ' TYR . 24.4 t0 -124.33 88.71 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.816 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.16 89.57 6.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 50.59 2.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.774 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.53 83.8 1.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -127.08 147.05 60.09 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.883 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.471 2.114 . . . . 0.0 112.37 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.8 t . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.955 0.407 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -68.05 138.51 92.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' HG11 ' A' ' 85' ' ' VAL . 36.0 Cg_endo -67.41 -172.57 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.421 2.081 . . . . 0.0 112.665 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -111.41 124.4 52.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.408 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.59 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -84.44 106.82 16.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 13.3 mttp -93.32 112.65 24.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.359 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 mp -101.16 164.96 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 112.055 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.648 ' O ' HD22 ' A' ' 22' ' ' LEU . 5.6 pt-20 -155.68 143.39 19.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.15 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.91 110.49 20.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 111.322 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 15.8 mm -81.5 145.25 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.321 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t80 -106.33 141.76 23.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.7 Cg_endo -93.14 -0.14 53.49 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.085 -1.214 . . . . 0.0 112.445 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -161.66 94.56 0.96 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -176.04 169.19 41.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.668 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -151.46 121.73 7.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.587 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.572 ' N ' HD13 ' A' ' 22' ' ' LEU . 45.3 ttp85 -115.09 132.89 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 25' ' ' SER . 38.3 t -124.42 158.96 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.83 144.89 25.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.7 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.86 128.33 12.15 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.497 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 17.0 Cg_endo -58.01 95.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.513 2.142 . . . . 0.0 111.7 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.1 t0 -60.29 160.6 8.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -147.36 46.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.922 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.14 89.0 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.686 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' CD1' HG21 ' A' ' 85' ' ' VAL . 10.3 m-85 -84.15 -171.21 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.261 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -132.02 -28.33 1.76 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.66 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.4 tp -140.34 132.37 27.86 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.246 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 26' ' ' ILE . 44.1 t80 -124.59 92.85 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.612 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -86.83 132.08 33.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' HG22 ' A' ' 83' ' ' THR . 40.8 t80 -121.52 123.27 41.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.39 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -125.06 118.84 27.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -150.91 133.04 4.11 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.253 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -105.92 148.92 27.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.338 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD13 ' HH2' ' A' ' 52' ' ' TRP . 17.6 tp -99.57 122.18 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.0 t-20 59.34 58.91 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.1 tt0 175.47 109.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 41.8 mt-10 . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.36 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.928 0.394 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.53 -25.21 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.633 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.29 -110.43 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.426 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -142.49 -80.09 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.735 0.303 . . . . 0.0 110.584 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.663 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 17.3 m-90 -61.05 94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.43 83.0 1.94 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.318 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -133.77 133.67 41.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.56 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.612 ' OD1' ' HB2' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -106.43 111.65 24.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.893 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.694 HD12 ' HD2' ' A' ' 34' ' ' PHE . 9.7 mt -93.06 152.09 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 33' ' ' LEU . 78.7 p -119.91 -23.59 6.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.71 121.0 27.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.59 0.233 . . . . 0.0 111.23 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.469 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 31.7 Cg_exo -58.66 -164.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.409 2.072 . . . . 0.0 112.086 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -45.65 2.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 179.18 80.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.499 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.88 0.59 34.68 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 8.0 mtm180 -156.99 131.23 8.47 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.389 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.573 ' CG ' HD11 ' A' ' 26' ' ' ILE . 15.0 m95 -77.09 155.62 32.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.92 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -134.72 118.95 17.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.394 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 49.6 t80 -110.62 89.45 3.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.079 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.93 137.45 32.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.274 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -138.11 100.91 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.591 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 22.44 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.597 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.65 26.79 5.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.315 . . . . 0.0 111.037 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.92 100.1 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -73.78 75.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.803 ' CD1' HD23 ' A' ' 22' ' ' LEU . 4.1 mt -86.31 163.47 17.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.791 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -141.65 148.2 38.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.035 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -55.62 142.22 34.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.259 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.5 -32.43 6.26 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.4 t70 -59.83 151.19 26.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.912 0.387 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -114.7 154.3 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.517 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.3 mp -109.25 146.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.061 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 97.6 m-85 -144.17 122.34 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.907 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.4 p90 -157.8 -174.9 5.08 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -154.77 131.6 10.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.816 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 76.5 p -110.35 151.87 26.91 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.81 ' CE2' HD11 ' A' ' 86' ' ' ILE . 19.9 t80 -135.76 129.43 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.105 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -113.73 164.08 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.375 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' CE2' ' A' ' 84' ' ' TYR . 24.4 mm -137.52 107.28 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.883 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -99.94 57.12 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.5 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 t0 68.95 69.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.771 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.816 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.75 25.29 75.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.31 73.72 1.39 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.201 0.524 . . . . 0.0 110.233 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.25 161.08 29.92 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.552 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -152.13 146.56 25.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.741 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -124.37 150.55 45.41 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -106.6 72.27 0.9 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.665 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.3 p-10 -78.47 176.03 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.47 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 61.05 18.23 8.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.62 162.44 54.31 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.87 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 2.8 tt0 -154.39 155.28 34.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.895 0.379 . . . . 0.0 111.111 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.634 ' HB2' HD13 ' A' ' 14' ' ' LEU . 51.7 t90 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.423 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.4 t -108.52 159.75 16.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 101' ' ' VAL . 17.5 t -121.42 -1.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.795 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.405 ' CG2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -66.82 -9.92 42.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.813 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.7 pt-20 -131.45 150.61 52.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.9 m-85 -129.45 143.44 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.012 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 15' ' ' GLU . 11.2 m . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 0.0 111.094 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.2 t . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.97 0.415 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -72.96 138.77 79.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.57 ' HD2' HG11 ' A' ' 85' ' ' VAL . 41.1 Cg_endo -67.06 -167.89 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.601 2.2 . . . . 0.0 112.455 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -109.47 114.98 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.887 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.12 104.87 13.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.8 159.22 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.751 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.37 150.9 32.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.193 0.521 . . . . 0.0 111.888 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -145.71 142.78 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.941 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.83 115.73 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 23' ' ' ARG . 17.0 mm -88.25 129.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.244 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 25.2 t80 -93.77 141.5 23.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -94.17 4.52 53.74 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.332 -1.112 . . . . 0.0 112.477 0.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.97 97.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.025 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.25 176.95 47.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.326 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -150.73 138.87 20.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 110.998 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.804 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.44 110.74 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.491 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 13' ' ' LYS . 24.0 t -119.82 146.58 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.82 151.63 36.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.548 HD11 ' CG ' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -139.95 130.12 13.97 Favored Pre-proline 0 N--CA 1.467 0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.008 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.98 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.243 1.962 . . . . 0.0 111.567 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 22.5 t0 -61.98 160.7 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.691 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 30.0 t70 -150.46 45.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.757 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.48 92.34 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.336 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 85' ' ' VAL . 21.3 m-85 -76.81 -124.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.348 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -179.58 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.4 tp -140.8 131.21 25.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.703 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 24.1 t80 -120.01 108.34 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.142 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -111.05 120.59 42.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 18.4 t80 -110.04 128.81 55.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.635 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -124.74 124.75 42.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.9 140.03 7.12 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.143 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.0 ttmt -112.21 149.18 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 110.468 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD1' HD23 ' A' ' 73' ' ' LEU . 4.8 tp -98.09 119.46 36.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.078 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.5 t-20 62.53 57.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.06 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 52.7 tt0 177.24 109.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.35 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 32.3 mt-10 . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.634 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.917 0.389 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -60.88 -17.12 48.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 40.74 -131.56 3.06 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 3.0 t60 -129.8 -68.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 0.0 110.574 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.9 m-90 -77.13 90.87 3.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.992 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.07 88.54 2.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.931 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.2 tpm_? -133.81 127.63 33.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.93 118.86 32.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 58' ' ' LYS . 26.7 mt -100.04 146.76 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.352 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.721 HG22 ' CD1' ' A' ' 33' ' ' LEU . 8.9 p -132.77 36.21 3.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.564 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.21 91.4 1.72 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 43.2 Cg_exo -56.91 171.93 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.592 2.195 . . . . 0.0 112.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.15 32.84 4.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.792 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 79.46 89.5 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.04 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 73.16 -3.51 29.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.957 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -157.67 127.26 6.0 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.796 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.548 ' CG ' HD11 ' A' ' 26' ' ' ILE . 13.2 m95 -79.85 157.58 26.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -134.33 118.71 17.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 11.6 t80 -116.57 84.97 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -94.66 146.41 24.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.142 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD1' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -138.0 109.78 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 22.24 2.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -144.03 36.55 1.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.08 126.71 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -79.46 75.86 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.735 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 40' ' ' LEU . 39.7 mt -101.23 130.73 47.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.784 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -121.03 153.89 36.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.961 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.75 132.01 51.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.283 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -26.55 16.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.504 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.3 t70 -55.43 154.46 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 151.01 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.536 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -110.42 147.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 112.162 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 37.6 m-85 -144.31 125.31 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.1 p90 -160.64 -174.27 4.37 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.513 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.9 p-90 -151.99 134.32 15.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.288 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.65 161.28 13.71 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.013 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.791 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 10.5 t80 -141.4 138.19 32.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.703 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.24 161.86 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.722 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 33.7 mm -136.79 111.19 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.722 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.8 tttt -105.7 67.93 0.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.26 55.86 2.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.808 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 81.82 28.17 43.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.7 mt -143.84 75.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.215 0.531 . . . . 0.0 110.212 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.08 160.56 40.71 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.376 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 29.3 m-85 -152.26 153.04 32.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.675 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -135.74 146.59 47.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.452 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.0 tt0 -104.68 75.42 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.461 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.9 p30 -78.2 175.22 10.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.565 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 60.47 18.54 8.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.61 161.6 52.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.005 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -154.46 145.49 22.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.536 ' CE3' HD13 ' A' ' 79' ' ' ILE . 42.0 t90 -141.12 165.95 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.079 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.8 t -111.15 162.02 15.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.56 ' O ' HD22 ' A' ' 75' ' ' LEU . 2.8 t -124.37 11.53 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -73.1 -10.2 59.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.921 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.827 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.6 mt-10 -122.98 140.99 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.703 0.287 . . . . 0.0 110.799 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 75' ' ' LEU . 9.8 m-85 -122.15 129.42 52.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' HD13 ' A' ' 17' ' ' ILE . 28.5 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.206 0.527 . . . . 0.0 111.239 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.3 t . . . . . 0 CA--C 1.526 0.054 0 CA-C-O 120.813 0.34 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.642 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.7 p -66.74 130.4 94.02 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.267 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 24.2 Cg_exo -63.14 -170.25 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.72 2.28 . . . . 0.0 112.587 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -110.87 124.97 53.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.47 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -77.64 104.49 8.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.24 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.54 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.252 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.661 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.2 mp -106.18 162.44 13.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.93 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 24.9 mm-40 -152.96 145.3 24.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.945 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.893 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -87.07 120.85 28.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 111.567 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' CG2' ' A' ' 105' ' ' VAL . 18.6 mm -98.19 114.25 35.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.176 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 54.5 t80 -79.21 142.03 58.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 98.9 Cg_endo -96.73 4.99 40.44 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.603 0.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.76 95.63 0.9 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . 169.23 167.19 29.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.555 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB3' HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -158.27 121.8 3.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.745 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 tmm_? -97.07 134.91 39.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 ' HG ' ' A' ' 14' ' ' LEU . 39.8 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.009 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.01 152.95 30.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.553 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.2 pt -147.37 122.03 5.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.48 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 9.4 Cg_endo -55.24 99.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.105 1.87 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 20.1 t0 -62.68 161.48 12.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.597 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -145.39 44.69 1.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.671 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.58 42.69 62.7 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.736 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.2 m-85 -88.08 -171.19 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.401 0.62 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' ILE . 37.8 t -132.04 -27.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.697 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.717 HD12 HG22 ' A' ' 57' ' ' THR . 8.0 tp -138.3 134.99 35.0 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.254 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.756 ' HD2' HD12 ' A' ' 56' ' ' ILE . 18.6 t80 -126.31 90.65 3.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -84.89 124.65 31.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.659 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 52' ' ' TRP . 78.8 t80 -114.59 117.59 31.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.4 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.808 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -122.57 125.46 45.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -157.65 141.88 8.14 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.927 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.0 148.54 40.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 110.447 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.444 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.7 tp -99.46 126.16 45.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.7 t-20 58.1 53.49 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.1 tt0 176.69 109.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.167 0.508 . . . . 0.0 110.382 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 29.2 mt-10 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.442 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.88 0.371 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -56.33 -20.31 18.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.599 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.52 -130.47 4.93 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.923 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -129.3 -70.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.8 m-90 -72.77 94.06 1.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.808 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.09 91.98 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.1 tpt85 -139.51 125.58 19.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -86.4 130.35 34.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.36 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.756 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.9 mt -110.42 152.97 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.344 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.717 HG22 HD12 ' A' ' 33' ' ' LEU . 32.9 p -144.48 27.78 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -151.05 87.38 4.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 21.6 Cg_exo -66.02 -170.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.816 2.344 . . . . 0.0 112.445 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -121.95 24.14 9.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.588 178.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 82.49 90.96 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.352 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 76.0 0.76 65.94 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.759 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -157.83 121.3 4.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.553 ' CD1' HD11 ' A' ' 26' ' ' ILE . 19.2 m95 -82.95 157.57 22.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 119.7 18.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.57 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 56' ' ' ILE . 31.9 t80 -122.64 93.76 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 mmm-85 -95.49 143.35 26.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.345 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.13 94.25 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -89.27 22.6 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.597 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -126.67 28.66 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.71 110.79 20.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.01 76.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 22' ' ' LEU . 6.8 mt -86.79 153.28 21.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.9 142.92 47.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.6 OUTLIER -54.14 132.0 42.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.297 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.98 -28.37 12.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.2 t70 -62.84 161.77 12.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 111.079 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -121.07 158.4 27.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG21 ' CE2' ' A' ' 81' ' ' PHE . 1.3 mp -116.73 145.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.112 0.482 . . . . 0.0 112.176 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 31.1 m-85 -144.3 126.33 15.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.46 -174.18 4.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 31.9 p-90 -156.7 128.27 7.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.449 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 6.5 p -106.9 152.63 23.66 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.2 t80 -135.9 117.36 14.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -103.99 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.266 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.771 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.3 mm -137.16 109.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.845 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.89 68.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.875 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 63.31 65.53 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.799 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.0 27.01 73.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.399 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -144.52 74.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.179 0.514 . . . . 0.0 110.097 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.54 162.11 30.28 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.375 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.05 147.71 26.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.642 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -126.06 141.23 52.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.488 ' N ' HG21 ' A' ' 9' ' ' VAL . 2.6 tt0 -99.26 76.44 2.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.237 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.5 p30 -83.43 179.69 7.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.232 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.0 t30 59.05 18.38 6.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.57 163.24 44.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.078 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.39 158.38 39.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.1 0.476 . . . . 0.0 111.476 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CE3' HD13 ' A' ' 79' ' ' ILE . 49.7 t90 -147.66 165.69 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.8 t -107.75 157.44 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.9 t -119.69 -4.19 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.638 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' CD2' ' A' ' 75' ' ' LEU . 27.3 m -62.1 -15.97 49.05 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.607 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -108.93 159.19 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -138.09 129.87 28.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.001 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 16' ' ' ALA . 22.7 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 121.29 0.567 . . . . 0.0 111.956 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 9' ' ' VAL . 28.4 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -66.56 138.28 95.53 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 9' ' ' VAL . 36.6 Cg_endo -66.01 -168.09 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.493 2.129 . . . . 0.0 112.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -109.55 116.99 32.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -80.45 107.9 13.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.401 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' C ' HD12 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -81.86 156.81 24.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.74 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 5.1 mp -146.69 149.9 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.45 . . . . 0.0 111.879 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -148.66 142.37 25.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.95 114.51 23.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.123 0.487 . . . . 0.0 111.465 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 105' ' ' VAL . 24.3 mm -89.68 130.39 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.238 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.1 t80 -92.93 142.27 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 94.6 Cg_endo -92.49 -2.69 50.5 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.484 0.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -163.27 95.52 0.85 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.9 171.16 43.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.282 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -147.47 132.02 17.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.0 111.25 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.692 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.6 ttt180 -117.97 125.8 51.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.391 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.487 HG23 HD12 ' A' ' 22' ' ' LEU . 61.9 t -126.85 152.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -152.45 145.1 24.23 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.985 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.1 pp -143.98 117.06 5.77 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.304 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.11 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.419 2.079 . . . . 0.0 112.284 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 43.0 t0 -80.14 143.52 33.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 111.361 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.96 48.88 2.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.608 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.91 38.49 96.11 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.889 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CD1' HG21 ' A' ' 85' ' ' VAL . 22.1 m-85 -68.65 -123.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.282 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 177.32 -35.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 57' ' ' THR . 7.5 tp -141.12 126.3 18.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.088 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.704 ' HD2' HD12 ' A' ' 56' ' ' ILE . 11.8 t80 -118.67 95.02 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -93.61 120.14 33.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.0 t80 -105.83 126.91 52.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.266 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.47 122.29 33.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.37 139.38 6.16 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.806 -1.664 . . . . 0.0 114.211 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -117.23 146.97 42.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.503 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.0 tp -89.3 133.09 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 44.76 63.08 1.82 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 177.49 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.38 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 50.9 mt-10 . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.383 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.56 -45.25 56.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.51 -122.44 28.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.17 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -137.96 -72.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.904 0.383 . . . . 0.0 110.451 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.459 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.1 m-90 -60.76 88.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.946 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.79 94.3 4.4 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.001 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 3.9 tpt85 -146.94 127.83 14.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.971 0.415 . . . . 0.0 112.117 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.22 123.93 35.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.386 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.704 HD12 ' HD2' ' A' ' 34' ' ' PHE . 14.5 mt -108.15 151.47 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.363 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.858 HG22 HD12 ' A' ' 33' ' ' LEU . 28.5 p -141.11 30.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.8 pttm -153.15 92.16 3.3 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.2 Cg_exo -58.25 169.03 3.19 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.562 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.93 33.93 3.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.828 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 81.12 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.161 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.64 -2.74 21.46 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.846 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -157.61 124.2 4.93 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.619 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.1 m95 -76.62 154.94 33.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -134.67 120.52 19.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.658 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.7 t80 -121.41 106.08 11.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -110.17 141.4 43.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -138.09 111.17 7.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -89.37 22.34 2.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.347 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -125.52 36.8 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.82 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 81.23 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.654 HD11 HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -78.97 169.9 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.599 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 145.22 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -55.22 136.86 48.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.18 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.31 -29.84 9.58 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.275 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.3 t70 -59.33 152.92 20.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -115.25 148.89 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.438 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.544 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -105.31 150.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.056 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 75.1 m-85 -144.07 128.04 17.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.161 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.9 p90 -161.07 -174.4 4.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.085 0.945 . . . . 0.0 113.361 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 52.4 p-90 -158.67 135.79 9.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.13 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 12' ' ' ALA . 32.5 p -99.36 163.03 12.7 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.27 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.87 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 14.8 t80 -144.93 105.5 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.8 164.38 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.87 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.3 mm -141.03 109.65 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.598 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 67.4 0.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.31 65.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.17 28.53 71.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.43 73.27 1.39 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.177 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -83.18 160.64 38.64 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.501 -0.772 . . . . 0.0 114.233 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.24 147.85 26.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.604 ' C ' HG11 ' A' ' 9' ' ' VAL . 12.4 ptt-85 -126.28 147.65 49.66 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.529 0.681 . . . . 0.0 112.701 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -106.01 74.07 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.439 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.0 p30 -82.27 176.21 9.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.703 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 60.05 19.76 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.625 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.86 162.15 42.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -154.34 162.7 41.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.963 0.411 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CE3' HD13 ' A' ' 79' ' ' ILE . 46.9 t90 -155.08 165.82 35.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.166 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.438 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.2 t -105.65 160.88 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.4 t -121.89 -0.3 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.746 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 p -63.44 -14.06 46.66 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -129.17 154.55 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.704 0.288 . . . . 0.0 110.879 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.589 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -135.54 144.63 46.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 17' ' ' ILE . 17.3 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 23.0 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.763 0.316 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.791 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.7 p -66.59 131.03 94.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 20.8 Cg_exo -65.47 -177.53 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.356 2.038 . . . . 0.0 111.988 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -107.79 129.73 55.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 111.674 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.682 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -81.0 101.17 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.224 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -83.26 100.63 10.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 3.7 mp -92.96 157.52 16.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.8 mm-40 -148.92 142.23 25.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.227 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.86 110.54 20.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.141 0.496 . . . . 0.0 111.29 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 23' ' ' ARG . 19.0 mm -83.35 150.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.252 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.422 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -114.0 143.83 30.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.737 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 9.9 Cg_endo -89.55 3.5 69.26 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.285 0.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -170.18 98.39 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.514 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -172.42 -176.45 41.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.426 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -158.07 134.87 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 17' ' ' ILE . 4.1 tmm_? -126.25 119.79 28.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.11 147.75 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.282 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.52 148.82 34.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -146.61 126.32 6.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.68 116.35 2.31 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.259 1.973 . . . . 0.0 111.681 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 46.3 t0 -83.06 112.11 19.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 0.0 111.335 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -101.43 43.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.813 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.03 31.84 80.1 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.882 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CD2' HG11 ' A' ' 85' ' ' VAL . 95.5 m-85 -61.2 -113.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.799 0.299 . . . . 0.0 110.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . 6.7 t 176.87 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.749 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.4 132.02 28.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.793 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CD1' HD13 ' A' ' 26' ' ' ILE . 17.0 t80 -122.32 98.0 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.732 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -102.3 119.03 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 40.1 t80 -106.01 128.36 53.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.64 122.11 35.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.582 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.98 145.95 12.0 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.863 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 161.6 21.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.456 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 HD22 ' A' ' 73' ' ' LEU . 21.3 tp -96.51 118.19 32.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 52.7 t30 57.66 70.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 73.9 tt0 171.33 110.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.375 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 51.4 mt-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.793 0.33 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.54 -30.91 44.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.642 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.46 -137.44 15.67 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.584 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.1 -74.78 0.6 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.5 m-90 -60.43 90.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.069 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.96 85.22 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.868 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -130.63 127.63 39.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.735 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -94.43 110.89 22.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.517 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mm -92.1 133.75 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 t -129.79 36.65 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.05 90.35 1.23 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.9 Cg_exo -53.6 170.26 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.74 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 1.2 tmtm? -112.93 42.13 1.94 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.461 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 1.3 mp0 72.77 88.62 0.1 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.489 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.23 -3.47 22.73 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.052 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 7.1 ttt180 -157.84 125.52 5.25 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.847 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.465 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 11.9 m95 -76.3 154.7 34.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 m -134.63 120.64 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.505 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 14.7 t80 -120.5 115.7 23.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -111.14 145.1 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.243 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.08 104.34 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 22.49 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.64 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.03 40.72 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.349 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.53 93.11 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -73.95 75.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.691 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 22' ' ' LEU . 4.6 mt -97.69 168.01 10.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -142.02 143.82 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.3 OUTLIER -52.57 133.2 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.352 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.96 -28.89 11.68 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.216 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' A' ' 101' ' ' VAL . 8.5 t70 -64.39 162.62 14.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.851 0.358 . . . . 0.0 111.244 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -121.47 158.42 28.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.207 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.3 mp -113.89 149.91 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.173 0.511 . . . . 0.0 112.17 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 m-85 -143.84 125.18 14.68 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.682 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 1.7 p90 -159.5 -175.3 5.11 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.275 1.035 . . . . 0.0 113.721 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.439 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 38.7 p-90 -153.46 133.95 13.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.483 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.94 155.48 17.66 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.163 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.1 t80 -135.6 109.66 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 0.0 111.168 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.834 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -102.91 168.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.393 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.749 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 45.7 mm -145.5 104.44 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 O-C-N 123.292 0.37 . . . . 0.0 111.03 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -98.64 75.85 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.328 179.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.25 57.88 1.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.355 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.862 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.27 17.76 77.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.277 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.97 69.58 1.28 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.423 0.63 . . . . 0.0 110.013 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 85' ' ' VAL . . . -83.58 -170.42 46.36 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.432 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.2 m-85 -151.97 171.04 18.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.775 -0.712 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.791 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -144.18 143.7 31.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.442 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.13 74.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.519 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -77.9 174.21 11.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.37 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 59.56 19.42 7.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.35 162.79 53.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.198 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 2.9 tt0 -154.4 147.46 24.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 54.2 t90 -141.49 165.23 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.366 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.5 t -106.06 156.7 18.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 77' ' ' ASP . 4.6 t -119.86 -3.59 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.936 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 75' ' ' LEU . 18.7 m -62.06 -16.1 49.57 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.935 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.657 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.1 mt-10 -125.09 150.75 46.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 7.7 m-85 -132.63 145.54 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 0.0 110.834 179.742 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 19.4 t . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.817 0.341 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.748 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -66.65 137.69 95.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD2' HG11 ' A' ' 85' ' ' VAL . 43.5 Cg_endo -70.54 -171.01 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.51 2.14 . . . . 0.0 112.89 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -108.27 127.36 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -85.71 106.88 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.605 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 108.45 21.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.67 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.8 mp -102.7 156.03 17.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 112.154 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.418 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -137.19 140.62 41.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.014 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.49 100.87 12.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.176 0.512 . . . . 0.0 111.361 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 12.5 mm -74.73 141.95 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.309 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 26.2 t80 -104.16 141.05 21.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.57 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 77.3 Cg_endo -94.41 2.8 51.43 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.306 -1.122 . . . . 0.0 112.369 0.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.67 96.46 0.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.582 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.5 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -177.52 165.87 35.91 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 23' ' ' ARG . 4.8 tp -138.95 143.64 38.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.746 ' N ' HD12 ' A' ' 22' ' ' LEU . 4.3 ttt180 -135.19 101.91 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.856 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.67 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.9 t -100.32 158.53 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.407 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -152.68 145.0 23.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.681 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -144.75 126.67 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.788 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 13.2 Cg_endo -56.67 95.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.454 2.103 . . . . 0.0 111.709 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.71 159.69 8.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.1 t0 -146.85 44.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.585 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.61 40.77 85.75 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.529 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.7 m-85 -82.96 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.374 0.607 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -131.72 -27.53 1.9 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.515 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 6.7 tp -140.01 132.28 28.24 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.876 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.703 ' HD2' HD12 ' A' ' 56' ' ' ILE . 31.2 t80 -123.68 98.36 5.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.313 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -91.88 124.85 36.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 36.7 t80 -116.95 122.69 45.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.352 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -160.85 147.36 14.0 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 118.918 -1.611 . . . . 0.0 114.073 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 132.08 53.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.58 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 101' ' ' VAL . 11.0 tp -79.82 105.69 11.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.1 t-20 76.59 65.39 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.6 tt0 171.98 109.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 32.4 mt-10 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.672 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.14 -24.38 10.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.672 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.43 -139.57 1.7 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.636 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 12.6 m170 -122.43 -74.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.163 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.652 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -67.98 88.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.98 86.37 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 ttm180 -135.02 143.85 46.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.982 0.42 . . . . 0.0 111.707 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -107.76 118.62 37.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.627 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.8 mt -95.1 151.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.069 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 44.7 p -140.24 42.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.133 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 98.19 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 58.8 Cg_exo -52.08 -176.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.506 2.138 . . . . 0.0 112.228 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -48.51 3.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.157 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.8 80.76 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.537 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . 70.81 2.05 42.86 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.7 mtt180 -156.79 133.43 10.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.711 -0.244 . . . . 0.0 110.597 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.562 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.4 m95 -79.77 153.97 28.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.3 m -135.2 120.26 18.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 44.0 t80 -110.55 82.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.521 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -92.3 126.94 37.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.291 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -138.04 111.44 8.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 22.29 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.345 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.59 31.24 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -108.48 127.0 53.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.052 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -87.24 75.86 9.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.652 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 56.0 mt -82.5 154.54 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -130.93 144.51 51.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.409 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -67.35 131.46 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.386 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.88 -24.69 25.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.622 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 40' ' ' LEU . 8.9 t70 -59.36 159.97 7.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -108.36 164.83 11.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.636 HG13 ' CE3' ' A' ' 99' ' ' TRP . 5.1 mm -125.99 146.17 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 75.4 m-85 -144.44 130.92 19.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.413 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 4.0 p90 -161.57 -176.4 5.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 122.156 0.979 . . . . 0.0 113.607 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.577 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.5 p-90 -153.37 133.28 13.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.477 -1.692 . . . . 0.0 108.293 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.701 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.8 p -111.95 153.27 27.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.098 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.817 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.5 t80 -136.39 141.02 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.277 0.361 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -128.85 163.25 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.804 HD11 ' CE2' ' A' ' 84' ' ' TYR . 25.6 mm -137.52 107.23 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.904 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.22 68.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t0 63.62 65.77 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.804 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.6 29.0 71.62 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.533 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.2 75.2 1.45 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.132 0.491 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.23 159.08 27.21 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.505 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -152.43 150.47 29.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.748 ' C ' HG11 ' A' ' 9' ' ' VAL . 18.1 ptt-85 -129.09 149.99 50.67 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.573 0.702 . . . . 0.0 112.87 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -105.58 75.22 1.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.768 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -74.92 172.44 12.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.396 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.1 t30 61.57 18.39 9.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.9 165.41 29.84 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.823 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -154.23 149.23 26.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.074 0.464 . . . . 0.0 111.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.636 ' CE3' HG13 ' A' ' 79' ' ' ILE . 28.6 t90 -151.99 164.57 36.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.984 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -114.21 163.05 15.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 40' ' ' LEU . 1.7 t -129.67 15.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.715 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.527 ' O ' HD21 ' A' ' 75' ' ' LEU . 6.6 p -56.29 -24.51 43.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 66.9 mt-10 -142.68 172.78 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 13.8 m-85 -133.06 150.04 52.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.121 0.486 . . . . 0.0 110.928 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 9' ' ' VAL . 41.6 t . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 94' ' ' GLN . 7.6 p -78.78 141.36 59.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 82.8 Cg_exo -51.66 -169.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.7 2.267 . . . . 0.0 112.291 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 t -107.29 139.73 41.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.236 0.541 . . . . 0.0 112.274 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 24' ' ' VAL . . . -84.2 115.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.222 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.72 106.51 13.72 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.574 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.1 mp -97.98 152.03 19.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.244 0.545 . . . . 0.0 111.994 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 105' ' ' VAL . 17.5 mt-10 -141.9 136.73 30.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.685 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.733 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.39 98.88 11.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.152 0.501 . . . . 0.0 111.188 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 27.1 mm -74.52 147.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.455 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -106.48 146.81 33.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.545 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 12.1 Cg_endo -90.59 3.6 67.81 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.159 -1.184 . . . . 0.0 112.353 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.86 79.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 68' ' ' ASP . . . -146.58 -172.12 16.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 23' ' ' ARG . 19.5 tp -154.69 142.62 20.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.12 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.688 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -135.7 99.31 4.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.42 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.752 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 18.4 t -116.95 142.2 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -146.15 141.75 27.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.464 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.591 ' CG2' ' HB2' ' A' ' 12' ' ' ALA . 1.2 pp -135.9 120.15 12.97 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.762 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 10' ' ' PRO . 86.2 Cg_exo -46.27 123.09 6.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.115 1.877 . . . . 0.0 112.172 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 15.2 t0 -79.02 158.88 27.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.191 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -145.37 46.44 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.867 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.41 37.58 86.01 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.4 m-85 -82.94 -172.16 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.266 0.555 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ILE . 48.4 t -131.59 -26.47 2.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.799 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 12.2 tp -146.45 132.95 19.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.334 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.1 t80 -117.99 106.19 12.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -103.79 118.4 36.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 24.2 t80 -106.23 125.84 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -124.95 122.72 38.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.81 137.83 5.84 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 118.853 -1.642 . . . . 0.0 114.252 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -111.53 142.46 43.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 101' ' ' VAL . 36.5 tp -97.28 125.69 42.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.987 0.422 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 63.78 50.94 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.9 tt0 176.42 109.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.578 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 44.8 mt-10 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.373 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 1.4 mt-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -53.35 -26.04 17.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.813 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.32 -117.03 3.45 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.379 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.6 m80 -140.41 -73.4 0.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.728 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 6.7 m-90 -60.39 90.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.05 87.29 2.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 118.08 19.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.007 0.432 . . . . 0.0 111.617 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -92.99 106.45 18.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.9 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 9.1 mm -86.42 148.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.614 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 t -140.1 39.34 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.421 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.41 99.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.1 Cg_exo -51.73 -175.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.438 2.092 . . . . 0.0 112.362 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -116.82 -67.12 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.069 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.47 84.35 1.37 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.747 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.82 -0.73 34.98 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 5.6 ptp85 -157.81 160.38 37.71 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.69 0.281 . . . . 0.0 110.908 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.47 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 5.7 m95 -94.92 156.2 16.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.855 0.359 . . . . 0.0 110.225 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -134.69 116.24 14.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 54' ' ' ARG . 11.1 t80 -110.94 112.7 24.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.393 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 2.4 t0 -138.06 107.88 6.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -89.21 22.59 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.53 33.09 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.12 105.27 16.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -73.82 75.89 1.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.728 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 61.6 mt -87.25 156.83 19.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.078 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.46 134.92 34.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.424 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.6 OUTLIER -56.8 131.65 49.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.264 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.01 -29.92 9.22 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.05 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 101' ' ' VAL . 7.3 t70 -69.22 162.45 27.08 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -114.08 172.5 6.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.988 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.791 HD11 HG22 ' A' ' 101' ' ' VAL . 2.7 mp -127.85 142.44 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.785 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 47.2 m-85 -144.31 128.18 17.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.7 p90 -161.13 -177.56 6.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.492 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 55.8 p-90 -149.12 131.19 15.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.151 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -100.48 155.47 17.82 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.823 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.867 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 8.2 t80 -134.87 148.15 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.763 0.316 . . . . 0.0 111.057 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -137.91 165.31 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.957 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.698 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 16.8 mm -141.4 107.7 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 O-C-N 123.069 0.231 . . . . 0.0 111.025 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.68 62.58 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.446 0.466 . . . . 0.0 110.56 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 t70 69.28 65.72 0.27 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.811 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.32 28.21 71.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.518 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.83 74.22 1.42 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.01 161.67 45.79 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.403 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' O ' HG13 ' A' ' 85' ' ' VAL . 83.7 m-85 -152.18 148.99 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -134.17 143.11 47.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.729 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 tt0 -102.54 76.52 1.54 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 5.0 p-10 -77.2 -179.06 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.27 16.23 8.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.657 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.41 162.49 49.79 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.004 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -154.42 152.59 30.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 0.0 111.251 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.708 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.7 t90 -155.07 164.94 38.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.061 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.781 ' OG1' HG22 ' A' ' 102' ' ' THR . 5.7 t -108.48 158.57 17.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.791 HG22 HD11 ' A' ' 79' ' ' ILE . 2.6 t -119.85 -7.11 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.98 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.781 HG22 ' OG1' ' A' ' 100' ' ' THR . 2.4 t -66.04 -8.42 23.12 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.9 tt0 -134.34 137.2 43.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.053 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.4 m-85 -122.08 154.99 36.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 17' ' ' ILE . 6.2 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.112 0.482 . . . . 0.0 110.942 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 9' ' ' VAL . 11.2 t . . . . . 0 N--CA 1.46 0.065 0 CA-C-O 120.974 0.416 . . . . 0.0 111.558 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.561 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.7 p -68.66 138.41 90.86 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.473 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 11.9 Cg_exo -70.0 -178.46 2.45 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.61 2.206 . . . . 0.0 111.893 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -103.71 120.9 41.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.471 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.0 109.23 16.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.8 mmtm -90.05 130.18 36.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.365 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HG ' HG22 ' A' ' 24' ' ' VAL . 6.1 mp -121.98 154.79 36.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.145 0.498 . . . . 0.0 111.741 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' HG11 ' A' ' 105' ' ' VAL . 3.2 mp0 -147.54 144.62 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.111 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.98 130.61 34.39 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.006 0.432 . . . . 0.0 111.4 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 23' ' ' ARG . 9.7 mm -109.55 134.55 51.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.306 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -98.26 144.1 27.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.452 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.4 Cg_endo -90.35 -7.18 45.47 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.423 0.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -159.11 93.08 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.493 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.07 165.33 38.66 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.632 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -146.84 137.03 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -120.87 121.89 39.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG22 ' HG ' ' A' ' 14' ' ' LEU . 31.2 t -121.28 151.86 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -155.03 144.88 21.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -140.5 127.64 12.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 52.8 Cg_exo -53.96 106.71 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.238 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 36.4 t0 -76.07 144.84 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.002 0.43 . . . . 0.0 111.296 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 1.8 m-20 -132.59 44.95 2.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.954 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.99 53.64 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.7 m-85 -82.04 -170.88 3.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.341 0.591 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 1.1 t -130.92 -29.32 1.89 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.449 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.672 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.6 tp -140.47 136.01 32.55 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.811 -0.755 . . . . 0.0 112.396 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.65 ' HD2' HD12 ' A' ' 56' ' ' ILE . 14.3 t80 -123.74 104.16 8.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.371 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -99.35 126.67 45.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.811 0.339 . . . . 0.0 110.746 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.3 t80 -113.51 124.07 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.433 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -126.97 115.48 19.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -151.24 139.09 6.95 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 118.572 -1.775 . . . . 0.0 114.571 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -122.18 126.86 49.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 ' CH2' ' A' ' 52' ' ' TRP . 0.5 OUTLIER -91.7 141.32 28.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.71 40.62 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -176.9 109.55 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.4 mt-10 . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.992 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.904 0.383 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -55.84 -22.91 27.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.9 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.58 -108.98 0.69 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.042 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t-80 -133.9 -73.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.947 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 40' ' ' LEU . 27.9 m-90 -72.04 92.74 1.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.55 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.189 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 21.5 tpt180 -149.18 133.23 17.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.884 0.373 . . . . 0.0 111.947 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.75 143.35 26.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.713 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.65 HD12 ' HD2' ' A' ' 34' ' ' PHE . 11.7 mt -126.87 142.82 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.158 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 32' ' ' SER . 3.4 m -134.22 30.68 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -151.77 89.38 4.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.437 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 57.2 Cg_exo -51.89 171.85 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.578 2.186 . . . . 0.0 112.576 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.36 34.96 3.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.96 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.95 87.85 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.226 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.1 -5.82 12.47 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.818 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 9.4 mtt-85 -157.48 130.67 7.73 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.299 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.5 m95 -78.13 154.8 30.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.963 0.411 . . . . 0.0 110.02 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 97.1 m -134.76 118.54 17.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.217 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' HD11 ' A' ' 56' ' ' ILE . 82.5 t80 -120.81 91.8 3.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 146.19 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 26.4 t0 -138.04 106.89 5.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.673 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.25 22.35 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.651 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -134.65 43.45 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.09 123.24 42.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -73.94 76.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.695 HD13 HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -98.43 142.42 30.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 158.78 38.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 3.3 tt -68.87 133.37 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.015 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 105.93 -27.99 15.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' VAL . 10.9 t70 -59.46 164.48 3.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.089 0.471 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.1 153.58 42.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.438 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.4 mp -113.42 143.1 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.987 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.6 m-85 -144.18 125.71 14.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.618 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 5.0 p90 -161.09 -174.5 4.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 122.439 1.114 . . . . 0.0 113.939 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.467 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 16.4 p-90 -151.59 129.85 12.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.034 -1.894 . . . . 0.0 108.148 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -99.86 161.0 13.88 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.783 -178.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.939 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 18.3 t80 -141.59 137.87 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.622 0.248 . . . . 0.0 110.566 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -130.94 162.42 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.5 mm -135.16 105.79 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.855 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 66.81 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.529 0.518 . . . . 0.0 110.546 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.17 61.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 73.93 29.01 63.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -143.82 74.16 1.42 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.134 0.492 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.83 159.68 42.24 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.542 -0.753 . . . . 0.0 114.595 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -152.44 144.14 23.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.613 -0.793 . . . . 0.0 108.985 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -128.5 140.11 51.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.561 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.92 77.49 2.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.556 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 8.9 p-10 -80.8 176.28 9.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.417 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 60.57 18.31 8.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.36 162.02 50.77 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.131 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.42 158.72 40.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CE2' ' O ' ' A' ' 100' ' ' THR . 58.8 t90 -155.1 166.6 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.255 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 4.7 t -109.83 160.09 16.65 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.6 t -122.68 2.12 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.58 HG22 ' HA2' ' A' ' 76' ' ' GLY . 44.6 p -63.77 -13.44 43.95 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.752 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.6 tt0 -131.33 150.87 51.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.034 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 9.3 m-85 -131.73 145.21 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.165 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.448 HG11 ' HG2' ' A' ' 15' ' ' GLU . 25.4 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 9' ' ' VAL . 3.3 p . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 121.379 0.609 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.793 ' H ' HG22 ' A' ' 8' ' ' VAL . 7.3 p -81.36 137.75 48.57 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.237 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 14.2 Cg_exo -68.35 -174.49 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.586 2.191 . . . . 0.0 112.145 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.71 118.63 37.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.378 . . . . 0.0 111.888 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -76.8 105.68 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.431 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.95 107.23 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.048 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.753 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.9 mp -96.45 159.22 15.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.232 0.539 . . . . 0.0 111.773 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.12 137.24 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.47 102.63 14.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.207 0.527 . . . . 0.0 111.058 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 23' ' ' ARG . 25.2 mm -73.1 135.51 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.409 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 57.9 t80 -94.89 141.28 23.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.695 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.3 Cg_endo -92.31 -3.29 49.77 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.432 0.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.84 94.95 0.87 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -168.96 -171.08 34.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.387 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD12 ' H ' ' A' ' 23' ' ' ARG . 13.3 tp -156.93 147.7 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB2' HD11 ' A' ' 17' ' ' ILE . 6.8 ttm180 -144.71 106.65 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.673 HG22 ' HG ' ' A' ' 14' ' ' LEU . 21.4 t -109.0 157.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.03 146.72 23.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 111.589 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.799 HG21 ' CZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -141.83 130.52 12.12 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.57 101.54 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.184 1.923 . . . . 0.0 111.052 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.453 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.8 t70 -69.14 149.8 48.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.298 0.57 . . . . 0.0 111.899 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.447 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 9.1 t70 -131.35 42.78 3.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.492 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.02 45.82 30.81 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.702 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 12.5 m-85 -87.5 -171.49 3.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.329 0.585 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ILE . 88.6 p -128.64 -29.18 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.498 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.845 ' CD1' HG22 ' A' ' 57' ' ' THR . 9.0 tp -142.63 140.53 31.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.593 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 26' ' ' ILE . 46.1 t80 -133.23 99.75 4.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.61 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -98.2 117.82 33.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.547 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.753 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 28.0 t80 -104.94 120.16 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.029 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.514 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -116.82 128.77 55.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.414 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -156.19 132.37 3.31 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.05 -1.548 . . . . 0.0 114.161 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 11.7 ttpt -106.65 144.69 32.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.5 tp -98.97 124.79 44.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.016 0.436 . . . . 0.0 111.547 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 t-20 65.11 49.36 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 60.7 tt0 175.81 109.82 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 110.613 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 45.7 mt-10 . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.766 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 4.7 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.762 0.315 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -49.16 -36.03 18.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.869 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.76 -112.33 3.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.026 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 66.0 t60 -145.19 -74.2 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.686 0.279 . . . . 0.0 110.919 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.666 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -63.79 101.07 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.29 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -115.93 76.63 1.03 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -96.41 114.3 25.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.502 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.43 95.54 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.161 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 58' ' ' LYS . 6.6 mt -104.03 152.89 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.269 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 33' ' ' LEU . 9.1 p -121.26 -8.53 9.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.4 mttp -135.38 120.09 13.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.484 0.183 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.6 Cg_exo -58.13 -165.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.456 2.104 . . . . 0.0 112.33 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -119.49 -44.9 2.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.223 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -178.59 82.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.711 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 -7.18 19.79 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.38 149.75 22.84 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.504 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 4.8 m95 -88.21 150.83 23.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.89 0.376 . . . . 0.0 110.163 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -135.52 122.06 20.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.547 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 37.4 t80 -109.22 154.02 22.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 118.78 10.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 0.0 111.229 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.3 t70 -121.34 98.37 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.406 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -89.16 22.59 2.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.553 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.33 27.99 4.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.42 100.99 10.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -73.79 75.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.041 0.448 . . . . 0.0 110.67 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.666 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 57.3 mt -91.57 142.15 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -125.55 146.44 49.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.19 144.92 14.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 95.08 -35.05 4.44 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.244 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.1 t0 -62.15 149.54 41.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -108.31 168.28 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HG22 ' A' ' 101' ' ' VAL . 3.0 mp -124.92 145.8 31.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.196 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 57.8 m-85 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -159.9 -177.53 6.4 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 57.4 p-90 -153.54 135.05 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.894 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 72.1 p -99.55 166.69 11.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.071 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.661 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 15.9 t80 -150.01 108.69 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.667 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.75 ' O ' HD13 ' A' ' 86' ' ' ILE . 1.4 m -102.8 169.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.66 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -144.53 101.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.537 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -96.16 62.26 2.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 t0 64.35 62.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.836 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.53 26.84 60.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.265 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.4 mt -143.29 71.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.21 0.528 . . . . 0.0 110.157 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -75.84 160.53 51.71 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.333 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 85' ' ' VAL . 58.4 m-85 -152.19 140.79 20.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.67 ' C ' HG11 ' A' ' 9' ' ' VAL . 8.0 ptt180 -121.84 144.59 48.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' N ' HG21 ' A' ' 9' ' ' VAL . 12.4 tt0 -105.4 69.62 0.85 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.689 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.2 p30 -78.24 176.14 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.516 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.8 t30 61.42 17.57 8.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.38 164.75 53.59 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.12 152.03 29.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.8 t90 -148.63 164.06 35.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.976 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -107.26 159.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.665 HG22 HD11 ' A' ' 79' ' ' ILE . 13.8 t -118.7 -5.22 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.814 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HD21 ' A' ' 75' ' ' LEU . 4.4 p -69.12 -5.23 20.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.959 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -136.09 149.1 48.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.703 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 m-85 -133.83 148.47 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.038 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.262 0.553 . . . . 0.0 110.92 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.9 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.979 0.419 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.614 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -70.37 138.05 86.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 9' ' ' VAL . 37.9 Cg_endo -67.18 -168.36 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.486 2.124 . . . . 0.0 112.662 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -105.22 117.66 34.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.451 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.92 99.42 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.616 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -82.16 152.26 26.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.586 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.463 HD22 ' CE2' ' A' ' 81' ' ' PHE . 3.6 mp -145.24 157.79 43.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.581 . . . . 0.0 112.07 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.538 ' O ' HD22 ' A' ' 22' ' ' LEU . 8.8 mt-10 -150.03 142.92 24.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.977 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . . . -86.26 101.68 13.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 111.547 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 23' ' ' ARG . 26.7 mm -71.82 122.94 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.199 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 34.0 t80 -87.45 141.83 32.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 90.3 Cg_endo -96.27 5.15 42.91 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.512 0.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -164.65 96.69 0.75 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.765 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . 177.07 166.16 33.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.507 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.634 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -149.47 120.76 7.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.715 0.293 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HG2' HD11 ' A' ' 17' ' ' ILE . 9.9 ptm180 -109.88 133.1 53.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 22.1 t -121.74 155.06 26.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.339 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.63 147.07 29.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.788 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -146.11 127.49 7.47 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.451 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 22.8 Cg_endo -60.72 96.94 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.456 2.104 . . . . 0.0 111.463 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 24.1 t0 -59.97 154.94 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.632 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t70 -139.37 43.6 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.571 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.28 41.51 52.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.709 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 85' ' ' VAL . 11.5 m-85 -85.24 -170.83 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.375 0.607 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -131.83 -28.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.544 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 57' ' ' THR . 10.1 tp -139.68 135.67 33.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.378 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 29.9 t80 -126.95 103.3 7.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.387 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.36 118.2 36.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.643 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.4 t80 -105.91 128.47 53.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.526 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -119.28 129.37 54.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -147.07 142.37 10.24 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 118.765 -1.683 . . . . 0.0 114.615 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.2 mttp -119.64 124.55 46.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.347 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD13 HD23 ' A' ' 73' ' ' LEU . 46.3 tp -81.7 112.99 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.824 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.5 t-20 58.89 65.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.9 tt0 174.28 110.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 38.1 mt-10 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.422 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.526 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.25 -25.87 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.796 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 48.22 -107.9 0.31 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.47 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.2 t60 -138.38 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.738 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 15.8 m-90 -65.56 87.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.58 86.36 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -133.41 126.65 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.001 0.429 . . . . 0.0 111.964 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.6 109.55 21.45 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.363 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 18.3 mt -93.3 141.01 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.813 HG22 HD12 ' A' ' 33' ' ' LEU . 9.8 p -129.58 23.79 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.91 87.61 7.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 53.6 Cg_exo -52.72 171.46 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.613 2.209 . . . . 0.0 112.538 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 63' ' ' ARG . 4.5 tptm -109.97 36.46 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.678 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 4.5 mt-10 76.64 88.99 0.08 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.22 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.6 -3.68 24.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.002 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 10.2 mtp180 -157.29 129.04 7.03 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.444 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.531 ' CD1' HD11 ' A' ' 26' ' ' ILE . 7.9 m95 -81.53 150.28 28.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -135.07 121.92 21.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 56' ' ' ILE . 18.0 t80 -110.44 143.89 40.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.427 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -141.76 118.1 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.197 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 16.1 t70 -126.87 101.56 6.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.636 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.21 22.42 2.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.72 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -123.09 28.77 7.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.29 106.9 15.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -73.93 76.94 1.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.806 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 4.1 mt -78.89 166.31 22.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.676 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.81 149.16 46.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -67.66 131.3 45.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.257 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.604 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.51 -26.23 16.89 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.7 t70 -58.26 158.73 6.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.96 14.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.592 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -122.66 150.95 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.296 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 78.1 m-85 -144.4 130.37 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -161.23 -178.45 6.72 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.15 0.976 . . . . 0.0 113.48 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.5 p-90 -155.03 132.35 11.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -99.91 163.01 12.63 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.417 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.82 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 40.9 t80 -144.26 122.39 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.772 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -117.75 163.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.82 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 32.9 mm -136.39 109.27 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.582 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -103.77 74.4 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.034 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 t0 58.05 48.21 13.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.788 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 87.27 30.18 20.3 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.332 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.8 mt -143.94 75.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.157 0.503 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.34 158.95 44.35 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.429 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -152.35 150.1 29.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.63 -0.785 . . . . 0.0 108.932 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.614 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.54 147.47 52.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 4.1 tt0 -107.37 73.51 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.8 p30 -85.75 -179.88 6.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.523 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 t30 61.07 18.21 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.518 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.18 163.14 42.95 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.27 128.82 9.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 47.5 t90 -120.1 170.18 9.53 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 3.7 t -110.62 160.95 16.21 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 77' ' ' ASP . 2.1 t -126.71 15.17 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.667 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.593 ' O ' HD21 ' A' ' 75' ' ' LEU . 26.8 p -58.79 -24.55 61.99 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.892 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 81.7 mt-10 -137.31 161.33 36.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.856 0.36 . . . . 0.0 111.177 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 9.5 m-85 -130.18 145.86 51.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.796 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 17' ' ' ILE . 25.5 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.093 0.473 . . . . 0.0 110.502 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.8 t . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.78 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.6 p -68.63 135.32 90.41 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.499 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' HG11 ' A' ' 85' ' ' VAL . 16.5 Cg_exo -66.68 -173.6 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.618 2.212 . . . . 0.0 112.236 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.26 125.24 51.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -85.37 106.23 16.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.958 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 ttmt -92.32 119.84 32.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.621 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.717 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.1 mp -108.14 158.72 17.18 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.818 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.12 140.63 26.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.116 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.34 120.27 27.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.305 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 105' ' ' VAL . 19.8 mm -92.62 130.72 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.342 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -92.14 142.49 26.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.614 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.2 Cg_endo -93.23 -0.96 51.59 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.386 0.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.59 94.93 0.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.485 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.86 173.11 46.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.476 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -152.29 130.01 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 111.07 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' N ' HD13 ' A' ' 22' ' ' LEU . 9.8 ttt180 -120.26 115.5 23.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.719 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.717 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.3 t -110.86 161.5 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.453 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -152.68 143.58 22.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.046 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.683 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.59 124.06 10.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 10.8 Cg_endo -56.61 99.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.058 1.838 . . . . 0.0 111.359 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.1 t0 -65.51 160.07 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.809 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 4.1 t0 -143.23 43.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.96 42.68 68.19 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.808 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.2 m-85 -84.2 -170.53 3.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.282 0.563 . . . . 0.0 111.114 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -131.97 -28.01 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.645 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 9.6 tp -140.27 134.91 31.7 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.189 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.69 ' HD2' HD12 ' A' ' 56' ' ' ILE . 47.8 t80 -127.4 90.3 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.67 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -85.1 125.4 32.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.487 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 14.2 t80 -115.04 124.02 50.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.345 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.612 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -125.08 122.31 36.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -156.06 147.01 15.07 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.972 -1.585 . . . . 0.0 114.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.79 155.36 39.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.444 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -92.72 115.23 27.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER 59.88 71.9 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 74.2 tt0 174.31 110.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 31.4 mt-10 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.135 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.81 -26.37 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.664 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.79 -160.2 0.12 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.635 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -100.6 -74.22 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 110.696 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.621 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 m-90 -63.49 91.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.15 91.28 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.255 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.8 tmm_? -145.85 125.34 13.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.679 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.72 128.25 35.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.853 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.8 mt -102.99 159.51 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 56' ' ' ILE . 10.6 t -148.39 39.98 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 111.23 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -175.77 96.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.447 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 74.4 Cg_exo -49.75 179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.403 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -106.55 -58.43 1.93 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.194 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 82.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.382 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . 74.09 -2.42 43.49 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 33.6 mtt85 -156.66 147.25 21.59 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.354 0.261 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.609 ' CG ' HD11 ' A' ' 26' ' ' ILE . 9.9 m95 -83.91 159.11 21.37 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.64 118.02 16.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.409 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 36' ' ' PHE . 8.3 t80 -99.8 94.59 6.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.313 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -93.34 124.93 37.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.378 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.421 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.6 t70 -138.12 97.57 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.25 22.36 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -133.87 44.15 2.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -118.74 115.64 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.068 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.96 76.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 22' ' ' LEU . 6.4 mt -82.81 164.98 20.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -141.68 150.53 42.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.979 0.419 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -70.58 132.89 46.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.304 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.47 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.61 -26.4 16.24 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.9 t70 -60.5 165.95 3.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.66 163.32 16.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.383 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -117.6 148.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 3.9 m-85 -144.33 129.71 18.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 3.0 p90 -161.1 -175.51 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 122.0 0.905 . . . . 0.0 113.2 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 32.2 p-90 -157.03 124.65 5.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.859 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.6 p -107.2 151.26 25.66 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.981 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 86' ' ' ILE . 24.4 t80 -133.81 124.58 26.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.229 0.331 . . . . 0.0 111.043 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -108.28 163.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.797 HD11 ' CE2' ' A' ' 84' ' ' TYR . 22.4 mm -136.91 114.31 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.911 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 70.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.4 t0 66.45 62.38 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.768 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.2 28.64 72.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.637 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -145.06 77.91 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.171 0.51 . . . . 0.0 109.981 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -93.17 161.87 25.67 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.627 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -152.13 147.51 26.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.78 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -122.97 151.62 41.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.466 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -106.49 73.98 0.99 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.504 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.6 p30 -84.96 179.59 7.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.442 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 58.55 19.53 6.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.916 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.85 163.46 33.47 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.279 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.27 161.58 41.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.515 ' CZ2' ' HA ' ' A' ' 15' ' ' GLU . 54.8 t90 -146.43 169.06 19.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.526 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' CZ3' ' A' ' 99' ' ' TRP . 5.1 t -105.22 154.81 19.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.634 ' O ' HD22 ' A' ' 75' ' ' LEU . 1.9 t -124.25 17.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.295 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -70.49 -10.71 59.89 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -127.29 162.73 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.549 ' CE2' HD23 ' A' ' 75' ' ' LEU . 6.3 m-85 -135.29 123.53 23.08 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.7 m . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 110.852 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.2 t . . . . . 0 N--CA 1.46 0.044 0 CA-C-O 120.932 0.396 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.622 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.5 p -66.39 132.15 94.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.492 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.6 Cg_exo -64.19 -177.13 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.549 2.166 . . . . 0.0 111.933 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.6 122.69 47.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -81.14 109.79 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -95.3 102.35 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.162 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.1 mp -90.29 162.65 15.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.102 0.477 . . . . 0.0 111.935 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 105' ' ' VAL . 37.9 mt-10 -146.58 140.28 25.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.09 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.73 110.62 20.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.995 0.426 . . . . 0.0 111.448 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 16.9 mm -83.41 159.73 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 8.8 t80 -122.57 140.82 33.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.597 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 8.8 Cg_endo -88.96 1.78 68.97 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.4 -1.083 . . . . 0.0 112.419 0.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.8 98.21 0.3 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.929 0.395 . . . . 0.0 111.008 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.668 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -166.59 -173.13 34.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.437 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -155.81 137.61 14.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.803 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -133.63 106.72 7.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.37 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 22' ' ' LEU . 16.4 t -114.26 155.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.86 145.01 25.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.643 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.674 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -138.21 127.02 14.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.6 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.4 Cg_endo -58.4 93.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.344 2.029 . . . . 0.0 111.706 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.6 t0 -58.6 160.82 5.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.628 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 6.0 t0 -145.62 44.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.39 44.06 60.13 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.961 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.2 m-85 -88.28 -170.88 3.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.465 0.65 . . . . 0.0 111.22 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -131.69 -28.94 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.476 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 8.7 tp -138.38 135.3 35.19 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.163 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.706 ' HD2' HD12 ' A' ' 56' ' ' ILE . 37.1 t80 -125.44 98.58 5.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.028 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -92.88 126.22 37.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 111.062 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' CD2' HG22 ' A' ' 83' ' ' THR . 25.3 t80 -115.86 123.05 47.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.632 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -127.07 120.64 29.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.83 135.23 4.93 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 118.587 -1.768 . . . . 0.0 114.792 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -105.89 147.75 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.126 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.1 tp -97.19 125.26 41.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.279 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 56.8 57.72 4.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 76.5 tt0 174.64 109.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.14 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 60.7 mt-10 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 0.0 111.783 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.4 -25.65 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.9 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.71 -117.71 3.14 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.454 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 38' ' ' GLY . 1.1 t60 -137.48 -73.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.768 0.318 . . . . 0.0 110.555 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 12.8 m-90 -69.98 90.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.32 90.16 3.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.135 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.19 130.17 18.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 112.035 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.26 123.6 34.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.554 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 34' ' ' PHE . 13.3 mt -102.46 143.32 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.234 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 19.9 p -134.31 34.57 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.27 91.87 1.69 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 48.4 Cg_exo -55.88 170.03 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.57 2.18 . . . . 0.0 112.451 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.73 34.49 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.929 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 80.81 87.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.38 -1.75 25.37 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.735 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -157.14 125.3 5.55 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.393 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.566 ' CG ' HD11 ' A' ' 26' ' ' ILE . 18.4 m95 -77.48 156.6 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.2 m -134.59 118.93 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.41 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 56' ' ' ILE . 54.0 t80 -111.24 93.13 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.6 139.7 30.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.1 t70 -138.02 106.12 5.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.23 22.43 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.667 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -135.31 31.78 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.516 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -112.99 108.71 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.01 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -73.71 83.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 21' ' ' GLY . 37.5 mt -86.08 115.48 23.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.87 131.43 52.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -52.02 133.57 32.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.432 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.62 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.94 -29.71 11.61 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 101' ' ' VAL . 30.9 t0 -65.85 160.9 22.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -119.37 160.23 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.2 mp -114.75 146.79 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.786 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 33.7 m-85 -144.23 125.05 14.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.8 p90 -161.08 -174.29 4.29 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.208 1.004 . . . . 0.0 113.404 -178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.518 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.9 p-90 -151.01 127.43 10.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.378 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 24.4 p -107.07 149.7 27.32 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.461 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.773 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.4 t80 -131.51 146.4 52.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.306 0.379 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.55 162.52 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.103 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.773 HD11 ' CE2' ' A' ' 84' ' ' TYR . 31.1 mm -134.52 117.13 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.813 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -114.6 65.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t0 66.87 64.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.779 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.27 28.39 71.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.1 mt -144.96 77.9 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.233 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.81 161.25 28.11 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.47 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.6 m-85 -152.18 139.7 19.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -123.3 145.07 49.0 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.622 ' N ' HG21 ' A' ' 9' ' ' VAL . 28.1 tt0 -100.35 75.74 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.923 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.8 p-10 -79.97 176.5 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.06 19.65 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.809 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.07 165.81 52.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.264 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.15 161.09 42.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.962 0.411 . . . . 0.0 111.225 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.624 ' HB2' HD13 ' A' ' 14' ' ' LEU . 55.7 t90 -155.21 166.25 34.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 5.6 t -107.03 158.01 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' ASP . 3.8 t -122.33 -3.26 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.099 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.62 HG22 ' HA2' ' A' ' 76' ' ' GLY . 76.1 p -62.02 -16.08 49.07 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -114.28 161.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.628 0.251 . . . . 0.0 110.574 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 75' ' ' LEU . 45.5 m-85 -137.99 138.01 38.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 15' ' ' GLU . 3.2 m . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.298 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.6 t . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.943 0.402 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.65 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.5 p -70.36 137.93 86.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 26.0 Cg_endo -63.64 -174.71 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.428 2.085 . . . . 0.0 112.554 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -110.1 116.48 31.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.546 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -73.38 99.58 2.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -87.45 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.991 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.0 mp -105.7 163.84 12.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.268 0.556 . . . . 0.0 112.16 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HG2' HG11 ' A' ' 105' ' ' VAL . 2.0 mp0 -151.06 140.27 21.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.893 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.653 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.64 119.14 26.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.374 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.5 mm -93.42 152.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -116.44 149.18 43.26 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 3.2 Cg_exo -81.06 -6.99 44.27 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.221 0.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -168.36 93.46 0.35 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 111.0 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -158.47 -167.92 19.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.366 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.586 HD12 ' H ' ' A' ' 23' ' ' ARG . 43.3 tp -158.19 148.3 20.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -143.19 104.79 4.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.647 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.752 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.2 t -113.28 159.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 111.476 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.08 145.01 21.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -142.35 115.9 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.953 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 85.0 Cg_exo -47.13 105.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.166 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 32.4 t0 -71.51 148.9 46.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.205 0.526 . . . . 0.0 111.21 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.2 t0 -134.72 45.34 2.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.488 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.67 36.98 76.55 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.282 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.5 m-85 -78.14 -172.19 2.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 86' ' ' ILE . 95.7 p -133.08 -26.91 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.771 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.8 tp -140.57 128.12 21.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.386 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.656 ' HD2' HD12 ' A' ' 56' ' ' ILE . 13.6 t80 -120.6 93.78 4.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.936 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -95.82 120.35 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.975 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 52' ' ' TRP . 37.9 t80 -106.18 130.36 54.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.482 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.98 116.41 20.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -155.61 139.79 6.87 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.551 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 9.6 tptp -117.04 145.56 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 HD23 ' A' ' 73' ' ' LEU . 21.6 tp -93.43 122.6 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 111.146 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.8 t-20 57.25 66.46 1.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 42.8 tt0 170.27 111.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.435 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 19.1 mm-40 . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.735 0.303 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -44.85 -40.18 5.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.6 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.32 176.23 0.07 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 53' ' ' ALA . 6.3 m-70 -79.84 -78.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.534 0.207 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.688 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 8.2 m-90 -57.21 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.49 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 51' ' ' HIS . . . -118.5 90.09 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.252 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 4.4 ttp180 -149.12 133.21 17.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 111.955 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -91.04 136.56 32.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.0 mt -115.8 148.62 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 111.193 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.581 HG22 HD12 ' A' ' 33' ' ' LEU . 48.1 p -137.84 22.55 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.3 mmpt? -146.79 88.49 5.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 56.0 Cg_exo -52.17 171.44 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.587 2.191 . . . . 0.0 112.641 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.72 39.8 1.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.657 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 3.2 mt-10 74.01 89.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.432 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.71 -5.26 17.77 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.5 mtp180 -157.56 132.69 8.83 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.621 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.61 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.3 m95 -81.81 156.45 24.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 ' CD ' ' A' ' 67' ' ' ARG . 1.1 m -134.62 119.38 18.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.393 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 3.1 t80 -112.86 89.62 3.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.508 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.431 ' CD ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -104.25 148.99 25.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 22' ' ' LEU . 1.9 m-20 -138.1 115.56 11.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.771 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.1 22.01 2.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -145.32 27.02 1.28 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.31 30.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.1 76.03 10.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.3 mt -103.31 132.3 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.437 ' N ' HG11 ' A' ' 101' ' ' VAL . 13.2 mttt -122.76 152.68 40.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 111.553 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -54.16 131.82 41.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.297 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.72 -27.0 13.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.9 t70 -57.8 149.79 21.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.981 0.419 . . . . 0.0 111.097 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 149.8 32.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.488 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.735 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -109.22 148.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.207 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -144.45 125.39 14.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.547 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.7 p90 -161.2 -174.35 4.29 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 51.2 p-90 -157.97 134.33 9.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.153 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 24.6 p -99.74 161.99 13.27 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.118 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.888 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 23.8 t80 -144.18 106.05 4.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.645 0.259 . . . . 0.0 110.871 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.54 164.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.372 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 23.9 mm -140.58 106.62 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.875 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -102.5 74.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.661 0.601 . . . . 0.0 110.589 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 57.61 62.28 2.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.814 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.74 31.37 62.61 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.217 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.6 mt -142.59 70.36 1.32 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.21 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -77.68 157.84 46.18 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 114.361 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.42 143.86 23.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.65 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -126.51 146.29 50.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 3.0 tt0 -105.38 73.82 1.05 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.232 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 19.0 p-10 -85.14 176.78 8.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.72 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 60.05 19.97 9.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.455 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.95 162.87 41.23 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.077 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -154.29 138.97 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.947 0.404 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.735 ' CE3' HD13 ' A' ' 79' ' ' ILE . 31.6 t90 -129.67 166.17 20.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.048 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.9 t -111.58 162.69 14.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 77' ' ' ASP . 11.7 t -123.83 5.4 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.401 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 3.2 p -62.01 -16.97 55.57 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.349 -0.387 . . . . 0.0 112.008 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 mm-40 -136.7 157.31 47.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.342 . . . . 0.0 111.025 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 16.3 m-85 -135.83 145.57 46.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.037 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' ' 15' ' ' GLU . 14.4 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 9' ' ' VAL . 21.3 t . . . . . 0 C--O 1.228 -0.075 0 CA-C-O 121.093 0.473 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.67 HG11 ' N ' ' A' ' 94' ' ' GLN . 2.7 p -66.95 145.82 98.98 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.072 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 9' ' ' VAL . 21.2 Cg_exo -65.22 -166.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.605 2.203 . . . . 0.0 111.995 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.53 123.65 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.0 111.67 21.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.717 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 tptt -81.99 156.88 24.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.686 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' A' ' 24' ' ' VAL . 4.9 mp -147.4 143.9 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.981 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -142.1 144.7 33.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.959 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.13 110.03 19.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.7 mm -80.6 127.61 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.333 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -89.73 143.01 29.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 60.7 Cg_endo -93.28 2.68 57.12 Favored 'Cis proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.444 0.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -167.55 96.64 0.47 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.54 -178.2 45.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 23' ' ' ARG . 5.4 tp -156.09 138.41 14.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 110.972 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.837 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.44 120.59 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.477 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 42.8 t -123.59 150.44 27.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.553 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -153.16 144.49 23.19 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -137.54 125.84 14.49 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.2 Cg_endo -64.49 89.55 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.012 1.808 . . . . 0.0 111.414 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 16.5 t0 -50.87 160.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.332 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 36.0 t0 -140.05 41.5 1.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.46 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.96 49.5 7.6 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.088 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' HG21 ' A' ' 85' ' ' VAL . 7.7 m-85 -94.41 -173.58 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.473 0.654 . . . . 0.0 111.169 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 86' ' ' ILE . 12.6 m -127.66 -29.98 2.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.105 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.1 tp -141.36 141.74 33.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.728 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.613 ' CD1' HD13 ' A' ' 26' ' ' ILE . 51.6 t80 -128.13 103.32 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.299 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.87 121.6 38.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 0.0 110.982 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HG22 ' A' ' 83' ' ' THR . 18.8 t80 -112.17 123.04 49.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.524 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -123.71 122.67 38.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -152.24 136.51 5.46 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 118.836 -1.649 . . . . 0.0 114.463 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.45 127.12 46.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.619 HD12 ' CG ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -89.98 140.75 29.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.873 0.368 . . . . 0.0 110.937 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.56 6.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.786 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 36.4 tt0 -179.9 109.05 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.193 0.521 . . . . 0.0 110.445 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.3 mt-10 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.596 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.748 0.309 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.616 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -52.84 -24.89 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.67 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.56 -130.83 11.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.541 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -127.95 -77.4 0.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.81 0.338 . . . . 0.0 110.531 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.639 ' NE1' HD23 ' A' ' 22' ' ' LEU . 28.9 m-90 -62.85 94.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.206 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.5 87.88 2.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.9 tpm_? -136.81 127.68 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.953 0.406 . . . . 0.0 112.029 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.87 107.01 18.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.458 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 3.1 mp -89.04 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.444 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 t -129.58 28.23 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -150.28 88.07 4.8 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 51.4 Cg_exo -54.99 170.46 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.3 tpmp? -108.41 31.34 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.698 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 81.42 93.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.678 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.31 -6.8 7.04 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.456 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 11.6 ptt180 -157.53 134.95 10.44 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.893 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' A' ' 26' ' ' ILE . 6.1 m95 -85.23 154.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -134.6 100.06 4.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.557 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 39.9 t80 -95.88 143.13 27.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.919 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -144.87 145.03 31.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.406 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 47.5 t0 -138.03 100.19 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.476 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -89.17 22.44 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.683 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -138.67 32.52 2.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 0.0 110.811 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB1' ' CZ2' ' A' ' 52' ' ' TRP . . . -104.43 129.56 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.21 83.25 6.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.596 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.0 OUTLIER -102.73 121.33 42.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.68 145.93 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -59.0 133.4 56.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.968 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.72 -28.85 14.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.045 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.619 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 t70 -61.77 163.25 7.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 111.115 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -122.49 156.75 33.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.493 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.506 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -113.05 145.83 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.207 0.527 . . . . 0.0 112.125 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 15.9 m-85 -144.32 120.35 10.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -152.51 -176.27 5.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.203 1.001 . . . . 0.0 113.674 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.504 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 60.1 p-90 -152.38 125.29 8.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.318 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 45.1 p -100.0 149.0 23.9 Favored 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.793 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.888 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.0 t80 -127.26 157.13 40.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 123.334 0.396 . . . . 0.0 110.849 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.662 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 20.8 mm -138.53 106.29 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.808 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -104.01 62.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.544 0.527 . . . . 0.0 110.72 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 t0 71.71 65.4 0.15 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.771 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.72 28.78 71.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.579 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.6 mt -144.35 77.71 1.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.267 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -84.35 158.63 34.47 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.562 -0.745 . . . . 0.0 114.568 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -152.54 148.79 27.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.169 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.98 152.4 51.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.67 ' N ' HG11 ' A' ' 9' ' ' VAL . 3.2 tt0 -107.6 76.3 1.06 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.449 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.3 p30 -77.96 178.29 7.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.334 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 63.18 15.04 8.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.2 162.39 54.66 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.978 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.4 157.63 38.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.641 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.506 ' CE3' HD13 ' A' ' 79' ' ' ILE . 40.3 t90 -155.17 164.41 38.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.061 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 102' ' ' THR . 6.7 t -105.57 158.91 16.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.561 HG21 ' HB3' ' A' ' 77' ' ' ASP . 10.3 t -120.33 -4.35 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.047 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 100' ' ' THR . 9.6 t -66.49 -8.59 27.36 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.0 mt-10 -124.24 139.37 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 82.9 m-85 -130.42 131.62 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 0.0 110.835 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.99 0.424 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -66.81 127.36 93.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.29 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.9 Cg_exo -67.41 -178.64 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.477 2.118 . . . . 0.0 112.212 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.3 135.19 47.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.267 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.606 ' HB1' HG11 ' A' ' 24' ' ' VAL . . . -88.63 111.05 21.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.842 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -92.18 94.14 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.845 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -83.83 163.2 20.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 0.0 112.315 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.618 ' CD ' HG11 ' A' ' 105' ' ' VAL . 28.7 mt-10 -150.71 138.86 20.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.526 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.39 114.89 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.242 0.544 . . . . 0.0 111.683 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.532 HD13 HG22 ' A' ' 105' ' ' VAL . 20.1 mm -96.45 108.65 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -78.92 150.78 75.65 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.01 2.58 69.66 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.962 -1.266 . . . . 0.0 112.282 0.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.59 93.18 0.26 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -171.07 175.25 44.78 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 23' ' ' ARG . 7.7 tp -150.14 138.87 20.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 110.828 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 22' ' ' LEU . 22.0 ttt85 -137.11 107.31 6.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.724 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.606 HG11 ' HB1' ' A' ' 12' ' ' ALA . 21.1 t -116.95 155.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.409 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.442 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -143.12 144.01 32.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.679 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.644 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -136.74 128.07 16.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.394 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.92 102.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.346 2.031 . . . . 0.0 111.785 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.5 t0 -67.76 151.44 47.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.403 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -139.91 45.95 1.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.717 179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.31 92.58 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.1 m-85 -78.48 -171.52 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.368 0.604 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 86' ' ' ILE . 40.4 m -131.8 -27.16 1.91 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 56' ' ' ILE . 10.3 tp -143.36 132.19 22.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.627 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.726 ' HD2' HD12 ' A' ' 56' ' ' ILE . 39.0 t80 -122.32 101.64 7.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.906 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.44 126.73 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.615 ' CD2' HG22 ' A' ' 83' ' ' THR . 10.6 t80 -112.72 130.49 56.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.1 119.13 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.75 139.32 6.64 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 118.586 -1.768 . . . . 0.0 114.676 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.25 142.93 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.233 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.424 HD22 HD23 ' A' ' 73' ' ' LEU . 30.4 tp -96.01 143.04 27.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 p30 44.36 48.98 8.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.363 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 179.44 109.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 110.398 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 56.0 mt-10 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.639 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.825 0.345 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -54.48 -24.34 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.745 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.53 -115.58 1.93 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.544 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' GLY . 6.3 t-160 -137.61 -72.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.649 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.6 m-90 -68.38 88.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.34 88.99 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 39.7 ttt-85 -146.94 130.37 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.632 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.11 136.49 34.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.2 mt -111.81 157.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 56' ' ' ILE . 12.2 t -144.54 41.96 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.41 102.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.1 Cg_exo -54.27 -169.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.427 2.085 . . . . 0.0 112.366 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -119.03 -53.55 2.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.1 83.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.563 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.79 -2.17 34.3 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 3.0 mtt180 -156.92 145.64 19.91 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.769 -0.215 . . . . 0.0 110.473 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.493 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.7 m95 -81.97 161.94 22.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -134.11 116.95 16.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.48 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 24.2 t80 -99.94 84.12 2.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.353 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.96 124.92 36.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.46 110.13 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.755 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 22.15 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.439 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -135.18 40.22 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -107.89 111.57 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.207 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -73.96 75.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 78.7 mt -95.92 134.03 39.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.22 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.512 ' N ' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -128.04 141.45 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.625 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.5 OUTLIER -52.44 132.22 34.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.68 -27.77 18.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.38 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.1 t0 -62.18 151.24 36.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.815 0.341 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -110.93 152.95 26.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.84 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.737 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -112.21 145.34 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.561 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.5 m-85 -144.59 124.92 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.845 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.5 p90 -161.22 -173.83 4.04 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.496 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 63.5 p-90 -153.44 128.24 9.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.662 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 23.0 p -106.82 148.96 27.89 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.754 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 93' ' ' ARG . 5.1 t80 -129.61 145.0 51.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.365 0.415 . . . . 0.0 111.063 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -131.18 160.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.373 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 37.8 mm -129.63 117.58 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.594 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 55.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 t0 71.87 67.19 0.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.786 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.34 23.37 77.47 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.371 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.7 mt -145.89 79.15 1.55 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.208 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -97.61 165.93 22.58 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.48 -0.782 . . . . 0.0 114.399 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -152.05 150.87 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.631 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.2 ptt-85 -128.88 145.37 51.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.576 ' N ' HG21 ' A' ' 9' ' ' VAL . 5.8 tt0 -99.5 77.63 2.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.808 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.1 p30 -81.77 178.74 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 59.54 19.1 7.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.63 166.4 53.27 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.102 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.11 156.59 37.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.737 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -154.67 165.45 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -110.82 161.97 15.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 79' ' ' ILE . 21.3 t -120.44 -3.13 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.805 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.625 HG23 ' CD2' ' A' ' 75' ' ' LEU . 9.0 m -62.26 -14.34 37.6 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.885 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tt0 -131.49 148.54 52.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.8 m-85 -130.41 161.42 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.618 HG11 ' CD ' ' A' ' 15' ' ' GLU . 12.0 m . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 111.051 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 9' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.857 HG22 ' HB3' ' A' ' 92' ' ' TYR . 13.2 t -66.08 129.78 94.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.993 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.32 -171.13 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.354 2.036 . . . . 0.0 111.974 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -114.61 113.57 24.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.73 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.17 106.39 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.526 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' C ' HD12 ' A' ' 14' ' ' LEU . 7.2 tttt -90.77 163.7 14.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.124 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.692 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -147.91 159.76 43.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.976 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -148.92 141.43 24.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.095 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.07 104.44 16.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.968 0.413 . . . . 0.0 111.512 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 23' ' ' ARG . 42.8 mm -72.19 146.36 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.427 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -105.08 142.22 24.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.739 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 97.7 Cg_endo -89.47 -7.79 46.05 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.848 -1.314 . . . . 0.0 112.222 -0.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 94.13 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -160.72 -165.85 18.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.492 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 23' ' ' ARG . 27.0 tp -155.54 145.73 21.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.773 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -140.33 96.34 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 45.8 t -107.38 151.45 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.58 144.32 22.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.926 0.393 . . . . 0.0 111.612 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.5 pp -137.25 131.75 17.72 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.597 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 104.75 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.148 1.899 . . . . 0.0 111.477 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.445 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 t0 -70.53 157.99 36.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.367 0.603 . . . . 0.0 111.737 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 2.8 m-20 -146.97 42.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.329 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 45.43 9.49 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.744 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m-85 -86.05 -173.29 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.447 0.641 . . . . 0.0 111.102 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -133.59 -26.54 1.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.684 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.756 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.4 tp -142.05 129.49 21.28 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.234 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.843 ' CD2' HD12 ' A' ' 56' ' ' ILE . 6.0 t80 -120.58 91.34 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.173 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -90.63 132.82 35.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.989 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TRP . 38.8 t80 -116.94 126.5 53.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.982 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -128.24 117.91 22.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.26 138.4 6.55 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.737 -1.697 . . . . 0.0 114.631 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.4 OUTLIER -109.78 147.17 33.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.202 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' HH2' ' A' ' 52' ' ' TRP . 15.0 tp -99.46 127.52 45.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.202 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.0 t30 57.45 54.81 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 66.6 tt0 175.55 109.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.244 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 35.3 mt-10 . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.365 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 5.7 mm-40 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.9 0.381 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -55.37 -22.05 17.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.085 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.51 4.39 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.245 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -131.64 -79.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.661 0.267 . . . . 0.0 110.347 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.623 ' HH2' HD13 ' A' ' 40' ' ' LEU . 13.2 m-90 -61.53 91.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.64 88.65 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.168 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -143.57 124.07 13.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.025 0.44 . . . . 0.0 111.861 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 4.2 p-10 -87.8 128.67 35.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.663 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.843 HD12 ' CD2' ' A' ' 34' ' ' PHE . 11.2 mt -103.65 154.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 45.06 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.009 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.5 93.18 0.25 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.5 Cg_exo -52.06 -176.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.462 2.108 . . . . 0.0 112.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -113.95 -44.86 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.233 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.02 84.37 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.651 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.97 -2.8 32.17 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.424 -0.894 . . . . 0.0 110.923 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -157.11 148.51 22.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.771 ' CD1' HD11 ' A' ' 26' ' ' ILE . 5.1 m95 -90.12 157.28 17.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -134.64 114.73 13.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.6 t80 -107.41 89.37 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -94.69 144.87 25.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.099 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -138.0 108.44 6.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.582 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -89.18 22.39 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.522 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -141.26 28.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 115.66 27.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -73.91 75.97 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.629 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 96.2 mt -96.75 142.12 29.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 142.27 49.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.782 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 102' ' ' THR . 1.4 tt -56.85 130.2 44.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.631 ' HA2' HG23 ' A' ' 102' ' ' THR . . . 106.01 -28.39 14.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.133 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 101' ' ' VAL . 8.9 t70 -66.56 153.09 43.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.95 0.405 . . . . 0.0 110.877 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.68 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.615 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -114.83 144.58 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.861 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.0 m-85 -144.53 121.28 11.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.692 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.3 p90 -158.5 -172.37 3.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.13 0.967 . . . . 0.0 113.572 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.6 p-90 -155.54 134.25 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.979 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 12' ' ' ALA . 17.8 p -99.92 165.45 11.55 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.721 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.859 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.2 t80 -147.08 108.13 4.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.66 164.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.791 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 12.1 mm -145.23 106.84 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 90' ' ' LEU . 11.9 ptmt -99.63 46.43 0.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 13.7 t0 81.1 77.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.474 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.807 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.02 21.51 75.48 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.265 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.3 mt -145.64 79.37 1.57 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.332 0.586 . . . . 0.0 110.274 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.04 161.71 41.92 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.325 -0.852 . . . . 0.0 114.44 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.857 ' HB3' HG22 ' A' ' 9' ' ' VAL . 49.3 m-85 -144.8 134.38 23.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.838 ' C ' HG11 ' A' ' 9' ' ' VAL . 5.7 ptt180 -123.81 140.17 53.25 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.71 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.8 73.15 1.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.83 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.6 p-10 -81.48 173.33 12.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.689 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 59.65 20.34 8.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.4 162.7 44.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.059 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -154.46 145.95 23.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.263 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 79' ' ' ILE . 38.7 t90 -140.2 164.29 30.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.5 t -105.01 158.11 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ASP . 4.0 t -121.12 -3.97 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.768 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -62.63 -14.33 41.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.628 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.9 tt0 -125.3 149.16 48.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 110.846 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.596 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -134.32 146.4 49.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.261 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG2' HD13 ' A' ' 17' ' ' ILE . 15.1 m . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.718 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.2 t . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 120.958 0.409 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 ' C ' ' A' ' 93' ' ' ARG . 4.5 p -66.9 132.86 93.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.085 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' HG11 ' A' ' 85' ' ' VAL . 22.5 Cg_exo -64.41 -168.48 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.645 2.23 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.46 124.73 50.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.804 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.75 104.52 13.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.488 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -93.16 103.9 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.379 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.5 mp -97.07 161.53 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.567 ' HB3' HG11 ' A' ' 105' ' ' VAL . 31.3 mt-10 -147.04 136.59 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.893 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.55 102.6 14.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.1 mm -74.82 156.81 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.541 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -119.0 145.54 38.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.534 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -84.18 -2.66 56.92 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.302 0.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.12 98.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -163.35 -171.31 29.43 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.374 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.633 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.82 139.13 18.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.05 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.873 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -133.9 101.52 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.638 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 14' ' ' LEU . 14.0 t -109.36 156.47 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -154.98 146.27 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.666 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -143.95 122.04 6.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.497 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 13.1 Cg_endo -57.72 101.18 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.092 1.861 . . . . 0.0 111.436 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.3 t0 -63.06 159.53 17.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -140.71 43.48 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.568 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.94 46.04 47.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.59 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 29' ' ' ASP . 10.5 m-85 -90.4 -171.51 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.409 0.623 . . . . 0.0 111.419 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 86' ' ' ILE . 27.7 t -130.8 -28.26 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.552 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.711 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.1 tp -139.43 135.45 33.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.205 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' ILE . 26.2 t80 -124.72 106.51 10.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.878 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.15 117.51 34.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 111.017 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.703 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 56.2 t80 -106.55 124.57 49.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -125.59 129.35 49.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -159.52 139.99 6.54 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 114.438 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.7 tmtp? -116.78 135.79 53.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.214 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 HG21 ' A' ' 101' ' ' VAL . 5.6 tp -91.05 125.83 35.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 16.6 t-20 65.46 50.06 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.528 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.8 tt0 170.27 110.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.021 0.439 . . . . 0.0 110.337 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.3 mt-10 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.508 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.83 0.347 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.92 -25.72 8.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 42.64 -124.96 4.18 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.088 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -137.36 -73.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.302 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 5.6 m-90 -63.61 82.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.717 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.26 93.04 3.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.212 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 4.3 tpm_? -141.46 125.77 17.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.945 0.402 . . . . 0.0 111.874 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.46 131.96 35.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.826 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.588 HD12 ' HD2' ' A' ' 34' ' ' PHE . 7.7 mt -117.44 143.86 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.983 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.42 26.6 4.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.0 mmmt -153.42 92.52 3.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.163 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 52.7 Cg_exo -52.72 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.252 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.8 -49.67 2.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.826 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -179.99 82.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.303 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.11 2.72 49.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HD3' ' CB ' ' A' ' 25' ' ' SER . 20.9 ttm-85 -157.61 140.49 15.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.523 0.201 . . . . 0.0 111.001 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.474 ' CG ' HD11 ' A' ' 26' ' ' ILE . 7.6 m95 -89.18 154.48 20.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.98 0.419 . . . . 0.0 110.311 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -134.73 119.89 18.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 17.0 t80 -113.65 106.8 14.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.614 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 139.39 38.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.428 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -137.37 105.37 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.729 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.29 22.77 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.632 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -134.06 29.87 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.51 99.16 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.073 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -74.09 75.93 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.764 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.633 HD11 ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -91.65 146.43 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.935 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.421 ' N ' HG11 ' A' ' 101' ' ' VAL . 9.6 ttpp -130.92 139.82 50.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -52.69 132.55 36.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.2 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.92 -29.17 12.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.067 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 7.8 t0 -66.35 153.87 41.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.019 0.438 . . . . 0.0 111.158 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 160.35 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.792 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -118.88 147.11 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.066 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 42.2 m-85 -144.55 129.43 18.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -161.11 -177.87 6.37 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.577 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.8 p-90 -151.02 133.06 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.481 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -99.98 156.98 16.86 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -178.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 12.0 t80 -139.24 138.8 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.62 0.247 . . . . 0.0 110.838 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -134.25 161.08 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.711 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.0 mm -135.85 107.19 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.968 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -100.35 57.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.538 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 68.55 68.7 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.741 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.831 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.97 25.47 75.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.392 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.94 73.02 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -87.63 160.96 31.9 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.289 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -152.22 153.1 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.749 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -132.84 147.84 52.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -104.05 76.75 1.37 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.399 177.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.19 177.27 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 61.78 17.28 8.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.801 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.18 163.91 54.9 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.951 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.47 153.84 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.459 . . . . 0.0 111.166 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.792 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.6 t90 -153.1 166.75 31.5 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -112.12 162.75 15.08 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.69 HG22 HD11 ' A' ' 79' ' ' ILE . 20.3 t -121.9 -9.26 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.668 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 76' ' ' GLY . 25.6 p -60.36 -14.35 18.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.718 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.45 162.36 22.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 89.9 m-85 -140.88 148.07 39.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 15' ' ' GLU . 4.7 m . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.81 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 20.6 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.924 0.392 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 93' ' ' ARG . 11.0 t -66.29 127.26 93.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.77 -177.12 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.467 2.112 . . . . 0.0 112.331 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 t -110.93 111.43 22.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.506 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.82 109.61 17.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.521 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.778 ' O ' HG13 ' A' ' 24' ' ' VAL . 9.4 mttt -84.23 164.45 19.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.187 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.727 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.2 mp -154.12 138.62 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.074 0.464 . . . . 0.0 112.094 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -135.2 136.7 41.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.496 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.745 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.75 114.52 23.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.7 mm -91.67 111.61 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -83.07 147.01 52.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.438 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 91.2 Cg_endo -92.23 -3.69 49.06 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.897 -1.293 . . . . 0.0 112.606 0.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 91.68 1.18 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.66 173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.574 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -153.44 144.51 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.507 ' H ' HD13 ' A' ' 22' ' ' LEU . 19.7 ttt180 -133.72 109.88 9.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 13' ' ' LYS . 30.0 t -122.76 142.88 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.357 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.52 146.94 33.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.2 pp -136.41 122.92 13.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.303 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 72.1 Cg_exo -47.61 108.68 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.494 2.129 . . . . 0.0 112.026 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 27.5 t0 -76.64 151.03 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 0.0 111.399 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t0 -140.89 46.09 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.752 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.98 69.85 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.404 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 10.1 m-85 -73.64 -170.97 0.94 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.637 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -132.94 -27.76 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.768 HD21 ' OD2' ' A' ' 55' ' ' ASP . 5.8 tp -139.87 127.25 21.39 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.251 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' HD12 ' A' ' 56' ' ' ILE . 2.4 t80 -118.49 94.36 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -101.82 114.78 29.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' TRP . 32.5 t80 -105.91 126.36 52.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.49 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.44 132.47 3.52 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.152 -1.499 . . . . 0.0 114.04 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 18.1 tptm -108.62 141.63 40.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 73' ' ' LEU . 62.4 tp -92.24 117.16 29.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.889 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 57.8 t-20 63.92 65.17 0.72 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 36.1 tt0 172.86 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.163 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 78.1 mt-10 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.436 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -57.44 -32.14 66.6 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.713 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.16 -103.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.279 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -148.59 -78.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 110.546 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 36' ' ' PHE . 10.6 m-90 -59.25 89.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.4 88.86 3.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.223 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -132.45 125.71 31.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.042 0.449 . . . . 0.0 111.776 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD21 ' A' ' 33' ' ' LEU . 10.2 t0 -105.74 94.31 5.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.45 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 58' ' ' LYS . 16.6 mt -81.49 146.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.142 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.17 22.71 6.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.678 ' H ' HG22 ' A' ' 56' ' ' ILE . 7.2 ptpt -154.89 100.54 2.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.1 Cg_exo -52.1 171.56 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.426 2.084 . . . . 0.0 112.542 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -114.66 40.9 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 6.4 tt0 84.0 86.65 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.845 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.96 -5.72 6.0 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.954 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 1.1 mtt180 -157.25 137.52 12.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.582 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.641 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.4 m95 -83.36 154.28 24.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -134.71 119.48 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 11.4 t80 -108.28 87.54 2.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.242 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 132.85 36.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.184 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.0 t0 -138.1 103.12 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 7.0 ptt-85 -89.18 22.41 2.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -133.1 42.07 3.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.5 100.76 7.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.93 99.82 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.655 HD11 HD23 ' A' ' 22' ' ' LEU . 2.5 mt -122.01 164.19 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -138.52 144.38 39.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.85 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -62.64 126.75 28.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.572 . . . . 0.0 110.724 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.757 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 125.37 -31.09 4.32 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.354 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.5 t0 -72.91 149.62 43.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 164.23 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 101' ' ' VAL . 2.8 mp -118.87 147.81 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.13 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 63.5 m-85 -144.46 125.77 14.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.579 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -157.5 -178.62 7.47 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.498 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.0 p-90 -155.7 134.6 12.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.671 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.733 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.81 160.97 13.9 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.941 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.916 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 16.3 t80 -145.33 105.46 4.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 111.06 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.61 165.17 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 19.7 mm -142.51 105.99 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.877 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.7 ttpt -96.05 70.01 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.427 0.454 . . . . 0.0 111.104 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 56.72 46.02 20.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.263 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.796 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 98.45 28.68 7.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.729 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -142.9 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -64.85 155.98 47.61 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.191 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.749 ' HB3' HG22 ' A' ' 9' ' ' VAL . 69.9 m-85 -152.52 134.24 14.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.34 -0.93 . . . . 0.0 108.677 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.869 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.9 140.7 49.15 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.562 0.696 . . . . 0.0 112.687 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.7 ' N ' HG11 ' A' ' 9' ' ' VAL . 2.5 tt0 -104.33 73.8 1.14 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.452 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.5 p30 -81.32 174.33 11.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.564 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.18 18.82 9.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.07 163.29 52.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.911 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -152.55 150.67 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.646 ' CE3' HD13 ' A' ' 79' ' ' ILE . 27.8 t90 -149.18 164.45 34.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -106.4 158.56 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 79' ' ' ILE . 21.5 t -119.86 -10.6 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.178 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.757 HG22 ' HA2' ' A' ' 76' ' ' GLY . 20.9 p -60.24 -11.51 6.53 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -132.47 148.12 52.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.745 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 40.9 m-85 -135.32 149.95 49.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.362 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.083 0.468 . . . . 0.0 110.491 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 9' ' ' VAL . 14.8 t . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.856 0.36 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.681 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.2 p -66.89 130.38 93.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.206 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' CD ' HG11 ' A' ' 85' ' ' VAL . 38.8 Cg_exo -60.35 -175.26 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.688 2.259 . . . . 0.0 112.383 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.83 125.81 52.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.58 105.7 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.726 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -95.87 109.78 22.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.009 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.3 mp -105.76 157.01 17.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.265 0.555 . . . . 0.0 112.266 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 38.4 mt-10 -140.69 141.44 34.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.512 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.13 122.78 30.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.157 0.503 . . . . 0.0 111.367 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.494 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.8 mm -104.69 109.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -79.0 150.55 75.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.883 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.59 -1.62 61.82 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.188 0.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.75 98.12 0.31 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.4 164.84 36.06 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 23' ' ' ARG . 22.9 tp -138.37 144.55 40.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 111.149 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.678 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -135.54 99.5 4.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.473 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.7 t -105.96 158.06 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.985 0.421 . . . . 0.0 111.774 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -155.13 149.76 26.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.667 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -144.51 126.92 8.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.0 Cg_endo -57.1 95.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.386 2.057 . . . . 0.0 111.568 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.7 t0 -59.17 160.63 6.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 3.9 t0 -145.86 45.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.152 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.55 89.63 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.885 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 85' ' ' VAL . 20.0 m-85 -83.67 -170.03 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.266 0.555 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -129.82 -29.27 2.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.645 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.7 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.86 137.54 34.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.508 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.709 ' HD2' HD12 ' A' ' 56' ' ' ILE . 25.2 t80 -127.4 97.02 4.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.463 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.832 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.06 135.63 37.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.412 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 52' ' ' TRP . 9.6 t80 -121.28 125.85 48.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -123.8 123.37 40.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -157.43 139.28 6.31 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 118.816 -1.659 . . . . 0.0 114.442 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -111.86 148.38 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.343 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tp -100.03 120.15 39.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.8 t-20 61.76 54.83 2.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 51.0 tt0 174.06 109.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 36.0 mt-10 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.9 mt-10 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.834 0.35 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.85 -26.57 10.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.655 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.71 -121.63 7.01 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.435 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -137.88 -73.71 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.749 0.309 . . . . 0.0 110.547 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.5 m-90 -61.3 90.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.037 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.22 87.28 2.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.142 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -136.6 129.63 31.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.989 0.423 . . . . 0.0 111.919 -179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -99.4 126.67 45.33 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.709 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.7 mt -111.96 142.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -130.71 28.7 4.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -155.92 98.12 2.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 36.1 Cg_exo -57.29 169.14 2.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.477 2.118 . . . . 0.0 112.589 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' ARG . 11.9 tptp -105.18 34.64 3.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.91 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 82.06 88.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.48 -5.86 13.95 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.864 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.0 mtt180 -157.26 130.42 7.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.563 ' CD1' HD11 ' A' ' 26' ' ' ILE . 15.6 m95 -78.64 158.16 28.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 67' ' ' ARG . 9.5 m -134.26 112.57 11.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' ILE . 5.2 t80 -113.8 85.39 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.599 ' HD2' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -103.96 151.13 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.45 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -138.13 113.19 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.13 22.39 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -143.83 31.01 1.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.5 128.8 44.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.5 96.15 5.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.68 152.47 28.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.12 150.63 41.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.184 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.622 HD23 ' HE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.42 130.8 46.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.421 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.15 25.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.8 t70 -56.39 152.91 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 152.64 29.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.543 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.71 HD11 HG22 ' A' ' 101' ' ' VAL . 2.6 mp -112.72 146.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 m-85 -144.55 126.16 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 79' ' ' ILE . 1.3 p90 -161.03 -176.72 5.65 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.509 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 61.2 p-90 -152.83 135.13 15.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.591 -1.64 . . . . 0.0 108.97 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 12' ' ' ALA . 14.1 p -99.79 163.74 12.34 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.2 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.832 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.0 t80 -145.1 113.8 6.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.667 0.27 . . . . 0.0 111.012 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -107.73 164.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.7 mm -138.99 104.48 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.4 59.66 1.86 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.573 0.545 . . . . 0.0 110.668 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 64.43 64.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.678 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.01 25.58 63.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.315 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.16 71.23 1.33 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.16 160.66 44.54 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.4 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -152.28 149.01 28.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.681 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.4 ptt180 -128.68 144.97 51.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.496 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.68 75.81 1.34 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.405 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.487 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.98 175.9 10.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.573 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.45 18.16 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.806 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.57 162.79 52.36 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.97 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -154.39 146.43 23.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.903 0.382 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -142.65 167.04 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.062 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.1 t -115.45 163.41 15.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 79' ' ' ILE . 3.4 t -125.83 17.78 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.923 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.537 ' HA ' HD13 ' A' ' 75' ' ' LEU . 1.2 p -65.95 -13.04 59.06 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.701 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.4 mt-10 -147.25 162.25 39.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.622 ' HE2' HD23 ' A' ' 75' ' ' LEU . 95.3 m-85 -130.47 140.69 50.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.704 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 121.166 0.507 . . . . 0.0 110.79 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.6 t . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.84 0.353 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 ' C ' ' A' ' 93' ' ' ARG . 12.0 p -71.92 142.79 85.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.4 Cg_exo -68.36 -178.44 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -110.33 120.76 43.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -82.27 116.05 21.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.473 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.3 ttmt -103.78 101.75 11.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.1 mp -91.23 168.6 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 111.838 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -155.92 154.09 30.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.473 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.94 128.34 35.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 111.825 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 16' ' ' ALA . 1.3 mp -112.66 115.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.715 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -78.85 143.7 62.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.6 Cg_endo -91.69 -4.11 49.93 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.037 -1.234 . . . . 0.0 112.491 -0.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -165.54 89.23 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.435 ' C ' ' HB ' ' A' ' 17' ' ' ILE . . . -156.48 -174.52 26.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.691 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -158.24 131.8 7.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.713 0.292 . . . . 0.0 110.829 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.713 ' N ' HD12 ' A' ' 22' ' ' LEU . 12.7 ttt85 -129.24 114.74 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 25' ' ' SER . 25.6 t -122.93 158.47 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 111.541 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.01 144.88 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.871 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.695 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.1 pp -138.22 127.04 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.101 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 18.0 Cg_endo -60.67 104.17 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.174 1.916 . . . . 0.0 111.693 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 14.5 t0 -66.82 158.12 31.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.49 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -142.78 45.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.673 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.88 46.12 47.28 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 6.5 m-85 -88.52 -172.64 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.519 0.676 . . . . 0.0 111.184 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 86' ' ' ILE . 9.7 m -133.19 -27.49 1.59 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.595 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.9 tp -141.5 131.05 23.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.121 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.624 ' O ' HD12 ' A' ' 56' ' ' ILE . 16.3 t80 -122.63 101.66 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -105.38 121.28 43.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 15.3 t80 -106.89 131.7 53.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -128.14 122.53 32.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -153.85 147.54 17.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 118.87 -1.633 . . . . 0.0 114.428 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.1 tmtt? -119.15 145.0 46.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 110.431 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 79' ' ' ILE . 11.9 tp -94.17 117.58 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.57 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 66.75 67.4 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.069 0.461 . . . . 0.0 110.491 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 80' ' ' TYR . 44.7 tt0 179.19 111.78 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . 20.3 mt-10 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.377 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -62.43 -19.03 63.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.059 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.04 -135.75 6.91 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -118.83 -76.8 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.708 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 10.2 m-90 -67.43 86.78 0.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.88 87.69 2.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.453 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.0 ttt180 -142.49 127.54 18.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 111.85 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.3 p30 -88.37 135.51 33.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' PHE . 1.9 mt -121.61 151.45 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.4 t -139.5 24.3 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.31 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 3.9 mtmp? -145.86 94.58 5.0 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.4 Cg_exo -53.53 -172.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.256 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.6 -48.69 2.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -178.79 83.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.432 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.43 -0.3 42.41 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.76 148.93 21.37 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 120.626 0.251 . . . . 0.0 110.803 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' A' ' 26' ' ' ILE . 11.4 m95 -90.19 161.09 15.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.177 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.9 m -134.32 116.7 15.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.516 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 6.1 t80 -106.25 95.29 5.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -101.28 139.8 36.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.413 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.06 106.16 5.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -89.21 22.5 2.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.679 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.07 38.32 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -104.85 115.79 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -73.93 76.58 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.708 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 10.5 mt -97.36 139.23 33.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.981 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 152.64 51.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.897 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -55.43 137.83 47.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.8 -29.47 7.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.62 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 12.4 t70 -58.88 160.16 6.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.951 0.405 . . . . 0.0 111.213 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -124.35 159.3 30.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.628 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 1.4 mp -116.07 145.22 22.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 112.018 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 43' ' ' GLU . 98.0 m-85 -144.52 126.53 15.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.917 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.6 p90 -161.32 -173.12 3.67 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.125 0.964 . . . . 0.0 113.427 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.508 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 11.7 p-90 -154.34 133.64 12.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.62 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 5.6 p -99.68 163.49 12.46 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.079 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 13.4 t80 -143.64 124.77 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.612 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -119.57 166.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.686 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 mm -141.34 106.28 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.921 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -103.63 64.49 0.81 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.711 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.3 t0 67.7 64.59 0.39 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.41 28.86 70.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.37 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.84 73.62 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 0.0 110.189 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.61 162.04 46.9 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.392 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 85' ' ' VAL . 28.5 m-85 -152.28 143.28 23.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.628 ' C ' HG11 ' A' ' 9' ' ' VAL . 10.3 ptt85 -126.08 142.97 51.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.4 tt0 -101.0 75.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.657 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 33.8 p-10 -78.32 174.77 10.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.623 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 t30 60.25 18.31 7.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.38 159.93 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.07 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -154.65 161.69 41.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.0 0.428 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.822 ' HB2' HD13 ' A' ' 14' ' ' LEU . 70.7 t90 -147.6 166.26 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.434 ' O ' ' CH2' ' A' ' 99' ' ' TRP . 5.5 t -110.25 155.74 21.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.615 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.0 t -118.79 7.88 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.328 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 19.1 m -70.94 -9.9 58.71 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.752 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -123.47 163.97 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.897 ' CE2' HD23 ' A' ' 75' ' ' LEU . 23.2 m-85 -137.28 120.82 17.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.862 HG11 ' HG2' ' A' ' 15' ' ' GLU . 6.2 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.963 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.788 0.327 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 43.1 t80 -86.03 175.12 8.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.097 0.475 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.8 t -118.99 159.9 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.356 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -68.05 138.51 92.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' HG11 ' A' ' 85' ' ' VAL . 36.0 Cg_endo -67.41 -172.57 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.421 2.081 . . . . 0.0 112.665 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -111.41 124.4 52.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.408 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.59 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -84.44 106.82 16.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 13.3 mttp -93.32 112.65 24.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.359 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 mp -101.16 164.96 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 112.055 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.648 ' O ' HD22 ' A' ' 22' ' ' LEU . 5.6 pt-20 -155.68 143.39 19.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.15 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.91 110.49 20.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 111.322 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 15.8 mm -81.5 145.25 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.321 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t80 -106.33 141.76 23.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.7 Cg_endo -93.14 -0.14 53.49 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.085 -1.214 . . . . 0.0 112.445 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -161.66 94.56 0.96 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -176.04 169.19 41.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.668 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -151.46 121.73 7.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.797 0.332 . . . . 0.0 110.587 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.572 ' N ' HD13 ' A' ' 22' ' ' LEU . 45.3 ttp85 -115.09 132.89 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 25' ' ' SER . 38.3 t -124.42 158.96 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.484 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.83 144.89 25.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.7 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.86 128.33 12.15 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.497 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 17.0 Cg_endo -58.01 95.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.513 2.142 . . . . 0.0 111.7 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 18.1 t0 -60.29 160.6 8.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -147.36 46.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.922 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.14 89.0 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.686 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' CD1' HG21 ' A' ' 85' ' ' VAL . 10.3 m-85 -84.15 -171.21 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.261 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -132.02 -28.33 1.76 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.66 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.4 tp -140.34 132.37 27.86 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.246 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 26' ' ' ILE . 44.1 t80 -124.59 92.85 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.523 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.612 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -86.83 132.08 33.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' HG22 ' A' ' 83' ' ' THR . 40.8 t80 -121.52 123.27 41.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.39 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -125.06 118.84 27.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -150.91 133.04 4.11 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.83 -1.652 . . . . 0.0 114.253 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -105.92 148.92 27.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.316 . . . . 0.0 110.338 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD13 ' HH2' ' A' ' 52' ' ' TRP . 17.6 tp -99.57 122.18 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.0 t-20 59.34 58.91 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.095 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.1 tt0 175.47 109.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 41.8 mt-10 -56.25 -168.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.13 148.49 13.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -134.53 45.4 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.01 -130.76 2.21 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.531 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.35 72.99 1.08 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 144.29 26.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.016 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.53 -25.21 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.633 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.29 -110.43 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.426 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -142.49 -80.09 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.735 0.303 . . . . 0.0 110.584 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.663 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 17.3 m-90 -61.05 94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.43 83.0 1.94 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.318 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -133.77 133.67 41.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.56 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.612 ' OD1' ' HB2' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -106.43 111.65 24.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.893 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.694 HD12 ' HD2' ' A' ' 34' ' ' PHE . 9.7 mt -93.06 152.09 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 33' ' ' LEU . 78.7 p -119.91 -23.59 6.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.71 121.0 27.58 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.59 0.233 . . . . 0.0 111.23 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.469 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 31.7 Cg_exo -58.66 -164.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.409 2.072 . . . . 0.0 112.086 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -45.65 2.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 179.18 80.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.499 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.88 0.59 34.68 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 8.0 mtm180 -156.99 131.23 8.47 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.682 -0.259 . . . . 0.0 110.389 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.573 ' CG ' HD11 ' A' ' 26' ' ' ILE . 15.0 m95 -77.09 155.62 32.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.92 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -134.72 118.95 17.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.394 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 49.6 t80 -110.62 89.45 3.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.079 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.93 137.45 32.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.274 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -138.11 100.91 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.591 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 22.44 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.597 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.65 26.79 5.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.315 . . . . 0.0 111.037 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.92 100.1 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -73.78 75.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.803 ' CD1' HD23 ' A' ' 22' ' ' LEU . 4.1 mt -86.31 163.47 17.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.791 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -141.65 148.2 38.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.035 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -55.62 142.22 34.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.259 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.5 -32.43 6.26 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.4 t70 -59.83 151.19 26.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.912 0.387 . . . . 0.0 111.149 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -114.7 154.3 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.517 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.3 mp -109.25 146.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.061 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 97.6 m-85 -144.17 122.34 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.907 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.4 p90 -157.8 -174.9 5.08 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 66.9 p-90 -154.77 131.6 10.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.329 -1.759 . . . . 0.0 108.816 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 76.5 p -110.35 151.87 26.91 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.703 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.81 ' CE2' HD11 ' A' ' 86' ' ' ILE . 19.9 t80 -135.76 129.43 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.105 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -113.73 164.08 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.375 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' CE2' ' A' ' 84' ' ' TYR . 24.4 mm -137.52 107.28 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.883 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -99.94 57.12 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.5 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 t0 68.95 69.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.771 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.816 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.75 25.29 75.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.31 73.72 1.39 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.201 0.524 . . . . 0.0 110.233 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.25 161.08 29.92 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.552 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -152.13 146.56 25.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.741 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -124.37 150.55 45.41 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -106.6 72.27 0.9 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.665 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.3 p-10 -78.47 176.03 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.47 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 61.05 18.23 8.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.76 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.62 162.44 54.31 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.87 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 79' ' ' ILE . 2.8 tt0 -154.39 155.28 34.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.895 0.379 . . . . 0.0 111.111 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.634 ' HB2' HD13 ' A' ' 14' ' ' LEU . 51.7 t90 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.423 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.4 t -108.52 159.75 16.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 101' ' ' VAL . 17.5 t -121.42 -1.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.795 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.405 ' CG2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -66.82 -9.92 42.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.813 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.7 pt-20 -131.45 150.61 52.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 8.9 m-85 -129.45 143.44 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.012 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -98.69 162.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 0.0 111.094 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.703 ' ND2' ' HB2' ' A' ' 112' ' ' ALA . 7.0 m-20 -86.21 152.15 23.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.31 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.19 -18.08 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.55 -31.31 68.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.944 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.72 18.98 5.05 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.381 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.9 p -139.69 157.61 69.64 Favored Pre-proline 0 CA--C 1.517 -0.317 0 CA-C-O 121.334 0.587 . . . . 0.0 111.366 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 51.2 Cg_exo -51.66 126.2 19.01 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.976 2.451 . . . . 0.0 113.083 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HB2' ' ND2' ' A' ' 106' ' ' ASN . . . -114.74 42.69 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.654 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -128.25 100.82 5.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.768 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.836 HG23 HD12 ' A' ' 116' ' ' LEU . 6.0 t -115.64 43.8 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.003 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.0 m 60.56 54.1 3.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.836 HD12 HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -138.88 79.94 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -87.37 112.61 49.28 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.399 2.066 . . . . 0.0 112.339 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.816 0.341 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 46.0 t80 -66.5 175.61 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.2 t -115.59 159.22 15.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.45 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -72.96 138.77 79.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.57 ' HD2' HG11 ' A' ' 85' ' ' VAL . 41.1 Cg_endo -67.06 -167.89 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.601 2.2 . . . . 0.0 112.455 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -109.47 114.98 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.367 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.887 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.12 104.87 13.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.8 159.22 23.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.751 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.37 150.9 32.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.193 0.521 . . . . 0.0 111.888 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -145.71 142.78 29.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.941 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.83 115.73 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 23' ' ' ARG . 17.0 mm -88.25 129.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.244 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 25.2 t80 -93.77 141.5 23.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -94.17 4.52 53.74 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.332 -1.112 . . . . 0.0 112.477 0.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.97 97.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.025 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.25 176.95 47.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.326 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -150.73 138.87 20.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 110.998 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.804 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.44 110.74 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.491 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 13' ' ' LYS . 24.0 t -119.82 146.58 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.82 151.63 36.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.548 HD11 ' CG ' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -139.95 130.12 13.97 Favored Pre-proline 0 N--CA 1.467 0.406 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.008 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.98 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.243 1.962 . . . . 0.0 111.567 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 22.5 t0 -61.98 160.7 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.691 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 30.0 t70 -150.46 45.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.757 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.48 92.34 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.336 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 85' ' ' VAL . 21.3 m-85 -76.81 -124.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.348 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -179.58 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.4 tp -140.8 131.21 25.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.703 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 24.1 t80 -120.01 108.34 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.142 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -111.05 120.59 42.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 18.4 t80 -110.04 128.81 55.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.635 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -124.74 124.75 42.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.9 140.03 7.12 Favored Glycine 0 CA--C 1.51 -0.25 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.143 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.0 ttmt -112.21 149.18 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 110.468 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD1' HD23 ' A' ' 73' ' ' LEU . 4.8 tp -98.09 119.46 36.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.078 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.5 t-20 62.53 57.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.06 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 52.7 tt0 177.24 109.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.35 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 32.3 mt-10 -57.9 -169.51 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.634 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.69 151.66 3.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.352 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 67.8 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.022 0.439 . . . . 0.0 110.759 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.16 -136.81 5.84 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.689 HD22 ' CH2' ' A' ' 82' ' ' TRP . 22.0 mt -119.71 68.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.144 0.497 . . . . 0.0 110.895 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.73 156.82 23.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -60.88 -17.12 48.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 40.74 -131.56 3.06 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.935 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 3.0 t60 -129.8 -68.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.79 0.328 . . . . 0.0 110.574 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 7.9 m-90 -77.13 90.87 3.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.992 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.07 88.54 2.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.931 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.2 tpm_? -133.81 127.63 33.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.93 118.86 32.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 58' ' ' LYS . 26.7 mt -100.04 146.76 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.352 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.721 HG22 ' CD1' ' A' ' 33' ' ' LEU . 8.9 p -132.77 36.21 3.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.564 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.21 91.4 1.72 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 43.2 Cg_exo -56.91 171.93 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.592 2.195 . . . . 0.0 112.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.15 32.84 4.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.792 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 79.46 89.5 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.04 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 73.16 -3.51 29.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.957 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -157.67 127.26 6.0 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.796 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.548 ' CG ' HD11 ' A' ' 26' ' ' ILE . 13.2 m95 -79.85 157.58 26.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -134.33 118.71 17.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 11.6 t80 -116.57 84.97 2.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -94.66 146.41 24.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.142 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD1' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -138.0 109.78 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 22.24 2.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -144.03 36.55 1.26 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.08 126.71 44.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -79.46 75.86 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.735 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 40' ' ' LEU . 39.7 mt -101.23 130.73 47.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.784 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -121.03 153.89 36.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.961 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.75 132.01 51.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.283 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.88 -26.55 16.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.504 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.3 t70 -55.43 154.46 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 151.01 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.536 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -110.42 147.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 112.162 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 37.6 m-85 -144.31 125.31 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 2.1 p90 -160.64 -174.27 4.37 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.689 ' CH2' HD22 ' A' ' 47' ' ' LEU . 57.9 p-90 -151.99 134.32 15.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.288 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.65 161.28 13.71 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.013 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.791 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 10.5 t80 -141.4 138.19 32.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.703 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.24 161.86 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.722 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 33.7 mm -136.79 111.19 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.722 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.8 tttt -105.7 67.93 0.77 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.748 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.26 55.86 2.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.808 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 81.82 28.17 43.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.434 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.7 mt -143.84 75.24 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.215 0.531 . . . . 0.0 110.212 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.08 160.56 40.71 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.376 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 91' ' ' GLY . 29.3 m-85 -152.26 153.04 32.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.675 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -135.74 146.59 47.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.452 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 3.0 tt0 -104.68 75.42 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.461 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.9 p30 -78.2 175.22 10.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.565 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 60.47 18.54 8.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.61 161.6 52.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.005 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -154.46 145.49 22.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.536 ' CE3' HD13 ' A' ' 79' ' ' ILE . 42.0 t90 -141.12 165.95 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.079 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.8 t -111.15 162.02 15.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.56 ' O ' HD22 ' A' ' 75' ' ' LEU . 2.8 t -124.37 11.53 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -73.1 -10.2 59.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.921 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.827 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.6 mt-10 -122.98 140.99 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.703 0.287 . . . . 0.0 110.799 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 75' ' ' LEU . 9.8 m-85 -122.15 129.42 52.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 110' ' ' THR . 28.5 m -98.8 166.8 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.206 0.527 . . . . 0.0 111.239 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 110' ' ' THR . 33.8 t30 -81.21 154.16 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.372 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.34 -16.35 5.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -31.93 63.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.033 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.62 22.57 3.98 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.368 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 1.1 p -133.96 166.78 26.67 Favored Pre-proline 0 C--O 1.222 -0.353 0 CA-C-N 117.046 0.423 . . . . 0.0 110.915 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 36.6 Cg_endo -71.8 118.45 5.64 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.056 1.837 . . . . 0.0 112.13 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -174.04 74.58 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.558 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.07 145.62 49.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.7 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.8 p -64.97 -51.74 60.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 m -70.23 105.65 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -172.7 83.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.962 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 62.49 148.49 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.972 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.549 2.166 . . . . 0.0 112.295 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.905 0.383 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 50.2 t80 -93.73 174.59 7.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 111.031 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.3 t -112.53 162.01 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.224 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.642 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.7 p -66.74 130.4 94.02 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.267 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 24.2 Cg_exo -63.14 -170.25 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.72 2.28 . . . . 0.0 112.587 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t -110.87 124.97 53.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.47 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -77.64 104.49 8.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.24 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.54 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.252 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.661 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.2 mp -106.18 162.44 13.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.93 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 24.9 mm-40 -152.96 145.3 24.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.945 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.893 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -87.07 120.85 28.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 111.567 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' CG2' ' A' ' 105' ' ' VAL . 18.6 mm -98.19 114.25 35.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.176 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 54.5 t80 -79.21 142.03 58.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 98.9 Cg_endo -96.73 4.99 40.44 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.603 0.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.76 95.63 0.9 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.907 0.385 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . 169.23 167.19 29.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.555 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB3' HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -158.27 121.8 3.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.745 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 tmm_? -97.07 134.91 39.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 ' HG ' ' A' ' 14' ' ' LEU . 39.8 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.009 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.01 152.95 30.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.553 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.2 pt -147.37 122.03 5.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.48 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 9.4 Cg_endo -55.24 99.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.105 1.87 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 20.1 t0 -62.68 161.48 12.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.597 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -145.39 44.69 1.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.671 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.58 42.69 62.7 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.736 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CG ' ' CG2' ' A' ' 85' ' ' VAL . 9.2 m-85 -88.08 -171.19 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.401 0.62 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' ILE . 37.8 t -132.04 -27.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.697 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.717 HD12 HG22 ' A' ' 57' ' ' THR . 8.0 tp -138.3 134.99 35.0 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.254 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.756 ' HD2' HD12 ' A' ' 56' ' ' ILE . 18.6 t80 -126.31 90.65 3.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -84.89 124.65 31.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.659 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 52' ' ' TRP . 78.8 t80 -114.59 117.59 31.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.4 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.808 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -122.57 125.46 45.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -157.65 141.88 8.14 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.927 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.0 148.54 40.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 110.447 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.444 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.7 tp -99.46 126.16 45.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 7.7 t-20 58.1 53.49 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.1 tt0 176.69 109.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.167 0.508 . . . . 0.0 110.382 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 29.2 mt-10 -57.81 -168.13 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.442 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.33 154.04 24.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.186 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -142.84 85.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 111.06 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 99.48 99.17 2.21 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.617 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' CZ3' ' A' ' 82' ' ' TRP . 1.2 mt 16.25 72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.618 0.767 . . . . 0.0 112.64 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -89.34 147.95 23.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.823 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -56.33 -20.31 18.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.599 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.52 -130.47 4.93 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.923 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -129.3 -70.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 6.8 m-90 -72.77 94.06 1.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.808 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.09 91.98 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 1.1 tpt85 -139.51 125.58 19.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -86.4 130.35 34.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.36 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.756 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.9 mt -110.42 152.97 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.344 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.717 HG22 HD12 ' A' ' 33' ' ' LEU . 32.9 p -144.48 27.78 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -151.05 87.38 4.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 21.6 Cg_exo -66.02 -170.3 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.816 2.344 . . . . 0.0 112.445 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -121.95 24.14 9.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.588 178.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 82.49 90.96 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.352 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 76.0 0.76 65.94 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.759 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -157.83 121.3 4.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.553 ' CD1' HD11 ' A' ' 26' ' ' ILE . 19.2 m95 -82.95 157.57 22.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 119.7 18.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.57 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 56' ' ' ILE . 31.9 t80 -122.64 93.76 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 mmm-85 -95.49 143.35 26.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.345 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.13 94.25 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -89.27 22.6 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.597 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -126.67 28.66 5.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.71 110.79 20.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -74.01 76.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 22' ' ' LEU . 6.8 mt -86.79 153.28 21.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.9 142.92 47.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.019 0.438 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.6 OUTLIER -54.14 132.0 42.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.297 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.98 -28.37 12.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.2 t70 -62.84 161.77 12.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 111.079 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -121.07 158.4 27.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.375 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG21 ' CE2' ' A' ' 81' ' ' PHE . 1.3 mp -116.73 145.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.112 0.482 . . . . 0.0 112.176 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 31.1 m-85 -144.3 126.33 15.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 0.6 OUTLIER -157.46 -174.18 4.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.517 ' CZ3' HD22 ' A' ' 47' ' ' LEU . 31.9 p-90 -156.7 128.27 7.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.705 -1.588 . . . . 0.0 108.449 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 6.5 p -106.9 152.63 23.66 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.2 t80 -135.9 117.36 14.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -103.99 163.77 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.266 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.771 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.3 mm -137.16 109.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.845 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.89 68.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.875 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 63.31 65.53 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.799 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.0 27.01 73.58 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.399 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -144.52 74.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.179 0.514 . . . . 0.0 110.097 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -89.54 162.11 30.28 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.473 -0.785 . . . . 0.0 114.375 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.05 147.71 26.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.642 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -126.06 141.23 52.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.488 ' N ' HG21 ' A' ' 9' ' ' VAL . 2.6 tt0 -99.26 76.44 2.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.237 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.5 p30 -83.43 179.69 7.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.232 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.0 t30 59.05 18.38 6.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.57 163.24 44.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.078 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.39 158.38 39.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.1 0.476 . . . . 0.0 111.476 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.459 ' CE3' HD13 ' A' ' 79' ' ' ILE . 49.7 t90 -147.66 165.69 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 5.8 t -107.75 157.44 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.9 t -119.69 -4.19 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.638 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' CD2' ' A' ' 75' ' ' LEU . 27.3 m -62.1 -15.97 49.05 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.607 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -108.93 159.19 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.444 ' HB2' ' CB ' ' A' ' 113' ' ' ASP . 21.0 m-85 -138.09 129.87 28.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 16' ' ' ALA . 22.7 m -98.67 179.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.29 0.567 . . . . 0.0 111.956 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -92.34 152.94 19.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.411 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.94 -16.55 7.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.27 -30.75 65.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.179 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.6 18.46 5.27 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.452 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 p -138.01 154.95 74.71 Favored Pre-proline 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 111.512 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 31.4 Cg_exo -57.7 121.52 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.026 2.484 . . . . 0.0 112.388 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 111' ' ' PRO . . . 171.28 79.97 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.56 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.444 ' CB ' ' HB2' ' A' ' 104' ' ' PHE . 35.9 t70 -116.85 90.82 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.641 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 114' ' ' THR . 8.8 t -61.14 90.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.231 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.62 -170.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tt -125.62 67.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -143.35 132.67 11.64 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.444 2.096 . . . . 0.0 112.367 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.803 0.335 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 34.8 t80 -95.75 176.06 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.235 0.54 . . . . 0.0 111.087 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 9' ' ' VAL . 28.4 t -125.3 162.89 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.068 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.1 p -66.56 138.28 95.53 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 9' ' ' VAL . 36.6 Cg_endo -66.01 -168.09 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.493 2.129 . . . . 0.0 112.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -109.55 116.99 32.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -80.45 107.9 13.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.401 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' C ' HD12 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -81.86 156.81 24.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.74 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 5.1 mp -146.69 149.9 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.45 . . . . 0.0 111.879 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -148.66 142.37 25.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.95 114.51 23.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.123 0.487 . . . . 0.0 111.465 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 105' ' ' VAL . 24.3 mm -89.68 130.39 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.238 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.1 t80 -92.93 142.27 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 94.6 Cg_endo -92.49 -2.69 50.5 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.484 0.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -163.27 95.52 0.85 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.9 171.16 43.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.282 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -147.47 132.02 17.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.0 111.25 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.692 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.6 ttt180 -117.97 125.8 51.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.391 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.487 HG23 HD12 ' A' ' 22' ' ' LEU . 61.9 t -126.85 152.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -152.45 145.1 24.23 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.985 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.1 pp -143.98 117.06 5.77 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.304 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.11 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.419 2.079 . . . . 0.0 112.284 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 43.0 t0 -80.14 143.52 33.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 0.0 111.361 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -133.96 48.88 2.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.608 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.91 38.49 96.11 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.889 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CD1' HG21 ' A' ' 85' ' ' VAL . 22.1 m-85 -68.65 -123.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.282 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 177.32 -35.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 57' ' ' THR . 7.5 tp -141.12 126.3 18.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.088 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.704 ' HD2' HD12 ' A' ' 56' ' ' ILE . 11.8 t80 -118.67 95.02 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -93.61 120.14 33.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.486 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.0 t80 -105.83 126.91 52.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.266 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.47 122.29 33.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.37 139.38 6.16 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.806 -1.664 . . . . 0.0 114.211 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -117.23 146.97 42.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.503 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.0 tp -89.3 133.09 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 44.76 63.08 1.82 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 177.49 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.38 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 80' ' ' TYR . 50.9 mt-10 -56.0 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.383 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 81' ' ' PHE . 2.0 mtp -147.47 144.25 28.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.656 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.42 77.67 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 84.13 101.93 0.58 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.429 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.8 mt 24.72 88.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.511 0.724 . . . . 0.0 112.527 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -109.65 143.0 40.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.547 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.56 -45.25 56.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.51 -122.44 28.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.17 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -137.96 -72.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.904 0.383 . . . . 0.0 110.451 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.459 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.1 m-90 -60.76 88.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.946 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.79 94.3 4.4 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.001 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 3.9 tpt85 -146.94 127.83 14.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.971 0.415 . . . . 0.0 112.117 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.22 123.93 35.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.386 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.704 HD12 ' HD2' ' A' ' 34' ' ' PHE . 14.5 mt -108.15 151.47 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.363 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.858 HG22 HD12 ' A' ' 33' ' ' LEU . 28.5 p -141.11 30.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.8 pttm -153.15 92.16 3.3 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.2 Cg_exo -58.25 169.03 3.19 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.572 2.181 . . . . 0.0 112.562 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.93 33.93 3.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.828 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 81.12 88.27 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.161 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.64 -2.74 21.46 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.846 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -157.61 124.2 4.93 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.619 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.1 m95 -76.62 154.94 33.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -134.67 120.52 19.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.474 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.658 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.7 t80 -121.41 106.08 11.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -110.17 141.4 43.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -138.09 111.17 7.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.763 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -89.37 22.34 2.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.347 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -125.52 36.8 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.82 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 81.23 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.654 HD11 HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -78.97 169.9 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.599 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.66 145.22 46.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -55.22 136.86 48.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.18 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.31 -29.84 9.58 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.275 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.3 t70 -59.33 152.92 20.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -115.25 148.89 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.438 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.544 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -105.31 150.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.056 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 43' ' ' GLU . 75.1 m-85 -144.07 128.04 17.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.161 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.9 p90 -161.07 -174.4 4.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.085 0.945 . . . . 0.0 113.361 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 52.4 p-90 -158.67 135.79 9.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.626 -1.625 . . . . 0.0 109.13 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 12' ' ' ALA . 32.5 p -99.36 163.03 12.7 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.27 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.87 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 14.8 t80 -144.93 105.5 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.8 164.38 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.87 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.3 mm -141.03 109.65 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.598 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 67.4 0.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.31 65.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.17 28.53 71.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.48 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.43 73.27 1.39 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.177 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -83.18 160.64 38.64 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.501 -0.772 . . . . 0.0 114.233 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -152.24 147.85 26.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.604 ' C ' HG11 ' A' ' 9' ' ' VAL . 12.4 ptt-85 -126.28 147.65 49.66 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.529 0.681 . . . . 0.0 112.701 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -106.01 74.07 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.439 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.0 p30 -82.27 176.21 9.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.703 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 60.05 19.76 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.625 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.86 162.15 42.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -154.34 162.7 41.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.963 0.411 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CE3' HD13 ' A' ' 79' ' ' ILE . 46.9 t90 -155.08 165.82 35.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.166 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.438 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.2 t -105.65 160.88 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 101' ' ' VAL . 21.4 t -121.89 -0.3 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.746 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 p -63.44 -14.06 46.66 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -129.17 154.55 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.704 0.288 . . . . 0.0 110.879 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.589 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -135.54 144.63 46.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 17' ' ' ILE . 17.3 m -98.77 168.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 0.0 110.83 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 110' ' ' THR . 9.7 m-20 -86.59 151.13 23.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.225 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -54.85 -17.44 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.09 -29.98 64.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.192 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.81 14.43 6.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.227 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.2 p -134.07 161.21 65.12 Favored Pre-proline 0 CA--C 1.515 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.886 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 77.9 Cg_exo -46.48 130.55 14.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.861 2.374 . . . . 0.0 113.11 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.51 112.54 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.412 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -123.81 -169.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 65.9 37.74 5.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -147.06 90.66 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.813 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 tp 61.94 73.37 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.823 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.73 94.76 28.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.525 2.15 . . . . 0.0 112.397 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.776 0.322 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 37.1 t80 -95.58 177.23 5.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 23.0 t -124.77 162.27 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.293 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.791 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.7 p -66.59 131.03 94.09 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 20.8 Cg_exo -65.47 -177.53 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.356 2.038 . . . . 0.0 111.988 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -107.79 129.73 55.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 111.674 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.682 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -81.0 101.17 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.224 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -83.26 100.63 10.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.357 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 3.7 mp -92.96 157.52 16.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 99' ' ' TRP . 5.8 mm-40 -148.92 142.23 25.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.227 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.86 110.54 20.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.141 0.496 . . . . 0.0 111.29 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 23' ' ' ARG . 19.0 mm -83.35 150.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.252 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -114.0 143.83 30.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.737 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 9.9 Cg_endo -89.55 3.5 69.26 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.285 0.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -170.18 98.39 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.807 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -172.42 -176.45 41.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.426 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -158.07 134.87 9.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 17' ' ' ILE . 4.1 tmm_? -126.25 119.79 28.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.11 147.75 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.282 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.52 148.82 34.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -146.61 126.32 6.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.68 116.35 2.31 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.259 1.973 . . . . 0.0 111.681 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB3' ' C ' ' A' ' 62' ' ' GLY . 46.3 t0 -83.06 112.11 19.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 0.0 111.335 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 24.2 t0 -101.43 43.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.813 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.03 31.84 80.1 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.882 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CD2' HG11 ' A' ' 85' ' ' VAL . 95.5 m-85 -61.2 -113.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.799 0.299 . . . . 0.0 110.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . 6.7 t 176.87 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.749 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.4 132.02 28.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.793 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CD1' HD13 ' A' ' 26' ' ' ILE . 17.0 t80 -122.32 98.0 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.732 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -102.3 119.03 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 40.1 t80 -106.01 128.36 53.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -125.64 122.11 35.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.582 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -159.98 145.95 12.0 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.863 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 161.6 21.19 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.456 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 HD22 ' A' ' 73' ' ' LEU . 21.3 tp -96.51 118.19 32.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.258 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 52.7 t30 57.66 70.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 73.9 tt0 171.33 110.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.375 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 51.4 mt-10 -57.21 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.139 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -152.05 149.25 28.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.556 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -137.16 81.78 1.89 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 90.42 100.53 1.16 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.462 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 46' ' ' GLY . 2.0 mt 20.88 89.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.736 0.814 . . . . 0.0 112.742 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.83 138.54 40.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.723 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -53.54 -30.91 44.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.642 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.46 -137.44 15.67 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.584 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.1 -74.78 0.6 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 12.5 m-90 -60.43 90.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.069 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.96 85.22 2.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.868 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -130.63 127.63 39.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.934 0.397 . . . . 0.0 111.735 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -94.43 110.89 22.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.517 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mm -92.1 133.75 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 t -129.79 36.65 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.05 90.35 1.23 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.9 Cg_exo -53.6 170.26 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.74 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 1.2 tmtm? -112.93 42.13 1.94 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.461 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 1.3 mp0 72.77 88.62 0.1 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.489 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.23 -3.47 22.73 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.052 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 7.1 ttt180 -157.84 125.52 5.25 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.847 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.465 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 11.9 m95 -76.3 154.7 34.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.0 m -134.63 120.64 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.505 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 14.7 t80 -120.5 115.7 23.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -111.14 145.1 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.243 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.08 104.34 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 22.49 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.64 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.03 40.72 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.349 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.53 93.11 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -73.95 75.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.691 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 HD23 ' A' ' 22' ' ' LEU . 4.6 mt -97.69 168.01 10.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -142.02 143.82 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.3 OUTLIER -52.57 133.2 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.352 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.96 -28.89 11.68 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.216 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' A' ' 101' ' ' VAL . 8.5 t70 -64.39 162.62 14.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.851 0.358 . . . . 0.0 111.244 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -121.47 158.42 28.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.207 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 81' ' ' PHE . 1.3 mp -113.89 149.91 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.173 0.511 . . . . 0.0 112.17 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 m-85 -143.84 125.18 14.68 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.682 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 1.7 p90 -159.5 -175.3 5.11 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.275 1.035 . . . . 0.0 113.721 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.439 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 38.7 p-90 -153.46 133.95 13.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.483 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -99.94 155.48 17.66 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.163 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.1 t80 -135.6 109.66 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 0.0 111.168 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.834 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -102.91 168.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.393 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.749 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 45.7 mm -145.5 104.44 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 O-C-N 123.292 0.37 . . . . 0.0 111.03 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -98.64 75.85 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.357 . . . . 0.0 110.328 179.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.25 57.88 1.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.355 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.862 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.27 17.76 77.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.277 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.97 69.58 1.28 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.423 0.63 . . . . 0.0 110.013 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 85' ' ' VAL . . . -83.58 -170.42 46.36 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.432 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 85' ' ' VAL . 21.2 m-85 -151.97 171.04 18.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.775 -0.712 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.791 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -144.18 143.7 31.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.442 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.13 74.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.519 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -77.9 174.21 11.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.37 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 59.56 19.42 7.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.35 162.79 53.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.198 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 2.9 tt0 -154.4 147.46 24.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 54.2 t90 -141.49 165.23 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.366 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 6.5 t -106.06 156.7 18.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 77' ' ' ASP . 4.6 t -119.86 -3.59 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.936 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 75' ' ' LEU . 18.7 m -62.06 -16.1 49.57 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.935 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.657 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.1 mt-10 -125.09 150.75 46.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 7.7 m-85 -132.63 145.54 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 12.8 m -98.59 164.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 0.0 110.834 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 110' ' ' THR . 24.4 t30 -89.43 151.3 22.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.479 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.46 -17.93 6.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.4 -30.93 67.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.846 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.57 20.54 4.61 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.261 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -143.07 159.06 57.4 Favored Pre-proline 0 C--O 1.223 -0.319 0 CA-C-O 121.339 0.59 . . . . 0.0 111.44 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 77.3 Cg_exo -49.34 126.73 16.33 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.022 2.481 . . . . 0.0 113.31 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.46 96.86 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.318 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.51 169.99 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.17 90.69 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -164.97 121.75 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 84.1 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.04 116.07 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.888 0.375 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 41.2 t80 -91.24 175.92 6.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.186 0.517 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 9' ' ' VAL . 19.4 t -117.24 160.74 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.748 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.3 p -66.65 137.69 95.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD2' HG11 ' A' ' 85' ' ' VAL . 43.5 Cg_endo -70.54 -171.01 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.51 2.14 . . . . 0.0 112.89 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -108.27 127.36 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -85.71 106.88 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.605 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 108.45 21.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.67 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.8 mp -102.7 156.03 17.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 112.154 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -137.19 140.62 41.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.014 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.49 100.87 12.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.176 0.512 . . . . 0.0 111.361 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 12.5 mm -74.73 141.95 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.309 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 26.2 t80 -104.16 141.05 21.71 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.57 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 77.3 Cg_endo -94.41 2.8 51.43 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.306 -1.122 . . . . 0.0 112.369 0.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.67 96.46 0.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.582 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.5 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -177.52 165.87 35.91 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.678 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 23' ' ' ARG . 4.8 tp -138.95 143.64 38.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.746 ' N ' HD12 ' A' ' 22' ' ' LEU . 4.3 ttt180 -135.19 101.91 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.856 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.67 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.9 t -100.32 158.53 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.407 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -152.68 145.0 23.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.701 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.681 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -144.75 126.67 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.788 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 13.2 Cg_endo -56.67 95.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.454 2.103 . . . . 0.0 111.709 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.71 159.69 8.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.1 t0 -146.85 44.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.585 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.61 40.77 85.75 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.529 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.7 m-85 -82.96 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.374 0.607 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -131.72 -27.53 1.9 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.515 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 6.7 tp -140.01 132.28 28.24 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.876 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.703 ' HD2' HD12 ' A' ' 56' ' ' ILE . 31.2 t80 -123.68 98.36 5.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.313 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -91.88 124.85 36.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 36.7 t80 -116.95 122.69 45.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.352 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -160.85 147.36 14.0 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 118.918 -1.611 . . . . 0.0 114.073 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 132.08 53.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.58 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 101' ' ' VAL . 11.0 tp -79.82 105.69 11.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.1 t-20 76.59 65.39 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 37.6 tt0 171.98 109.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 32.4 mt-10 -53.36 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -172.34 122.99 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.413 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -118.47 70.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.381 . . . . 0.0 110.793 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.63 -129.15 2.83 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.671 HD22 ' CH2' ' A' ' 82' ' ' TRP . 35.5 mt -124.86 56.89 1.29 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.198 0.523 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -69.08 146.76 52.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.14 -24.38 10.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.672 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.43 -139.57 1.7 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.636 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 12.6 m170 -122.43 -74.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.163 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.652 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -67.98 88.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -117.98 86.37 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 ttm180 -135.02 143.85 46.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.982 0.42 . . . . 0.0 111.707 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -107.76 118.62 37.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.627 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.8 mt -95.1 151.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.069 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 44.7 p -140.24 42.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.133 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 98.19 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 58.8 Cg_exo -52.08 -176.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.506 2.138 . . . . 0.0 112.228 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -48.51 3.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.157 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -178.8 80.76 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.537 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . 70.81 2.05 42.86 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.7 mtt180 -156.79 133.43 10.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.711 -0.244 . . . . 0.0 110.597 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.562 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.4 m95 -79.77 153.97 28.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.3 m -135.2 120.26 18.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 44.0 t80 -110.55 82.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.521 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -92.3 126.94 37.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.291 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -138.04 111.44 8.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.812 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 22.29 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.345 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.59 31.24 6.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -108.48 127.0 53.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.052 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -87.24 75.86 9.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.765 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.652 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 56.0 mt -82.5 154.54 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -130.93 144.51 51.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.409 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -67.35 131.46 45.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.386 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.88 -24.69 25.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.622 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 40' ' ' LEU . 8.9 t70 -59.36 159.97 7.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -108.36 164.83 11.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.588 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.636 HG13 ' CE3' ' A' ' 99' ' ' TRP . 5.1 mm -125.99 146.17 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 75.4 m-85 -144.44 130.92 19.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.413 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 4.0 p90 -161.57 -176.4 5.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 122.156 0.979 . . . . 0.0 113.607 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.671 ' CH2' HD22 ' A' ' 47' ' ' LEU . 66.5 p-90 -153.37 133.28 13.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.477 -1.692 . . . . 0.0 108.293 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.701 HG21 ' HB2' ' A' ' 12' ' ' ALA . 1.8 p -111.95 153.27 27.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.098 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.817 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.5 t80 -136.39 141.02 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.277 0.361 . . . . 0.0 110.704 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -128.85 163.25 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.804 HD11 ' CE2' ' A' ' 84' ' ' TYR . 25.6 mm -137.52 107.23 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.904 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.22 68.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t0 63.62 65.77 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.804 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.6 29.0 71.62 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.533 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.1 mt -144.2 75.2 1.45 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.132 0.491 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.23 159.08 27.21 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.505 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -152.43 150.47 29.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.748 ' C ' HG11 ' A' ' 9' ' ' VAL . 18.1 ptt-85 -129.09 149.99 50.67 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.573 0.702 . . . . 0.0 112.87 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -105.58 75.22 1.12 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.768 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.0 p30 -74.92 172.44 12.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.396 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.1 t30 61.57 18.39 9.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.9 165.41 29.84 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.823 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -154.23 149.23 26.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.074 0.464 . . . . 0.0 111.426 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.636 ' CE3' HG13 ' A' ' 79' ' ' ILE . 28.6 t90 -151.99 164.57 36.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.984 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -114.21 163.05 15.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 40' ' ' LEU . 1.7 t -129.67 15.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.715 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.527 ' O ' HD21 ' A' ' 75' ' ' LEU . 6.6 p -56.29 -24.51 43.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.524 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 66.9 mt-10 -142.68 172.78 12.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 13.8 m-85 -133.06 150.04 52.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.032 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 12.1 m -98.64 171.11 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.121 0.486 . . . . 0.0 110.928 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 110' ' ' THR . 19.3 t30 -92.21 151.23 20.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.08 -16.87 5.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.87 -29.35 64.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.275 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.65 15.03 6.52 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.129 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.3 p -139.47 163.28 46.46 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 110.822 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 89.0 Cg_exo -43.1 130.7 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.902 2.401 . . . . 0.0 113.328 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.0 112.97 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.451 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -113.56 148.72 35.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.795 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.57 38.55 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.0 m -59.04 167.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.31 79.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -143.12 94.68 6.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.845 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.441 2.094 . . . . 0.0 112.313 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.78 0.324 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.484 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 84.2 t80 -70.26 167.08 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.213 0.53 . . . . 0.0 110.911 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 9' ' ' VAL . 41.6 t -140.3 160.61 25.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.191 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 94' ' ' GLN . 7.6 p -78.78 141.36 59.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 82.8 Cg_exo -51.66 -169.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.7 2.267 . . . . 0.0 112.291 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 t -107.29 139.73 41.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.236 0.541 . . . . 0.0 112.274 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 24' ' ' VAL . . . -84.2 115.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.222 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -81.72 106.51 13.72 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.574 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.1 mp -97.98 152.03 19.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.244 0.545 . . . . 0.0 111.994 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 105' ' ' VAL . 17.5 mt-10 -141.9 136.73 30.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.685 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.733 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.39 98.88 11.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.152 0.501 . . . . 0.0 111.188 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 27.1 mm -74.52 147.92 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.455 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -106.48 146.81 33.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.545 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 12.1 Cg_endo -90.59 3.6 67.81 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.159 -1.184 . . . . 0.0 112.353 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.86 79.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 68' ' ' ASP . . . -146.58 -172.12 16.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 23' ' ' ARG . 19.5 tp -154.69 142.62 20.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.12 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.688 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -135.7 99.31 4.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.42 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.752 ' CG1' ' HB1' ' A' ' 12' ' ' ALA . 18.4 t -116.95 142.2 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -146.15 141.75 27.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.464 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.591 ' CG2' ' HB2' ' A' ' 12' ' ' ALA . 1.2 pp -135.9 120.15 12.97 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.762 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 10' ' ' PRO . 86.2 Cg_exo -46.27 123.09 6.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.115 1.877 . . . . 0.0 112.172 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 15.2 t0 -79.02 158.88 27.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.191 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -145.37 46.44 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.867 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.41 37.58 86.01 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.58 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.4 m-85 -82.94 -172.16 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.266 0.555 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ILE . 48.4 t -131.59 -26.47 2.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.799 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 12.2 tp -146.45 132.95 19.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.334 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 26' ' ' ILE . 17.1 t80 -117.99 106.19 12.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.083 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -103.79 118.4 36.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 24.2 t80 -106.23 125.84 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -124.95 122.72 38.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -154.81 137.83 5.84 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 118.853 -1.642 . . . . 0.0 114.252 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -111.53 142.46 43.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 101' ' ' VAL . 36.5 tp -97.28 125.69 42.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.987 0.422 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 63.78 50.94 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.9 tt0 176.42 109.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.578 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 44.8 mt-10 -57.49 -167.64 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.373 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.54 157.53 14.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.324 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -143.29 49.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.469 . . . . 0.0 110.852 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.67 -137.87 4.81 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD22 ' CH2' ' A' ' 82' ' ' TRP . 23.3 mt -121.02 67.11 0.86 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.264 0.554 . . . . 0.0 111.094 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 1.4 mt-10 -87.67 147.34 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.939 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -53.35 -26.04 17.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.813 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.32 -117.03 3.45 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.379 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.6 m80 -140.41 -73.4 0.35 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.728 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 6.7 m-90 -60.39 90.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.05 87.29 2.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG2' HD11 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 118.08 19.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.007 0.432 . . . . 0.0 111.617 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -92.99 106.45 18.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.9 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 9.1 mm -86.42 148.76 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.614 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 t -140.1 39.34 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.421 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.41 99.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.1 Cg_exo -51.73 -175.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.438 2.092 . . . . 0.0 112.362 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -116.82 -67.12 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.069 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -150.47 84.35 1.37 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.747 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.82 -0.73 34.98 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 5.6 ptp85 -157.81 160.38 37.71 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 120.69 0.281 . . . . 0.0 110.908 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.47 ' CE2' ' HG3' ' A' ' 59' ' ' PRO . 5.7 m95 -94.92 156.2 16.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.855 0.359 . . . . 0.0 110.225 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -134.69 116.24 14.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 54' ' ' ARG . 11.1 t80 -110.94 112.7 24.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.393 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 2.4 t0 -138.06 107.88 6.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -89.21 22.59 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.493 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.53 33.09 2.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.12 105.27 16.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -73.82 75.89 1.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.595 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.728 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 61.6 mt -87.25 156.83 19.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.078 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.46 134.92 34.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.424 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 0.6 OUTLIER -56.8 131.65 49.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.264 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.01 -29.92 9.22 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.05 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 101' ' ' VAL . 7.3 t70 -69.22 162.45 27.08 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -114.08 172.5 6.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.988 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.791 HD11 HG22 ' A' ' 101' ' ' VAL . 2.7 mp -127.85 142.44 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.785 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 47.2 m-85 -144.31 128.18 17.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.7 p90 -161.13 -177.56 6.15 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.649 ' CH2' HD22 ' A' ' 47' ' ' LEU . 55.8 p-90 -149.12 131.19 15.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.151 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -100.48 155.47 17.82 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.823 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.867 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 8.2 t80 -134.87 148.15 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.763 0.316 . . . . 0.0 111.057 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -137.91 165.31 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.957 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.698 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 16.8 mm -141.4 107.7 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 O-C-N 123.069 0.231 . . . . 0.0 111.025 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.68 62.58 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.446 0.466 . . . . 0.0 110.56 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 t70 69.28 65.72 0.27 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.811 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.32 28.21 71.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.518 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.83 74.22 1.42 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.01 161.67 45.79 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.403 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' O ' HG13 ' A' ' 85' ' ' VAL . 83.7 m-85 -152.18 148.99 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -134.17 143.11 47.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.729 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 tt0 -102.54 76.52 1.54 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 5.0 p-10 -77.2 -179.06 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.27 16.23 8.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.657 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.41 162.49 49.79 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.004 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -154.42 152.59 30.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 0.0 111.251 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.708 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.7 t90 -155.07 164.94 38.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.061 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.781 ' OG1' HG22 ' A' ' 102' ' ' THR . 5.7 t -108.48 158.57 17.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.791 HG22 HD11 ' A' ' 79' ' ' ILE . 2.6 t -119.85 -7.11 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.98 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.781 HG22 ' OG1' ' A' ' 100' ' ' THR . 2.4 t -66.04 -8.42 23.12 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.9 tt0 -134.34 137.2 43.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.053 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.4 m-85 -122.08 154.99 36.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 17' ' ' ILE . 6.2 m -109.67 151.75 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.112 0.482 . . . . 0.0 110.942 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 110' ' ' THR . 7.0 m-20 -82.16 153.48 25.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -55.49 -17.25 4.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.39 -30.72 64.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.047 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.24 5.28 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.416 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.7 p -142.84 161.48 48.75 Favored Pre-proline 0 CA--C 1.517 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.0 111.107 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 82.9 Cg_exo -44.95 128.43 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.935 2.424 . . . . 0.0 113.264 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.85 93.22 8.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.355 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -171.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -66.56 -33.67 76.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.7 t 61.98 179.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 116' ' ' LEU . 1.1 pp -136.19 79.85 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.9 120.22 70.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 122.443 2.095 . . . . 0.0 112.304 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 65.6 t80 -61.74 170.22 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 110.773 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.481 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 11.2 t -104.93 157.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.7 p -68.66 138.41 90.86 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.473 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 11.9 Cg_exo -70.0 -178.46 2.45 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.61 2.206 . . . . 0.0 111.893 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -103.71 120.9 41.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.471 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.0 109.23 16.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.8 mmtm -90.05 130.18 36.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.365 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HG ' HG22 ' A' ' 24' ' ' VAL . 6.1 mp -121.98 154.79 36.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.145 0.498 . . . . 0.0 111.741 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' HG11 ' A' ' 105' ' ' VAL . 3.2 mp0 -147.54 144.62 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.111 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.98 130.61 34.39 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.006 0.432 . . . . 0.0 111.4 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 23' ' ' ARG . 9.7 mm -109.55 134.55 51.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.306 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -98.26 144.1 27.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.452 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.4 Cg_endo -90.35 -7.18 45.47 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.423 0.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -159.11 93.08 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.493 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -170.07 165.33 38.66 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.632 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -146.84 137.03 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -120.87 121.89 39.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG22 ' HG ' ' A' ' 14' ' ' LEU . 31.2 t -121.28 151.86 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 111.616 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -155.03 144.88 21.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -140.5 127.64 12.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 52.8 Cg_exo -53.96 106.71 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.426 2.084 . . . . 0.0 112.238 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 36.4 t0 -76.07 144.84 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.002 0.43 . . . . 0.0 111.296 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 1.8 m-20 -132.59 44.95 2.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.954 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.99 53.64 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.857 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.7 m-85 -82.04 -170.88 3.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.341 0.591 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 86' ' ' ILE . 1.1 t -130.92 -29.32 1.89 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.449 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.672 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.6 tp -140.47 136.01 32.55 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.811 -0.755 . . . . 0.0 112.396 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.65 ' HD2' HD12 ' A' ' 56' ' ' ILE . 14.3 t80 -123.74 104.16 8.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.371 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -99.35 126.67 45.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.811 0.339 . . . . 0.0 110.746 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 52' ' ' TRP . 58.3 t80 -113.51 124.07 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.433 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.618 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -126.97 115.48 19.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -151.24 139.09 6.95 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 118.572 -1.775 . . . . 0.0 114.571 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -122.18 126.86 49.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD22 ' CH2' ' A' ' 52' ' ' TRP . 0.5 OUTLIER -91.7 141.32 28.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.71 40.62 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -176.9 109.55 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.4 mt-10 -50.71 -172.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.992 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.413 ' CE ' ' HA ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -119.38 135.43 54.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.067 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -150.64 64.14 0.93 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . 113.99 129.24 4.84 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.716 HD22 ' CH2' ' A' ' 82' ' ' TRP . 6.9 mt -43.03 91.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 111.675 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' GLY . 4.6 mt-10 -116.7 154.04 31.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.932 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -55.84 -22.91 27.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.9 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.58 -108.98 0.69 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.042 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t-80 -133.9 -73.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.947 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 40' ' ' LEU . 27.9 m-90 -72.04 92.74 1.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.55 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.189 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 21.5 tpt180 -149.18 133.23 17.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.884 0.373 . . . . 0.0 111.947 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.75 143.35 26.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.713 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.65 HD12 ' HD2' ' A' ' 34' ' ' PHE . 11.7 mt -126.87 142.82 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.158 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 32' ' ' SER . 3.4 m -134.22 30.68 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -151.77 89.38 4.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.437 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 57.2 Cg_exo -51.89 171.85 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.578 2.186 . . . . 0.0 112.576 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.36 34.96 3.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.96 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.95 87.85 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.226 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.1 -5.82 12.47 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.818 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 9.4 mtt-85 -157.48 130.67 7.73 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.299 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.5 m95 -78.13 154.8 30.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.963 0.411 . . . . 0.0 110.02 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 97.1 m -134.76 118.54 17.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.217 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' HD11 ' A' ' 56' ' ' ILE . 82.5 t80 -120.81 91.8 3.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.49 146.19 29.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 26.4 t0 -138.04 106.89 5.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.673 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.25 22.35 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.651 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -134.65 43.45 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.09 123.24 42.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -73.94 76.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.695 HD13 HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -98.43 142.42 30.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 158.78 38.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.976 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 3.3 tt -68.87 133.37 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.015 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 105.93 -27.99 15.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.218 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' A' ' 101' ' ' VAL . 10.9 t70 -59.46 164.48 3.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.089 0.471 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.1 153.58 42.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.607 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.438 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.4 mp -113.42 143.1 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.987 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 57.6 m-85 -144.18 125.71 14.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.618 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 5.0 p90 -161.09 -174.5 4.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 122.439 1.114 . . . . 0.0 113.939 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.716 ' CH2' HD22 ' A' ' 47' ' ' LEU . 16.4 p-90 -151.59 129.85 12.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.034 -1.894 . . . . 0.0 108.148 177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -99.86 161.0 13.88 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.783 -178.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.939 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 18.3 t80 -141.59 137.87 32.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.622 0.248 . . . . 0.0 110.566 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -130.94 162.42 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 ' CE2' ' A' ' 84' ' ' TYR . 30.5 mm -135.16 105.79 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.855 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 66.81 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.529 0.518 . . . . 0.0 110.546 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.17 61.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.825 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 73.93 29.01 63.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.9 mt -143.82 74.16 1.42 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.134 0.492 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.83 159.68 42.24 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.542 -0.753 . . . . 0.0 114.595 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -152.44 144.14 23.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.613 -0.793 . . . . 0.0 108.985 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -128.5 140.11 51.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.561 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.92 77.49 2.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.556 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 8.9 p-10 -80.8 176.28 9.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.417 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 60.57 18.31 8.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.36 162.02 50.77 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.131 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.42 158.72 40.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CE2' ' O ' ' A' ' 100' ' ' THR . 58.8 t90 -155.1 166.6 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.255 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 4.7 t -109.83 160.09 16.65 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 77' ' ' ASP . 3.6 t -122.68 2.12 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.58 HG22 ' HA2' ' A' ' 76' ' ' GLY . 44.6 p -63.77 -13.44 43.95 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.752 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.6 tt0 -131.33 150.87 51.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.034 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 9.3 m-85 -131.73 145.21 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.165 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.448 HG11 ' HG2' ' A' ' 15' ' ' GLU . 25.4 m -98.6 163.22 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' THR . 33.8 t30 -83.9 152.52 24.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -55.96 -17.11 5.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.31 -30.72 65.04 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.914 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.87 17.85 5.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.446 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -137.95 159.19 69.56 Favored Pre-proline 0 C--O 1.222 -0.342 0 CA-C-O 121.309 0.576 . . . . 0.0 111.103 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 77.6 Cg_exo -48.87 128.46 19.0 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.959 2.439 . . . . 0.0 113.286 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.96 124.28 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.228 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.94 133.69 48.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -59.55 93.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.82 161.71 37.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -85.22 57.46 4.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 62.98 130.31 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 C--O 1.251 1.146 0 C-N-CA 122.449 2.099 . . . . 0.0 112.387 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 68.2 t80 -61.05 169.68 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 9' ' ' VAL . 3.3 p -105.57 179.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.379 0.609 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.793 ' H ' HG22 ' A' ' 8' ' ' VAL . 7.3 p -81.36 137.75 48.57 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.237 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 14.2 Cg_exo -68.35 -174.49 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.586 2.191 . . . . 0.0 112.145 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.71 118.63 37.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.895 0.378 . . . . 0.0 111.888 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -76.8 105.68 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.431 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.95 107.23 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.048 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.753 HD21 ' CZ ' ' A' ' 36' ' ' PHE . 4.9 mp -96.45 159.22 15.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.232 0.539 . . . . 0.0 111.773 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.12 137.24 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.47 102.63 14.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.207 0.527 . . . . 0.0 111.058 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 23' ' ' ARG . 25.2 mm -73.1 135.51 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.409 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 57.9 t80 -94.89 141.28 23.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.695 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.3 Cg_endo -92.31 -3.29 49.77 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.432 0.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.84 94.95 0.87 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -168.96 -171.08 34.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.387 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD12 ' H ' ' A' ' 23' ' ' ARG . 13.3 tp -156.93 147.7 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB2' HD11 ' A' ' 17' ' ' ILE . 6.8 ttm180 -144.71 106.65 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.673 HG22 ' HG ' ' A' ' 14' ' ' LEU . 21.4 t -109.0 157.84 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.03 146.72 23.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.895 0.379 . . . . 0.0 111.589 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.799 HG21 ' CZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -141.83 130.52 12.12 Favored Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.57 101.54 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.184 1.923 . . . . 0.0 111.052 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.453 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.8 t70 -69.14 149.8 48.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.298 0.57 . . . . 0.0 111.899 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.447 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 9.1 t70 -131.35 42.78 3.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.492 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.02 45.82 30.81 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.702 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 12.5 m-85 -87.5 -171.49 3.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.329 0.585 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ILE . 88.6 p -128.64 -29.18 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.498 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.845 ' CD1' HG22 ' A' ' 57' ' ' THR . 9.0 tp -142.63 140.53 31.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.593 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 26' ' ' ILE . 46.1 t80 -133.23 99.75 4.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.61 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -98.2 117.82 33.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.547 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.753 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 28.0 t80 -104.94 120.16 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.029 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.514 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -116.82 128.77 55.59 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.414 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -156.19 132.37 3.31 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.05 -1.548 . . . . 0.0 114.161 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 11.7 ttpt -106.65 144.69 32.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD13 ' CD2' ' A' ' 73' ' ' LEU . 12.5 tp -98.97 124.79 44.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.016 0.436 . . . . 0.0 111.547 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 t-20 65.11 49.36 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.59 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 60.7 tt0 175.81 109.82 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 110.613 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 45.7 mt-10 -55.26 -175.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.766 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.11 156.82 43.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.438 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.57 44.11 1.29 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.247 0.546 . . . . 0.0 110.429 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.37 -134.02 3.14 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.439 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.812 HD22 ' CH2' ' A' ' 82' ' ' TRP . 18.0 mt -124.42 75.32 1.39 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 120.956 0.408 . . . . 0.0 111.026 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 4.7 mt-10 -98.85 145.73 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -49.16 -36.03 18.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.869 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.76 -112.33 3.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.026 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 66.0 t60 -145.19 -74.2 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.686 0.279 . . . . 0.0 110.919 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.666 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 7.7 m-90 -63.79 101.07 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.29 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -115.93 76.63 1.03 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -96.41 114.3 25.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.502 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.43 95.54 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.161 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 58' ' ' LYS . 6.6 mt -104.03 152.89 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.269 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 33' ' ' LEU . 9.1 p -121.26 -8.53 9.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.4 mttp -135.38 120.09 13.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.484 0.183 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 32.6 Cg_exo -58.13 -165.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.456 2.104 . . . . 0.0 112.33 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -119.49 -44.9 2.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.223 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -178.59 82.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.711 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 -7.18 19.79 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.38 149.75 22.84 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.504 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' CD1' HD11 ' A' ' 26' ' ' ILE . 4.8 m95 -88.21 150.83 23.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.89 0.376 . . . . 0.0 110.163 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -135.52 122.06 20.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.547 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 37.4 t80 -109.22 154.02 22.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 118.78 10.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 0.0 111.229 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.3 t70 -121.34 98.37 5.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.406 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -89.16 22.59 2.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.553 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -131.33 27.99 4.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.42 100.99 10.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -73.79 75.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.041 0.448 . . . . 0.0 110.67 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.666 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 57.3 mt -91.57 142.15 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -125.55 146.44 49.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.689 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.19 144.92 14.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 95.08 -35.05 4.44 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.244 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.1 t0 -62.15 149.54 41.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -108.31 168.28 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HG22 ' A' ' 101' ' ' VAL . 3.0 mp -124.92 145.8 31.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.196 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 57.8 m-85 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -159.9 -177.53 6.4 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.812 ' CH2' HD22 ' A' ' 47' ' ' LEU . 57.4 p-90 -153.54 135.05 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.894 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 72.1 p -99.55 166.69 11.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.071 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.661 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 15.9 t80 -150.01 108.69 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.667 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.75 ' O ' HD13 ' A' ' 86' ' ' ILE . 1.4 m -102.8 169.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.66 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -144.53 101.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.537 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -96.16 62.26 2.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 t0 64.35 62.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.836 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.53 26.84 60.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.265 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.4 mt -143.29 71.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.21 0.528 . . . . 0.0 110.157 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -75.84 160.53 51.71 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.333 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 85' ' ' VAL . 58.4 m-85 -152.19 140.79 20.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.67 ' C ' HG11 ' A' ' 9' ' ' VAL . 8.0 ptt180 -121.84 144.59 48.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' N ' HG21 ' A' ' 9' ' ' VAL . 12.4 tt0 -105.4 69.62 0.85 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.689 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.2 p30 -78.24 176.14 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.516 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.8 t30 61.42 17.57 8.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.38 164.75 53.59 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.12 152.03 29.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.248 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.8 t90 -148.63 164.06 35.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.976 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -107.26 159.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.665 HG22 HD11 ' A' ' 79' ' ' ILE . 13.8 t -118.7 -5.22 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.814 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HD21 ' A' ' 75' ' ' LEU . 4.4 p -69.12 -5.23 20.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.959 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -136.09 149.1 48.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.703 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 m-85 -133.83 148.47 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.038 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 7.8 m -98.64 168.04 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.262 0.553 . . . . 0.0 110.92 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 110' ' ' THR . 9.4 m-20 -94.99 149.67 21.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.436 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -18.82 8.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.15 -30.86 70.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.879 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.68 23.4 3.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.323 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.1 p -149.44 159.07 37.33 Favored Pre-proline 0 CA--C 1.517 -0.322 0 CA-C-O 121.453 0.644 . . . . 0.0 111.758 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 76.8 Cg_exo -49.15 125.55 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.163 2.575 . . . . 0.0 113.236 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.11 69.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.191 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -65.3 173.1 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.2 p -100.86 34.76 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.967 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -127.48 144.1 51.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 116' ' ' LEU . 8.3 mp -107.65 66.7 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.89 120.36 81.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.429 2.086 . . . . 0.0 112.352 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.787 0.327 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 43.1 t80 -77.64 176.87 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.032 0.444 . . . . 0.0 110.891 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 18.9 t -119.38 160.02 19.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.614 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -70.37 138.05 86.52 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 9' ' ' VAL . 37.9 Cg_endo -67.18 -168.36 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.486 2.124 . . . . 0.0 112.662 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -105.22 117.66 34.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.451 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.92 99.42 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.616 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -82.16 152.26 26.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.586 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.463 HD22 ' CE2' ' A' ' 81' ' ' PHE . 3.6 mp -145.24 157.79 43.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.581 . . . . 0.0 112.07 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.538 ' O ' HD22 ' A' ' 22' ' ' LEU . 8.8 mt-10 -150.03 142.92 24.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.977 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . . . -86.26 101.68 13.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 111.547 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 23' ' ' ARG . 26.7 mm -71.82 122.94 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.199 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 34.0 t80 -87.45 141.83 32.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 90.3 Cg_endo -96.27 5.15 42.91 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.512 0.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -164.65 96.69 0.75 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.765 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . 177.07 166.16 33.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.507 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.634 HD23 ' CD1' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -149.47 120.76 7.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.715 0.293 . . . . 0.0 110.835 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HG2' HD11 ' A' ' 17' ' ' ILE . 9.9 ptm180 -109.88 133.1 53.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 22.1 t -121.74 155.06 26.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.339 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -147.63 147.07 29.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.788 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -146.11 127.49 7.47 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.451 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 22.8 Cg_endo -60.72 96.94 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.456 2.104 . . . . 0.0 111.463 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 24.1 t0 -59.97 154.94 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.632 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t70 -139.37 43.6 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.571 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.28 41.51 52.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.709 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.468 ' CD1' HG21 ' A' ' 85' ' ' VAL . 11.5 m-85 -85.24 -170.83 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.375 0.607 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -131.83 -28.51 1.78 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.544 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 57' ' ' THR . 10.1 tp -139.68 135.67 33.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.378 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 26' ' ' ILE . 29.9 t80 -126.95 103.3 7.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.387 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.36 118.2 36.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.643 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 52' ' ' TRP . 36.4 t80 -105.91 128.47 53.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.526 ' NE2' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -119.28 129.37 54.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -147.07 142.37 10.24 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 118.765 -1.683 . . . . 0.0 114.615 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.2 mttp -119.64 124.55 46.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.347 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD13 HD23 ' A' ' 73' ' ' LEU . 46.3 tp -81.7 112.99 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.824 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.5 t-20 58.89 65.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 69.9 tt0 174.28 110.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 38.1 mt-10 -54.5 -168.93 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -152.05 145.54 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.686 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -130.63 44.57 2.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.187 0.518 . . . . 0.0 110.408 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.56 -140.75 7.41 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.726 HD22 ' CH2' ' A' ' 82' ' ' TRP . 18.4 mt -119.49 73.82 0.97 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.989 0.423 . . . . 0.0 110.977 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.25 143.71 26.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.093 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.526 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -50.25 -25.87 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.796 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 48.22 -107.9 0.31 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.47 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.2 t60 -138.38 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.738 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 15.8 m-90 -65.56 87.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.58 86.36 2.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -133.41 126.65 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.001 0.429 . . . . 0.0 111.964 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.6 109.55 21.45 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.363 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 18.3 mt -93.3 141.01 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.304 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.813 HG22 HD12 ' A' ' 33' ' ' LEU . 9.8 p -129.58 23.79 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.91 87.61 7.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 53.6 Cg_exo -52.72 171.46 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.613 2.209 . . . . 0.0 112.538 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 63' ' ' ARG . 4.5 tptm -109.97 36.46 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.678 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 4.5 mt-10 76.64 88.99 0.08 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.22 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.6 -3.68 24.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.002 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 10.2 mtp180 -157.29 129.04 7.03 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.444 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.531 ' CD1' HD11 ' A' ' 26' ' ' ILE . 7.9 m95 -81.53 150.28 28.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -135.07 121.92 21.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 56' ' ' ILE . 18.0 t80 -110.44 143.89 40.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.427 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -141.76 118.1 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.197 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 16.1 t70 -126.87 101.56 6.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.636 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.21 22.42 2.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.72 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -123.09 28.77 7.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.29 106.9 15.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -73.93 76.94 1.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.806 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 4.1 mt -78.89 166.31 22.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.676 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.81 149.16 46.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -67.66 131.3 45.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.257 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.604 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.51 -26.23 16.89 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.7 t70 -58.26 158.73 6.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.96 14.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.592 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -122.66 150.95 26.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.296 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 78.1 m-85 -144.4 130.37 19.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -161.23 -178.45 6.72 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.15 0.976 . . . . 0.0 113.48 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.726 ' CH2' HD22 ' A' ' 47' ' ' LEU . 53.5 p-90 -155.03 132.35 11.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -99.91 163.01 12.63 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.417 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.82 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 40.9 t80 -144.26 122.39 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.772 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -117.75 163.57 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.82 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 32.9 mm -136.39 109.27 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.582 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -103.77 74.4 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.034 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 t0 58.05 48.21 13.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.788 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 87.27 30.18 20.3 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.332 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.8 mt -143.94 75.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.157 0.503 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.34 158.95 44.35 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.429 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -152.35 150.1 29.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.63 -0.785 . . . . 0.0 108.932 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.614 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.54 147.47 52.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 83' ' ' THR . 4.1 tt0 -107.37 73.51 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.8 p30 -85.75 -179.88 6.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.523 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 t30 61.07 18.21 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.518 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.18 163.14 42.95 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.171 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -154.27 128.82 9.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 16' ' ' ALA . 47.5 t90 -120.1 170.18 9.53 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 3.7 t -110.62 160.95 16.21 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 77' ' ' ASP . 2.1 t -126.71 15.17 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.667 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.593 ' O ' HD21 ' A' ' 75' ' ' LEU . 26.8 p -58.79 -24.55 61.99 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.892 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 81.7 mt-10 -137.31 161.33 36.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.856 0.36 . . . . 0.0 111.177 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 9.5 m-85 -130.18 145.86 51.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.796 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 17' ' ' ILE . 25.5 m -98.53 167.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.093 0.473 . . . . 0.0 110.502 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 110' ' ' THR . 10.0 m-20 -89.2 150.36 22.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.423 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.87 -18.26 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.3 -30.57 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.079 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.72 18.25 5.29 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.245 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.4 p -141.89 162.25 47.12 Favored Pre-proline 0 C--O 1.222 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 80.2 Cg_exo -44.02 129.93 7.96 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.87 2.38 . . . . 0.0 113.445 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.09 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.365 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -132.58 -171.36 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.4 m -104.11 85.08 2.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -65.57 164.86 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.13 90.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.49 142.77 25.22 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.504 2.136 . . . . 0.0 112.324 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.79 0.329 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.1 t80 -90.72 174.26 7.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.2 0.524 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.8 t -111.84 159.56 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.78 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.6 p -68.63 135.32 90.41 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.499 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' HG11 ' A' ' 85' ' ' VAL . 16.5 Cg_exo -66.68 -173.6 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.618 2.212 . . . . 0.0 112.236 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.26 125.24 51.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB3' ' HE2' ' A' ' 81' ' ' PHE . . . -85.37 106.23 16.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.958 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 ttmt -92.32 119.84 32.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.621 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.717 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.1 mp -108.14 158.72 17.18 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.818 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.12 140.63 26.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.116 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.34 120.27 27.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.305 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 105' ' ' VAL . 19.8 mm -92.62 130.72 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.342 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -92.14 142.49 26.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.614 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 88.2 Cg_endo -93.23 -0.96 51.59 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.031 -1.237 . . . . 0.0 112.386 0.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.59 94.93 0.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.909 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.485 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.86 173.11 46.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.476 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -152.29 130.01 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 111.07 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' N ' HD13 ' A' ' 22' ' ' LEU . 9.8 ttt180 -120.26 115.5 23.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.719 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.717 HG22 ' HG ' ' A' ' 14' ' ' LEU . 5.3 t -110.86 161.5 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.453 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -152.68 143.58 22.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.046 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.683 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -140.59 124.06 10.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.472 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 10.8 Cg_endo -56.61 99.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.058 1.838 . . . . 0.0 111.359 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.1 t0 -65.51 160.07 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.809 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 4.1 t0 -143.23 43.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.787 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.96 42.68 68.19 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.808 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 85' ' ' VAL . 12.2 m-85 -84.2 -170.53 3.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.282 0.563 . . . . 0.0 111.114 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -131.97 -28.01 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.645 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 9.6 tp -140.27 134.91 31.7 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.189 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.69 ' HD2' HD12 ' A' ' 56' ' ' ILE . 47.8 t80 -127.4 90.3 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.67 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -85.1 125.4 32.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.487 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 14.2 t80 -115.04 124.02 50.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.345 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.612 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -125.08 122.31 36.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -156.06 147.01 15.07 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.972 -1.585 . . . . 0.0 114.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.79 155.36 39.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 110.444 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -92.72 115.23 27.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER 59.88 71.9 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 74.2 tt0 174.31 110.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 31.4 mt-10 -56.31 -167.57 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.135 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.5 mtp -145.95 143.28 29.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -135.69 81.13 1.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.474 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 84.47 99.84 0.63 Allowed Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.4 mt 18.46 96.19 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.725 0.81 . . . . 0.0 112.824 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -109.3 140.97 42.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.642 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.81 -26.37 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.664 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.79 -160.2 0.12 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.635 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -100.6 -74.22 0.62 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 110.696 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.621 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 m-90 -63.49 91.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.15 91.28 3.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.255 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.8 tmm_? -145.85 125.34 13.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.679 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.72 128.25 35.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.853 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 34' ' ' PHE . 12.8 mt -102.99 159.51 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 56' ' ' ILE . 10.6 t -148.39 39.98 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 111.23 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -175.77 96.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.95 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.447 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 74.4 Cg_exo -49.75 179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.403 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -106.55 -58.43 1.93 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.194 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.86 82.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.382 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . 74.09 -2.42 43.49 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 33.6 mtt85 -156.66 147.25 21.59 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.354 0.261 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.609 ' CG ' HD11 ' A' ' 26' ' ' ILE . 9.9 m95 -83.91 159.11 21.37 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.64 118.02 16.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.409 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 36' ' ' PHE . 8.3 t80 -99.8 94.59 6.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.313 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -93.34 124.93 37.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.378 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.421 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.6 t70 -138.12 97.57 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.25 22.36 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.659 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -133.87 44.15 2.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.973 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -118.74 115.64 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.068 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.96 76.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 22' ' ' LEU . 6.4 mt -82.81 164.98 20.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -141.68 150.53 42.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.979 0.419 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -70.58 132.89 46.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.304 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.47 ' N ' HD13 ' A' ' 75' ' ' LEU . . . 93.61 -26.4 16.24 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 101' ' ' VAL . 10.9 t70 -60.5 165.95 3.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.66 163.32 16.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.383 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -117.6 148.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 3.9 m-85 -144.33 129.71 18.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' A' ' 12' ' ' ALA . 3.0 p90 -161.1 -175.51 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 122.0 0.905 . . . . 0.0 113.2 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 32.2 p-90 -157.03 124.65 5.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.729 -1.578 . . . . 0.0 108.859 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.6 p -107.2 151.26 25.66 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.981 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 86' ' ' ILE . 24.4 t80 -133.81 124.58 26.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.229 0.331 . . . . 0.0 111.043 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.713 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -108.28 163.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.797 HD11 ' CE2' ' A' ' 84' ' ' TYR . 22.4 mm -136.91 114.31 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.911 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 70.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.4 t0 66.45 62.38 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.768 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.2 28.64 72.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.637 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -145.06 77.91 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.171 0.51 . . . . 0.0 109.981 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -93.17 161.87 25.67 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.627 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -152.13 147.51 26.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.78 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -122.97 151.62 41.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.466 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -106.49 73.98 0.99 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.504 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.6 p30 -84.96 179.59 7.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.442 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 58.55 19.53 6.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.916 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.85 163.46 33.47 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.279 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.27 161.58 41.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.515 ' CZ2' ' HA ' ' A' ' 15' ' ' GLU . 54.8 t90 -146.43 169.06 19.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.526 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' CZ3' ' A' ' 99' ' ' TRP . 5.1 t -105.22 154.81 19.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.634 ' O ' HD22 ' A' ' 75' ' ' LEU . 1.9 t -124.25 17.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.295 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -70.49 -10.71 59.89 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -127.29 162.73 25.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.549 ' CE2' HD23 ' A' ' 75' ' ' LEU . 6.3 m-85 -135.29 123.53 23.08 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.7 m -97.98 153.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 110.852 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 110' ' ' THR . 24.4 t30 -72.79 155.42 39.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.603 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.25 -16.87 6.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -73.25 -31.73 64.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.895 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.76 7.16 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.288 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 106' ' ' ASN . 4.4 p -127.21 157.49 72.23 Favored Pre-proline 0 CA--C 1.515 -0.38 0 CA-C-O 121.252 0.548 . . . . 0.0 110.977 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 41.8 Cg_exo -54.31 129.02 32.46 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.775 2.317 . . . . 0.0 112.955 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 114' ' ' THR . . . -99.28 62.84 1.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -57.22 122.62 12.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 112' ' ' ALA . 70.2 p -137.54 -42.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.654 ' C ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER 69.0 53.89 0.46 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.951 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 115' ' ' SER . 1.0 OUTLIER 40.17 67.55 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.721 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 60.99 155.55 0.11 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.526 2.15 . . . . 0.0 112.189 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.843 0.354 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.0 t80 -77.64 173.16 12.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.177 0.513 . . . . 0.0 110.793 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.2 t -110.89 160.71 9.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.236 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.622 HG21 ' N ' ' A' ' 94' ' ' GLN . 12.5 p -66.39 132.15 94.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.492 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 22.6 Cg_exo -64.19 -177.13 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.549 2.166 . . . . 0.0 111.933 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.6 122.69 47.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -81.14 109.79 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -95.3 102.35 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.162 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 2.1 mp -90.29 162.65 15.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.102 0.477 . . . . 0.0 111.935 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 105' ' ' VAL . 37.9 mt-10 -146.58 140.28 25.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.09 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.73 110.62 20.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.995 0.426 . . . . 0.0 111.448 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 16.9 mm -83.41 159.73 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 8.8 t80 -122.57 140.82 33.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.597 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 8.8 Cg_endo -88.96 1.78 68.97 Favored 'Cis proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.4 -1.083 . . . . 0.0 112.419 0.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.8 98.21 0.3 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.929 0.395 . . . . 0.0 111.008 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.668 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -166.59 -173.13 34.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.437 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -155.81 137.61 14.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.803 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -133.63 106.72 7.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.37 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 22' ' ' LEU . 16.4 t -114.26 155.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.86 145.01 25.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.643 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.674 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -138.21 127.02 14.44 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.6 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.4 Cg_endo -58.4 93.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.344 2.029 . . . . 0.0 111.706 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.6 t0 -58.6 160.82 5.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.628 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 6.0 t0 -145.62 44.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.39 44.06 60.13 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.961 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 11.2 m-85 -88.28 -170.88 3.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.465 0.65 . . . . 0.0 111.22 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -131.69 -28.94 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.476 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 57' ' ' THR . 8.7 tp -138.38 135.3 35.19 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.163 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.706 ' HD2' HD12 ' A' ' 56' ' ' ILE . 37.1 t80 -125.44 98.58 5.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.028 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -92.88 126.22 37.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 111.062 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' CD2' HG22 ' A' ' 83' ' ' THR . 25.3 t80 -115.86 123.05 47.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.632 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -127.07 120.64 29.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.83 135.23 4.93 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 118.587 -1.768 . . . . 0.0 114.792 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -105.89 147.75 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.126 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.1 tp -97.19 125.26 41.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.279 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 t30 56.8 57.72 4.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 76.5 tt0 174.64 109.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.14 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' CE2' ' A' ' 80' ' ' TYR . 60.7 mt-10 -53.11 176.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.507 0.67 . . . . 0.0 111.783 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.48 ' HG2' ' C ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -141.24 138.97 33.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.276 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -132.86 48.08 2.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.112 0.482 . . . . 0.0 110.761 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.36 -138.74 5.6 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD22 ' CH2' ' A' ' 82' ' ' TRP . 20.9 mt -119.26 69.41 0.82 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.189 0.519 . . . . 0.0 111.0 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -91.15 145.86 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.996 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -50.4 -25.65 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.9 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.71 -117.71 3.14 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.454 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 38' ' ' GLY . 1.1 t60 -137.48 -73.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.768 0.318 . . . . 0.0 110.555 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 71' ' ' ALA . 12.8 m-90 -69.98 90.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 36' ' ' PHE . . . -118.32 90.16 3.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.135 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.19 130.17 18.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 112.035 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.26 123.6 34.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.554 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 34' ' ' PHE . 13.3 mt -102.46 143.32 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.234 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.782 HG22 HD12 ' A' ' 33' ' ' LEU . 19.9 p -134.31 34.57 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -160.27 91.87 1.69 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 48.4 Cg_exo -55.88 170.03 1.16 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.57 2.18 . . . . 0.0 112.451 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.73 34.49 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.929 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 80.81 87.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.38 -1.75 25.37 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.735 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -157.14 125.3 5.55 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.393 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.566 ' CG ' HD11 ' A' ' 26' ' ' ILE . 18.4 m95 -77.48 156.6 30.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.2 m -134.59 118.93 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.41 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 56' ' ' ILE . 54.0 t80 -111.24 93.13 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.6 139.7 30.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 1.1 t70 -138.02 106.12 5.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.23 22.43 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.667 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -135.31 31.78 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 111.072 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.516 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -112.99 108.71 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.01 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -73.71 83.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 21' ' ' GLY . 37.5 mt -86.08 115.48 23.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.87 131.43 52.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -52.02 133.57 32.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.432 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.62 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.94 -29.71 11.61 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 101' ' ' VAL . 30.9 t0 -65.85 160.9 22.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -119.37 160.23 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 99' ' ' TRP . 1.2 mp -114.75 146.79 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.786 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 43' ' ' GLU . 33.7 m-85 -144.23 125.05 14.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 1.8 p90 -161.08 -174.29 4.29 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.208 1.004 . . . . 0.0 113.404 -178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.518 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 66.9 p-90 -151.01 127.43 10.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.378 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 24.4 p -107.07 149.7 27.32 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.461 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.773 ' CE2' HD11 ' A' ' 86' ' ' ILE . 17.4 t80 -131.51 146.4 52.21 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.306 0.379 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.55 162.52 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.103 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.773 HD11 ' CE2' ' A' ' 84' ' ' TYR . 31.1 mm -134.52 117.13 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.813 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -114.6 65.12 0.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t0 66.87 64.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.767 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.779 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.27 28.39 71.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.1 mt -144.96 77.9 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.233 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -90.81 161.25 28.11 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.47 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' HG13 ' A' ' 85' ' ' VAL . 21.6 m-85 -152.18 139.7 19.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -123.3 145.07 49.0 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.622 ' N ' HG21 ' A' ' 9' ' ' VAL . 28.1 tt0 -100.35 75.74 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.923 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.8 p-10 -79.97 176.5 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.06 19.65 7.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.809 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.07 165.81 52.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.264 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.15 161.09 42.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.962 0.411 . . . . 0.0 111.225 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.624 ' HB2' HD13 ' A' ' 14' ' ' LEU . 55.7 t90 -155.21 166.25 34.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' CE2' ' A' ' 99' ' ' TRP . 5.6 t -107.03 158.01 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' ASP . 3.8 t -122.33 -3.26 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.099 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.62 HG22 ' HA2' ' A' ' 76' ' ' GLY . 76.1 p -62.02 -16.08 49.07 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 9.3 pt-20 -114.28 161.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.628 0.251 . . . . 0.0 110.574 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 75' ' ' LEU . 45.5 m-85 -137.99 138.01 38.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 15' ' ' GLU . 3.2 m -98.27 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.298 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 110' ' ' THR . 18.3 m-20 -114.7 145.81 41.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.674 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.37 -19.87 10.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -67.2 -29.35 69.0 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.857 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.63 25.57 3.09 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.615 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.4 p -145.14 151.76 49.2 Favored Pre-proline 0 CA--C 1.514 -0.416 0 CA-C-O 121.497 0.665 . . . . 0.0 112.42 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.588 ' HA ' HG12 ' A' ' 105' ' ' VAL . 37.7 Cg_exo -59.65 69.84 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.56 2.84 . . . . 0.0 114.293 -178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . 68.62 155.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.549 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.4 109.01 6.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -135.49 71.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.6 -171.21 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.14 78.62 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -118.54 127.51 26.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.759 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 122.413 2.075 . . . . 0.0 112.313 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.762 0.315 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 46.9 t80 -60.0 173.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.071 0.462 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.6 t -117.21 159.89 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.393 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.65 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.5 p -70.36 137.93 86.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD2' HG23 ' A' ' 9' ' ' VAL . 26.0 Cg_endo -63.64 -174.71 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.428 2.085 . . . . 0.0 112.554 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -110.1 116.48 31.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.546 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -73.38 99.58 2.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -87.45 110.62 20.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.991 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.0 mp -105.7 163.84 12.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.268 0.556 . . . . 0.0 112.16 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HG2' HG11 ' A' ' 105' ' ' VAL . 2.0 mp0 -151.06 140.27 21.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.893 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.653 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.64 119.14 26.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.374 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 18.5 mm -93.42 152.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -116.44 149.18 43.26 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 3.2 Cg_exo -81.06 -6.99 44.27 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.221 0.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -168.36 93.46 0.35 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 111.0 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.523 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -158.47 -167.92 19.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.366 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.586 HD12 ' H ' ' A' ' 23' ' ' ARG . 43.3 tp -158.19 148.3 20.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -143.19 104.79 4.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.647 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.752 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.2 t -113.28 159.92 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 111.476 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -155.08 145.01 21.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.0 OUTLIER -142.35 115.9 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.953 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 63' ' ' ARG . 85.0 Cg_exo -47.13 105.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.166 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 32.4 t0 -71.51 148.9 46.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.205 0.526 . . . . 0.0 111.21 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.2 t0 -134.72 45.34 2.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.488 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.67 36.98 76.55 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.282 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CD1' HG21 ' A' ' 85' ' ' VAL . 9.5 m-85 -78.14 -172.19 2.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 86' ' ' ILE . 95.7 p -133.08 -26.91 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.771 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.8 tp -140.57 128.12 21.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.386 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.656 ' HD2' HD12 ' A' ' 56' ' ' ILE . 13.6 t80 -120.6 93.78 4.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.936 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -95.82 120.35 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.975 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 52' ' ' TRP . 37.9 t80 -106.18 130.36 54.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.482 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -127.98 116.41 20.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -155.61 139.79 6.87 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.551 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 9.6 tptp -117.04 145.56 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.682 HD13 HD23 ' A' ' 73' ' ' LEU . 21.6 tp -93.43 122.6 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 111.146 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.8 t-20 57.25 66.46 1.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 42.8 tt0 170.27 111.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -54.9 -168.92 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.9 mtp -143.47 120.37 11.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.053 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 57.79 3.91 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 85.17 103.75 0.66 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.536 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.4 mt 29.04 77.38 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.405 0.682 . . . . 0.0 112.6 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 19.1 mm-40 -95.26 155.71 16.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.56 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -44.85 -40.18 5.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.6 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.32 176.23 0.07 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 53' ' ' ALA . 6.3 m-70 -79.84 -78.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.534 0.207 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.688 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 8.2 m-90 -57.21 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.49 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 51' ' ' HIS . . . -118.5 90.09 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.252 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 4.4 ttp180 -149.12 133.21 17.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.42 . . . . 0.0 111.955 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -91.04 136.56 32.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.0 mt -115.8 148.62 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 111.193 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.581 HG22 HD12 ' A' ' 33' ' ' LEU . 48.1 p -137.84 22.55 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 1.3 mmpt? -146.79 88.49 5.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 56.0 Cg_exo -52.17 171.44 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.587 2.191 . . . . 0.0 112.641 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -107.72 39.8 1.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.657 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 3.2 mt-10 74.01 89.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.432 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 72.71 -5.26 17.77 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LYS . 10.5 mtp180 -157.56 132.69 8.83 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.621 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.61 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.3 m95 -81.81 156.45 24.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 ' CD ' ' A' ' 67' ' ' ARG . 1.1 m -134.62 119.38 18.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.393 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 3.1 t80 -112.86 89.62 3.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.508 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.431 ' CD ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -104.25 148.99 25.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 22' ' ' LEU . 1.9 m-20 -138.1 115.56 11.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.771 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.1 22.01 2.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -145.32 27.02 1.28 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.31 30.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.1 76.03 10.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.3 mt -103.31 132.3 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.567 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.437 ' N ' HG11 ' A' ' 101' ' ' VAL . 13.2 mttt -122.76 152.68 40.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 111.553 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -54.16 131.82 41.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.297 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.72 -27.0 13.47 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.9 t70 -57.8 149.79 21.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.981 0.419 . . . . 0.0 111.097 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 149.8 32.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.488 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.735 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -109.22 148.79 12.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.207 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -144.45 125.39 14.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.547 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.7 p90 -161.2 -174.35 4.29 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 51.2 p-90 -157.97 134.33 9.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.153 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 24.6 p -99.74 161.99 13.27 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.118 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.888 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 23.8 t80 -144.18 106.05 4.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.645 0.259 . . . . 0.0 110.871 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.54 164.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.372 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 23.9 mm -140.58 106.62 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.875 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -102.5 74.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.661 0.601 . . . . 0.0 110.589 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 57.61 62.28 2.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.814 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 72.74 31.37 62.61 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.217 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.6 mt -142.59 70.36 1.32 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.21 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -77.68 157.84 46.18 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 114.361 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.42 143.86 23.37 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.65 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -126.51 146.29 50.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' TRP . 3.0 tt0 -105.38 73.82 1.05 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.232 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 19.0 p-10 -85.14 176.78 8.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.72 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 60.05 19.97 9.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.455 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.95 162.87 41.23 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.077 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -154.29 138.97 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.947 0.404 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.735 ' CE3' HD13 ' A' ' 79' ' ' ILE . 31.6 t90 -129.67 166.17 20.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.048 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.9 t -111.58 162.69 14.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 77' ' ' ASP . 11.7 t -123.83 5.4 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.401 177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 3.2 p -62.01 -16.97 55.57 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.349 -0.387 . . . . 0.0 112.008 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 5.7 mm-40 -136.7 157.31 47.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.342 . . . . 0.0 111.025 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 16.3 m-85 -135.83 145.57 46.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.037 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 14.4 m -98.71 157.93 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 110' ' ' THR . 34.9 t30 -82.62 153.48 25.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.543 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -55.81 -16.94 5.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -73.07 -30.71 63.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.957 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.01 5.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.329 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 p -139.35 159.08 67.49 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-O 121.303 0.573 . . . . 0.0 111.299 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 77.8 Cg_exo -49.1 127.25 16.95 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.041 2.494 . . . . 0.0 113.179 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.82 73.54 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -75.45 86.87 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.8 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.27 81.36 1.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -113.49 73.9 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.6 75.76 1.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.794 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.44 125.42 91.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.776 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.382 2.055 . . . . 0.0 112.289 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 61.9 t80 -59.47 168.53 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 21.3 t -123.41 159.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.635 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.67 HG11 ' N ' ' A' ' 94' ' ' GLN . 2.7 p -66.95 145.82 98.98 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.072 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 9' ' ' VAL . 21.2 Cg_exo -65.22 -166.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.605 2.203 . . . . 0.0 111.995 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.53 123.65 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.0 111.67 21.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.717 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 tptt -81.99 156.88 24.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.686 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' A' ' 24' ' ' VAL . 4.9 mp -147.4 143.9 28.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.0 111.981 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -142.1 144.7 33.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.959 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.13 110.03 19.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.7 mm -80.6 127.61 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.333 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -89.73 143.01 29.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 60.7 Cg_endo -93.28 2.68 57.12 Favored 'Cis proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.444 0.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -167.55 96.64 0.47 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -175.54 -178.2 45.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 23' ' ' ARG . 5.4 tp -156.09 138.41 14.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 110.972 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.837 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -125.44 120.59 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.477 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 42.8 t -123.59 150.44 27.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.553 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -153.16 144.49 23.19 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -137.54 125.84 14.49 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 18.2 Cg_endo -64.49 89.55 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.012 1.808 . . . . 0.0 111.414 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 16.5 t0 -50.87 160.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.332 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 36.0 t0 -140.05 41.5 1.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.46 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.96 49.5 7.6 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.088 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' HG21 ' A' ' 85' ' ' VAL . 7.7 m-85 -94.41 -173.58 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.473 0.654 . . . . 0.0 111.169 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 86' ' ' ILE . 12.6 m -127.66 -29.98 2.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.105 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.1 tp -141.36 141.74 33.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.728 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.613 ' CD1' HD13 ' A' ' 26' ' ' ILE . 51.6 t80 -128.13 103.32 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.299 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.87 121.6 38.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 0.0 110.982 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HG22 ' A' ' 83' ' ' THR . 18.8 t80 -112.17 123.04 49.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.524 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -123.71 122.67 38.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -152.24 136.51 5.46 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 118.836 -1.649 . . . . 0.0 114.463 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.45 127.12 46.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.619 HD12 ' CG ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -89.98 140.75 29.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.873 0.368 . . . . 0.0 110.937 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.56 6.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.786 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 36.4 tt0 -179.9 109.05 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.193 0.521 . . . . 0.0 110.445 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 43.3 mt-10 -59.88 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.596 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.06 144.09 2.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.315 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.83 47.39 2.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.0 110.914 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.79 -128.15 1.57 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.64 HD22 ' CH2' ' A' ' 82' ' ' TRP . 23.9 mt -124.2 66.27 1.06 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -79.66 144.35 33.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.912 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.616 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -52.84 -24.89 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.67 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.56 -130.83 11.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.541 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -127.95 -77.4 0.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.81 0.338 . . . . 0.0 110.531 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.639 ' NE1' HD23 ' A' ' 22' ' ' LEU . 28.9 m-90 -62.85 94.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.206 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.5 87.88 2.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.9 tpm_? -136.81 127.68 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.953 0.406 . . . . 0.0 112.029 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.87 107.01 18.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.458 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 58' ' ' LYS . 3.1 mp -89.04 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.444 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 t -129.58 28.23 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -150.28 88.07 4.8 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.772 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 51.4 Cg_exo -54.99 170.46 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.3 tpmp? -108.41 31.34 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.698 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER 81.42 93.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.678 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.31 -6.8 7.04 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.456 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 11.6 ptt180 -157.53 134.95 10.44 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.893 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.499 ' CD1' HD11 ' A' ' 26' ' ' ILE . 6.1 m95 -85.23 154.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -134.6 100.06 4.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.557 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 54' ' ' ARG . 39.9 t80 -95.88 143.13 27.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.919 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -144.87 145.03 31.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.406 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 47.5 t0 -138.03 100.19 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.476 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -89.17 22.44 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.683 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -138.67 32.52 2.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.885 0.374 . . . . 0.0 110.811 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB1' ' CZ2' ' A' ' 52' ' ' TRP . . . -104.43 129.56 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.21 83.25 6.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.596 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 1.0 OUTLIER -102.73 121.33 42.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.68 145.93 37.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.552 HD11 ' OD1' ' A' ' 113' ' ' ASP . 0.3 OUTLIER -59.0 133.4 56.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.968 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.72 -28.85 14.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.045 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.619 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 t70 -61.77 163.25 7.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 111.115 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -122.49 156.75 33.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.493 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.506 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.2 mp -113.05 145.83 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.207 0.527 . . . . 0.0 112.125 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 15.9 m-85 -144.32 120.35 10.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 37' ' ' HIS . 1.7 p90 -152.51 -176.27 5.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.203 1.001 . . . . 0.0 113.674 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CH2' HD22 ' A' ' 47' ' ' LEU . 60.1 p-90 -152.38 125.29 8.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.318 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 45.1 p -100.0 149.0 23.9 Favored 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.793 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.888 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 9.0 t80 -127.26 157.13 40.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 123.334 0.396 . . . . 0.0 110.849 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.662 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 20.8 mm -138.53 106.29 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.808 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -104.01 62.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.544 0.527 . . . . 0.0 110.72 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 t0 71.71 65.4 0.15 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.771 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.72 28.78 71.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.579 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.6 mt -144.35 77.71 1.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 110.267 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -84.35 158.63 34.47 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.562 -0.745 . . . . 0.0 114.568 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -152.54 148.79 27.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.169 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -131.98 152.4 51.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.67 ' N ' HG11 ' A' ' 9' ' ' VAL . 3.2 tt0 -107.6 76.3 1.06 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.449 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 4.3 p30 -77.96 178.29 7.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.334 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 63.18 15.04 8.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.2 162.39 54.66 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.978 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.4 157.63 38.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.066 0.46 . . . . 0.0 111.641 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.506 ' CE3' HD13 ' A' ' 79' ' ' ILE . 40.3 t90 -155.17 164.41 38.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.061 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 102' ' ' THR . 6.7 t -105.57 158.91 16.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.561 HG21 ' HB3' ' A' ' 77' ' ' ASP . 10.3 t -120.33 -4.35 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.047 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 100' ' ' THR . 9.6 t -66.49 -8.59 27.36 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.0 mt-10 -124.24 139.37 53.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 82.9 m-85 -130.42 131.62 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 19.7 m -98.73 159.6 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 0.0 110.835 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.677 ' ND2' ' HB2' ' A' ' 112' ' ' ALA . 7.1 m-20 -79.59 153.36 29.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.309 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -17.5 5.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.23 -31.5 65.88 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.921 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.79 18.74 5.1 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.484 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.8 p -135.08 156.17 78.49 Favored Pre-proline 0 C--O 1.222 -0.376 0 CA-C-O 121.385 0.612 . . . . 0.0 111.28 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 42.7 Cg_exo -55.1 126.15 21.58 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.832 2.354 . . . . 0.0 113.104 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.677 ' HB2' ' ND2' ' A' ' 106' ' ' ASN . . . -139.19 44.48 2.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.853 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.552 ' OD1' HD11 ' A' ' 75' ' ' LEU . 6.5 t0 -56.55 -177.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 t -79.65 66.17 5.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 t 63.89 130.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -114.76 66.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -162.36 104.72 1.1 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.497 2.131 . . . . 0.0 112.274 179.963 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.791 0.329 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 51.6 t80 -85.81 173.24 10.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.065 0.459 . . . . 0.0 110.76 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 9' ' ' VAL . 17.1 t -111.68 158.98 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.429 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 ' C ' ' A' ' 93' ' ' ARG . 8.2 p -66.81 127.36 93.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.29 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.9 Cg_exo -67.41 -178.64 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.477 2.118 . . . . 0.0 112.212 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -105.3 135.19 47.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.267 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.606 ' HB1' HG11 ' A' ' 24' ' ' VAL . . . -88.63 111.05 21.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.842 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -92.18 94.14 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.845 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -83.83 163.2 20.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 0.0 112.315 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.618 ' CD ' HG11 ' A' ' 105' ' ' VAL . 28.7 mt-10 -150.71 138.86 20.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.526 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.39 114.89 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.242 0.544 . . . . 0.0 111.683 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.532 HD13 HG22 ' A' ' 105' ' ' VAL . 20.1 mm -96.45 108.65 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.44 ' CE1' ' CB ' ' A' ' 112' ' ' ALA . 35.6 p90 -78.92 150.78 75.65 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.812 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.01 2.58 69.66 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.962 -1.266 . . . . 0.0 112.282 0.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.59 93.18 0.26 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -171.07 175.25 44.78 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 23' ' ' ARG . 7.7 tp -150.14 138.87 20.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 110.828 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 22' ' ' LEU . 22.0 ttt85 -137.11 107.31 6.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.724 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.606 HG11 ' HB1' ' A' ' 12' ' ' ALA . 21.1 t -116.95 155.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.409 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.442 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -143.12 144.01 32.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.679 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.644 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -136.74 128.07 16.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.394 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.92 102.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.346 2.031 . . . . 0.0 111.785 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 63' ' ' ARG . 22.5 t0 -67.76 151.44 47.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.403 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -139.91 45.95 1.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.717 179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.31 92.58 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 85' ' ' VAL . 14.1 m-85 -78.48 -171.52 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.368 0.604 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 86' ' ' ILE . 40.4 m -131.8 -27.16 1.91 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.634 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 56' ' ' ILE . 10.3 tp -143.36 132.19 22.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.627 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.726 ' HD2' HD12 ' A' ' 56' ' ' ILE . 39.0 t80 -122.32 101.64 7.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.906 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.44 126.73 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.615 ' CD2' HG22 ' A' ' 83' ' ' THR . 10.6 t80 -112.72 130.49 56.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -128.1 119.13 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.75 139.32 6.64 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 118.586 -1.768 . . . . 0.0 114.676 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.25 142.93 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.233 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 HD22 HD23 ' A' ' 73' ' ' LEU . 30.4 tp -96.01 143.04 27.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 p30 44.36 48.98 8.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.363 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 179.44 109.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 110.398 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.499 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 56.0 mt-10 -57.4 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.639 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.97 156.33 12.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.358 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -143.15 65.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.024 0.44 . . . . 0.0 110.802 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.99 8.73 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD22 ' CH2' ' A' ' 82' ' ' TRP . 27.8 mt -118.1 65.22 0.75 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.131 0.491 . . . . 0.0 111.073 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.43 150.55 23.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 37' ' ' HIS . . . -54.48 -24.34 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.745 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.53 -115.58 1.93 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.544 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' GLY . 6.3 t-160 -137.61 -72.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.649 ' CZ2' HD21 ' A' ' 73' ' ' LEU . 9.6 m-90 -68.38 88.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.34 88.99 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 39.7 ttt-85 -146.94 130.37 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 0.0 111.632 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.11 136.49 34.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 34' ' ' PHE . 17.2 mt -111.81 157.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 56' ' ' ILE . 12.2 t -144.54 41.96 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.41 102.26 0.21 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 50.1 Cg_exo -54.27 -169.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.427 2.085 . . . . 0.0 112.366 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -119.03 -53.55 2.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.1 83.37 0.11 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.563 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.79 -2.17 34.3 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 3.0 mtt180 -156.92 145.64 19.91 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.769 -0.215 . . . . 0.0 110.473 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.493 ' CG ' HD11 ' A' ' 26' ' ' ILE . 10.7 m95 -81.97 161.94 22.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -134.11 116.95 16.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.48 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 24.2 t80 -99.94 84.12 2.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.353 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.96 124.92 36.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.46 110.13 9.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.755 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 22.15 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.439 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -135.18 40.22 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.87 0.367 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB2' ' HE1' ' A' ' 52' ' ' TRP . . . -107.89 111.57 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.207 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -73.96 75.72 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.484 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 78.7 mt -95.92 134.03 39.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.22 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.512 ' N ' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -128.04 141.45 51.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.625 ' CD2' HG23 ' A' ' 102' ' ' THR . 0.5 OUTLIER -52.44 132.22 34.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.68 -27.77 18.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.38 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.1 t0 -62.18 151.24 36.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.815 0.341 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -110.93 152.95 26.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.84 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.737 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -112.21 145.34 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.561 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.5 m-85 -144.59 124.92 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.845 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.5 p90 -161.22 -173.83 4.04 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.533 ' CH2' HD22 ' A' ' 47' ' ' LEU . 63.5 p-90 -153.44 128.24 9.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.387 -1.733 . . . . 0.0 108.662 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 23.0 p -106.82 148.96 27.89 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.754 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CD2' ' HB3' ' A' ' 93' ' ' ARG . 5.1 t80 -129.61 145.0 51.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.365 0.415 . . . . 0.0 111.063 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -131.18 160.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.373 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.68 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 37.8 mm -129.63 117.58 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.594 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 55.03 0.66 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 t0 71.87 67.19 0.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.786 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.34 23.37 77.47 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.371 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.7 mt -145.89 79.15 1.55 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.208 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 85' ' ' VAL . . . -97.61 165.93 22.58 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.48 -0.782 . . . . 0.0 114.399 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -152.05 150.87 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.631 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.2 ptt-85 -128.88 145.37 51.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.576 ' N ' HG21 ' A' ' 9' ' ' VAL . 5.8 tt0 -99.5 77.63 2.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.808 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.1 p30 -81.77 178.74 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.377 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 59.54 19.1 7.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.63 166.4 53.27 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.102 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.11 156.59 37.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.737 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -154.67 165.45 36.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -110.82 161.97 15.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 79' ' ' ILE . 21.3 t -120.44 -3.13 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.805 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.625 HG23 ' CD2' ' A' ' 75' ' ' LEU . 9.0 m -62.26 -14.34 37.6 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.885 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 4.2 tt0 -131.49 148.54 52.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 4.8 m-85 -130.41 161.42 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.618 HG11 ' CD ' ' A' ' 15' ' ' GLU . 12.0 m -118.67 152.8 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.207 0.527 . . . . 0.0 111.051 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 110' ' ' THR . 36.1 t30 -76.53 155.25 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.397 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.13 -16.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.2 -30.87 62.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.02 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 15.58 6.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.347 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.7 p -132.61 159.01 74.22 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 121.252 0.549 . . . . 0.0 110.853 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 59.8 Cg_exo -50.01 128.84 23.19 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 113.056 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' CB ' ' CE1' ' A' ' 18' ' ' TYR . . . -89.24 105.51 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.248 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 112' ' ' ALA . 1.7 t70 52.53 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.584 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.2 p 51.48 52.51 14.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.124 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.4 p -158.52 174.92 14.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.61 47.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.1 155.13 80.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.559 2.173 . . . . 0.0 112.296 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.755 0.312 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 37.5 t80 -74.08 175.78 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.154 0.502 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 9' ' ' VAL . 22.0 t -121.91 161.69 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.301 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.857 HG22 ' HB3' ' A' ' 92' ' ' TYR . 13.2 t -66.08 129.78 94.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.993 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.32 -171.13 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.354 2.036 . . . . 0.0 111.974 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -114.61 113.57 24.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.73 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -88.17 106.39 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.526 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' C ' HD12 ' A' ' 14' ' ' LEU . 7.2 tttt -90.77 163.7 14.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.124 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.692 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.8 mp -147.91 159.76 43.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.976 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -148.92 141.43 24.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.095 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -87.07 104.44 16.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.968 0.413 . . . . 0.0 111.512 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 23' ' ' ARG . 42.8 mm -72.19 146.36 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.427 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -105.08 142.22 24.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.739 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 97.7 Cg_endo -89.47 -7.79 46.05 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.848 -1.314 . . . . 0.0 112.222 -0.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.53 94.13 1.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -160.72 -165.85 18.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.492 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 23' ' ' ARG . 27.0 tp -155.54 145.73 21.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.945 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.773 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -140.33 96.34 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.84 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 66' ' ' PHE . 45.8 t -107.38 151.45 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.58 144.32 22.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.926 0.393 . . . . 0.0 111.612 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.5 pp -137.25 131.75 17.72 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.597 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.59 104.75 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.148 1.899 . . . . 0.0 111.477 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 t0 -70.53 157.99 36.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.367 0.603 . . . . 0.0 111.737 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 2.8 m-20 -146.97 42.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.329 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 45.43 9.49 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.744 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m-85 -86.05 -173.29 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.447 0.641 . . . . 0.0 111.102 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -133.59 -26.54 1.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.684 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.756 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 10.4 tp -142.05 129.49 21.28 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.234 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.843 ' CD2' HD12 ' A' ' 56' ' ' ILE . 6.0 t80 -120.58 91.34 3.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.173 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -90.63 132.82 35.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.989 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TRP . 38.8 t80 -116.94 126.5 53.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.982 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -128.24 117.91 22.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -151.26 138.4 6.55 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 118.737 -1.697 . . . . 0.0 114.631 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.4 OUTLIER -109.78 147.17 33.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.202 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' HH2' ' A' ' 52' ' ' TRP . 15.0 tp -99.46 127.52 45.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.202 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.0 t30 57.45 54.81 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 66.6 tt0 175.55 109.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.244 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 35.3 mt-10 -56.96 -171.93 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.365 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.1 mtt -129.8 157.91 40.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.348 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -162.67 43.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.47 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . 145.35 125.89 1.8 Allowed Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' CH2' ' A' ' 82' ' ' TRP . 5.9 mt -39.21 89.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.087 0.47 . . . . 0.0 112.066 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' GLY . 5.7 mm-40 -110.67 152.34 26.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -55.37 -22.05 17.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.085 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.73 -119.51 4.39 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.245 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -131.64 -79.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.661 0.267 . . . . 0.0 110.347 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.623 ' HH2' HD13 ' A' ' 40' ' ' LEU . 13.2 m-90 -61.53 91.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.64 88.65 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.168 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -143.57 124.07 13.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.025 0.44 . . . . 0.0 111.861 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 4.2 p-10 -87.8 128.67 35.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.663 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.843 HD12 ' CD2' ' A' ' 34' ' ' PHE . 11.2 mt -103.65 154.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 45.06 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.009 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.5 93.18 0.25 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 56.5 Cg_exo -52.06 -176.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.462 2.108 . . . . 0.0 112.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -113.95 -44.86 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.233 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 178.02 84.37 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.651 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.97 -2.8 32.17 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.424 -0.894 . . . . 0.0 110.923 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -157.11 148.51 22.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.771 ' CD1' HD11 ' A' ' 26' ' ' ILE . 5.1 m95 -90.12 157.28 17.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -134.64 114.73 13.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 56' ' ' ILE . 32.6 t80 -107.41 89.37 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -94.69 144.87 25.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.099 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -138.0 108.44 6.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.582 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -89.18 22.39 2.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.522 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -141.26 28.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 115.66 27.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -73.91 75.97 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.629 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' CZ2' ' A' ' 52' ' ' TRP . 96.2 mt -96.75 142.12 29.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 142.27 49.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.782 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 102' ' ' THR . 1.4 tt -56.85 130.2 44.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.631 ' HA2' HG23 ' A' ' 102' ' ' THR . . . 106.01 -28.39 14.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.133 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 101' ' ' VAL . 8.9 t70 -66.56 153.09 43.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.95 0.405 . . . . 0.0 110.877 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.68 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.728 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.615 HD13 ' CE3' ' A' ' 99' ' ' TRP . 1.1 mp -114.83 144.58 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.861 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 58.0 m-85 -144.53 121.28 11.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.692 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 2.3 p90 -158.5 -172.37 3.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.13 0.967 . . . . 0.0 113.572 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 53.6 p-90 -155.54 134.25 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.979 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 12' ' ' ALA . 17.8 p -99.92 165.45 11.55 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.721 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.859 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 14.2 t80 -147.08 108.13 4.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.66 164.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.791 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 12.1 mm -145.23 106.84 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 111.42 0.156 . . . . 0.0 111.42 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' CG ' ' HB2' ' A' ' 90' ' ' LEU . 11.9 ptmt -99.63 46.43 0.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 13.7 t0 81.1 77.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.474 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.807 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 69.02 21.51 75.48 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.265 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 89' ' ' GLY . 6.3 mt -145.64 79.37 1.57 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.332 0.586 . . . . 0.0 110.274 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -82.04 161.71 41.92 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.325 -0.852 . . . . 0.0 114.44 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.857 ' HB3' HG22 ' A' ' 9' ' ' VAL . 49.3 m-85 -144.8 134.38 23.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.838 ' C ' HG11 ' A' ' 9' ' ' VAL . 5.7 ptt180 -123.81 140.17 53.25 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.71 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.8 73.15 1.56 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.83 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 6.6 p-10 -81.48 173.33 12.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.689 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 59.65 20.34 8.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.4 162.7 44.03 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.059 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 99' ' ' TRP . 0.4 OUTLIER -154.46 145.95 23.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.263 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 79' ' ' ILE . 38.7 t90 -140.2 164.29 30.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 6.5 t -105.01 158.11 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ASP . 4.0 t -121.12 -3.97 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.768 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -62.63 -14.33 41.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.628 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.9 tt0 -125.3 149.16 48.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 110.846 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.596 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 10.1 m-85 -134.32 146.4 49.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.261 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG2' HD13 ' A' ' 17' ' ' ILE . 15.1 m -102.81 166.01 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' O ' ' A' ' 110' ' ' THR . 20.8 t30 -79.26 153.69 29.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.041 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -15.59 3.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -76.48 -28.33 56.43 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.353 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 3.27 16.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.15 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.4 p -119.29 164.63 20.43 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.368 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 83.3 Cg_exo -43.24 133.57 6.43 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.732 2.288 . . . . 0.0 113.215 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 161.11 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.11 179.99 6.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.6 t -84.93 -35.45 22.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.64 169.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 61.36 98.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -134.83 148.05 65.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.474 2.116 . . . . 0.0 112.401 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.909 0.385 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 52.8 t80 -89.22 173.71 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 9' ' ' VAL . 15.2 t -110.09 159.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.481 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 ' C ' ' A' ' 93' ' ' ARG . 4.5 p -66.9 132.86 93.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.085 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' HG11 ' A' ' 85' ' ' VAL . 22.5 Cg_exo -64.41 -168.48 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.645 2.23 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 t -108.46 124.73 50.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.804 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -83.75 104.52 13.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.488 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -93.16 103.9 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.379 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.707 ' HG ' HG22 ' A' ' 24' ' ' VAL . 5.5 mp -97.07 161.53 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.567 ' HB3' HG11 ' A' ' 105' ' ' VAL . 31.3 mt-10 -147.04 136.59 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.893 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 104' ' ' PHE . . . -86.55 102.6 14.28 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 23' ' ' ARG . 28.1 mm -74.82 156.81 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.541 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -119.0 145.54 38.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.534 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -84.18 -2.66 56.92 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.302 0.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.12 98.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' CA ' ' HB ' ' A' ' 17' ' ' ILE . . . -163.35 -171.31 29.43 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.374 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.633 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.82 139.13 18.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.05 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.873 ' HB2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -133.9 101.52 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.638 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.707 HG22 ' HG ' ' A' ' 14' ' ' LEU . 14.0 t -109.36 156.47 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.989 0.423 . . . . 0.0 111.442 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -154.98 146.27 22.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.666 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.1 pt -143.95 122.04 6.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.497 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 13.1 Cg_endo -57.72 101.18 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.092 1.861 . . . . 0.0 111.436 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 15.3 t0 -63.06 159.53 17.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -140.71 43.48 1.84 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.568 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.94 46.04 47.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.59 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 29' ' ' ASP . 10.5 m-85 -90.4 -171.51 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.409 0.623 . . . . 0.0 111.419 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 86' ' ' ILE . 27.7 t -130.8 -28.26 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.552 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.711 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.1 tp -139.43 135.45 33.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.205 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' ILE . 26.2 t80 -124.72 106.51 10.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.878 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -106.15 117.51 34.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 111.017 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.703 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 56.2 t80 -106.55 124.57 49.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -125.59 129.35 49.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 81' ' ' PHE . . . -159.52 139.99 6.54 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 114.438 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 1.7 tmtp? -116.78 135.79 53.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.214 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 HG21 ' A' ' 101' ' ' VAL . 5.6 tp -91.05 125.83 35.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 16.6 t-20 65.46 50.06 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.528 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 47.8 tt0 170.27 110.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.021 0.439 . . . . 0.0 110.337 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 45.3 mt-10 -53.65 -173.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.508 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.7 mmm -128.85 112.66 14.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.23 58.24 3.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.675 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . 89.2 100.87 1.03 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.507 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.8 mt 24.45 78.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.624 0.77 . . . . 0.0 112.731 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.66 157.73 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.725 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.92 -25.72 8.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . 42.64 -124.96 4.18 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.088 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -137.36 -73.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.302 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 37' ' ' HIS . 5.6 m-90 -63.61 82.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.717 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.26 93.04 3.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.212 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 4.3 tpm_? -141.46 125.77 17.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.945 0.402 . . . . 0.0 111.874 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.46 131.96 35.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.826 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.588 HD12 ' HD2' ' A' ' 34' ' ' PHE . 7.7 mt -117.44 143.86 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.983 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.42 26.6 4.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 56' ' ' ILE . 5.0 mmmt -153.42 92.52 3.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.163 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 64' ' ' TRP . 52.7 Cg_exo -52.72 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.252 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -112.8 -49.67 2.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.826 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -179.99 82.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.303 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' C ' ' HB3' ' A' ' 28' ' ' ASP . . . 71.11 2.72 49.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HD3' ' CB ' ' A' ' 25' ' ' SER . 20.9 ttm-85 -157.61 140.49 15.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.523 0.201 . . . . 0.0 111.001 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.474 ' CG ' HD11 ' A' ' 26' ' ' ILE . 7.6 m95 -89.18 154.48 20.1 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.98 0.419 . . . . 0.0 110.311 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.3 m -134.73 119.89 18.8 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.294 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 17.0 t80 -113.65 106.8 14.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.614 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 139.39 38.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.428 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -137.37 105.37 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.729 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.29 22.77 2.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.632 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -134.06 29.87 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.51 99.16 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.073 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -74.09 75.93 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.764 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.633 HD11 ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -91.65 146.43 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.935 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.421 ' N ' HG11 ' A' ' 101' ' ' VAL . 9.6 ttpp -130.92 139.82 50.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -52.69 132.55 36.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.2 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 103.92 -29.17 12.63 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.067 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 101' ' ' VAL . 7.8 t0 -66.35 153.87 41.57 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.019 0.438 . . . . 0.0 111.158 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 160.35 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.792 HD13 ' CE3' ' A' ' 99' ' ' TRP . 2.1 mp -118.88 147.11 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.066 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 42.2 m-85 -144.55 129.43 18.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -161.11 -177.87 6.37 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.577 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 57.8 p-90 -151.02 133.06 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.481 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.804 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -99.98 156.98 16.86 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.879 -178.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 12.0 t80 -139.24 138.8 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.62 0.247 . . . . 0.0 110.838 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -134.25 161.08 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.711 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 30.0 mm -135.85 107.19 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.968 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -100.35 57.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.538 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 68.55 68.7 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.741 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.831 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.97 25.47 75.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.392 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.94 73.02 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -87.63 160.96 31.9 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.289 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -152.22 153.1 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.749 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -132.84 147.84 52.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' N ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -104.05 76.75 1.37 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.399 177.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.19 177.27 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 61.78 17.28 8.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.801 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.18 163.91 54.9 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.951 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.47 153.84 35.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.459 . . . . 0.0 111.166 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.792 ' CE3' HD13 ' A' ' 79' ' ' ILE . 26.6 t90 -153.1 166.75 31.5 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -112.12 162.75 15.08 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.69 HG22 HD11 ' A' ' 79' ' ' ILE . 20.3 t -121.9 -9.26 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.668 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 76' ' ' GLY . 25.6 p -60.36 -14.35 18.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.718 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -123.45 162.36 22.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 89.9 m-85 -140.88 148.07 39.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 15' ' ' GLU . 4.7 m -98.15 -161.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.81 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 110' ' ' THR . 17.8 t30 -108.73 145.39 35.16 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.959 0.409 . . . . 0.0 111.607 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.24 -19.89 6.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.47 -30.02 70.27 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.935 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.76 17.63 5.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.208 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.4 p -140.79 156.13 68.96 Favored Pre-proline 0 CA--C 1.514 -0.432 0 CA-C-O 121.372 0.606 . . . . 0.0 111.736 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 53.0 Cg_exo -52.3 78.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.511 2.807 . . . . 0.0 114.011 -178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . 80.74 -174.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.419 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -119.45 98.74 6.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -28.01 67.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.63 -175.34 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.39 88.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.84 143.38 15.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.527 2.151 . . . . 0.0 112.242 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.868 0.366 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CG ' ' N ' ' A' ' 8' ' ' VAL . 39.5 t80 -74.15 176.33 6.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 9' ' ' VAL . 20.6 t -117.67 161.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.368 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 93' ' ' ARG . 11.0 t -66.29 127.26 93.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.77 -177.12 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.467 2.112 . . . . 0.0 112.331 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 t -110.93 111.43 22.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.506 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.82 109.61 17.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.521 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.778 ' O ' HG13 ' A' ' 24' ' ' VAL . 9.4 mttt -84.23 164.45 19.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.187 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.727 ' HG ' HG22 ' A' ' 24' ' ' VAL . 3.2 mp -154.12 138.62 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.074 0.464 . . . . 0.0 112.094 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -135.2 136.7 41.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.496 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.745 ' HB1' ' CD2' ' A' ' 104' ' ' PHE . . . -86.75 114.52 23.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 111.366 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.7 mm -91.67 111.61 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -83.07 147.01 52.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.438 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 91.2 Cg_endo -92.23 -3.69 49.06 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.897 -1.293 . . . . 0.0 112.606 0.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 91.68 1.18 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.66 173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.574 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -153.44 144.51 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.507 ' H ' HD13 ' A' ' 22' ' ' LEU . 19.7 ttt180 -133.72 109.88 9.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 13' ' ' LYS . 30.0 t -122.76 142.88 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.357 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.52 146.94 33.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 12' ' ' ALA . 1.2 pp -136.41 122.92 13.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.303 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 63' ' ' ARG . 72.1 Cg_exo -47.61 108.68 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.494 2.129 . . . . 0.0 112.026 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 27.5 t0 -76.64 151.03 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 0.0 111.399 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 3.2 t0 -140.89 46.09 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.752 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.98 69.85 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.404 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 10.1 m-85 -73.64 -170.97 0.94 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.637 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -132.94 -27.76 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.768 HD21 ' OD2' ' A' ' 55' ' ' ASP . 5.8 tp -139.87 127.25 21.39 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.251 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' HD12 ' A' ' 56' ' ' ILE . 2.4 t80 -118.49 94.36 4.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . . . -101.82 114.78 29.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.908 0.385 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' TRP . 32.5 t80 -105.91 126.36 52.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.49 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -154.44 132.47 3.52 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.152 -1.499 . . . . 0.0 114.04 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 18.1 tptm -108.62 141.63 40.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 73' ' ' LEU . 62.4 tp -92.24 117.16 29.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.889 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 57.8 t-20 63.92 65.17 0.72 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 36.1 tt0 172.86 110.98 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.163 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 78.1 mt-10 -54.09 -169.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.436 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 81' ' ' PHE . 8.3 mtp -143.22 142.34 31.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.05 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -140.07 42.4 1.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.932 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.57 -143.31 9.54 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.169 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.51 HD22 ' CH2' ' A' ' 82' ' ' TRP . 13.3 mt -116.86 80.28 1.45 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.048 0.451 . . . . 0.0 110.978 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -101.03 150.05 23.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.099 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -57.44 -32.14 66.6 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.713 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 55.16 -103.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.279 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -148.59 -78.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 110.546 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 36' ' ' PHE . 10.6 m-90 -59.25 89.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.4 88.86 3.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.223 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -132.45 125.71 31.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.042 0.449 . . . . 0.0 111.776 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD21 ' A' ' 33' ' ' LEU . 10.2 t0 -105.74 94.31 5.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.45 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 58' ' ' LYS . 16.6 mt -81.49 146.51 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.142 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.17 22.71 6.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.678 ' H ' HG22 ' A' ' 56' ' ' ILE . 7.2 ptpt -154.89 100.54 2.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.1 Cg_exo -52.1 171.56 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.426 2.084 . . . . 0.0 112.542 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -114.66 40.9 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 6.4 tt0 84.0 86.65 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.845 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.96 -5.72 6.0 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.954 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 27' ' ' PRO . 1.1 mtt180 -157.25 137.52 12.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.582 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.641 ' CD1' HD11 ' A' ' 26' ' ' ILE . 12.4 m95 -83.36 154.28 24.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -134.71 119.48 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . 11.4 t80 -108.28 87.54 2.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.242 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 132.85 36.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.184 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 13.0 t0 -138.1 103.12 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 7.0 ptt-85 -89.18 22.41 2.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.698 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -133.1 42.07 3.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.5 100.76 7.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.93 99.82 3.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.655 HD11 HD23 ' A' ' 22' ' ' LEU . 2.5 mt -122.01 164.19 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -138.52 144.38 39.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.85 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -62.64 126.75 28.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.572 . . . . 0.0 110.724 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.757 ' HA2' HG22 ' A' ' 102' ' ' THR . . . 125.37 -31.09 4.32 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.354 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.5 t0 -72.91 149.62 43.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 164.23 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 101' ' ' VAL . 2.8 mp -118.87 147.81 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.13 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 43' ' ' GLU . 63.5 m-85 -144.46 125.77 14.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.579 ' CZ ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -157.5 -178.62 7.47 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.51 ' CH2' HD22 ' A' ' 47' ' ' LEU . 52.0 p-90 -155.7 134.6 12.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.671 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.733 HG21 ' HB2' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -99.81 160.97 13.9 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.941 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.916 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 16.3 t80 -145.33 105.46 4.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 111.06 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -102.61 165.17 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 19.7 mm -142.51 105.99 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.877 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 5.7 ttpt -96.05 70.01 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.427 0.454 . . . . 0.0 111.104 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 56.72 46.02 20.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.263 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.796 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 98.45 28.68 7.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.729 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 89' ' ' GLY . 7.4 mt -142.9 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -64.85 155.98 47.61 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.191 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.749 ' HB3' HG22 ' A' ' 9' ' ' VAL . 69.9 m-85 -152.52 134.24 14.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.34 -0.93 . . . . 0.0 108.677 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.869 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -131.9 140.7 49.15 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.562 0.696 . . . . 0.0 112.687 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.7 ' N ' HG11 ' A' ' 9' ' ' VAL . 2.5 tt0 -104.33 73.8 1.14 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.452 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 3.5 p30 -81.32 174.33 11.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.564 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.18 18.82 9.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.647 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.07 163.29 52.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.911 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -152.55 150.67 29.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.646 ' CE3' HD13 ' A' ' 79' ' ' ILE . 27.8 t90 -149.18 164.45 34.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -106.4 158.56 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 79' ' ' ILE . 21.5 t -119.86 -10.6 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.178 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.757 HG22 ' HA2' ' A' ' 76' ' ' GLY . 20.9 p -60.24 -11.51 6.53 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -132.47 148.12 52.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.836 0.351 . . . . 0.0 111.056 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.745 ' CD2' ' HB1' ' A' ' 16' ' ' ALA . 40.9 m-85 -135.32 149.95 49.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.362 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m -98.87 155.25 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.083 0.468 . . . . 0.0 110.491 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' CG ' ' HB2' ' A' ' 112' ' ' ALA . 7.1 m-20 -83.99 152.02 24.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.275 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -17.84 4.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.41 -30.98 66.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.901 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.67 21.79 4.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.365 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.469 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 2.9 p -147.05 159.8 41.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.177 0.513 . . . . 0.0 111.394 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 79.4 Cg_exo -47.38 126.88 12.57 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.113 2.542 . . . . 0.0 113.063 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB2' ' CG ' ' A' ' 106' ' ' ASN . . . -101.08 53.4 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.001 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -171.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.49 32.9 16.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 p -109.63 -176.89 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.95 92.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.04 89.74 2.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.55 2.167 . . . . 0.0 112.367 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.89 0.376 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 8' ' ' VAL . 53.1 t80 -89.28 172.71 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 9' ' ' VAL . 14.8 t -108.9 160.05 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.27 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.681 HG11 ' C ' ' A' ' 93' ' ' ARG . 7.2 p -66.89 130.38 93.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.206 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' CD ' HG11 ' A' ' 85' ' ' VAL . 38.8 Cg_exo -60.35 -175.26 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.688 2.259 . . . . 0.0 112.383 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -108.83 125.81 52.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.407 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -82.58 105.7 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.726 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -95.87 109.78 22.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.009 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 24' ' ' VAL . 4.3 mp -105.76 157.01 17.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.265 0.555 . . . . 0.0 112.266 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 99' ' ' TRP . 38.4 mt-10 -140.69 141.44 34.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.512 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -86.13 122.78 30.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.157 0.503 . . . . 0.0 111.367 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.494 ' HB ' ' HA3' ' A' ' 21' ' ' GLY . 10.8 mm -104.69 109.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -79.0 150.55 75.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.883 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.59 -1.62 61.82 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.188 0.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.75 98.12 0.31 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 17' ' ' ILE . . . -174.4 164.84 36.06 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 23' ' ' ARG . 22.9 tp -138.37 144.55 40.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 111.149 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.678 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -135.54 99.5 4.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.473 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.7 t -105.96 158.06 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.985 0.421 . . . . 0.0 111.774 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -155.13 149.76 26.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.667 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.613 HD13 ' CD1' ' A' ' 34' ' ' PHE . 1.2 pt -144.51 126.92 8.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' PRO . 12.0 Cg_endo -57.1 95.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.386 2.057 . . . . 0.0 111.568 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 19.7 t0 -59.17 160.63 6.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 3.9 t0 -145.86 45.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.152 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.79 38.55 89.63 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.885 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 85' ' ' VAL . 20.0 m-85 -83.67 -170.03 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.266 0.555 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -129.82 -29.27 2.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.645 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.7 ' HB3' ' CG1' ' A' ' 86' ' ' ILE . 11.5 tp -139.86 137.54 34.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.508 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.709 ' HD2' HD12 ' A' ' 56' ' ' ILE . 25.2 t80 -127.4 97.02 4.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.463 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.832 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -96.06 135.63 37.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.412 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 52' ' ' TRP . 9.6 t80 -121.28 125.85 48.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB3' ' NE1' ' A' ' 82' ' ' TRP . 0.1 OUTLIER -123.8 123.37 40.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 81' ' ' PHE . . . -157.43 139.28 6.31 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 118.816 -1.659 . . . . 0.0 114.442 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -111.86 148.38 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.343 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tp -100.03 120.15 39.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.8 t-20 61.76 54.83 2.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' ASN . 51.0 tt0 174.06 109.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 36.0 mt-10 -55.76 -168.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.465 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.47 120.66 7.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.643 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.96 57.6 4.25 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.013 0.435 . . . . 0.0 110.518 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.91 -120.18 3.37 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD22 ' CE3' ' A' ' 82' ' ' TRP . 14.4 mt -124.95 75.47 1.44 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.049 0.452 . . . . 0.0 110.985 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 8.9 mt-10 -88.38 155.28 19.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.157 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -51.85 -26.57 10.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.655 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.71 -121.63 7.01 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.435 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -137.88 -73.71 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.749 0.309 . . . . 0.0 110.547 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' PHE . 8.5 m-90 -61.3 90.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.037 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.22 87.28 2.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.142 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -136.6 129.63 31.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.989 0.423 . . . . 0.0 111.919 -179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -99.4 126.67 45.33 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.709 HD12 ' HD2' ' A' ' 34' ' ' PHE . 10.7 mt -111.96 142.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -130.71 28.7 4.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' H ' HG22 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -155.92 98.12 2.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 36.1 Cg_exo -57.29 169.14 2.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.477 2.118 . . . . 0.0 112.589 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' ARG . 11.9 tptp -105.18 34.64 3.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.91 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 82.06 88.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.48 -5.86 13.95 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.864 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 27' ' ' PRO . 16.0 mtt180 -157.26 130.42 7.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.563 ' CD1' HD11 ' A' ' 26' ' ' ILE . 15.6 m95 -78.64 158.16 28.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 67' ' ' ARG . 9.5 m -134.26 112.57 11.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 56' ' ' ILE . 5.2 t80 -113.8 85.39 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.599 ' HD2' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -103.96 151.13 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.45 ' O ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -138.13 113.19 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.13 22.39 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -143.83 31.01 1.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.5 128.8 44.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.5 96.15 5.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.68 152.47 28.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.12 150.63 41.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.184 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.622 HD23 ' HE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.42 130.8 46.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.421 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.15 25.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' HB3' HG21 ' A' ' 101' ' ' VAL . 9.8 t70 -56.39 152.91 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.03 152.64 29.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.543 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.71 HD11 HG22 ' A' ' 101' ' ' VAL . 2.6 mp -112.72 146.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 m-85 -144.55 126.16 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 79' ' ' ILE . 1.3 p90 -161.03 -176.72 5.65 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.509 ' NE1' ' HB3' ' A' ' 37' ' ' HIS . 61.2 p-90 -152.83 135.13 15.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.591 -1.64 . . . . 0.0 108.97 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 12' ' ' ALA . 14.1 p -99.79 163.74 12.34 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.2 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.832 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 17.0 t80 -145.1 113.8 6.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.667 0.27 . . . . 0.0 111.012 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -107.73 164.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.75 HD11 ' CZ ' ' A' ' 84' ' ' TYR . 34.7 mm -138.99 104.48 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.4 59.66 1.86 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.573 0.545 . . . . 0.0 110.668 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 64.43 64.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.678 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 77.01 25.58 63.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.315 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.5 mt -143.16 71.23 1.33 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -80.16 160.66 44.54 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.4 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -152.28 149.01 28.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.681 ' C ' HG11 ' A' ' 9' ' ' VAL . 13.4 ptt180 -128.68 144.97 51.28 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.496 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.68 75.81 1.34 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.405 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.487 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 2.3 p30 -80.98 175.9 10.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.573 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.45 18.16 9.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.806 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.57 162.79 52.36 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.97 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -154.39 146.43 23.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.903 0.382 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CE3' HD13 ' A' ' 79' ' ' ILE . 29.6 t90 -142.65 167.04 23.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.062 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 99' ' ' TRP . 4.1 t -115.45 163.41 15.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 79' ' ' ILE . 3.4 t -125.83 17.78 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.923 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.537 ' HA ' HD13 ' A' ' 75' ' ' LEU . 1.2 p -65.95 -13.04 59.06 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.701 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 2.4 mt-10 -147.25 162.25 39.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.622 ' HE2' HD23 ' A' ' 75' ' ' LEU . 95.3 m-85 -130.47 140.69 50.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.704 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 17' ' ' ILE . 14.2 m -98.54 161.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.166 0.507 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 110' ' ' THR . 6.3 m-80 -82.74 152.13 25.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.378 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.17 -17.39 4.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.05 -31.28 65.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.975 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.74 18.55 5.18 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.384 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 106' ' ' ASN . 3.6 p -136.29 158.17 74.07 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.387 0.613 . . . . 0.0 111.128 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 51.0 Cg_exo -51.56 128.01 24.56 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.926 2.417 . . . . 0.0 113.244 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 113.67 14.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.23 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -125.21 147.72 48.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.2 -53.75 3.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -149.8 124.36 9.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.32 91.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 60.76 89.67 0.1 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.248 1.024 0 C-N-CA 122.553 2.169 . . . . 0.0 112.339 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.85 0.357 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.467 ' CE2' ' O ' ' A' ' 8' ' ' VAL . 52.6 t80 -79.2 173.3 12.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.783 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' VAL . 16.6 t -115.36 159.43 15.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.492 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 ' C ' ' A' ' 93' ' ' ARG . 12.0 p -71.92 142.79 85.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 15.4 Cg_exo -68.36 -178.44 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -110.33 120.76 43.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 26' ' ' ILE . . . -82.27 116.05 21.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.473 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 2.3 ttmt -103.78 101.75 11.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 1.1 mp -91.23 168.6 11.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 111.838 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -155.92 154.09 30.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.473 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 105' ' ' VAL . . . -86.94 128.34 35.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.973 0.416 . . . . 0.0 111.825 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 16' ' ' ALA . 1.3 mp -112.66 115.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.715 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -78.85 143.7 62.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 93.6 Cg_endo -91.69 -4.11 49.93 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 C-N-CA 124.037 -1.234 . . . . 0.0 112.491 -0.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -165.54 89.23 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' C ' ' HB ' ' A' ' 17' ' ' ILE . . . -156.48 -174.52 26.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.691 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 23' ' ' ARG . 6.7 tp -158.24 131.8 7.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.713 0.292 . . . . 0.0 110.829 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.713 ' N ' HD12 ' A' ' 22' ' ' LEU . 12.7 ttt85 -129.24 114.74 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 25' ' ' SER . 25.6 t -122.93 158.47 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 111.541 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -150.01 144.88 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.871 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.695 HD11 ' CD1' ' A' ' 64' ' ' TRP . 1.1 pp -138.22 127.04 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.101 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 18.0 Cg_endo -60.67 104.17 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.174 1.916 . . . . 0.0 111.693 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB2' ' CD1' ' A' ' 64' ' ' TRP . 14.5 t0 -66.82 158.12 31.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.49 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -142.78 45.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.673 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.88 46.12 47.28 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.417 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 6.5 m-85 -88.52 -172.64 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.519 0.676 . . . . 0.0 111.184 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 86' ' ' ILE . 9.7 m -133.19 -27.49 1.59 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.595 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.9 tp -141.5 131.05 23.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.121 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.624 ' O ' HD12 ' A' ' 56' ' ' ILE . 16.3 t80 -122.63 101.66 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . -105.38 121.28 43.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 81' ' ' PHE . 15.3 t80 -106.89 131.7 53.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -128.14 122.53 32.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 51' ' ' HIS . . . -153.85 147.54 17.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 118.87 -1.633 . . . . 0.0 114.428 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' HIS . 4.1 tmtt? -119.15 145.0 46.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.886 0.374 . . . . 0.0 110.431 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 79' ' ' ILE . 11.9 tp -94.17 117.58 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.57 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 66.75 67.4 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.069 0.461 . . . . 0.0 110.491 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 44' ' ' MET . 44.7 tt0 179.19 111.78 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' MET . 20.3 mt-10 -69.3 30.93 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.377 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.568 ' H ' ' C ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER 52.5 149.86 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.207 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -142.05 60.75 1.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.708 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.23 127.17 5.71 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.523 HD22 ' CZ3' ' A' ' 82' ' ' TRP . 4.5 mt -39.87 97.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.004 0.43 . . . . 0.0 111.39 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -121.97 -178.16 3.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.167 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' HA ' ' NE2' ' A' ' 37' ' ' HIS . . . -62.43 -19.03 63.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.059 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.04 -135.75 6.91 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -118.83 -76.8 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.708 ' HZ2' HD21 ' A' ' 73' ' ' LEU . 10.2 m-90 -67.43 86.78 0.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 37' ' ' HIS . . . -118.88 87.69 2.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.453 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' PHE . 7.0 ttt180 -142.49 127.54 18.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 111.85 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.3 p30 -88.37 135.51 33.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' PHE . 1.9 mt -121.61 151.45 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.4 t -139.5 24.3 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.31 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' H ' HG22 ' A' ' 56' ' ' ILE . 3.9 mtmp? -145.86 94.58 5.0 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' CE2' ' A' ' 64' ' ' TRP . 52.4 Cg_exo -53.53 -172.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.256 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.6 -48.69 2.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -178.79 83.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.432 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.43 -0.3 42.41 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HA ' ' H ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -157.76 148.93 21.37 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 120.626 0.251 . . . . 0.0 110.803 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' A' ' 26' ' ' ILE . 11.4 m95 -90.19 161.09 15.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.177 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.9 m -134.32 116.7 15.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.462 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.516 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 6.1 t80 -106.25 95.29 5.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -101.28 139.8 36.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.413 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.06 106.16 5.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -89.21 22.5 2.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.679 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.07 38.32 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -104.85 115.79 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -73.93 76.58 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.708 HD21 ' HZ2' ' A' ' 52' ' ' TRP . 10.5 mt -97.36 139.23 33.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.981 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 152.64 51.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.897 HD23 ' CE2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -55.43 137.83 47.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.8 -29.47 7.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.62 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 12.4 t70 -58.88 160.16 6.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.951 0.405 . . . . 0.0 111.213 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -124.35 159.3 30.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.628 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 99' ' ' TRP . 1.4 mp -116.07 145.22 22.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.096 0.474 . . . . 0.0 112.018 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 43' ' ' GLU . 98.0 m-85 -144.52 126.53 15.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.917 ' CZ ' HD11 ' A' ' 14' ' ' LEU . 3.6 p90 -161.32 -173.12 3.67 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 122.125 0.964 . . . . 0.0 113.427 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.523 ' CZ3' HD22 ' A' ' 47' ' ' LEU . 11.7 p-90 -154.34 133.64 12.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.62 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 93' ' ' ARG . 5.6 p -99.68 163.49 12.46 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.079 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' HD11 ' A' ' 86' ' ' ILE . 13.4 t80 -143.64 124.77 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.612 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -119.57 166.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.289 -0.264 . . . . 0.0 110.289 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.686 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 mm -141.34 106.28 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.921 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -103.63 64.49 0.81 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.711 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.3 t0 67.7 64.59 0.39 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.817 ' O ' HD23 ' A' ' 90' ' ' LEU . . . 70.41 28.86 70.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.37 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 89' ' ' GLY . 8.3 mt -143.84 73.62 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 0.0 110.189 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -79.61 162.04 46.9 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.392 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 85' ' ' VAL . 28.5 m-85 -152.28 143.28 23.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.628 ' C ' HG11 ' A' ' 9' ' ' VAL . 10.3 ptt85 -126.08 142.97 51.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' N ' HG21 ' A' ' 9' ' ' VAL . 4.4 tt0 -101.0 75.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.657 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 82' ' ' TRP . 33.8 p-10 -78.32 174.77 10.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.623 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.6 t30 60.25 18.31 7.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.38 159.93 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.07 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -154.65 161.69 41.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.0 0.428 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.822 ' HB2' HD13 ' A' ' 14' ' ' LEU . 70.7 t90 -147.6 166.26 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.434 ' O ' ' CH2' ' A' ' 99' ' ' TRP . 5.5 t -110.25 155.74 21.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.615 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.0 t -118.79 7.88 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.328 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 75' ' ' LEU . 19.1 m -70.94 -9.9 58.71 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.752 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -123.47 163.97 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.897 ' CE2' HD23 ' A' ' 75' ' ' LEU . 23.2 m-85 -137.28 120.82 17.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.862 HG11 ' HG2' ' A' ' 15' ' ' GLU . 6.2 m -98.39 -168.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.963 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 110' ' ' THR . 14.0 t30 -109.2 145.33 36.0 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.415 ' HG3' HG23 ' A' ' 17' ' ' ILE . 16.8 mt-10 -54.42 -18.87 4.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.78 -28.99 68.08 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.62 22.61 3.96 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.705 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 106' ' ' ASN . 2.6 p -143.55 152.17 55.89 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-O 121.51 0.671 . . . . 0.0 112.085 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 31.7 Cg_exo -58.84 76.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.447 2.765 . . . . 0.0 113.538 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 120.54 3.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.225 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.412 ' OD2' ' CD2' ' A' ' 18' ' ' TYR . 24.4 t0 -124.33 88.71 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.816 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.16 89.57 6.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 50.59 2.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.774 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.53 83.8 1.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -127.08 147.05 60.09 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.883 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.471 2.114 . . . . 0.0 112.37 179.972 . . . . . . . . 0 0 . 1 stop_ save_